data_1afj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1afj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.212 0.53 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -158.94 92.95 1.13 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -118.36 161.27 20.23 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.757 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.464 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 89.6 m -137.68 122.56 18.89 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' ' 72' ' ' GLN . 34.2 m -132.99 174.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.28 163.71 12.79 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.1 mp -135.45 143.74 46.07 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.277 -1.369 . . . . 0.0 111.604 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -114.22 99.3 7.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 7.4 p -112.34 80.08 3.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.117 -0.989 . . . . 0.0 111.932 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.5 Cg_endo -68.54 -1.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.508 1.268 . . . . 0.0 111.221 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.37 -26.52 3.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.552 ' CE ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -149.05 -165.19 2.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -1.234 . . . . 0.0 110.215 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 12' ' ' MET . 5.3 t -179.75 67.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.127 -0.983 . . . . 0.0 111.093 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -166.17 177.32 7.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.05 -1.031 . . . . 0.0 109.334 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.69 74.69 5.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 110.078 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.09 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 111.377 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 10.4 m -89.77 -42.6 0.42 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.98 -1.075 . . . . 0.0 112.88 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.6 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 5.5 Cg_endo -65.18 -41.22 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 38' ' ' PHE . 4.0 mt -61.47 -27.35 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 29.6 m -67.03 -27.98 67.85 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.101 -0.999 . . . . 0.0 108.334 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 84.6 t -64.58 -32.15 56.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 tttm -65.28 -39.26 92.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -68.92 -24.89 64.34 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.885 0.85 . . . . 0.0 109.149 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 60' ' ' ALA . . . -70.89 -56.14 6.92 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.72 -0.612 . . . . 0.0 110.514 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.46 -30.65 70.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t -72.81 -25.36 61.12 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -108.07 7.13 27.55 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.684 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 11.3 p -61.81 -48.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.95 -1.093 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 165.45 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.0 -1.062 . . . . 0.0 111.238 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -91.82 4.67 78.99 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.124 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.5 p -41.03 129.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.167 -1.196 . . . . 0.0 110.17 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -16.49 13.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -161.9 156.03 21.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.676 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.56 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 45.6 t -150.64 145.49 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.893 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' O ' HG11 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -162.3 92.99 0.84 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.3 m -108.39 -164.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.025 -1.047 . . . . 0.0 111.185 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -140.99 118.94 1.44 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -47.53 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.4 tt0 -35.45 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.019 -1.051 . . . . 0.0 111.538 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.19 30.58 0.46 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.893 -1.13 . . . . 0.0 110.898 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER 6.14 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' LYS . 10.0 tt0 -145.79 112.75 6.06 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.669 -1.27 . . . . 0.0 110.593 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.71 120.65 43.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.874 -1.141 . . . . 0.0 111.979 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.52 115.67 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 46' ' ' THR . 14.5 t -132.04 154.15 39.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.131 -1.428 . . . . 0.0 113.132 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -115.29 158.17 22.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 52.7 p90 -171.91 -177.7 2.0 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.562 -1.255 . . . . 0.0 110.918 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.0 m-20 -107.29 110.64 22.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.17 -12.96 4.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 1' ' ' ALA . 14.4 t -60.44 -32.3 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 110.154 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 -3.73 6.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -142.67 -168.02 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.6 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 22.0 t 179.42 154.8 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.935 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 15.2 m -43.61 -35.47 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.189 -0.944 . . . . 0.0 109.614 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.77 -46.38 78.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.007 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 2.4 mmtp -63.1 -25.37 68.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.547 -0.72 . . . . 0.0 110.271 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 47' ' ' PHE . 61.4 mt -69.88 -55.61 9.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.873 -1.142 . . . . 0.0 108.733 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.462 ' HA ' HD22 ' A' ' 7' ' ' LEU . 1.3 m -62.94 -22.38 66.75 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -81.37 -27.15 34.97 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.49 -0.756 . . . . 0.0 109.213 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -70.18 -42.93 71.78 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.161 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' HG11 ' A' ' 21' ' ' VAL . 12.4 t -75.32 -38.02 60.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -61.49 -24.26 66.47 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.17 -23.76 26.4 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.87 -16.85 60.66 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.07 27.56 3.4 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.7 m-85 -138.05 82.61 24.6 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.567 -0.961 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.85 97.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.672 1.354 . . . . 0.0 109.974 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 10.9 p -108.49 -161.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.781 0.801 . . . . 0.0 111.316 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.5 t -146.32 -170.32 3.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.577 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.5 p -138.98 153.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 O-C-N 120.831 -1.168 . . . . 0.0 111.294 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -157.89 61.72 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.75 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.2 pt20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.425 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.28 0.562 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -160.03 91.72 0.97 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.3 pm0 -127.7 163.15 24.93 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.059 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 12.0 m -125.69 133.97 51.97 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.327 0.584 . . . . 0.0 109.718 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' HD11 ' A' ' 57' ' ' LEU . 7.0 m -135.75 169.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.543 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 13.5 t -108.5 161.99 14.54 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.5 mp -133.79 154.64 50.85 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.487 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -121.48 100.37 6.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 9.3 p -111.67 89.23 10.65 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.176 -0.952 . . . . 0.0 111.522 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HA ' ' NH1' ' A' ' 41' ' ' ARG . 3.7 Cg_endo -68.69 -7.77 21.42 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.596 1.314 . . . . 0.0 110.713 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.82 0.45 57.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.55 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -92.34 176.67 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -1.204 . . . . 0.0 109.987 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.9 -9.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -163.5 -156.75 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.766 -1.834 . . . . 0.0 111.112 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.43 60.21 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.844 -1.16 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -169.94 -40.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 111.09 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m -93.79 -45.82 0.3 Allowed Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.69 -1.256 . . . . 0.0 111.962 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.6 Cg_exo -62.01 -57.88 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 122.965 0.981 . . . . 0.0 109.897 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -54.72 -29.44 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.711 . . . . 0.0 110.76 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 17.9 m -64.28 -27.15 68.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.805 -1.184 . . . . 0.0 109.055 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 73.4 t -67.12 -30.23 48.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 3.8 tttt -70.55 -44.64 67.03 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.02 -23.15 64.04 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.884 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -70.93 -49.03 50.16 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.701 -0.624 . . . . 0.0 110.468 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -61.62 -42.41 98.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 0.0 109.625 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -70.4 -20.19 62.95 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.225 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.03 -7.85 41.53 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.503 -0.748 . . . . 0.0 109.699 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 3.8 t -52.17 -76.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 167.76 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.521 0.677 . . . . 0.0 109.768 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.36 -8.19 49.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 9.9 p -48.59 126.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -1.171 . . . . 0.0 109.907 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.39 -14.6 14.4 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -162.2 160.5 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.56 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 35' ' ' ASP . 67.0 t -149.78 149.58 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.13 -0.981 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB3' HG13 ' A' ' 44' ' ' VAL . 30.3 t0 -167.4 91.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.603 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.0 m -108.39 -156.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.003 0.906 . . . . 0.0 111.345 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -154.37 91.6 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -38.2 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.936 -0.743 . . . . 0.0 111.17 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 13.0 tp10 -34.34 -40.82 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.454 -0.779 . . . . 0.0 110.731 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' GLU . 1.2 tmtp? -87.25 46.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 109.571 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -6.15 72.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -149.82 117.17 6.07 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.838 -1.163 . . . . 0.0 110.321 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -108.88 116.99 33.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.399 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -108.94 109.53 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG11 ' N ' ' A' ' 46' ' ' THR . 40.1 t -129.14 151.16 35.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.98 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.536 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.7 m -109.8 157.57 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 3' ' ' GLN . 50.9 p90 -172.5 -179.03 2.1 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.335 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 7.9 m-20 -107.92 113.98 27.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' HB2' ' NE2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -59.84 -9.89 3.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.937 -178.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.532 HG21 ' N ' ' A' ' 51' ' ' LYS . 9.3 t -64.95 -25.42 67.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.899 -1.126 . . . . 0.0 110.404 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.532 ' N ' HG21 ' A' ' 50' ' ' THR . 2.0 mtmt -126.78 -32.91 2.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -117.71 -167.64 1.37 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.641 -0.662 . . . . 0.0 109.917 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.54 153.04 0.86 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.573 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 24.4 m -43.02 -36.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.754 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.512 ' N ' HG21 ' A' ' 54' ' ' VAL . 4.5 tt0 -67.58 -45.08 76.56 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -60.94 -27.03 67.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.583 HD13 ' CE2' ' A' ' 47' ' ' PHE . 44.8 mt -69.17 -52.58 26.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.242 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.45 ' HA ' HD22 ' A' ' 7' ' ' LEU . 1.5 m -65.52 -17.62 64.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -83.81 -24.5 30.97 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -72.03 -42.3 66.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.829 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 11.5 t -76.61 -38.7 54.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -59.37 -28.24 66.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.1 m-20 -84.46 -24.44 29.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -71.37 -16.45 62.42 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.51 27.81 4.27 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.4 m-85 -135.99 97.13 12.51 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.482 -1.011 . . . . 0.0 110.401 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.11 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.619 1.326 . . . . 0.0 110.054 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.522 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 3.4 p -108.43 -165.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 110.788 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 84.9 p -148.55 -171.91 3.96 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.8 p -139.23 152.08 23.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 110.983 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.517 ' HG3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.27 42.68 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.169 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 71' ' ' LYS . 1.4 mt-30 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.018 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.174 0.512 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.79 95.92 1.93 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 2.1 mt-30 -108.74 159.03 17.09 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.627 0.727 . . . . 0.0 110.987 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.527 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 m -139.31 127.74 22.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.912 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.569 ' CG2' HD11 ' A' ' 57' ' ' LEU . 5.3 m -133.32 169.72 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.504 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 14.8 t -108.2 160.33 15.91 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.52 145.64 50.32 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.483 -178.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -117.54 100.49 7.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.558 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 6.5 p -109.66 80.02 1.52 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.123 . . . . 0.0 112.552 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 Cg_endo -67.58 -3.78 10.85 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.467 1.246 . . . . 0.0 110.811 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -41.84 -32.17 0.9 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.558 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 99.2 mmm -146.62 -160.65 1.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.478 -1.013 . . . . 0.0 109.372 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.7 t 179.92 71.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' HA ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -169.49 -178.91 3.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.186 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB1' ' A' ' 16' ' ' ALA . . . -78.79 73.64 5.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.049 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.22 -51.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 m -86.84 -43.99 0.54 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.9 -1.125 . . . . 0.0 112.894 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 2.2 Cg_endo -63.51 -44.57 13.84 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 8.7 mt -64.41 -25.29 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.674 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 62.3 m -64.18 -23.68 67.4 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.738 -1.226 . . . . 0.0 108.059 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 45.0 t -71.0 -32.79 49.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.561 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 3.4 tttt -63.43 -38.43 91.1 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.3 -32.14 72.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.189 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -62.86 -51.57 66.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.569 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -70.62 -27.54 64.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.358 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -25.34 66.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.75 17.37 6.85 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.119 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.543 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 7.6 p -60.58 -47.24 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.4 OUTLIER 175.27 -84.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 110.928 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -100.6 8.41 58.32 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.657 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 9.1 p -40.26 130.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -1.111 . . . . 0.0 110.445 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -110.12 -16.9 13.68 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.748 0.785 . . . . 0.0 108.925 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.42 158.82 27.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.546 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.515 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 7.1 p -157.74 151.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.504 ' N ' HG21 ' A' ' 34' ' ' VAL . 7.1 p-10 -169.38 98.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.0 m -109.04 -157.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 112.005 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' N ' HG22 ' A' ' 36' ' ' VAL . . . -147.2 122.98 1.67 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -53.25 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.147 -0.619 . . . . 0.0 111.562 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -23.53 -38.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.557 -0.714 . . . . 0.0 112.912 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 38' ' ' PHE . 2.5 ttpt -81.24 32.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.737 -1.227 . . . . 0.0 111.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 7.5 87.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.6 tm-20 -156.43 110.15 2.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.055 . . . . 0.0 110.21 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -114.02 117.4 31.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.754 -1.216 . . . . 0.0 111.661 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.2 t -108.45 121.23 61.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 33' ' ' LYS . 52.8 t -139.83 152.16 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.079 -1.448 . . . . 0.0 113.144 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.3 m -111.49 162.4 15.14 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 2' ' ' THR . 52.4 p90 -172.69 -176.95 1.59 Allowed 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.489 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 72.6 m-20 -106.58 122.21 45.87 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -65.62 -4.5 6.27 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.929 -177.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.7 p -76.15 -26.84 56.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 2.2 mmmt -125.61 -6.49 6.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -147.28 -168.45 3.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.616 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 35.4 t -178.17 152.54 0.72 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 70' ' ' VAL . 3.6 p -41.76 -39.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.469 -0.77 . . . . 0.0 109.377 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.62 -45.7 82.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 53' ' ' SER . 1.3 mttt -60.66 -23.64 64.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.465 -0.772 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.594 HD13 ' CE2' ' A' ' 47' ' ' PHE . 32.5 mt -74.4 -51.96 13.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.729 -1.232 . . . . 0.0 108.35 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 1.8 m -64.02 -18.84 64.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.06 -26.79 33.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . . . -71.14 -41.46 70.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.034 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 13.0 t -76.0 -39.51 55.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' THR . . . -60.69 -26.37 67.07 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.64 -19.81 23.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -73.51 -18.07 61.14 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.83 28.42 3.94 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -137.15 101.47 9.27 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.98 . . . . 0.0 110.746 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.53 95.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.662 1.348 . . . . 0.0 109.773 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 12.6 t -108.94 -168.6 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.14 178.35 7.76 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 7' ' ' LEU . 6.4 p -138.29 148.0 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.725 -1.235 . . . . 0.0 112.511 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' CD ' HG23 ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.04 77.47 1.66 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.603 -0.686 . . . . 0.0 109.825 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.209 0.528 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -155.9 93.22 1.43 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -113.81 -171.23 1.86 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.035 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.458 HG22 ' OG1' ' A' ' 46' ' ' THR . 20.4 m -153.0 156.92 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -170.44 169.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.27 1.033 . . . . 0.0 110.34 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 3.7 t -109.73 165.16 11.91 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.55 145.63 50.27 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.624 -1.23 . . . . 0.0 111.664 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.534 ' CB ' ' NH1' ' A' ' 41' ' ' ARG . . . -110.56 100.1 8.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 3.4 p -112.03 79.52 2.75 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.04 -1.037 . . . . 0.0 111.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.503 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 4.2 Cg_endo -67.17 -4.66 12.04 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.608 1.32 . . . . 0.0 110.917 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -42.1 -43.49 4.49 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.537 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -139.06 -159.03 0.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -1.077 . . . . 0.0 109.604 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 12' ' ' MET . 3.8 t -179.04 79.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.03 -1.044 . . . . 0.0 110.628 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.6 -177.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.418 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -81.62 70.96 8.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.056 . . . . 0.0 110.292 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -177.31 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 111.679 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 8.3 m -93.93 -43.42 0.31 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 120.803 -1.186 . . . . 0.0 112.646 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.4 Cg_endo -65.64 -37.6 28.16 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 N-CA-C 108.577 -1.355 . . . . 0.0 108.577 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 20' ' ' THR . 1.6 tt -65.28 -33.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.953 0.882 . . . . 0.0 108.973 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 76.0 m -60.74 -20.24 60.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 62.3 t -74.82 -36.12 38.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -60.48 -33.92 73.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.34 -46.68 69.5 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.483 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.77 -57.55 9.79 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.164 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.031 -1.043 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.507 ' CA ' HG23 ' A' ' 34' ' ' VAL . 7.4 t -63.44 -20.06 65.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.6 16.32 5.91 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.598 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.534 ' CG2' ' HG2' ' A' ' 29' ' ' GLU . 4.8 p -55.25 -56.59 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 0.0 110.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 28' ' ' VAL . 5.7 pt-20 170.86 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.92 3.62 16.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 3.6 p -50.3 134.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.4 -8.63 11.59 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 8.8 ttmm -155.24 160.87 41.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' ' HD3' ' A' ' 22' ' ' LYS . 54.6 t -152.62 137.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.501 0.667 . . . . 0.0 110.337 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.2 m-20 -167.92 92.43 0.36 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.573 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.7 m -107.97 -153.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 111.845 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.511 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -147.77 111.99 0.57 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -82.22 65.03 7.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.959 0.885 . . . . 0.0 110.502 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -178.66 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.317 -0.865 . . . . 0.0 108.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -89.88 42.06 1.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.534 ' NH1' ' CB ' ' A' ' 8' ' ' ALA . 3.7 ppt_? 23.46 84.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.114 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 tt0 -150.42 116.16 5.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.464 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.16 117.59 33.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.115 . . . . 0.0 111.222 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -110.01 114.62 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 46' ' ' THR . 56.5 t -138.07 151.07 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.445 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.572 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.5 m -109.43 166.26 11.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 53.2 p90 -172.85 -171.05 0.72 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.885 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -107.28 111.28 23.58 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -61.98 -9.65 7.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 -177.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -75.99 -30.37 58.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.877 -1.14 . . . . 0.0 109.662 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 1.3 10.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.979 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -155.1 -169.37 3.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.62 155.68 0.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.755 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 11.7 m -42.41 -37.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' VAL . 6.1 tt0 -64.04 -46.91 82.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.251 -0.906 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -61.49 -29.75 70.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.452 -0.78 . . . . 0.0 110.027 179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 47' ' ' PHE . 68.0 mt -65.51 -52.9 49.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 69' ' ' SER . 5.5 m -64.35 -18.36 64.58 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 20.1 ttpt -80.58 -27.89 37.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.51 66.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.91 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.537 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 10.2 t -73.23 -35.61 66.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -58.8 -31.46 68.46 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.52 -16.44 28.85 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.573 -0.704 . . . . 0.0 109.466 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -73.46 -18.98 61.06 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.48 23.96 4.58 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -139.34 93.26 10.11 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.614 -0.933 . . . . 0.0 110.557 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.91 95.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.705 1.371 . . . . 0.0 109.432 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 5.4 p -108.39 -159.09 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.853 0.835 . . . . 0.0 111.391 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -151.53 -167.08 2.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.56 ' CG2' HG23 ' A' ' 5' ' ' VAL 0.258 3.3 p -139.4 146.39 25.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.191 -0.943 . . . . 0.0 110.749 -178.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD2' HG22 ' A' ' 6' ' ' THR . 0.8 OUTLIER -160.6 50.22 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.825 -178.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 4.9 pp0? . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.494 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.208 0.528 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.52 86.99 1.84 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 47' ' ' PHE . 4.4 pt20 -120.44 149.37 42.48 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.589 -0.844 . . . . 0.0 112.17 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.556 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -119.16 138.98 52.56 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.646 0.736 . . . . 0.0 110.194 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.549 ' CG2' HD11 ' A' ' 57' ' ' LEU . 35.1 m -130.92 169.76 20.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.588 -0.695 . . . . 0.0 109.171 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.546 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 12.0 t -107.49 159.79 16.15 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.4 mp -133.58 153.33 51.74 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.466 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -124.01 106.06 10.09 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 7.2 p -115.69 78.05 6.65 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.931 -1.106 . . . . 0.0 111.518 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 8.6 Cg_endo -72.53 2.73 4.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.744 1.392 . . . . 0.0 111.351 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -55.36 -29.79 53.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -172.72 119.91 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.676 -0.896 . . . . 0.0 109.4 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 41' ' ' ARG . 2.9 t -143.49 110.0 5.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 13' ' ' THR . 1.8 m -148.55 -61.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.0 109.082 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.76 27.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.613 -0.679 . . . . 0.0 109.871 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -168.68 -40.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 111.646 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 8.2 m -67.2 -44.86 49.95 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.128 . . . . 0.0 112.035 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 4.3 Cg_endo -64.14 -41.65 21.31 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -63.4 -31.92 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.652 0.739 . . . . 0.0 109.317 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 30.8 m -61.7 -23.08 65.88 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.566 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 60.7 t -73.18 -33.66 42.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 65.2 tttt -62.1 -35.08 77.63 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -65.86 -43.02 89.66 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.567 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -55.77 -59.29 5.08 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.75 -0.594 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.566 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -64.65 -29.29 70.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.001 -1.062 . . . . 0.0 109.924 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 22' ' ' LYS . 20.0 m -59.5 -30.3 68.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -135.28 21.93 3.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.792 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.546 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 10.7 p -54.18 -45.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.72 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 110.557 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -97.1 1.69 61.03 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 12.6 p -42.72 128.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.059 -1.26 . . . . 0.0 110.159 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.01 -9.17 15.09 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.432 0.634 . . . . 0.0 109.657 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -166.67 163.03 16.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.361 -0.837 . . . . 0.0 109.549 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.71 162.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.3 t0 -170.72 85.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 23.8 t -106.94 176.29 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.741 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.8 118.36 2.3 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 17.9 p90 -87.24 63.82 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.945 0.878 . . . . 0.0 109.858 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 2.1 tt0 179.58 -63.88 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.2 mtmt -73.26 -2.69 22.89 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.2 tmm_? 59.5 75.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.7 -0.625 . . . . 0.0 110.879 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' O ' HG11 ' A' ' 36' ' ' VAL . 11.3 pt-20 -156.88 122.35 4.7 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.736 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -109.21 115.58 30.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.098 -1.001 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.0 t -109.2 119.37 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 25' ' ' LEU . 24.7 t -135.64 156.88 38.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.017 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.62 154.34 26.19 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 35.3 p90 -170.88 177.88 3.65 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.22 -1.392 . . . . 0.0 111.668 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.37 123.74 48.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.499 ' CG ' ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -69.17 -0.74 6.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.311 -177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.7 p -73.18 -33.29 65.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -121.32 -13.7 8.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.068 -1.02 . . . . 0.0 110.557 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -140.87 -169.25 2.77 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.914 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.8 p 179.76 158.26 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.558 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 5.5 m -41.3 -40.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.769 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -60.97 -49.05 79.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -25.46 68.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.676 -0.64 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 39.2 mt -71.63 -52.87 15.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.775 -1.203 . . . . 0.0 108.621 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.522 ' N ' HD23 ' A' ' 7' ' ' LEU . 83.8 m -66.05 -19.2 65.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.27 -24.56 34.68 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . . . -72.07 -42.07 66.65 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.989 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 11.5 t -75.72 -38.71 58.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -59.74 -30.29 68.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.5 t70 -86.31 -20.68 28.01 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.03 -19.33 62.52 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 116.78 24.36 3.69 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.1 m-85 -138.42 99.39 8.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.441 -1.035 . . . . 0.0 110.391 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 4.9 Cg_exo -56.76 95.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.65 1.342 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.0 p -109.49 -162.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.858 . . . . 0.0 111.375 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.6 p -156.2 -173.2 4.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.5 p -135.8 156.15 37.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.848 -1.158 . . . . 0.0 110.958 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.546 ' HG2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.94 54.36 0.41 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.415 -1.314 . . . . 0.0 111.766 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.291 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.083 0.468 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -145.35 86.26 1.75 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 26.8 mm-40 -115.45 141.9 47.42 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.136 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.524 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -125.52 122.31 36.22 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.481 0.658 . . . . 0.0 109.719 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 57' ' ' LEU . 14.9 m -117.41 170.93 6.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.456 -0.777 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 14.8 t -107.64 154.3 21.65 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.1 mp -131.29 159.66 37.2 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.255 -1.378 . . . . 0.0 110.922 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . . . -126.83 123.91 38.42 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.969 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 3.7 t -112.48 76.7 2.08 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.02 -1.05 . . . . 0.0 111.542 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 9.4 Cg_endo -73.65 -23.04 17.36 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.111 1.208 . . . . 0.0 111.016 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -46.8 -50.33 15.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.488 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.8 mmm -147.17 158.83 44.08 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.312 -1.111 . . . . 0.0 110.159 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 1.1 t -178.78 112.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.618 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 4.4 p -166.66 -42.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 110.641 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . 178.83 30.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.894 -1.129 . . . . 0.0 110.668 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.564 ' N ' ' CD1' ' A' ' 19' ' ' ILE . . . 179.26 -32.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 110.65 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 50.8 m -70.05 -43.39 19.24 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.974 -1.079 . . . . 0.0 112.003 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.7 Cg_endo -72.72 -47.41 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 N-CA-C 107.126 -1.913 . . . . 0.0 107.126 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.664 ' CG1' ' CD1' ' A' ' 38' ' ' PHE 0.259 3.5 mt -54.95 -33.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 177.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 24.6 m -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 109.158 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.579 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 22.2 t -67.7 -31.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -67.9 -41.82 82.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.0 tmtt? -62.17 -37.95 87.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.567 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -59.54 -58.05 10.29 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.896 -0.503 . . . . 0.0 111.461 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.579 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -62.31 -33.98 75.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.041 -1.037 . . . . 0.0 109.831 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -63.35 -24.75 67.99 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -125.29 15.25 8.35 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.404 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 2.2 p -58.75 -63.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.168 -0.958 . . . . 0.0 111.276 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 28' ' ' VAL . 3.1 mt-10 -165.47 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.713 -1.242 . . . . 0.0 110.721 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.67 6.15 60.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.7 p -39.73 132.17 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.421 -1.046 . . . . 0.0 110.479 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -109.47 -13.03 14.64 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.564 0.697 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 2.9 tttt -165.83 160.58 17.13 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.799 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG11 ' N ' ' A' ' 35' ' ' ASP . 61.2 t -152.28 151.19 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' N ' HG11 ' A' ' 34' ' ' VAL . 1.4 p-10 -168.34 95.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.579 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.1 m -107.85 -158.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.113 0.958 . . . . 0.0 111.824 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 36' ' ' VAL . . . -142.95 115.72 0.95 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 19' ' ' ILE . 3.2 m-30 -52.69 -114.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.045 -0.68 . . . . 0.0 110.257 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.7 mt-10 -36.65 -30.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.044 -1.035 . . . . 0.0 110.548 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.4 mtpt -88.91 50.28 1.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.561 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 40' ' ' LYS . 3.1 ppt_? -16.37 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.544 0.687 . . . . 0.0 112.569 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 40' ' ' LYS . 15.4 tt0 -154.38 111.27 3.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.436 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -110.18 115.24 29.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.769 -1.207 . . . . 0.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 HG13 ' OD2' ' A' ' 35' ' ' ASP . 24.2 t -107.23 120.45 58.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.645 -1.285 . . . . 0.0 107.552 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.534 HG22 ' CD2' ' A' ' 25' ' ' LEU . 19.0 t -131.73 150.84 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.837 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.524 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -110.0 156.09 20.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 38.6 p90 -170.88 -177.27 2.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.14 -1.424 . . . . 0.0 111.797 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.0 m-20 -106.21 112.61 25.71 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -6.04 12.91 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.656 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.32 -18.46 63.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -138.25 -38.2 0.55 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.939 . . . . 0.0 110.479 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -108.15 -168.94 1.43 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.981 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.584 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER 179.26 160.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 110.412 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 3.8 p -41.78 -43.73 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.135 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.424 ' N ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -61.38 -44.24 97.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -0.956 . . . . 0.0 109.316 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 mtpp -64.15 -25.79 68.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.432 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 28.4 mt -72.79 -50.51 23.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.858 -1.151 . . . . 0.0 108.101 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 59.4 m -64.34 -18.14 64.36 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 3.2 ttpp -80.01 -28.88 39.35 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.85 72.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.325 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' HG12 ' A' ' 21' ' ' VAL . 11.1 t -74.42 -36.99 63.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.06 -28.52 67.86 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.99 -19.43 25.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.138 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.5 -14.06 60.4 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.612 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 102.6 35.08 3.91 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.2 m-85 -138.15 96.19 10.24 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.946 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 5.9 Cg_exo -55.34 97.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.636 1.335 . . . . 0.0 108.912 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.481 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -108.02 -177.91 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 111.794 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.16 133.31 17.29 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -99.79 158.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.611 -1.306 . . . . 0.0 111.207 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.536 ' HG2' ' CG2' ' A' ' 6' ' ' THR . 0.2 OUTLIER -154.47 50.73 0.63 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.645 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.1 pp0? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.133 0.492 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.77 91.09 1.35 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 4.3 mm100 -114.12 153.93 28.66 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.649 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.485 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 52.4 m -131.67 129.65 41.04 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 57' ' ' LEU . 31.5 m -133.93 170.85 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.968 -1.082 . . . . 0.0 110.273 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.523 ' CG2' HG21 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.2 159.33 16.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.566 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.31 154.1 50.97 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.337 -177.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -130.11 108.97 10.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.561 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 12.2 p -113.18 83.32 6.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.991 . . . . 0.0 111.203 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.542 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 6.9 Cg_endo -70.87 -6.61 19.54 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.624 1.329 . . . . 0.0 110.662 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -46.45 -40.03 10.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.6 mmm -156.56 132.19 9.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.539 -0.977 . . . . 0.0 109.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -133.75 93.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 110.234 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 13' ' ' THR . 0.1 OUTLIER -149.55 -71.45 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.825 -1.172 . . . . 0.0 110.258 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . 179.92 49.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 109.467 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.39 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.413 -0.805 . . . . 0.0 110.43 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.6 m -71.16 -50.63 11.23 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -57.68 -43.12 53.02 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 N-CA-C 107.927 -1.605 . . . . 0.0 107.927 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.22 -28.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.723 0.773 . . . . 0.0 109.816 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 42.6 m -66.47 -23.72 66.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.924 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 25.2 t -68.88 -28.63 40.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.591 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 29.2 tttt -64.15 -45.6 87.75 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 17.9 mmtt -69.58 -20.92 63.64 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.38 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' ALA . . . -72.86 -40.23 65.84 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.683 -0.635 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -77.97 -34.47 51.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 0.0 109.357 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.461 ' HA ' HG12 ' A' ' 31' ' ' VAL . 23.8 t -71.23 -21.82 62.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -110.38 -0.51 17.54 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.297 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 12.6 p -49.04 -45.16 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.91 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 2.2 mt-10 161.09 -83.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.735 -0.603 . . . . 0.0 111.275 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.29 7.39 72.2 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 4.0 p -41.04 134.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.198 -1.178 . . . . 0.0 110.293 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -14.82 14.26 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.813 0.816 . . . . 0.0 108.9 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -161.25 158.69 27.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -150.11 162.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 111.192 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t0 -156.61 151.47 26.0 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.591 ' CB ' ' HB2' ' A' ' 22' ' ' LYS . 1.6 p -154.37 161.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.201 -1.399 . . . . 0.0 111.982 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -137.91 111.48 0.82 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' LYS . 26.1 p90 -54.29 -155.78 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' PHE . 35.2 tt0 5.88 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -38.97 -24.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.496 -1.377 . . . . 0.0 111.737 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.7 tmm_? 62.94 76.97 0.35 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.121 -0.987 . . . . 0.0 111.358 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -165.38 126.41 1.94 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.051 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -125.77 128.36 47.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.8 -1.187 . . . . 0.0 110.245 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 6' ' ' THR . 0.9 OUTLIER -109.11 140.34 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.823 -1.173 . . . . 0.0 108.312 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG1' HD12 ' A' ' 57' ' ' LEU . 7.2 p -149.32 156.01 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.418 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.9 m -125.56 156.74 38.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 50.1 p90 -172.62 -179.61 2.2 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.823 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -107.33 123.48 48.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -65.21 -5.52 7.15 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.85 -177.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 1' ' ' ALA . 6.9 p -62.73 -37.59 87.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.168 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.84 23.27 5.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -169.53 -171.61 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.42 155.59 0.52 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' A' ' 70' ' ' VAL . 5.6 p -43.43 -34.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.533 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -65.3 -46.91 78.49 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.353 -0.842 . . . . 0.0 108.983 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.469 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -64.64 -24.64 67.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.62 -0.675 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD13 ' CE2' ' A' ' 47' ' ' PHE . 42.5 mt -72.06 -56.12 6.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.688 -1.258 . . . . 0.0 108.299 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.49 HG22 ' CA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -63.68 -19.74 65.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 2.7 ttpt -81.71 -26.21 34.8 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . -72.35 -41.72 66.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.096 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 62' ' ' ALA . 9.3 t -75.86 -36.85 59.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.509 ' N ' HG21 ' A' ' 61' ' ' THR . . . -60.43 -30.94 69.95 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -90.27 -15.58 31.0 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.47 -21.03 61.28 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 118.27 23.63 3.45 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.3 m-85 -139.39 105.28 7.11 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 0.0 110.561 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 6.3 Cg_exo -57.62 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.517 1.272 . . . . 0.0 109.34 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB2' ' CB ' ' A' ' 9' ' ' VAL . 3.8 t -110.49 -176.26 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.784 . . . . 0.0 111.158 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.49 ' CA ' HG22 ' A' ' 58' ' ' THR . 3.4 t -147.24 -176.43 5.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 9.5 p -134.81 159.68 41.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.681 -1.262 . . . . 0.0 111.657 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.91 47.04 1.01 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.061 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 71' ' ' LYS . 23.7 mp0 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.239 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.07 88.93 1.48 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 mm-40 -114.0 154.76 27.08 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.582 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 16.0 m -127.61 160.32 31.97 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 109.539 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.577 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -166.94 170.69 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.979 0.895 . . . . 0.0 109.798 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -109.27 163.72 13.12 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -135.66 144.2 45.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.93 -1.106 . . . . 0.0 111.303 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -113.82 99.52 7.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 109.487 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 5.4 p -111.19 85.47 5.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.038 -1.039 . . . . 0.0 111.962 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 1.7 Cg_endo -64.77 -6.3 12.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.629 1.331 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.85 2.06 56.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.575 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.33 173.76 6.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 110.613 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' CYS . 3.1 t -179.22 15.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.996 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 179.61 -162.16 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.281 -1.512 . . . . 0.0 110.197 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.83 52.72 2.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 110.28 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 17' ' ' CYS . . . -172.75 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 111.177 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.672 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 51.8 m -152.62 -50.83 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.325 -0.859 . . . . 0.0 111.48 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 9.8 Cg_endo -73.98 -50.31 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 N-CA-C 108.267 -1.474 . . . . 0.0 108.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.2 mt -65.7 -25.38 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.928 0.87 . . . . 0.0 108.692 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.465 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 2.7 m -62.81 -23.93 67.5 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 98.5 t -72.77 -32.98 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 15.1 tttt -59.77 -35.45 74.67 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.4 -37.61 77.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.816 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -61.17 -56.1 24.59 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.612 -0.68 . . . . 0.0 111.042 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -63.49 -32.93 74.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.055 . . . . 0.0 110.176 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.2 p -68.52 -20.19 64.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -120.07 6.85 10.79 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 8.6 p -55.6 -49.31 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.123 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 171.64 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 111.152 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.54 10.44 70.96 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.561 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' CG2' ' CG2' ' A' ' 34' ' ' VAL . 10.6 p -41.89 133.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.126 . . . . 0.0 110.089 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.26 -18.05 13.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 10.6 tttm -163.61 158.39 20.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' CG2' ' CG2' ' A' ' 31' ' ' VAL . 71.4 t -156.15 142.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 111.918 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.528 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -141.93 158.68 43.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 9.8 p -154.09 168.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 117.623 -1.631 . . . . 0.0 112.794 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.07 110.65 1.06 Allowed Glycine 0 N--CA 1.48 1.588 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.65 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.429 -0.453 . . . . 0.0 111.742 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 1.1 tt0 -28.68 -31.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.432 -0.793 . . . . 0.0 112.293 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 38' ' ' PHE . 55.2 mttt -80.38 27.81 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.734 -1.228 . . . . 0.0 110.996 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 13.49 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.5 tt0 -165.67 109.65 0.83 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.419 -1.426 . . . . 0.0 111.107 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.08 125.25 53.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.068 -1.02 . . . . 0.0 111.424 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 9.7 p -109.59 114.26 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 25' ' ' LEU . 22.3 t -128.42 150.03 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.468 -1.293 . . . . 0.0 113.113 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -112.42 160.38 17.8 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 50.3 p90 -171.68 -171.46 0.91 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.186 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.4 m-20 -106.57 123.56 48.28 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -71.85 3.54 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.442 -177.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.533 HG22 ' CB ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -85.23 -33.24 22.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.912 -1.118 . . . . 0.0 109.64 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 -4.42 10.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.098 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . . . -145.77 -172.7 3.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.606 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 179.68 153.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.822 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 26.7 m -43.35 -32.72 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.025 -1.047 . . . . 0.0 109.858 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.9 tt0 -68.18 -46.94 69.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 108.874 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 5.0 mttm -63.34 -25.5 68.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.544 -0.722 . . . . 0.0 110.297 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.588 HD13 ' CE2' ' A' ' 47' ' ' PHE . 46.2 mt -71.05 -53.11 15.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.846 -1.159 . . . . 0.0 108.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 61' ' ' THR . 5.1 m -62.27 -24.23 67.16 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -79.23 -28.73 42.49 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.39 -45.42 76.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.477 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 12.9 t -72.29 -38.18 68.83 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 61' ' ' THR . . . -58.64 -27.89 65.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -90.29 -20.69 22.64 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.554 -0.716 . . . . 0.0 109.413 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.09 -17.38 62.0 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.605 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 111.53 27.19 4.22 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.8 m-85 -138.6 92.38 11.6 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.555 -0.968 . . . . 0.0 110.166 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.22 96.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.583 1.307 . . . . 0.0 109.502 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' A' ' 9' ' ' VAL . 8.6 t -108.85 -167.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.392 -0.818 . . . . 0.0 111.34 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -142.87 -167.68 2.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 7' ' ' LEU . 1.6 p -142.9 155.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.944 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.68 53.77 0.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.4 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.516 ' N ' HG22 ' A' ' 5' ' ' VAL . 1.4 tm0? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.446 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.254 0.55 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 90.3 1.59 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mm-40 -109.97 169.33 8.8 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.016 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 46.7 m -144.02 125.58 14.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.506 -0.746 . . . . 0.0 109.553 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG12 ' CG2' ' A' ' 54' ' ' VAL . 2.7 t -130.28 169.65 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 5.1 t -108.73 159.25 16.91 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mp -133.58 152.03 51.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.208 -1.397 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.0 102.1 7.36 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 2.6 p -110.37 91.32 11.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.851 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.1 Cg_endo -66.29 -11.02 29.63 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.679 1.357 . . . . 0.0 110.305 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.84 48.8 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.543 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -136.42 158.16 45.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -1.154 . . . . 0.0 110.568 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 12' ' ' MET . 10.7 t 179.47 33.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.578 0.704 . . . . 0.0 109.161 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -160.93 127.05 3.92 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -35.68 83.49 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.64 -0.663 . . . . 0.0 111.615 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 177.83 -67.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.194 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 m -82.17 -44.16 1.01 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.945 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 23.7 Cg_exo -54.1 -55.94 3.0 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 38' ' ' PHE . 37.9 mt -53.9 -27.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.828 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 22.6 m -69.08 -30.96 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.003 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.549 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 55.5 t -65.95 -33.24 62.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HA ' HD11 ' A' ' 25' ' ' LEU . 8.0 tttt -70.05 -33.19 71.63 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mmtp -74.37 -29.01 61.37 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.264 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -62.8 -46.47 87.82 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.324 0.583 . . . . 0.0 109.804 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -72.7 -33.69 66.64 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.754 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -64.6 -18.62 65.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.62 8.58 6.41 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.774 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 14.6 p -49.52 -52.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 110.509 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 3.9 pt-20 165.17 -48.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.195 -0.941 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -125.1 2.12 8.38 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.739 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 1.1 t -42.82 130.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.29 . . . . 0.0 109.562 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.51 -13.48 14.56 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -163.6 164.15 24.22 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.47 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 7.2 p -152.82 162.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 111.179 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 34' ' ' VAL . 2.1 m-20 -168.63 80.14 0.14 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 42' ' ' GLU . 33.0 t -108.32 164.99 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.904 0.859 . . . . 0.0 111.556 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -126.42 107.34 0.91 Allowed Glycine 0 N--CA 1.48 1.611 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.46 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.605 -0.938 . . . . 0.0 111.764 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 38' ' ' PHE . 63.3 mt-10 -22.54 -67.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.8 -0.563 . . . . 0.0 112.273 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.638 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 19.5 tptp -42.1 -55.36 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.041 -1.037 . . . . 0.0 110.235 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.638 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.1 tmm_? 99.39 76.5 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 C-N-CA 123.493 0.717 . . . . 0.0 110.815 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -169.0 115.13 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 0.0 110.439 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -108.12 119.95 40.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.636 -1.29 . . . . 0.0 111.502 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.5 t -108.76 118.58 56.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.497 HG13 ' CG2' ' A' ' 31' ' ' VAL . 9.3 t -133.82 157.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.697 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.6 m -116.82 160.94 20.07 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 54.9 p90 -171.99 -175.23 1.44 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.906 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 14.1 p-10 -106.88 112.31 25.22 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -63.61 -9.65 14.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 0.0 110.718 -177.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.499 ' CG2' ' OD2' ' A' ' 48' ' ' ASP . 5.9 t -62.1 -23.72 66.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.01 -1.056 . . . . 0.0 109.776 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' N ' HG21 ' A' ' 50' ' ' THR . 0.0 OUTLIER -130.68 -38.5 1.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 110.317 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -108.0 -168.94 1.44 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.643 -0.66 . . . . 0.0 109.961 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.6 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 31.4 t -179.5 155.68 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.045 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.573 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 6.7 p -42.94 -40.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.624 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 50.4 tt0 -61.88 -44.72 96.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.361 -0.837 . . . . 0.0 109.451 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 38.0 mttp -67.34 -23.27 65.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 47' ' ' PHE . 40.0 mt -71.14 -51.57 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.619 -1.301 . . . . 0.0 108.492 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.488 ' HA ' HD22 ' A' ' 7' ' ' LEU . 1.3 m -64.99 -19.77 66.16 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 7.2 mttt -82.49 -25.47 33.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.06 67.9 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.438 -0.789 . . . . 0.0 109.134 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 62' ' ' ALA . 10.2 t -75.84 -38.73 57.73 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -61.49 -24.21 66.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 4.2 m-20 -88.22 -21.92 24.26 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -17.02 60.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.608 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.47 27.94 3.17 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -136.59 91.18 16.17 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.621 -0.929 . . . . 0.0 110.633 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.93 93.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 0.0 110.055 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -108.99 -163.85 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 110.942 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' HG23 ' A' ' 58' ' ' THR . 2.5 t -150.09 -170.86 3.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 7.5 p -139.9 160.06 26.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.993 -1.067 . . . . 0.0 111.452 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -172.07 48.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.408 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 71' ' ' LYS . 38.3 tt0 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.957 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.35 94.11 1.46 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 9.2 mm-40 -110.91 150.22 29.52 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.165 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.441 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 38.4 m -129.51 120.68 25.8 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 72' ' ' GLN . 33.4 m -127.7 170.42 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.539 HG22 ' CD ' ' A' ' 71' ' ' LYS . 15.1 t -108.14 157.6 18.15 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -132.48 152.37 51.56 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.104 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.51 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -120.88 109.19 14.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.566 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 12.4 t -111.47 73.91 1.11 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.725 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 6.6 Cg_endo -67.35 -7.52 19.32 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.317 1.167 . . . . 0.0 111.389 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' O ' ' SD ' ' A' ' 12' ' ' MET . . . -50.08 -42.34 39.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.496 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 65.4 mmm -152.2 163.38 39.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.446 -1.032 . . . . 0.0 109.134 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 39' ' ' GLU . 2.3 t -174.14 108.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 111.181 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 1.3 p -167.26 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 110.347 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . 177.2 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.748 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -123.76 22.79 8.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.671 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 81.8 m -121.23 -66.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.002 -1.061 . . . . 0.0 110.25 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.671 ' CD ' ' HB2' ' A' ' 17' ' ' CYS . 5.2 Cg_exo -52.87 -39.04 79.34 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.476 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -61.36 -38.3 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.641 0.734 . . . . 0.0 109.182 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 23.7 m -61.56 -22.08 64.86 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 11.9 t -77.11 -31.61 18.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.505 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.17 -36.83 85.44 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -74.01 -33.94 63.97 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.539 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -62.31 -49.86 73.96 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 110.794 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.569 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.45 -47.01 77.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 109.863 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 8.8 t -61.1 -17.54 53.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 108.676 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -103.51 -13.22 16.67 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.46 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.8 t -47.54 -57.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.448 -0.782 . . . . 0.0 109.602 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 154.67 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.616 0.722 . . . . 0.0 110.248 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -67.47 -22.75 73.34 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 22.9 t -42.63 121.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.41 -1.053 . . . . 0.0 109.703 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -109.53 -14.8 14.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.571 0.701 . . . . 0.0 109.782 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 21.5 tttt -154.3 155.69 35.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.451 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.484 ' CG1' ' HG2' ' A' ' 22' ' ' LYS . 3.7 t -149.33 153.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -170.45 94.81 0.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -107.63 -152.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.967 0.889 . . . . 0.0 111.742 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' HG22 ' A' ' 36' ' ' VAL . . . -146.59 108.73 0.46 Allowed Glycine 0 N--CA 1.48 1.582 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -81.92 62.25 5.62 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.535 0.683 . . . . 0.0 110.749 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.8 tp10 179.31 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.22 40.51 2.05 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 25.08 79.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.922 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 37' ' ' GLY . 4.3 tp10 -146.09 113.01 6.08 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.395 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -112.32 115.06 28.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.716 -1.24 . . . . 0.0 110.969 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.2 t -108.65 121.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 107.756 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CG2' HD12 ' A' ' 25' ' ' LEU . 75.2 t -136.97 155.03 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.226 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.523 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.3 m -115.92 157.21 24.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' THR . 49.0 p90 -172.8 178.84 2.5 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 117.891 -1.524 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 70.2 m-20 -106.69 120.52 42.21 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -62.75 -8.37 6.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.689 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -66.93 -27.27 67.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.01 . . . . 0.0 110.47 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -128.07 -8.39 5.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.001 -1.062 . . . . 0.0 111.129 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -146.02 -167.67 2.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 110.021 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -178.24 155.53 0.92 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 110.033 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.545 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 24.9 t -43.05 -39.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.7 tt0 -60.9 -46.07 92.1 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.506 -0.746 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.07 -22.04 65.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.412 -0.805 . . . . 0.0 111.028 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 33.8 mt -73.99 -56.75 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.653 -1.279 . . . . 0.0 108.319 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.514 ' N ' HD23 ' A' ' 7' ' ' LEU . 2.5 m -65.1 -20.45 66.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -81.69 -28.34 33.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -68.5 -41.87 79.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.905 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.542 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 11.0 t -74.77 -36.67 62.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.44 -27.19 67.32 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.1 -19.44 24.31 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.99 -18.74 61.32 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.17 27.31 3.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.596 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.2 98.41 9.29 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 110.856 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.08 93.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.611 1.322 . . . . 0.0 109.658 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 12.4 p -108.45 -161.44 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 111.317 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.5 p -156.95 -169.48 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.7 p -135.61 158.87 40.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.886 -1.134 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.539 ' CD ' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -171.54 47.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.756 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 1.4 pp0? . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.112 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.09 0.471 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.7 89.94 1.44 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.673 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 18.6 pt20 -122.21 165.16 16.59 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.792 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' VAL . 11.9 m -128.81 136.1 50.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.681 -0.637 . . . . 0.0 109.694 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.563 ' CG2' HD11 ' A' ' 57' ' ' LEU . 21.0 m -130.32 167.46 25.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.531 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -106.51 157.15 17.87 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.1 mp -133.92 149.27 51.28 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.355 -1.338 . . . . 0.0 111.219 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.488 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -119.94 113.98 21.37 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.756 -0.59 . . . . 0.0 109.45 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 2.3 t -117.06 78.11 9.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.026 -1.046 . . . . 0.0 111.062 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 13.6 Cg_endo -80.7 40.52 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.234 1.289 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.36 2.46 10.45 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -159.49 21.2 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.076 -1.249 . . . . 0.0 110.579 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 39' ' ' GLU . 15.5 m -47.19 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -179.8 112.15 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 108.55 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -26.17 77.01 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 174.74 -49.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.221 -0.925 . . . . 0.0 110.593 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 32.7 m -97.62 -39.41 0.25 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 6.2 Cg_exo -59.89 -38.57 78.41 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 N-CA-C 107.95 -1.596 . . . . 0.0 107.95 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 10.2 mt -63.89 -29.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 6.8 m -65.4 -23.77 67.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 59.8 t -70.21 -29.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -67.37 -39.26 85.66 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 23.0 mmtt -71.04 -29.85 65.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' HB2' ' A' ' 60' ' ' ALA . . . -63.76 -43.65 95.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.76 -0.588 . . . . 0.0 110.367 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -74.84 -36.23 62.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.022 . . . . 0.0 109.451 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.402 ' HA ' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.31 -19.85 65.7 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.4 mptp? -115.21 1.76 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.171 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 12.0 p -52.64 -40.66 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER 165.0 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.425 -0.797 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -99.49 5.96 58.96 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.06 -1.067 . . . . 0.0 110.752 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.497 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 8.1 p -39.49 129.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -1.077 . . . . 0.0 110.189 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.5 t -108.53 -10.99 15.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.469 0.652 . . . . 0.0 109.665 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -164.63 168.22 18.35 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.014 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 34' ' ' VAL . 10.2 p -165.5 152.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.962 . . . . 0.0 110.953 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' HG11 ' A' ' 44' ' ' VAL . 28.1 t0 -163.32 93.69 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.538 HG11 ' CA ' ' A' ' 43' ' ' ALA . 20.8 t -108.11 174.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 111.746 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.16 121.44 3.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.597 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 16.3 p90 -55.89 -145.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.56 ' C ' ' O ' ' A' ' 38' ' ' PHE . 14.1 tp10 1.13 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -36.01 -63.1 0.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.318 -0.864 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.689 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.2 tmm_? 103.98 77.47 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 C-N-CA 123.306 0.642 . . . . 0.0 111.17 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' O ' HG11 ' A' ' 36' ' ' VAL . 4.0 tm-20 -168.51 117.56 0.72 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.508 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -112.15 118.93 36.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.108 . . . . 0.0 111.329 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 35' ' ' ASP . 4.2 p -107.35 121.93 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.78 -1.2 . . . . 0.0 108.017 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.544 ' CG1' HD12 ' A' ' 57' ' ' LEU . 3.5 p -129.41 159.02 41.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.79 -1.164 . . . . 0.0 113.184 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -118.01 154.69 31.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' ' 3' ' ' GLN . 38.5 p90 -171.83 179.61 2.71 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.232 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 3.4 m-20 -106.79 117.16 33.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.5 t70 -64.15 -7.14 8.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.883 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.22 -26.2 61.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.935 -1.103 . . . . 0.0 110.196 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -0.54 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.197 -0.94 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -159.41 -166.39 1.78 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.572 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.44 159.16 0.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 8.0 p -41.08 -42.44 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.599 -0.688 . . . . 0.0 110.0 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -60.79 -46.78 89.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.256 -0.902 . . . . 0.0 109.682 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.87 -23.54 67.26 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 35.3 mt -72.49 -52.89 13.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.667 -1.271 . . . . 0.0 108.265 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 69' ' ' SER . 2.1 m -63.94 -21.1 66.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 9.5 ttpt -81.47 -26.58 35.13 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HB2' ' C ' ' A' ' 24' ' ' ALA . . . -71.07 -43.46 67.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.209 -0.932 . . . . 0.0 108.94 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 62' ' ' ALA . 9.4 t -74.23 -38.7 63.46 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 61' ' ' THR . . . -60.15 -27.14 66.85 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -90.21 -19.68 23.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.172 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -16.16 60.72 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 112.03 27.26 4.05 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.84 97.89 8.81 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.617 -0.931 . . . . 0.0 110.515 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.52 96.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.59 1.311 . . . . 0.0 109.4 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.91 -167.19 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 111.536 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -156.56 -172.22 3.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.8 p -133.63 161.8 40.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.595 -1.315 . . . . 0.0 111.444 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -148.07 54.76 1.04 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.721 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 110.238 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.44 87.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -127.08 153.02 46.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.05 -1.032 . . . . 0.0 111.624 -177.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -118.29 154.27 32.57 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.407 0.622 . . . . 0.0 109.634 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.545 ' CG2' HD11 ' A' ' 57' ' ' LEU . 17.5 m -145.76 170.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.342 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.542 ' OG1' ' CG2' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.55 156.48 19.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.1 mp -133.61 147.92 51.52 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.938 -1.505 . . . . 0.0 111.308 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -116.99 112.16 20.58 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG ' ' A' ' 41' ' ' ARG . 71.6 t -109.6 73.4 0.63 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.97 -1.081 . . . . 0.0 111.782 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 68' ' ' SER . 1.9 Cg_endo -58.6 -13.46 17.55 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.477 1.251 . . . . 0.0 110.073 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.64 15.24 31.7 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.571 ' HG2' ' CG ' ' A' ' 41' ' ' ARG . 2.2 ppp? -96.71 -164.71 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -1.221 . . . . 0.0 109.435 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.554 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.6 t 178.5 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.838 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 2.1 p -158.59 -154.16 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.536 -1.352 . . . . 0.0 110.673 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.93 42.5 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.951 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -145.81 -36.83 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.906 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.594 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 13.8 m -89.95 -44.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 0.0 111.757 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.0 Cg_endo -75.96 -43.94 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 N-CA-C 107.902 -1.615 . . . . 0.0 107.902 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.586 HG13 ' CD1' ' A' ' 38' ' ' PHE . 2.9 tt -55.66 -38.3 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.904 0.859 . . . . 0.0 109.635 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 5.2 m -62.8 -23.83 67.44 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.943 0.878 . . . . 0.0 108.636 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 32.6 t -69.32 -31.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 3.8 tttt -67.65 -41.78 83.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.55 -24.86 65.58 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.378 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -70.63 -54.7 10.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.803 -0.561 . . . . 0.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -59.66 -35.94 75.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.069 -1.02 . . . . 0.0 109.812 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -22.71 60.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.504 -0.748 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.81 -5.7 25.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.895 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.9 t -46.61 -81.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 4.0 tt0 169.93 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.348 -0.845 . . . . 0.0 109.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -104.95 -21.33 9.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 74.1 t -42.2 126.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -1.068 . . . . 0.0 109.79 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -113.13 -9.82 13.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -147.85 156.33 42.6 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.008 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.487 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 6.1 p -154.86 129.69 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.683 0.754 . . . . 0.0 111.01 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.68 89.66 1.57 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.2 m -108.32 -160.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.962 0.887 . . . . 0.0 111.47 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -144.57 110.06 0.55 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 4.9 m-30 -52.7 -98.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.019 -0.695 . . . . 0.0 109.927 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HA ' ' HE3' ' A' ' 12' ' ' MET . 1.2 mm-40 -54.42 -12.7 0.74 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.606 -1.309 . . . . 0.0 111.643 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.3 mptt -81.85 -24.83 35.57 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.194 . . . . 0.0 111.002 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' CG ' ' HG2' ' A' ' 12' ' ' MET . 7.4 tmm_? 68.41 63.52 0.35 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.581 -0.699 . . . . 0.0 110.655 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.7 tt0 -162.06 113.95 1.69 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.229 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.73 113.6 26.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.96 -1.087 . . . . 0.0 110.834 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.542 ' CG2' ' OG1' ' A' ' 6' ' ' THR . 89.2 t -114.31 121.76 67.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.631 -1.293 . . . . 0.0 108.967 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 4' ' ' THR . 25.8 m -137.66 -179.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 118.234 -1.386 . . . . 0.0 113.789 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.597 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.8 m -127.74 158.41 37.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 30.8 p90 -171.49 178.94 3.04 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.143 -1.423 . . . . 0.0 111.097 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.5 m-20 -107.41 117.7 34.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -63.25 -8.64 8.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 110.958 -177.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.474 HG21 ' N ' ' A' ' 51' ' ' LYS . 4.8 t -74.06 -26.73 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.629 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' N ' HG21 ' A' ' 50' ' ' THR . 1.0 OUTLIER -121.33 -13.22 8.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.498 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -148.14 -165.68 2.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.473 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.48 159.07 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG2' HG23 ' A' ' 70' ' ' VAL . 10.9 p -43.64 -37.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.773 . . . . 0.0 109.763 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -64.85 -44.22 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -0.856 . . . . 0.0 109.357 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 10.2 mtpt -67.68 -22.4 65.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.413 -0.805 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.586 HD13 ' CE2' ' A' ' 47' ' ' PHE . 23.8 mt -74.36 -58.51 3.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.664 -1.273 . . . . 0.0 108.413 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.451 HG22 ' CA ' ' A' ' 69' ' ' SER . 1.3 m -63.07 -21.53 66.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 8.4 ttmt -80.27 -27.97 38.49 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.13 79.41 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.306 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 62' ' ' ALA . 9.4 t -74.19 -38.01 63.76 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 61' ' ' THR . . . -58.72 -27.71 65.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -86.34 -23.4 26.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.3 -14.5 61.32 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.74 30.22 4.1 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.4 m-85 -135.82 94.96 14.27 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.703 -0.88 . . . . 0.0 110.514 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.09 93.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.7 1.369 . . . . 0.0 109.758 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -108.75 -169.06 1.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 111.139 -179.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.451 ' CA ' HG22 ' A' ' 58' ' ' THR . 0.5 OUTLIER -146.48 -174.99 4.61 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.568 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 4.8 p -139.86 150.44 22.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.705 -1.247 . . . . 0.0 112.654 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -134.14 77.62 1.71 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.435 0.636 . . . . 0.0 109.513 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.328 0.585 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -150.4 88.4 1.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 21.6 mm-40 -120.98 155.83 33.45 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.623 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.608 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 5.2 t -136.39 144.23 44.42 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 57' ' ' LEU . 28.3 m -136.46 174.31 12.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.664 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' A' ' 71' ' ' LYS . 12.1 t -107.98 153.49 23.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.57 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -130.41 150.26 51.71 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.444 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.479 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -118.25 115.94 25.76 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -110.99 76.18 1.2 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.019 -1.051 . . . . 0.0 111.49 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.2 Cg_endo -62.8 -15.23 45.61 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.466 1.245 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -55.65 -21.78 30.04 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.636 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.79 -174.5 4.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.955 . . . . 0.0 109.691 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 178.58 75.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 110.724 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.89 -178.61 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.888 -1.133 . . . . 0.0 110.047 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' HB1' ' A' ' 16' ' ' ALA . . . -79.37 75.48 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 109.822 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.53 -45.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.118 -0.989 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 5.3 m -96.84 -45.03 0.25 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.959 -1.088 . . . . 0.0 113.145 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -59.23 -38.23 86.91 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 N-CA-C 108.231 -1.488 . . . . 0.0 108.231 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 19' ' ' ILE . 2.2 tt -63.62 -35.23 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.18 0.99 . . . . 0.0 108.575 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 6.8 m -62.65 -20.75 65.12 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.575 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.9 t -73.81 -32.65 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 18.6 tttm -64.61 -36.13 83.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 26' ' ' SER . 0.1 OUTLIER -66.4 -37.54 85.47 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.25 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . . . -57.56 -59.6 4.92 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.821 -0.55 . . . . 0.0 110.357 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.31 -26.78 68.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 109.572 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 12.9 t -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.93 7.3 7.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.666 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 7.2 p -49.86 -49.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.826 -1.171 . . . . 0.0 110.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.9 -86.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.263 -0.898 . . . . 0.0 111.318 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -84.1 1.95 88.22 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.046 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 6.5 p -43.99 131.18 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.835 -1.391 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.57 -15.43 13.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -164.35 160.1 20.47 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.916 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 ' CG2' ' C ' ' A' ' 33' ' ' LYS . 14.1 t -150.96 151.99 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 110.318 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -169.95 96.24 0.28 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.591 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.2 m -107.88 -154.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.025 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -144.87 109.5 0.52 Allowed Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.621 ' O ' ' CD2' ' A' ' 38' ' ' PHE . 49.0 p90 -83.46 57.81 4.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.829 . . . . 0.0 110.437 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -179.01 -60.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.27 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -78.99 2.65 19.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 8.7 tmm_? 60.46 84.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.771 -0.581 . . . . 0.0 111.252 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' GLY . 22.5 tt0 -167.17 120.38 0.97 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.977 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -113.65 118.21 33.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.022 -1.049 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.3 t -107.94 124.45 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.748 -1.22 . . . . 0.0 107.825 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' A' ' 57' ' ' LEU . 8.7 p -134.49 150.07 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.478 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.608 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.95 157.68 21.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 33.3 p90 -171.44 -176.16 1.78 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.346 -1.342 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -106.79 113.52 27.07 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -59.72 -10.09 3.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.192 -177.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 51' ' ' LYS . 10.0 t -70.6 -28.01 64.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 110.643 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' N ' HG21 ' A' ' 50' ' ' THR . 11.1 mtpt -124.13 -14.08 7.12 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.88 -1.137 . . . . 0.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -141.24 -170.64 3.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.42 160.14 0.73 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.162 -0.961 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 70' ' ' VAL . 3.9 p -41.01 -44.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.563 -0.711 . . . . 0.0 109.914 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 32.5 tt0 -57.37 -47.77 80.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -27.09 68.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.571 -0.705 . . . . 0.0 110.894 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 45' ' ' VAL . 52.5 mt -70.43 -55.55 8.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.798 -1.189 . . . . 0.0 108.718 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.445 ' N ' HD23 ' A' ' 7' ' ' LEU . 6.5 m -64.34 -20.72 66.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -83.37 -24.85 31.85 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.42 -41.3 69.69 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.62 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 10.7 t -75.16 -39.4 60.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -56.09 -32.27 64.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -86.27 -21.78 27.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.528 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.98 60.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.212 -0.93 . . . . 0.0 108.734 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 104.24 31.77 4.55 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.434 -1.867 . . . . 0.0 108.434 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 24.5 m-85 -138.77 89.75 12.96 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 122.015 -0.697 . . . . 0.0 110.488 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -54.85 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.634 1.333 . . . . 0.0 109.642 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.04 -168.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 111.254 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.99 -179.19 7.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 7.4 p -134.32 156.25 40.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 120.371 -1.456 . . . . 0.0 111.863 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HD2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.65 43.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.129 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.511 ' OXT' ' N ' ' A' ' 6' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.906 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.199 0.523 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.5 87.5 1.58 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 25.6 mm-40 -109.83 157.04 19.6 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.001 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.473 HG21 ' OG1' ' A' ' 46' ' ' THR . 13.8 m -135.77 115.28 12.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 57' ' ' LEU . 11.4 m -121.84 168.05 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -107.98 159.01 16.88 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mp -131.89 152.08 51.28 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.324 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.496 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -122.74 106.1 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.584 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 10.6 p -112.24 88.56 10.76 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.026 -1.046 . . . . 0.0 111.937 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.9 Cg_endo -68.64 -1.19 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.592 1.312 . . . . 0.0 111.338 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.92 12.67 47.83 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.99 -164.45 0.99 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.336 -1.097 . . . . 0.0 110.338 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.52 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.7 t 179.77 -4.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 13.8 p -172.2 -158.77 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 119.72 -1.863 . . . . 0.0 110.273 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 62.57 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.203 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -162.27 -42.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 111.333 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 10.3 p -108.09 -25.05 0.17 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.5 Cg_endo -78.28 -37.76 0.7 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 N-CA-C 106.75 -2.058 . . . . 0.0 106.75 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.554 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 72.0 mt -63.88 -29.93 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.151 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.521 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 9.4 m -65.91 -20.65 66.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 58.1 t -69.53 -33.23 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.543 ' CD ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -67.92 -37.46 81.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -32.17 73.14 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.103 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -62.68 -56.3 18.98 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.76 -0.588 . . . . 0.0 110.543 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.74 -24.1 67.45 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -76.68 -21.41 55.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.48 1.06 16.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.483 -0.761 . . . . 0.0 109.91 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.6 t -46.61 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.084 -1.01 . . . . 0.0 109.418 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 10.4 pt-20 179.44 -41.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 110.802 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -112.54 -10.26 17.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.52 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 9.6 t -50.45 125.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 110.028 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.61 14.86 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.628 0.727 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -154.93 160.51 41.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.539 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 7.3 p -155.8 163.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.84 -1.163 . . . . 0.0 111.938 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.69 143.59 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.543 HG23 ' CD ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -108.95 127.88 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.042 . . . . 0.0 112.08 -177.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -114.75 49.73 0.83 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.603 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -25.76 -118.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.2 tp10 -41.32 -35.82 0.71 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.55 -1.344 . . . . 0.0 110.718 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -86.43 38.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.0 110.529 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 8.31 86.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 5.8 tt0 -162.07 110.87 1.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.014 -1.054 . . . . 0.0 110.715 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.58 120.23 41.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 110.248 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.6 t -107.94 122.03 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.861 -1.15 . . . . 0.0 108.037 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' HG21 ' A' ' 34' ' ' VAL . 24.6 t -132.94 152.66 36.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 118.141 -1.424 . . . . 0.0 113.332 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -114.59 155.31 26.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.62 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 48.7 p90 -172.51 -178.86 2.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.595 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -106.75 117.13 33.23 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 178.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 24.7 t0 -70.78 0.54 6.91 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.255 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 51' ' ' LYS . 14.0 t -64.62 -16.68 63.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.93 -1.107 . . . . 0.0 109.599 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' N ' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -138.32 -43.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.05 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -104.5 -169.34 1.61 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.766 -0.584 . . . . 0.0 109.721 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.62 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.5 t -178.35 158.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.553 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 2.7 p -41.94 -42.72 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -60.61 -45.83 92.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 108.957 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.415 -0.803 . . . . 0.0 111.075 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 34.8 mt -73.04 -55.82 5.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.586 -1.321 . . . . 0.0 108.302 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 54.4 m -62.76 -20.56 65.09 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -81.49 -28.86 33.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.548 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -69.05 -39.96 78.85 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.283 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 62' ' ' ALA . 13.1 t -75.46 -41.0 56.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' N ' HG22 ' A' ' 61' ' ' THR . . . -58.07 -26.49 62.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.53 -21.84 21.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.857 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.21 -17.49 61.35 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.159 -0.963 . . . . 0.0 108.649 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.51 24.85 4.24 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.3 m-85 -138.66 88.66 13.94 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.631 -0.923 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.84 95.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.853 1.449 . . . . 0.0 110.194 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.522 ' HB3' ' CA ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.5 -163.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 110.861 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -149.04 -171.44 3.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.0 p -139.1 153.44 24.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 111.826 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.53 ' HG3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -155.83 39.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.585 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 71' ' ' LYS . 79.1 mt-30 . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.392 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 88.22 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -110.01 156.66 20.21 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.683 -177.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.552 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 23.4 m -135.1 137.24 42.64 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.597 -0.689 . . . . 0.0 109.258 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 27.9 m -146.77 175.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.538 ' CG2' ' CG ' ' A' ' 71' ' ' LYS . 12.2 t -109.59 162.85 14.01 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.3 mp -130.68 138.99 50.3 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.074 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -112.91 93.8 4.59 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -115.73 101.47 54.13 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.178 -0.952 . . . . 0.0 111.262 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 9.7 Cg_endo -76.36 5.37 4.7 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.628 1.331 . . . . 0.0 111.066 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -82.08 8.29 60.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.609 ' CE ' ' HA ' ' A' ' 18' ' ' PRO . 3.8 ptm -139.87 156.97 46.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.4 -1.059 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.14 39.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -170.46 -178.27 2.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.5 76.26 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.722 -1.236 . . . . 0.0 109.807 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.88 -51.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.055 -1.028 . . . . 0.0 111.357 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.643 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.0 m -90.35 -45.8 0.39 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.894 -1.129 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 17.6 Cg_exo -59.43 -64.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 122.838 0.915 . . . . 0.0 110.759 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 38' ' ' PHE . 26.6 mt -45.48 -27.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.925 -1.109 . . . . 0.0 110.296 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 90.4 m -70.44 -38.17 74.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.801 -1.187 . . . . 0.0 108.771 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 19.7 t -60.01 -26.5 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' CD ' HG23 ' A' ' 36' ' ' VAL . 9.9 tptm -71.83 -43.76 65.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -66.21 -26.91 67.6 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.703 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 27' ' ' LYS . . . -66.63 -48.68 68.69 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.657 -0.652 . . . . 0.0 110.811 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -72.91 -41.49 64.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -0.996 . . . . 0.0 110.345 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.21 -24.07 67.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.538 -0.726 . . . . 0.0 109.276 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -122.24 7.62 9.68 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.434 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.573 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.1 p -50.89 -48.13 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.478 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.26 -84.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.398 -0.814 . . . . 0.0 110.778 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -85.23 0.07 88.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.843 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 14.6 p -44.14 127.93 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.888 -1.36 . . . . 0.0 110.0 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.29 -14.39 14.16 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.669 0.747 . . . . 0.0 109.116 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 2.9 tttm -162.57 161.63 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 9.2 p -150.65 154.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 110.725 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 15.0 t70 -168.99 82.91 0.14 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.7 m -109.23 -163.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.001 0.905 . . . . 0.0 111.475 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.15 93.19 0.15 Allowed Glycine 0 C--N 1.298 -1.552 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.627 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 p90 -54.93 -54.66 39.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.877 . . . . 0.0 109.675 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.14 -24.75 65.04 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.025 -1.047 . . . . 0.0 110.183 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 0.27 57.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' CE ' ' A' ' 12' ' ' MET . 0.2 OUTLIER 46.69 70.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.371 -0.831 . . . . 0.0 111.079 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.49 119.79 0.79 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.41 -0.806 . . . . 0.0 109.981 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -108.19 119.1 38.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.798 -1.188 . . . . 0.0 112.356 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 1.0 OUTLIER -110.13 110.22 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 HG11 ' N ' ' A' ' 46' ' ' THR . 60.2 t -130.45 150.79 34.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.309 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.4 m -109.68 159.43 17.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 54.0 p90 -171.81 -174.86 1.41 Allowed 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.055 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 4.2 m-20 -106.61 126.82 52.75 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 5.9 p-10 -75.01 10.75 1.33 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.61 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.472 HG21 ' HB2' ' A' ' 1' ' ' ALA . 61.5 p -87.28 -36.34 17.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -118.68 -11.27 9.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.088 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -135.7 -174.36 3.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.613 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 3.7 t -178.44 154.48 0.8 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.895 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 34.3 m -42.59 -38.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.253 -0.904 . . . . 0.0 109.488 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.6 tt0 -64.01 -47.25 81.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -62.0 -26.91 68.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.586 HD13 ' CE2' ' A' ' 47' ' ' PHE . 45.7 mt -69.65 -54.68 12.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.856 -1.152 . . . . 0.0 108.306 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.546 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.0 OUTLIER -65.55 -17.34 64.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.6 ttpt -86.15 -21.64 27.46 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.474 -0.766 . . . . 0.0 109.183 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.15 50.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.576 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.556 HG22 ' CB ' ' A' ' 68' ' ' SER . 1.9 t -79.94 -36.26 36.49 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -64.46 -27.72 69.18 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 m-20 -84.76 -20.29 31.3 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -19.56 60.66 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.36 28.76 2.93 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.624 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 21.6 m-85 -134.83 105.0 10.64 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.717 -0.872 . . . . 0.0 110.642 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 7.6 Cg_exo -49.39 101.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 61' ' ' THR . 53.0 p -107.82 158.22 17.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 112.05 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.495 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.3 t -126.84 -178.15 4.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.9 p -142.91 150.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 120.761 -1.212 . . . . 0.0 111.069 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' CG ' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -168.26 51.09 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.801 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.5 tt0 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 117.955 -1.022 . . . . 0.0 111.368 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.58 86.07 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.92 153.6 23.32 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.231 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.521 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 19.0 m -135.15 132.26 37.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.539 -0.725 . . . . 0.0 109.918 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' CG1' ' A' ' 54' ' ' VAL . 21.5 m -135.51 171.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.603 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.44 154.98 20.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.2 mp -130.01 157.12 43.22 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.155 -1.418 . . . . 0.0 111.214 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.462 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -127.31 112.15 14.72 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.358 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 62.0 t -116.85 74.56 6.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.923 -1.11 . . . . 0.0 111.408 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HG3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 Cg_endo -67.27 -5.52 14.02 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.591 1.311 . . . . 0.0 111.226 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -54.39 -23.16 25.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.617 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.5 -178.8 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 109.279 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 12' ' ' MET . 0.9 OUTLIER 177.91 75.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.021 -1.05 . . . . 0.0 110.721 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -149.33 -55.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 117.893 -1.523 . . . . 0.0 111.603 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . 176.67 -27.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.413 -1.429 . . . . 0.0 111.363 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -115.24 -40.42 3.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.611 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 7.6 m -66.3 -47.45 59.99 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.124 -0.985 . . . . 0.0 111.202 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 2.1 Cg_endo -62.54 -37.86 55.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.57 -24.6 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 21.6 m -62.97 -20.12 64.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 41.6 t -74.18 -33.45 35.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -62.48 -35.5 79.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' CE ' ' HE3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -67.14 -44.51 79.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.987 0.899 . . . . 0.0 109.837 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -57.35 -52.35 65.7 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -63.74 -41.22 98.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.017 -1.052 . . . . 0.0 109.854 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -63.11 -21.41 66.17 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HE3' ' CE ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -108.44 -2.11 19.3 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.414 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -46.01 -53.16 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -0.915 . . . . 0.0 109.541 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER 153.62 -72.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.79 0.805 . . . . 0.0 109.562 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -83.55 -16.72 67.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 14.4 p -38.75 122.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 110.348 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 m -112.68 -12.7 13.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.612 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 1.2 tttt -143.62 155.64 44.33 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.206 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.502 ' CG2' ' C ' ' A' ' 33' ' ' LYS . 4.3 t -151.23 129.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.662 0.744 . . . . 0.0 110.707 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 65.3 m-20 -155.02 89.2 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.4 m -109.42 -159.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 122.15 0.976 . . . . 0.0 111.816 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' CG ' ' A' ' 40' ' ' LYS . . . -149.93 113.93 0.63 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -49.99 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.731 -0.864 . . . . 0.0 111.825 -178.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -33.59 -33.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.337 -0.852 . . . . 0.0 111.372 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 41' ' ' ARG . 16.2 ptmt -89.6 51.41 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.501 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -13.42 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.411 0.624 . . . . 0.0 112.557 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' LYS . 18.3 mt-10 -152.22 112.79 4.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 110.156 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.21 115.67 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.903 -1.123 . . . . 0.0 111.095 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 8.2 t -107.53 116.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.642 -1.286 . . . . 0.0 108.298 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 4' ' ' THR . 11.8 m -132.43 162.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.245 -1.382 . . . . 0.0 113.354 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.612 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.6 m -119.07 162.35 18.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 3' ' ' GLN . 38.7 p90 -172.17 -175.22 1.39 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.959 -1.496 . . . . 0.0 111.815 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.29 116.95 32.82 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 7.8 p-10 -67.91 -2.07 6.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.373 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -24.74 44.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.008 -1.058 . . . . 0.0 110.614 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -125.72 -3.33 7.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.048 -1.033 . . . . 0.0 110.463 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.43 -168.42 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 109.882 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.6 p 179.7 164.71 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.555 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 4.1 m -43.2 -33.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.361 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.401 ' N ' ' CG2' ' A' ' 54' ' ' VAL . 3.0 tt0 -65.77 -47.87 73.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.472 -0.768 . . . . 0.0 109.148 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.67 -24.08 66.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.645 -0.66 . . . . 0.0 110.763 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 47' ' ' PHE . 41.7 mt -71.98 -55.82 6.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.814 -1.179 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.2 m -63.96 -19.89 65.47 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 1.6 ttmt -80.81 -27.37 36.6 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -69.73 -43.15 72.93 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.656 -0.817 . . . . 0.0 109.274 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 14.8 t -75.66 -37.38 59.68 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.25 -26.52 66.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.39 -21.63 22.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -72.81 -15.86 61.62 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.613 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 108.28 30.94 3.68 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.617 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 23.3 m-85 -138.29 102.74 8.06 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.639 -0.918 . . . . 0.0 110.603 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.09 98.92 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.564 1.297 . . . . 0.0 109.396 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.48 ' OG ' ' CG2' ' A' ' 58' ' ' THR . 12.4 p -107.95 -166.39 1.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.235 -0.916 . . . . 0.0 111.604 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.6 t -163.84 126.74 2.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.552 ' HA ' HD13 ' A' ' 7' ' ' LEU . 6.6 p -91.69 161.84 2.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.868 -1.145 . . . . 0.0 110.958 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLN . 3.9 ptmt -145.86 42.22 1.22 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.563 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 71' ' ' LYS . 8.2 mp0 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -147.45 89.72 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 3.9 mm100 -109.61 158.28 18.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.76 0.79 . . . . 0.0 111.627 -177.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.47 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 96.9 m -137.08 141.74 42.36 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.659 -0.651 . . . . 0.0 109.398 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.538 ' CG2' HD11 ' A' ' 57' ' ' LEU . 4.7 m -146.1 165.54 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.001 . . . . 0.0 109.766 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 13.6 t -107.42 151.84 25.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.577 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.4 mp -125.95 156.81 39.2 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 120.957 -1.09 . . . . 0.0 110.668 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -137.24 107.47 6.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.994 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 1.9 t -108.22 102.41 46.31 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.176 -0.952 . . . . 0.0 110.776 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.0 Cg_endo -71.11 9.95 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.366 1.377 . . . . 0.0 112.4 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.51 -5.71 42.15 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.508 -1.37 . . . . 0.0 110.167 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.584 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 4.2 mmm -93.39 151.25 19.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.207 -1.172 . . . . 0.0 110.179 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 12' ' ' MET . 9.3 t -179.04 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.134 -0.979 . . . . 0.0 111.543 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 179.03 162.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.678 -1.264 . . . . 0.0 109.536 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.16 79.86 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.708 -1.245 . . . . 0.0 110.483 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 178.13 -56.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.007 -1.058 . . . . 0.0 111.007 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.604 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.0 m -86.92 -45.15 0.54 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.236 -0.915 . . . . 0.0 111.873 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 21.1 Cg_exo -54.8 -52.19 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.51 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 27.6 mt -59.17 -23.82 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.632 -0.667 . . . . 0.0 110.105 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 37.2 m -65.75 -26.74 67.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 108.544 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 25' ' ' LEU . 33.1 t -69.89 -26.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HB2' HG23 ' A' ' 36' ' ' VAL . 14.2 tttt -68.58 -44.42 74.44 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 mptp? -67.45 -29.61 69.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.363 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 28' ' ' VAL . . . -59.29 -45.08 92.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.278 0.561 . . . . 0.0 109.891 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -66.9 -47.87 70.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.861 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.412 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 8.3 t -66.12 -11.46 49.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.479 -0.763 . . . . 0.0 109.006 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -110.58 -9.3 14.56 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.069 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.594 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.0 t -48.79 -58.34 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.106 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 154.79 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.606 0.717 . . . . 0.0 110.072 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.01 -8.07 87.97 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' LEU . 2.5 t -43.72 122.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 109.38 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.37 -11.17 15.23 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -156.23 161.17 40.3 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' A' ' 33' ' ' LYS . 12.9 t -150.0 152.27 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.028 -1.045 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 6.4 t0 -167.69 82.8 0.2 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.2 m -109.24 -165.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 111.773 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -152.07 95.35 0.16 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -46.06 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.707 -0.878 . . . . 0.0 111.666 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.2 mm-40 1.53 -75.31 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.201 0.524 . . . . 0.0 112.035 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -62.49 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 108.734 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 143.49 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 122.864 0.466 . . . . 0.0 109.91 178.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 19.5 mt-10 -134.29 116.78 15.67 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.18 115.38 29.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 0.0 111.606 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 3.0 t -106.83 124.16 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.713 -1.242 . . . . 0.0 107.71 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 3.9 p -139.34 161.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.457 -1.297 . . . . 0.0 113.536 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.8 m -121.39 157.66 29.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 47.9 p90 -171.63 -174.39 1.37 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.922 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 82.3 m-20 -106.76 123.46 48.17 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -71.88 1.9 6.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.032 -177.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.427 HG21 ' CB ' ' A' ' 1' ' ' ALA . 24.7 p -78.87 -27.33 44.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.961 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -122.58 -18.04 6.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -138.38 -169.9 2.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.372 -0.83 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -177.99 159.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 11.7 m -42.8 -42.58 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' N ' ' CG2' ' A' ' 54' ' ' VAL . 6.3 tt0 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.065 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -65.49 -24.17 67.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.57 -0.706 . . . . 0.0 111.011 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.552 HD12 ' CG1' ' A' ' 45' ' ' VAL . 23.0 mt -75.5 -52.83 9.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 0.0 108.289 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.504 ' N ' HD22 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -66.66 -18.76 65.54 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -84.15 -25.72 29.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.536 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -70.98 -42.34 69.8 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.944 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 21' ' ' VAL . 11.7 t -77.17 -38.78 51.0 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.34 -25.27 65.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.52 -25.93 28.44 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -13.29 60.88 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.66 32.69 3.3 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -135.16 84.17 37.09 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.691 -0.888 . . . . 0.0 110.21 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -54.19 97.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.781 1.411 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.518 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 49.5 p -107.8 -165.59 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.889 0.852 . . . . 0.0 111.886 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -153.44 126.19 8.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.577 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 6.7 p -95.05 159.72 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.93 -1.106 . . . . 0.0 110.431 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.542 ' HG2' ' CG2' ' A' ' 6' ' ' THR . 0.4 OUTLIER -151.3 51.49 0.84 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.224 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.482 ' O ' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.24 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.29 89.21 1.7 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 152.35 44.75 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.926 0.87 . . . . 0.0 111.943 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -121.0 152.66 38.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.446 0.641 . . . . 0.0 109.873 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 54' ' ' VAL . 16.0 m -142.51 174.34 5.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 11.1 t -108.17 160.97 15.41 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.4 mp -130.68 141.77 50.42 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.878 -1.529 . . . . 0.0 111.707 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.491 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -110.39 101.21 9.95 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 13.3 p -112.55 79.64 3.22 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 111.051 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.7 Cg_endo -68.11 -3.38 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.766 1.403 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -56.24 -17.28 17.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.561 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -154.18 -171.25 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 110.027 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 12' ' ' MET . 7.0 t 179.93 58.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -160.31 173.64 15.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.305 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -73.89 78.72 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 110.59 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.16 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.189 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 2.6 m -91.77 -44.7 0.36 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 4.9 Cg_exo -61.03 -44.59 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.581 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 85.4 mt -57.67 -29.66 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.967 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 14.6 m -65.46 -28.43 69.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 108.695 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' HD13 ' A' ' 25' ' ' LEU . 98.0 t -68.31 -27.42 36.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' CD ' ' HB ' ' A' ' 36' ' ' VAL . 5.9 tttt -69.84 -43.2 72.43 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.4 mptt -64.99 -25.01 67.68 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.351 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 60' ' ' ALA . . . -68.48 -43.27 77.28 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.777 -0.577 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -69.19 -41.89 76.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.055 -1.028 . . . . 0.0 109.64 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.52 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 2.9 p -67.4 -18.17 65.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -99.75 -9.65 22.77 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.903 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.5 t -45.32 -63.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.039 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 1.4 tt0 160.28 -64.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.355 0.597 . . . . 0.0 109.782 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -93.4 -6.91 62.37 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.565 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 26' ' ' SER . 13.7 p -41.77 129.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 109.732 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 m -108.24 -10.85 15.32 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.369 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -164.93 159.54 18.28 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.296 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 33' ' ' LYS . 60.4 t -147.49 160.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.838 -1.164 . . . . 0.0 111.581 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 44' ' ' VAL . 8.3 t70 -136.84 135.65 38.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' HB ' ' CD ' ' A' ' 22' ' ' LYS . 1.6 p -109.39 127.31 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.888 -1.133 . . . . 0.0 112.07 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -109.45 59.34 0.36 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.581 ' HB3' ' CG1' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -28.77 -110.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.373 0.606 . . . . 0.0 112.498 -177.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -50.9 -50.18 57.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.572 -1.33 . . . . 0.0 112.134 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.2 tmmm? -55.21 -14.04 1.54 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.0 111.506 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 tmm_? 61.45 84.01 0.14 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.432 -0.792 . . . . 0.0 111.216 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -171.8 120.51 0.46 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.398 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -114.04 119.55 37.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 110.487 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -107.36 123.62 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 57' ' ' LEU . 14.8 p -133.96 152.07 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.664 -1.214 . . . . 0.0 113.752 -176.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -113.16 152.33 29.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 35.0 p90 -170.45 -179.91 3.15 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 5.8 m-20 -107.11 123.69 48.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -67.34 -2.45 6.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.285 -177.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -81.57 -23.43 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 110.154 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -125.52 -5.84 7.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.155 -0.965 . . . . 0.0 110.479 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.15 -170.07 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.573 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.71 158.93 0.71 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 5' ' ' VAL . 17.4 m -41.84 -41.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' N ' HG22 ' A' ' 54' ' ' VAL . 22.2 tp60 -60.59 -45.61 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.392 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.61 -25.97 67.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.639 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.535 HD12 ' CG1' ' A' ' 45' ' ' VAL . 39.5 mt -72.62 -56.32 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.893 -1.129 . . . . 0.0 108.346 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 3.2 m -64.45 -17.74 64.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 4.2 ttmm -81.73 -27.95 33.63 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -71.41 -43.61 66.45 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.071 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.528 HG21 ' N ' ' A' ' 62' ' ' ALA . 9.9 t -74.29 -36.25 63.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' N ' HG21 ' A' ' 61' ' ' THR . . . -60.9 -29.77 69.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -90.28 -15.51 31.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.28 178.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.9 -18.82 58.06 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 117.48 23.91 3.62 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -142.13 90.56 8.25 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.571 -0.958 . . . . 0.0 109.993 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.71 97.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.63 1.332 . . . . 0.0 110.103 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.5 p -108.5 -163.21 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.874 . . . . 0.0 111.036 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -147.3 -175.37 4.81 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.585 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.2 p -139.56 142.08 33.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.817 -1.177 . . . . 0.0 112.184 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' CD ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -131.77 79.95 1.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.457 0.646 . . . . 0.0 109.595 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.436 ' HG3' HG13 ' A' ' 5' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -157.44 90.79 1.12 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -114.54 158.0 22.24 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.6 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.535 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 50.0 m -136.64 121.57 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.665 -0.647 . . . . 0.0 109.321 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.539 ' CG2' HD11 ' A' ' 57' ' ' LEU . 5.1 m -131.97 172.8 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.477 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 7' ' ' LEU . 10.6 t -108.48 157.33 18.54 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.576 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.6 mp -126.17 156.56 39.97 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.002 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -132.33 103.33 6.15 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' CG ' ' A' ' 12' ' ' MET . 1.6 t -108.71 102.76 49.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.526 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 4.6 Cg_endo -71.37 2.19 4.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.198 1.265 . . . . 0.0 111.8 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.41 -1.0 60.87 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.598 ' HE3' ' CD1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -107.16 161.2 14.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -1.22 . . . . 0.0 110.055 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 179.01 32.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.102 -0.999 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -173.19 170.37 4.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.739 -1.226 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 78.31 3.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 19' ' ' ILE . . . -179.8 -48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.588 ' CB ' ' HE2' ' A' ' 12' ' ' MET . 6.1 m -93.66 -44.72 0.31 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.978 -1.076 . . . . 0.0 112.048 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 1.5 Cg_endo -65.45 -38.11 27.27 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 107.661 -1.707 . . . . 0.0 107.661 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG13 ' CE1' ' A' ' 38' ' ' PHE 0.267 6.7 tt -59.21 -36.16 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.402 1.096 . . . . 0.0 108.711 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 49.9 m -63.44 -21.31 66.23 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.5 t -69.77 -33.09 54.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 27.5 tttm -66.16 -41.23 90.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -25.65 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.182 179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB3' ' C ' ' A' ' 60' ' ' ALA . . . -69.51 -55.6 9.75 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.687 -0.633 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.565 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -60.95 -37.23 81.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -70.37 -20.49 62.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 108.978 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -112.88 10.72 19.07 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.18 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 11.6 p -66.35 -44.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.457 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.44 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.476 -0.765 . . . . 0.0 111.269 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -90.27 0.98 79.07 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.271 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 7.3 p -42.86 128.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.922 -1.34 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -113.87 -14.87 12.45 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.596 0.713 . . . . 0.0 109.58 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -156.7 159.77 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.435 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 45' ' ' VAL . 13.4 p -152.65 157.4 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 111.08 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t0 -170.54 87.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.569 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 6.1 m -108.02 -159.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.885 . . . . 0.0 111.783 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.12 115.19 0.82 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.638 ' CE1' HG13 ' A' ' 19' ' ' ILE . 2.6 m-30 -56.6 -105.66 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 O-C-N 122.216 -0.579 . . . . 0.0 109.713 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 9.3 tt0 -47.87 -34.21 8.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.358 -1.464 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 33.4 tttt -52.78 -41.97 64.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.077 -1.014 . . . . 0.0 110.7 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER 81.37 70.03 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.425 0.631 . . . . 0.0 110.989 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -170.83 120.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.755 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.99 115.62 29.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.949 -1.094 . . . . 0.0 111.993 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.3 t -107.97 117.16 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 33' ' ' LYS . 21.8 t -137.3 155.5 32.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.228 -1.389 . . . . 0.0 113.09 -177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.8 m -114.9 160.55 19.39 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 3' ' ' GLN . 53.4 p90 -171.82 -176.52 1.75 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.796 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.63 114.78 29.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -62.67 -9.01 7.65 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.59 -177.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.4 t -67.59 -26.92 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.013 -1.054 . . . . 0.0 109.574 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -0.9 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.456 -0.778 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -148.35 -168.81 3.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 179.73 156.15 0.59 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.846 . . . . 0.0 109.62 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 8.2 m -44.74 -39.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.347 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.499 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.02 -43.74 97.87 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.327 -0.858 . . . . 0.0 109.105 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.24 -25.17 67.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.443 -0.786 . . . . 0.0 110.736 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.545 HD13 ' CE1' ' A' ' 47' ' ' PHE . 54.4 mt -69.57 -56.1 8.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.861 -1.149 . . . . 0.0 108.704 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.487 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 3.0 m -64.65 -21.43 66.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 27.3 mttp -81.43 -23.85 37.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 28' ' ' VAL . . . -73.47 -44.18 58.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.325 -0.86 . . . . 0.0 108.933 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 62' ' ' ALA . 11.5 t -75.59 -35.34 60.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -62.12 -29.78 70.57 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 40.3 t0 -79.21 -23.73 43.61 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.28 59.97 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.618 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.71 32.94 3.21 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 25.2 m-85 -137.35 84.62 23.33 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.681 -0.894 . . . . 0.0 110.262 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.19 97.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.67 1.353 . . . . 0.0 109.235 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.534 ' OG ' ' CG2' ' A' ' 9' ' ' VAL . 12.6 t -108.03 -172.03 1.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.887 0.851 . . . . 0.0 112.12 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.58 121.55 8.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -92.86 156.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.808 -1.182 . . . . 0.0 110.572 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -154.78 45.43 0.52 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.339 -1.344 . . . . 0.0 110.841 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.523 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.838 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.3 t -178.05 107.65 0.05 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.289 1.042 . . . . 0.0 108.725 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.656 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.7 pt20 -130.24 173.62 10.61 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.158 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.486 ' CG2' ' O ' ' A' ' 45' ' ' VAL . 7.0 m -126.37 137.82 53.49 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.578 -0.701 . . . . 0.0 109.737 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' HD11 ' A' ' 57' ' ' LEU . 33.7 m -133.13 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.91 157.01 18.1 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.59 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.47 152.4 50.51 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.814 -178.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.477 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.39 117.26 23.32 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.632 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.551 ' CG1' HG23 ' A' ' 21' ' ' VAL . 98.9 t -112.56 75.94 1.93 Allowed Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 120.845 -1.159 . . . . 0.0 112.184 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 68' ' ' SER . 5.9 Cg_endo -69.27 -13.95 36.79 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.222 1.117 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -43.89 -42.19 6.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.533 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . 83.5 mmm -153.39 140.14 19.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -1.067 . . . . 0.0 110.044 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.487 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 2.4 t -134.6 78.36 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 110.878 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -147.68 -142.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.035 -1.04 . . . . 0.0 108.881 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.11 64.81 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.805 -1.184 . . . . 0.0 109.335 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -179.04 -54.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.048 -1.032 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.641 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.1 m -77.29 -48.38 2.45 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 120.835 -1.165 . . . . 0.0 111.601 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 27.3 Cg_exo -51.02 -56.19 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.082 1.043 . . . . 0.0 109.776 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -57.66 -27.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.767 -0.583 . . . . 0.0 110.42 179.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 67.8 m -66.43 -24.54 66.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.741 -1.225 . . . . 0.0 108.717 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 57.3 t -69.17 -31.72 51.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HA ' HD11 ' A' ' 25' ' ' LEU . 17.4 tttm -70.51 -40.16 73.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -68.51 -21.05 64.61 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.451 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -72.51 -53.47 11.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.706 -0.621 . . . . 0.0 110.321 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.574 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.55 -30.13 70.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.0 109.373 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.8 -27.43 61.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.502 -0.749 . . . . 0.0 109.16 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.44 6.89 37.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.264 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 2.5 t -56.13 -77.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' N ' HG13 ' A' ' 28' ' ' VAL . 1.0 OUTLIER 177.89 -81.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.3 -1.06 87.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.492 ' CG2' HG22 ' A' ' 34' ' ' VAL . 5.4 p -42.11 133.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.206 -1.173 . . . . 0.0 110.582 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -110.15 -17.94 13.43 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 3.5 tttt -167.63 158.63 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.165 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.509 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 24.4 t -154.64 145.12 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.773 -1.204 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -141.66 154.67 45.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 35' ' ' ASP . 46.6 t -155.29 158.48 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.352 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -124.3 81.94 0.35 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -35.93 -101.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 122.276 -0.544 . . . . 0.0 111.812 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -28.8 -44.03 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.474 -0.766 . . . . 0.0 111.025 -179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -89.8 50.8 1.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -10.38 76.84 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' LYS . 5.6 tm-20 -149.82 109.6 4.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' CB ' HG21 ' A' ' 36' ' ' VAL . . . -110.17 126.79 54.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.815 -1.178 . . . . 0.0 111.431 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.47 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 1.0 OUTLIER -108.08 120.84 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG1' HD12 ' A' ' 57' ' ' LEU . 9.9 p -126.02 156.06 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.589 1.185 . . . . 0.0 113.955 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -121.43 153.31 38.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.692 ' O ' ' HA ' ' A' ' 2' ' ' THR . 43.9 p90 -172.31 179.86 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 117.879 -1.528 . . . . 0.0 111.294 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 8.0 m-20 -106.54 112.33 25.28 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -62.45 -8.22 5.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.985 -177.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 t -71.6 -10.26 59.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.996 -1.065 . . . . 0.0 110.155 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -132.39 -39.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -123.79 -169.96 2.04 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.724 -0.61 . . . . 0.0 109.696 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' ' C ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.28 154.28 5.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p -41.07 -30.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.844 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' N ' HG11 ' A' ' 54' ' ' VAL . 22.3 tt0 -70.08 -50.03 45.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -22.38 65.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.557 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 42.3 mt -72.27 -51.56 20.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.641 -1.287 . . . . 0.0 108.155 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -65.91 -19.31 65.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -82.57 -24.05 34.15 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . . . -72.7 -43.05 63.53 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.94 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.531 HG21 ' N ' ' A' ' 62' ' ' ALA . 8.3 t -76.46 -38.29 55.63 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.531 ' N ' HG21 ' A' ' 61' ' ' THR . . . -61.93 -26.08 67.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.55 -24.24 29.36 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.97 -19.08 62.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 113.03 28.56 3.32 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 17.3 m-85 -134.82 87.55 30.14 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 121.499 -1.0 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.25 100.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.795 1.418 . . . . 0.0 109.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 11.4 p -107.66 -167.91 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.59 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -150.47 129.64 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 6.9 p -99.14 158.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.889 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -137.7 45.58 2.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.657 -1.217 . . . . 0.0 110.915 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.582 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.212 0.53 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -158.94 92.95 1.13 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -118.36 161.27 20.23 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.757 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.464 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 89.6 m -137.68 122.56 18.89 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' ' 72' ' ' GLN . 34.2 m -132.99 174.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.28 163.71 12.79 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.1 mp -135.45 143.74 46.07 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.277 -1.369 . . . . 0.0 111.604 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -114.22 99.3 7.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 7.4 p -112.34 80.08 3.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.117 -0.989 . . . . 0.0 111.932 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.5 Cg_endo -68.54 -1.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.508 1.268 . . . . 0.0 111.221 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.37 -26.52 3.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.552 ' CE ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -149.05 -165.19 2.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -1.234 . . . . 0.0 110.215 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 12' ' ' MET . 5.3 t -179.75 67.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.127 -0.983 . . . . 0.0 111.093 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -166.17 177.32 7.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.05 -1.031 . . . . 0.0 109.334 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.69 74.69 5.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 110.078 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.09 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 111.377 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 10.4 m -89.77 -42.6 0.42 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.98 -1.075 . . . . 0.0 112.88 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.6 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 5.5 Cg_endo -65.18 -41.22 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 38' ' ' PHE . 4.0 mt -61.47 -27.35 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 29.6 m -67.03 -27.98 67.85 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.101 -0.999 . . . . 0.0 108.334 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 84.6 t -64.58 -32.15 56.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 tttm -65.28 -39.26 92.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -68.92 -24.89 64.34 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.885 0.85 . . . . 0.0 109.149 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 60' ' ' ALA . . . -70.89 -56.14 6.92 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.72 -0.612 . . . . 0.0 110.514 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.46 -30.65 70.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 t -72.81 -25.36 61.12 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -108.07 7.13 27.55 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.684 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 11.3 p -61.81 -48.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.95 -1.093 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 165.45 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.0 -1.062 . . . . 0.0 111.238 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -91.82 4.67 78.99 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.124 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.5 p -41.03 129.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.167 -1.196 . . . . 0.0 110.17 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -16.49 13.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -161.9 156.03 21.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.676 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.56 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 45.6 t -150.64 145.49 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.893 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' O ' HG11 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -162.3 92.99 0.84 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.3 m -108.39 -164.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.025 -1.047 . . . . 0.0 111.185 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -140.99 118.94 1.44 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -47.53 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.4 tt0 -35.45 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.019 -1.051 . . . . 0.0 111.538 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.19 30.58 0.46 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.893 -1.13 . . . . 0.0 110.898 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER 6.14 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' LYS . 10.0 tt0 -145.79 112.75 6.06 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.669 -1.27 . . . . 0.0 110.593 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.71 120.65 43.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.874 -1.141 . . . . 0.0 111.979 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.52 115.67 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 46' ' ' THR . 14.5 t -132.04 154.15 39.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.131 -1.428 . . . . 0.0 113.132 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -115.29 158.17 22.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 52.7 p90 -171.91 -177.7 2.0 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.562 -1.255 . . . . 0.0 110.918 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.0 m-20 -107.29 110.64 22.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.17 -12.96 4.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 1' ' ' ALA . 14.4 t -60.44 -32.3 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 110.154 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 -3.73 6.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -142.67 -168.02 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.6 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 22.0 t 179.42 154.8 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.935 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 15.2 m -43.61 -35.47 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.189 -0.944 . . . . 0.0 109.614 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.77 -46.38 78.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.007 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 2.4 mmtp -63.1 -25.37 68.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.547 -0.72 . . . . 0.0 110.271 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 47' ' ' PHE . 61.4 mt -69.88 -55.61 9.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.873 -1.142 . . . . 0.0 108.733 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.462 ' HA ' HD22 ' A' ' 7' ' ' LEU . 1.3 m -62.94 -22.38 66.75 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -81.37 -27.15 34.97 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.49 -0.756 . . . . 0.0 109.213 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -70.18 -42.93 71.78 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.161 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' HG11 ' A' ' 21' ' ' VAL . 12.4 t -75.32 -38.02 60.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -61.49 -24.26 66.47 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.17 -23.76 26.4 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.87 -16.85 60.66 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.07 27.56 3.4 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.7 m-85 -138.05 82.61 24.6 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.567 -0.961 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.85 97.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.672 1.354 . . . . 0.0 109.974 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 10.9 p -108.49 -161.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.781 0.801 . . . . 0.0 111.316 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.5 t -146.32 -170.32 3.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.577 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.5 p -138.98 153.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 O-C-N 120.831 -1.168 . . . . 0.0 111.294 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -157.89 61.72 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.75 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.2 pt20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.425 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.28 0.562 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -160.03 91.72 0.97 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.3 pm0 -127.7 163.15 24.93 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.059 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 12.0 m -125.69 133.97 51.97 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.327 0.584 . . . . 0.0 109.718 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' HD11 ' A' ' 57' ' ' LEU . 7.0 m -135.75 169.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.543 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 13.5 t -108.5 161.99 14.54 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.5 mp -133.79 154.64 50.85 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.487 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -121.48 100.37 6.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 9.3 p -111.67 89.23 10.65 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.176 -0.952 . . . . 0.0 111.522 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HA ' ' NH1' ' A' ' 41' ' ' ARG . 3.7 Cg_endo -68.69 -7.77 21.42 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.596 1.314 . . . . 0.0 110.713 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.82 0.45 57.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.55 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -92.34 176.67 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -1.204 . . . . 0.0 109.987 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.9 -9.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -163.5 -156.75 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.766 -1.834 . . . . 0.0 111.112 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.43 60.21 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.844 -1.16 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -169.94 -40.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 111.09 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m -93.79 -45.82 0.3 Allowed Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.69 -1.256 . . . . 0.0 111.962 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.6 Cg_exo -62.01 -57.88 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 122.965 0.981 . . . . 0.0 109.897 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -54.72 -29.44 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.711 . . . . 0.0 110.76 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 17.9 m -64.28 -27.15 68.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.805 -1.184 . . . . 0.0 109.055 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 73.4 t -67.12 -30.23 48.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 3.8 tttt -70.55 -44.64 67.03 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.02 -23.15 64.04 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.884 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -70.93 -49.03 50.16 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.701 -0.624 . . . . 0.0 110.468 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -61.62 -42.41 98.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 0.0 109.625 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -70.4 -20.19 62.95 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.225 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.03 -7.85 41.53 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.503 -0.748 . . . . 0.0 109.699 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 3.8 t -52.17 -76.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 167.76 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.521 0.677 . . . . 0.0 109.768 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.36 -8.19 49.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 9.9 p -48.59 126.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -1.171 . . . . 0.0 109.907 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.39 -14.6 14.4 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -162.2 160.5 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.56 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 35' ' ' ASP . 67.0 t -149.78 149.58 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.13 -0.981 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB3' HG13 ' A' ' 44' ' ' VAL . 30.3 t0 -167.4 91.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.603 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.0 m -108.39 -156.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.003 0.906 . . . . 0.0 111.345 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -154.37 91.6 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -38.2 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.936 -0.743 . . . . 0.0 111.17 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 13.0 tp10 -34.34 -40.82 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.454 -0.779 . . . . 0.0 110.731 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' GLU . 1.2 tmtp? -87.25 46.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 109.571 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -6.15 72.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -149.82 117.17 6.07 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.838 -1.163 . . . . 0.0 110.321 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -108.88 116.99 33.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.399 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -108.94 109.53 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG11 ' N ' ' A' ' 46' ' ' THR . 40.1 t -129.14 151.16 35.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.98 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.536 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.7 m -109.8 157.57 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 3' ' ' GLN . 50.9 p90 -172.5 -179.03 2.1 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.335 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 7.9 m-20 -107.92 113.98 27.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' HB2' ' NE2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -59.84 -9.89 3.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.937 -178.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.532 HG21 ' N ' ' A' ' 51' ' ' LYS . 9.3 t -64.95 -25.42 67.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.899 -1.126 . . . . 0.0 110.404 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.532 ' N ' HG21 ' A' ' 50' ' ' THR . 2.0 mtmt -126.78 -32.91 2.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -117.71 -167.64 1.37 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.641 -0.662 . . . . 0.0 109.917 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.54 153.04 0.86 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.573 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 24.4 m -43.02 -36.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.754 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.512 ' N ' HG21 ' A' ' 54' ' ' VAL . 4.5 tt0 -67.58 -45.08 76.56 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -60.94 -27.03 67.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.583 HD13 ' CE2' ' A' ' 47' ' ' PHE . 44.8 mt -69.17 -52.58 26.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.242 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.45 ' HA ' HD22 ' A' ' 7' ' ' LEU . 1.5 m -65.52 -17.62 64.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -83.81 -24.5 30.97 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -72.03 -42.3 66.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.829 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 11.5 t -76.61 -38.7 54.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -59.37 -28.24 66.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.1 m-20 -84.46 -24.44 29.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -71.37 -16.45 62.42 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.51 27.81 4.27 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.4 m-85 -135.99 97.13 12.51 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.482 -1.011 . . . . 0.0 110.401 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.11 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.619 1.326 . . . . 0.0 110.054 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.522 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 3.4 p -108.43 -165.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 110.788 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 84.9 p -148.55 -171.91 3.96 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.8 p -139.23 152.08 23.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 110.983 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' HG3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.27 42.68 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.169 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 71' ' ' LYS . 1.4 mt-30 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.018 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.174 0.512 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.79 95.92 1.93 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 2.1 mt-30 -108.74 159.03 17.09 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.627 0.727 . . . . 0.0 110.987 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.527 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 m -139.31 127.74 22.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.912 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.569 ' CG2' HD11 ' A' ' 57' ' ' LEU . 5.3 m -133.32 169.72 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.504 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 14.8 t -108.2 160.33 15.91 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.52 145.64 50.32 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.483 -178.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -117.54 100.49 7.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.558 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 6.5 p -109.66 80.02 1.52 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.123 . . . . 0.0 112.552 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 Cg_endo -67.58 -3.78 10.85 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.467 1.246 . . . . 0.0 110.811 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -41.84 -32.17 0.9 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.558 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 99.2 mmm -146.62 -160.65 1.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.478 -1.013 . . . . 0.0 109.372 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.7 t 179.92 71.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' HA ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -169.49 -178.91 3.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.186 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB1' ' A' ' 16' ' ' ALA . . . -78.79 73.64 5.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.049 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.22 -51.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 m -86.84 -43.99 0.54 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.9 -1.125 . . . . 0.0 112.894 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 2.2 Cg_endo -63.51 -44.57 13.84 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 8.7 mt -64.41 -25.29 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.674 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 62.3 m -64.18 -23.68 67.4 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.738 -1.226 . . . . 0.0 108.059 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 45.0 t -71.0 -32.79 49.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.561 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 3.4 tttt -63.43 -38.43 91.1 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.3 -32.14 72.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.189 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -62.86 -51.57 66.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.569 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -70.62 -27.54 64.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.358 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -25.34 66.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.75 17.37 6.85 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.119 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.543 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 7.6 p -60.58 -47.24 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.4 OUTLIER 175.27 -84.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 110.928 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -100.6 8.41 58.32 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.657 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 9.1 p -40.26 130.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -1.111 . . . . 0.0 110.445 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -110.12 -16.9 13.68 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.748 0.785 . . . . 0.0 108.925 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.42 158.82 27.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.546 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.515 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 7.1 p -157.74 151.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' N ' HG21 ' A' ' 34' ' ' VAL . 7.1 p-10 -169.38 98.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.0 m -109.04 -157.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 112.005 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' N ' HG22 ' A' ' 36' ' ' VAL . . . -147.2 122.98 1.67 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -53.25 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.147 -0.619 . . . . 0.0 111.562 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -23.53 -38.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.557 -0.714 . . . . 0.0 112.912 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 38' ' ' PHE . 2.5 ttpt -81.24 32.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.737 -1.227 . . . . 0.0 111.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 7.5 87.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.6 tm-20 -156.43 110.15 2.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.055 . . . . 0.0 110.21 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -114.02 117.4 31.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.754 -1.216 . . . . 0.0 111.661 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.2 t -108.45 121.23 61.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 33' ' ' LYS . 52.8 t -139.83 152.16 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.079 -1.448 . . . . 0.0 113.144 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.3 m -111.49 162.4 15.14 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 2' ' ' THR . 52.4 p90 -172.69 -176.95 1.59 Allowed 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.489 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 72.6 m-20 -106.58 122.21 45.87 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.511 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -65.62 -4.5 6.27 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.929 -177.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.7 p -76.15 -26.84 56.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 2.2 mmmt -125.61 -6.49 6.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -147.28 -168.45 3.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.616 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 35.4 t -178.17 152.54 0.72 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 70' ' ' VAL . 3.6 p -41.76 -39.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.469 -0.77 . . . . 0.0 109.377 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.62 -45.7 82.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 53' ' ' SER . 1.3 mttt -60.66 -23.64 64.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.465 -0.772 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.594 HD13 ' CE2' ' A' ' 47' ' ' PHE . 32.5 mt -74.4 -51.96 13.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.729 -1.232 . . . . 0.0 108.35 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 1.8 m -64.02 -18.84 64.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.06 -26.79 33.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . . . -71.14 -41.46 70.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.034 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 13.0 t -76.0 -39.51 55.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' THR . . . -60.69 -26.37 67.07 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.64 -19.81 23.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -73.51 -18.07 61.14 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.83 28.42 3.94 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -137.15 101.47 9.27 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.98 . . . . 0.0 110.746 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.53 95.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.662 1.348 . . . . 0.0 109.773 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 12.6 t -108.94 -168.6 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.14 178.35 7.76 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 7' ' ' LEU . 6.4 p -138.29 148.0 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.725 -1.235 . . . . 0.0 112.511 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' CD ' HG23 ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.04 77.47 1.66 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.603 -0.686 . . . . 0.0 109.825 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.209 0.528 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -155.9 93.22 1.43 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -113.81 -171.23 1.86 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.035 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.458 HG22 ' OG1' ' A' ' 46' ' ' THR . 20.4 m -153.0 156.92 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -170.44 169.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.27 1.033 . . . . 0.0 110.34 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 3.7 t -109.73 165.16 11.91 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.55 145.63 50.27 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.624 -1.23 . . . . 0.0 111.664 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' CB ' ' NH1' ' A' ' 41' ' ' ARG . . . -110.56 100.1 8.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 3.4 p -112.03 79.52 2.75 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.04 -1.037 . . . . 0.0 111.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.503 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 4.2 Cg_endo -67.17 -4.66 12.04 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.608 1.32 . . . . 0.0 110.917 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -42.1 -43.49 4.49 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.537 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -139.06 -159.03 0.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -1.077 . . . . 0.0 109.604 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 12' ' ' MET . 3.8 t -179.04 79.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.03 -1.044 . . . . 0.0 110.628 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.6 -177.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.418 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -81.62 70.96 8.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.056 . . . . 0.0 110.292 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -177.31 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 111.679 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 8.3 m -93.93 -43.42 0.31 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 120.803 -1.186 . . . . 0.0 112.646 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.4 Cg_endo -65.64 -37.6 28.16 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 N-CA-C 108.577 -1.355 . . . . 0.0 108.577 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 20' ' ' THR . 1.6 tt -65.28 -33.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.953 0.882 . . . . 0.0 108.973 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 76.0 m -60.74 -20.24 60.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 62.3 t -74.82 -36.12 38.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -60.48 -33.92 73.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.34 -46.68 69.5 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.483 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.77 -57.55 9.79 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.164 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.031 -1.043 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.507 ' CA ' HG23 ' A' ' 34' ' ' VAL . 7.4 t -63.44 -20.06 65.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.6 16.32 5.91 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.598 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.534 ' CG2' ' HG2' ' A' ' 29' ' ' GLU . 4.8 p -55.25 -56.59 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 0.0 110.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 28' ' ' VAL . 5.7 pt-20 170.86 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.92 3.62 16.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.555 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 3.6 p -50.3 134.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.4 -8.63 11.59 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 8.8 ttmm -155.24 160.87 41.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' ' HD3' ' A' ' 22' ' ' LYS . 54.6 t -152.62 137.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.501 0.667 . . . . 0.0 110.337 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.2 m-20 -167.92 92.43 0.36 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.7 m -107.97 -153.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 111.845 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.511 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -147.77 111.99 0.57 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -82.22 65.03 7.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.959 0.885 . . . . 0.0 110.502 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -178.66 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.317 -0.865 . . . . 0.0 108.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -89.88 42.06 1.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.534 ' NH1' ' CB ' ' A' ' 8' ' ' ALA . 3.7 ppt_? 23.46 84.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.114 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 tt0 -150.42 116.16 5.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.464 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.16 117.59 33.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.115 . . . . 0.0 111.222 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -110.01 114.62 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 46' ' ' THR . 56.5 t -138.07 151.07 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.445 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.572 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.5 m -109.43 166.26 11.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 53.2 p90 -172.85 -171.05 0.72 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.885 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -107.28 111.28 23.58 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -61.98 -9.65 7.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 -177.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -75.99 -30.37 58.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.877 -1.14 . . . . 0.0 109.662 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 1.3 10.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.979 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -155.1 -169.37 3.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.62 155.68 0.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.755 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 11.7 m -42.41 -37.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' VAL . 6.1 tt0 -64.04 -46.91 82.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.251 -0.906 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -61.49 -29.75 70.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.452 -0.78 . . . . 0.0 110.027 179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 47' ' ' PHE . 68.0 mt -65.51 -52.9 49.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 69' ' ' SER . 5.5 m -64.35 -18.36 64.58 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 20.1 ttpt -80.58 -27.89 37.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.51 66.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.91 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.537 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 10.2 t -73.23 -35.61 66.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -58.8 -31.46 68.46 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.52 -16.44 28.85 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.573 -0.704 . . . . 0.0 109.466 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -73.46 -18.98 61.06 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.48 23.96 4.58 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -139.34 93.26 10.11 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.614 -0.933 . . . . 0.0 110.557 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.91 95.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.705 1.371 . . . . 0.0 109.432 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 5.4 p -108.39 -159.09 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.853 0.835 . . . . 0.0 111.391 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -151.53 -167.08 2.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.56 ' CG2' HG23 ' A' ' 5' ' ' VAL 0.258 3.3 p -139.4 146.39 25.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.191 -0.943 . . . . 0.0 110.749 -178.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD2' HG22 ' A' ' 6' ' ' THR . 0.8 OUTLIER -160.6 50.22 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.825 -178.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 4.9 pp0? . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.494 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.208 0.528 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.52 86.99 1.84 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 47' ' ' PHE . 4.4 pt20 -120.44 149.37 42.48 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.589 -0.844 . . . . 0.0 112.17 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.556 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -119.16 138.98 52.56 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.646 0.736 . . . . 0.0 110.194 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.549 ' CG2' HD11 ' A' ' 57' ' ' LEU . 35.1 m -130.92 169.76 20.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.588 -0.695 . . . . 0.0 109.171 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.546 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 12.0 t -107.49 159.79 16.15 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.4 mp -133.58 153.33 51.74 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.466 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -124.01 106.06 10.09 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 7.2 p -115.69 78.05 6.65 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.931 -1.106 . . . . 0.0 111.518 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 8.6 Cg_endo -72.53 2.73 4.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.744 1.392 . . . . 0.0 111.351 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -55.36 -29.79 53.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -172.72 119.91 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.676 -0.896 . . . . 0.0 109.4 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 41' ' ' ARG . 2.9 t -143.49 110.0 5.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 13' ' ' THR . 1.8 m -148.55 -61.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.0 109.082 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.76 27.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.613 -0.679 . . . . 0.0 109.871 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -168.68 -40.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 111.646 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 8.2 m -67.2 -44.86 49.95 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.128 . . . . 0.0 112.035 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 4.3 Cg_endo -64.14 -41.65 21.31 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -63.4 -31.92 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.652 0.739 . . . . 0.0 109.317 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 30.8 m -61.7 -23.08 65.88 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.566 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 60.7 t -73.18 -33.66 42.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 65.2 tttt -62.1 -35.08 77.63 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -65.86 -43.02 89.66 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.567 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -55.77 -59.29 5.08 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.75 -0.594 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.566 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -64.65 -29.29 70.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.001 -1.062 . . . . 0.0 109.924 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 22' ' ' LYS . 20.0 m -59.5 -30.3 68.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -135.28 21.93 3.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.792 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.546 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 10.7 p -54.18 -45.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.72 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 110.557 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -97.1 1.69 61.03 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 12.6 p -42.72 128.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.059 -1.26 . . . . 0.0 110.159 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.01 -9.17 15.09 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.432 0.634 . . . . 0.0 109.657 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -166.67 163.03 16.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.361 -0.837 . . . . 0.0 109.549 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.71 162.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.3 t0 -170.72 85.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 23.8 t -106.94 176.29 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.741 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.8 118.36 2.3 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 17.9 p90 -87.24 63.82 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.945 0.878 . . . . 0.0 109.858 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 2.1 tt0 179.58 -63.88 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.2 mtmt -73.26 -2.69 22.89 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.2 tmm_? 59.5 75.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.7 -0.625 . . . . 0.0 110.879 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' O ' HG11 ' A' ' 36' ' ' VAL . 11.3 pt-20 -156.88 122.35 4.7 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.736 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -109.21 115.58 30.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.098 -1.001 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.0 t -109.2 119.37 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 25' ' ' LEU . 24.7 t -135.64 156.88 38.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.017 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.62 154.34 26.19 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 35.3 p90 -170.88 177.88 3.65 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.22 -1.392 . . . . 0.0 111.668 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.37 123.74 48.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.499 ' CG ' ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -69.17 -0.74 6.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.311 -177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.7 p -73.18 -33.29 65.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -121.32 -13.7 8.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.068 -1.02 . . . . 0.0 110.557 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -140.87 -169.25 2.77 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.914 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.8 p 179.76 158.26 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.558 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 5.5 m -41.3 -40.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.769 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -60.97 -49.05 79.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -25.46 68.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.676 -0.64 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 39.2 mt -71.63 -52.87 15.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.775 -1.203 . . . . 0.0 108.621 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 ' N ' HD23 ' A' ' 7' ' ' LEU . 83.8 m -66.05 -19.2 65.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.27 -24.56 34.68 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . . . -72.07 -42.07 66.65 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.989 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 11.5 t -75.72 -38.71 58.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -59.74 -30.29 68.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.5 t70 -86.31 -20.68 28.01 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.03 -19.33 62.52 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 116.78 24.36 3.69 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.1 m-85 -138.42 99.39 8.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.441 -1.035 . . . . 0.0 110.391 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 4.9 Cg_exo -56.76 95.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.65 1.342 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.0 p -109.49 -162.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.858 . . . . 0.0 111.375 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.6 p -156.2 -173.2 4.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.5 p -135.8 156.15 37.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.848 -1.158 . . . . 0.0 110.958 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.546 ' HG2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.94 54.36 0.41 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.415 -1.314 . . . . 0.0 111.766 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.291 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.083 0.468 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -145.35 86.26 1.75 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 26.8 mm-40 -115.45 141.9 47.42 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.136 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.524 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -125.52 122.31 36.22 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.481 0.658 . . . . 0.0 109.719 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 57' ' ' LEU . 14.9 m -117.41 170.93 6.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.456 -0.777 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 14.8 t -107.64 154.3 21.65 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.1 mp -131.29 159.66 37.2 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.255 -1.378 . . . . 0.0 110.922 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . . . -126.83 123.91 38.42 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.969 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 3.7 t -112.48 76.7 2.08 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.02 -1.05 . . . . 0.0 111.542 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 9.4 Cg_endo -73.65 -23.04 17.36 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.111 1.208 . . . . 0.0 111.016 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -46.8 -50.33 15.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.488 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.8 mmm -147.17 158.83 44.08 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.312 -1.111 . . . . 0.0 110.159 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 1.1 t -178.78 112.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.618 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 4.4 p -166.66 -42.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 110.641 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . 178.83 30.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.894 -1.129 . . . . 0.0 110.668 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.564 ' N ' ' CD1' ' A' ' 19' ' ' ILE . . . 179.26 -32.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 110.65 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 50.8 m -70.05 -43.39 19.24 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.974 -1.079 . . . . 0.0 112.003 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.7 Cg_endo -72.72 -47.41 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 N-CA-C 107.126 -1.913 . . . . 0.0 107.126 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.664 ' CG1' ' CD1' ' A' ' 38' ' ' PHE 0.259 3.5 mt -54.95 -33.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 177.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 24.6 m -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 109.158 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.579 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 22.2 t -67.7 -31.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -67.9 -41.82 82.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.0 tmtt? -62.17 -37.95 87.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.567 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -59.54 -58.05 10.29 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.896 -0.503 . . . . 0.0 111.461 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.579 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -62.31 -33.98 75.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.041 -1.037 . . . . 0.0 109.831 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -63.35 -24.75 67.99 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -125.29 15.25 8.35 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.404 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 2.2 p -58.75 -63.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.168 -0.958 . . . . 0.0 111.276 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 28' ' ' VAL . 3.1 mt-10 -165.47 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.713 -1.242 . . . . 0.0 110.721 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.67 6.15 60.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.7 p -39.73 132.17 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.421 -1.046 . . . . 0.0 110.479 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -109.47 -13.03 14.64 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.564 0.697 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 2.9 tttt -165.83 160.58 17.13 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.799 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG11 ' N ' ' A' ' 35' ' ' ASP . 61.2 t -152.28 151.19 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' N ' HG11 ' A' ' 34' ' ' VAL . 1.4 p-10 -168.34 95.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.579 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.1 m -107.85 -158.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.113 0.958 . . . . 0.0 111.824 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 36' ' ' VAL . . . -142.95 115.72 0.95 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 19' ' ' ILE . 3.2 m-30 -52.69 -114.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.045 -0.68 . . . . 0.0 110.257 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.7 mt-10 -36.65 -30.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.044 -1.035 . . . . 0.0 110.548 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.4 mtpt -88.91 50.28 1.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.561 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 40' ' ' LYS . 3.1 ppt_? -16.37 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.544 0.687 . . . . 0.0 112.569 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 40' ' ' LYS . 15.4 tt0 -154.38 111.27 3.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.436 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -110.18 115.24 29.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.769 -1.207 . . . . 0.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 HG13 ' OD2' ' A' ' 35' ' ' ASP . 24.2 t -107.23 120.45 58.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.645 -1.285 . . . . 0.0 107.552 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.534 HG22 ' CD2' ' A' ' 25' ' ' LEU . 19.0 t -131.73 150.84 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.837 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.524 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -110.0 156.09 20.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 38.6 p90 -170.88 -177.27 2.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.14 -1.424 . . . . 0.0 111.797 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.0 m-20 -106.21 112.61 25.71 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -6.04 12.91 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.656 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.32 -18.46 63.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -138.25 -38.2 0.55 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.939 . . . . 0.0 110.479 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -108.15 -168.94 1.43 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.981 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.584 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER 179.26 160.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 110.412 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 3.8 p -41.78 -43.73 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.135 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.424 ' N ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -61.38 -44.24 97.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -0.956 . . . . 0.0 109.316 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 mtpp -64.15 -25.79 68.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.432 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 28.4 mt -72.79 -50.51 23.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.858 -1.151 . . . . 0.0 108.101 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 59.4 m -64.34 -18.14 64.36 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 3.2 ttpp -80.01 -28.88 39.35 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.85 72.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.325 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' HG12 ' A' ' 21' ' ' VAL . 11.1 t -74.42 -36.99 63.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.06 -28.52 67.86 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.99 -19.43 25.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.138 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.5 -14.06 60.4 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.612 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 102.6 35.08 3.91 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.2 m-85 -138.15 96.19 10.24 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.946 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 5.9 Cg_exo -55.34 97.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.636 1.335 . . . . 0.0 108.912 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.481 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -108.02 -177.91 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 111.794 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.16 133.31 17.29 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -99.79 158.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.611 -1.306 . . . . 0.0 111.207 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.536 ' HG2' ' CG2' ' A' ' 6' ' ' THR . 0.2 OUTLIER -154.47 50.73 0.63 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.645 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.1 pp0? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.133 0.492 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.77 91.09 1.35 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 4.3 mm100 -114.12 153.93 28.66 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.649 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.485 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 52.4 m -131.67 129.65 41.04 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 57' ' ' LEU . 31.5 m -133.93 170.85 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.968 -1.082 . . . . 0.0 110.273 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.523 ' CG2' HG21 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.2 159.33 16.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.566 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.31 154.1 50.97 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.337 -177.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -130.11 108.97 10.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.561 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 12.2 p -113.18 83.32 6.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.991 . . . . 0.0 111.203 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 6.9 Cg_endo -70.87 -6.61 19.54 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.624 1.329 . . . . 0.0 110.662 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -46.45 -40.03 10.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.6 mmm -156.56 132.19 9.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.539 -0.977 . . . . 0.0 109.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -133.75 93.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 110.234 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 13' ' ' THR . 0.1 OUTLIER -149.55 -71.45 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.825 -1.172 . . . . 0.0 110.258 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . 179.92 49.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 109.467 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.39 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.413 -0.805 . . . . 0.0 110.43 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.6 m -71.16 -50.63 11.23 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -57.68 -43.12 53.02 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 N-CA-C 107.927 -1.605 . . . . 0.0 107.927 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.22 -28.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.723 0.773 . . . . 0.0 109.816 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 42.6 m -66.47 -23.72 66.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.924 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 25.2 t -68.88 -28.63 40.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.591 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 29.2 tttt -64.15 -45.6 87.75 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 17.9 mmtt -69.58 -20.92 63.64 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.38 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' ALA . . . -72.86 -40.23 65.84 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.683 -0.635 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -77.97 -34.47 51.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 0.0 109.357 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.461 ' HA ' HG12 ' A' ' 31' ' ' VAL . 23.8 t -71.23 -21.82 62.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -110.38 -0.51 17.54 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.297 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 12.6 p -49.04 -45.16 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.91 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 2.2 mt-10 161.09 -83.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.735 -0.603 . . . . 0.0 111.275 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.29 7.39 72.2 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 4.0 p -41.04 134.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.198 -1.178 . . . . 0.0 110.293 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -14.82 14.26 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.813 0.816 . . . . 0.0 108.9 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -161.25 158.69 27.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -150.11 162.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 111.192 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t0 -156.61 151.47 26.0 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.591 ' CB ' ' HB2' ' A' ' 22' ' ' LYS . 1.6 p -154.37 161.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.201 -1.399 . . . . 0.0 111.982 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -137.91 111.48 0.82 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' LYS . 26.1 p90 -54.29 -155.78 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' PHE . 35.2 tt0 5.88 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -38.97 -24.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.496 -1.377 . . . . 0.0 111.737 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.7 tmm_? 62.94 76.97 0.35 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.121 -0.987 . . . . 0.0 111.358 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -165.38 126.41 1.94 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.051 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -125.77 128.36 47.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.8 -1.187 . . . . 0.0 110.245 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 6' ' ' THR . 0.9 OUTLIER -109.11 140.34 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.823 -1.173 . . . . 0.0 108.312 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG1' HD12 ' A' ' 57' ' ' LEU . 7.2 p -149.32 156.01 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.418 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.9 m -125.56 156.74 38.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 50.1 p90 -172.62 -179.61 2.2 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.823 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -107.33 123.48 48.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -65.21 -5.52 7.15 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.85 -177.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 1' ' ' ALA . 6.9 p -62.73 -37.59 87.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.168 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.84 23.27 5.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -169.53 -171.61 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.42 155.59 0.52 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' A' ' 70' ' ' VAL . 5.6 p -43.43 -34.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.533 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -65.3 -46.91 78.49 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.353 -0.842 . . . . 0.0 108.983 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -64.64 -24.64 67.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.62 -0.675 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD13 ' CE2' ' A' ' 47' ' ' PHE . 42.5 mt -72.06 -56.12 6.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.688 -1.258 . . . . 0.0 108.299 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.49 HG22 ' CA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -63.68 -19.74 65.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 2.7 ttpt -81.71 -26.21 34.8 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . -72.35 -41.72 66.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.096 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 62' ' ' ALA . 9.3 t -75.86 -36.85 59.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.509 ' N ' HG21 ' A' ' 61' ' ' THR . . . -60.43 -30.94 69.95 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -90.27 -15.58 31.0 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.47 -21.03 61.28 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 118.27 23.63 3.45 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.3 m-85 -139.39 105.28 7.11 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 0.0 110.561 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 6.3 Cg_exo -57.62 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.517 1.272 . . . . 0.0 109.34 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB2' ' CB ' ' A' ' 9' ' ' VAL . 3.8 t -110.49 -176.26 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.784 . . . . 0.0 111.158 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.49 ' CA ' HG22 ' A' ' 58' ' ' THR . 3.4 t -147.24 -176.43 5.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 9.5 p -134.81 159.68 41.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.681 -1.262 . . . . 0.0 111.657 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.91 47.04 1.01 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.061 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 71' ' ' LYS . 23.7 mp0 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.239 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.07 88.93 1.48 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 mm-40 -114.0 154.76 27.08 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.582 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 16.0 m -127.61 160.32 31.97 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 109.539 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.577 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -166.94 170.69 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.979 0.895 . . . . 0.0 109.798 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -109.27 163.72 13.12 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -135.66 144.2 45.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.93 -1.106 . . . . 0.0 111.303 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -113.82 99.52 7.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 109.487 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 5.4 p -111.19 85.47 5.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.038 -1.039 . . . . 0.0 111.962 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 1.7 Cg_endo -64.77 -6.3 12.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.629 1.331 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.85 2.06 56.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.575 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.33 173.76 6.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 110.613 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' CYS . 3.1 t -179.22 15.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.996 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 179.61 -162.16 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.281 -1.512 . . . . 0.0 110.197 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.83 52.72 2.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 110.28 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 17' ' ' CYS . . . -172.75 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 111.177 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.672 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 51.8 m -152.62 -50.83 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.325 -0.859 . . . . 0.0 111.48 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 9.8 Cg_endo -73.98 -50.31 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 N-CA-C 108.267 -1.474 . . . . 0.0 108.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.2 mt -65.7 -25.38 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.928 0.87 . . . . 0.0 108.692 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.465 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 2.7 m -62.81 -23.93 67.5 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 98.5 t -72.77 -32.98 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 15.1 tttt -59.77 -35.45 74.67 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.4 -37.61 77.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.816 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -61.17 -56.1 24.59 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.612 -0.68 . . . . 0.0 111.042 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -63.49 -32.93 74.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.055 . . . . 0.0 110.176 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.2 p -68.52 -20.19 64.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -120.07 6.85 10.79 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 8.6 p -55.6 -49.31 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.123 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 171.64 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 111.152 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.54 10.44 70.96 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.561 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' CG2' ' CG2' ' A' ' 34' ' ' VAL . 10.6 p -41.89 133.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.126 . . . . 0.0 110.089 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.26 -18.05 13.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 10.6 tttm -163.61 158.39 20.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' CG2' ' CG2' ' A' ' 31' ' ' VAL . 71.4 t -156.15 142.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 111.918 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -141.93 158.68 43.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 9.8 p -154.09 168.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 117.623 -1.631 . . . . 0.0 112.794 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.07 110.65 1.06 Allowed Glycine 0 N--CA 1.48 1.588 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.65 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.429 -0.453 . . . . 0.0 111.742 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 1.1 tt0 -28.68 -31.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.432 -0.793 . . . . 0.0 112.293 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 38' ' ' PHE . 55.2 mttt -80.38 27.81 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.734 -1.228 . . . . 0.0 110.996 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 13.49 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.5 tt0 -165.67 109.65 0.83 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.419 -1.426 . . . . 0.0 111.107 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.08 125.25 53.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.068 -1.02 . . . . 0.0 111.424 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 9.7 p -109.59 114.26 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 25' ' ' LEU . 22.3 t -128.42 150.03 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.468 -1.293 . . . . 0.0 113.113 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -112.42 160.38 17.8 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 50.3 p90 -171.68 -171.46 0.91 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.186 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.4 m-20 -106.57 123.56 48.28 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -71.85 3.54 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.442 -177.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.533 HG22 ' CB ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -85.23 -33.24 22.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.912 -1.118 . . . . 0.0 109.64 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 -4.42 10.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.098 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . . . -145.77 -172.7 3.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.606 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 179.68 153.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.822 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 26.7 m -43.35 -32.72 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.025 -1.047 . . . . 0.0 109.858 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.9 tt0 -68.18 -46.94 69.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 108.874 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 5.0 mttm -63.34 -25.5 68.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.544 -0.722 . . . . 0.0 110.297 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.588 HD13 ' CE2' ' A' ' 47' ' ' PHE . 46.2 mt -71.05 -53.11 15.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.846 -1.159 . . . . 0.0 108.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 61' ' ' THR . 5.1 m -62.27 -24.23 67.16 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -79.23 -28.73 42.49 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.39 -45.42 76.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.477 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 12.9 t -72.29 -38.18 68.83 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 61' ' ' THR . . . -58.64 -27.89 65.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -90.29 -20.69 22.64 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.554 -0.716 . . . . 0.0 109.413 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.09 -17.38 62.0 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.605 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 111.53 27.19 4.22 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.8 m-85 -138.6 92.38 11.6 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.555 -0.968 . . . . 0.0 110.166 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.22 96.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.583 1.307 . . . . 0.0 109.502 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' A' ' 9' ' ' VAL . 8.6 t -108.85 -167.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.392 -0.818 . . . . 0.0 111.34 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -142.87 -167.68 2.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 7' ' ' LEU . 1.6 p -142.9 155.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.944 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.68 53.77 0.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.4 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.516 ' N ' HG22 ' A' ' 5' ' ' VAL . 1.4 tm0? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.446 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.254 0.55 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 90.3 1.59 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mm-40 -109.97 169.33 8.8 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.016 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.474 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 46.7 m -144.02 125.58 14.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.506 -0.746 . . . . 0.0 109.553 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG12 ' CG2' ' A' ' 54' ' ' VAL . 2.7 t -130.28 169.65 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 5.1 t -108.73 159.25 16.91 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mp -133.58 152.03 51.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.208 -1.397 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.0 102.1 7.36 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 2.6 p -110.37 91.32 11.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.851 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.1 Cg_endo -66.29 -11.02 29.63 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.679 1.357 . . . . 0.0 110.305 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.84 48.8 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.543 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -136.42 158.16 45.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -1.154 . . . . 0.0 110.568 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 12' ' ' MET . 10.7 t 179.47 33.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.578 0.704 . . . . 0.0 109.161 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -160.93 127.05 3.92 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -35.68 83.49 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.64 -0.663 . . . . 0.0 111.615 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 177.83 -67.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.194 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 m -82.17 -44.16 1.01 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.945 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 23.7 Cg_exo -54.1 -55.94 3.0 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 38' ' ' PHE . 37.9 mt -53.9 -27.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.828 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 22.6 m -69.08 -30.96 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.003 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.549 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 55.5 t -65.95 -33.24 62.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HA ' HD11 ' A' ' 25' ' ' LEU . 8.0 tttt -70.05 -33.19 71.63 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mmtp -74.37 -29.01 61.37 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.264 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -62.8 -46.47 87.82 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.324 0.583 . . . . 0.0 109.804 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -72.7 -33.69 66.64 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.754 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -64.6 -18.62 65.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.62 8.58 6.41 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.774 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 14.6 p -49.52 -52.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 110.509 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 3.9 pt-20 165.17 -48.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.195 -0.941 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -125.1 2.12 8.38 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.739 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 1.1 t -42.82 130.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.29 . . . . 0.0 109.562 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.51 -13.48 14.56 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -163.6 164.15 24.22 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.47 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 7.2 p -152.82 162.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 111.179 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 34' ' ' VAL . 2.1 m-20 -168.63 80.14 0.14 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 42' ' ' GLU . 33.0 t -108.32 164.99 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.904 0.859 . . . . 0.0 111.556 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -126.42 107.34 0.91 Allowed Glycine 0 N--CA 1.48 1.611 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.46 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.605 -0.938 . . . . 0.0 111.764 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 38' ' ' PHE . 63.3 mt-10 -22.54 -67.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.8 -0.563 . . . . 0.0 112.273 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.638 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 19.5 tptp -42.1 -55.36 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.041 -1.037 . . . . 0.0 110.235 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.638 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.1 tmm_? 99.39 76.5 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 C-N-CA 123.493 0.717 . . . . 0.0 110.815 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -169.0 115.13 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 0.0 110.439 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -108.12 119.95 40.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.636 -1.29 . . . . 0.0 111.502 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.5 t -108.76 118.58 56.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.497 HG13 ' CG2' ' A' ' 31' ' ' VAL . 9.3 t -133.82 157.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.697 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.6 m -116.82 160.94 20.07 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 54.9 p90 -171.99 -175.23 1.44 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.906 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 14.1 p-10 -106.88 112.31 25.22 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -63.61 -9.65 14.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 0.0 110.718 -177.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.499 ' CG2' ' OD2' ' A' ' 48' ' ' ASP . 5.9 t -62.1 -23.72 66.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.01 -1.056 . . . . 0.0 109.776 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' N ' HG21 ' A' ' 50' ' ' THR . 0.0 OUTLIER -130.68 -38.5 1.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 110.317 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -108.0 -168.94 1.44 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.643 -0.66 . . . . 0.0 109.961 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.6 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 31.4 t -179.5 155.68 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.045 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.573 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 6.7 p -42.94 -40.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.624 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 50.4 tt0 -61.88 -44.72 96.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.361 -0.837 . . . . 0.0 109.451 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 38.0 mttp -67.34 -23.27 65.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 47' ' ' PHE . 40.0 mt -71.14 -51.57 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.619 -1.301 . . . . 0.0 108.492 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.488 ' HA ' HD22 ' A' ' 7' ' ' LEU . 1.3 m -64.99 -19.77 66.16 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 7.2 mttt -82.49 -25.47 33.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.65 -44.06 67.9 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.438 -0.789 . . . . 0.0 109.134 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 62' ' ' ALA . 10.2 t -75.84 -38.73 57.73 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -61.49 -24.21 66.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 4.2 m-20 -88.22 -21.92 24.26 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -17.02 60.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.608 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.47 27.94 3.17 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -136.59 91.18 16.17 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.621 -0.929 . . . . 0.0 110.633 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.93 93.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 0.0 110.055 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -108.99 -163.85 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 110.942 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' HG23 ' A' ' 58' ' ' THR . 2.5 t -150.09 -170.86 3.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 7.5 p -139.9 160.06 26.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.993 -1.067 . . . . 0.0 111.452 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -172.07 48.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.408 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 71' ' ' LYS . 38.3 tt0 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.957 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.35 94.11 1.46 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 9.2 mm-40 -110.91 150.22 29.52 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.165 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.441 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 38.4 m -129.51 120.68 25.8 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 72' ' ' GLN . 33.4 m -127.7 170.42 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.539 HG22 ' CD ' ' A' ' 71' ' ' LYS . 15.1 t -108.14 157.6 18.15 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -132.48 152.37 51.56 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.104 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.51 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -120.88 109.19 14.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.566 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 12.4 t -111.47 73.91 1.11 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.725 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 6.6 Cg_endo -67.35 -7.52 19.32 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.317 1.167 . . . . 0.0 111.389 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' O ' ' SD ' ' A' ' 12' ' ' MET . . . -50.08 -42.34 39.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.496 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 65.4 mmm -152.2 163.38 39.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.446 -1.032 . . . . 0.0 109.134 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 39' ' ' GLU . 2.3 t -174.14 108.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 111.181 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 1.3 p -167.26 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 110.347 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . 177.2 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.748 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -123.76 22.79 8.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.671 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 81.8 m -121.23 -66.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.002 -1.061 . . . . 0.0 110.25 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.671 ' CD ' ' HB2' ' A' ' 17' ' ' CYS . 5.2 Cg_exo -52.87 -39.04 79.34 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.476 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -61.36 -38.3 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.641 0.734 . . . . 0.0 109.182 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 23.7 m -61.56 -22.08 64.86 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 11.9 t -77.11 -31.61 18.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.505 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.17 -36.83 85.44 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -74.01 -33.94 63.97 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.539 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -62.31 -49.86 73.96 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 110.794 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.569 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.45 -47.01 77.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 109.863 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 8.8 t -61.1 -17.54 53.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 108.676 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -103.51 -13.22 16.67 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.46 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.8 t -47.54 -57.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.448 -0.782 . . . . 0.0 109.602 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 154.67 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.616 0.722 . . . . 0.0 110.248 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -67.47 -22.75 73.34 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 22.9 t -42.63 121.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.41 -1.053 . . . . 0.0 109.703 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -109.53 -14.8 14.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.571 0.701 . . . . 0.0 109.782 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 21.5 tttt -154.3 155.69 35.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.451 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.484 ' CG1' ' HG2' ' A' ' 22' ' ' LYS . 3.7 t -149.33 153.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -170.45 94.81 0.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -107.63 -152.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.967 0.889 . . . . 0.0 111.742 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' HG22 ' A' ' 36' ' ' VAL . . . -146.59 108.73 0.46 Allowed Glycine 0 N--CA 1.48 1.582 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -81.92 62.25 5.62 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.535 0.683 . . . . 0.0 110.749 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.8 tp10 179.31 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.22 40.51 2.05 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 25.08 79.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.922 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 37' ' ' GLY . 4.3 tp10 -146.09 113.01 6.08 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.395 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -112.32 115.06 28.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.716 -1.24 . . . . 0.0 110.969 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.2 t -108.65 121.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 107.756 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CG2' HD12 ' A' ' 25' ' ' LEU . 75.2 t -136.97 155.03 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.226 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.523 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.3 m -115.92 157.21 24.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' THR . 49.0 p90 -172.8 178.84 2.5 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 117.891 -1.524 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 70.2 m-20 -106.69 120.52 42.21 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -62.75 -8.37 6.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.689 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -66.93 -27.27 67.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.01 . . . . 0.0 110.47 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -128.07 -8.39 5.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.001 -1.062 . . . . 0.0 111.129 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -146.02 -167.67 2.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 110.021 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -178.24 155.53 0.92 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 110.033 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.545 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 24.9 t -43.05 -39.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.7 tt0 -60.9 -46.07 92.1 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.506 -0.746 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.07 -22.04 65.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.412 -0.805 . . . . 0.0 111.028 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 33.8 mt -73.99 -56.75 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.653 -1.279 . . . . 0.0 108.319 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.514 ' N ' HD23 ' A' ' 7' ' ' LEU . 2.5 m -65.1 -20.45 66.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -81.69 -28.34 33.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -68.5 -41.87 79.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.905 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.542 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 11.0 t -74.77 -36.67 62.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.44 -27.19 67.32 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.1 -19.44 24.31 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.99 -18.74 61.32 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.17 27.31 3.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.596 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.2 98.41 9.29 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 110.856 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.08 93.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.611 1.322 . . . . 0.0 109.658 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 12.4 p -108.45 -161.44 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 111.317 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.5 p -156.95 -169.48 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.7 p -135.61 158.87 40.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.886 -1.134 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.539 ' CD ' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -171.54 47.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.756 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 1.4 pp0? . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.112 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.09 0.471 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.7 89.94 1.44 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.673 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 18.6 pt20 -122.21 165.16 16.59 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.792 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' VAL . 11.9 m -128.81 136.1 50.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.681 -0.637 . . . . 0.0 109.694 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.563 ' CG2' HD11 ' A' ' 57' ' ' LEU . 21.0 m -130.32 167.46 25.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.531 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -106.51 157.15 17.87 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.1 mp -133.92 149.27 51.28 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.355 -1.338 . . . . 0.0 111.219 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.488 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -119.94 113.98 21.37 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.756 -0.59 . . . . 0.0 109.45 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 2.3 t -117.06 78.11 9.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.026 -1.046 . . . . 0.0 111.062 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 13.6 Cg_endo -80.7 40.52 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.234 1.289 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.36 2.46 10.45 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -159.49 21.2 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.076 -1.249 . . . . 0.0 110.579 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 39' ' ' GLU . 15.5 m -47.19 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -179.8 112.15 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 108.55 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -26.17 77.01 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 174.74 -49.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.221 -0.925 . . . . 0.0 110.593 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 32.7 m -97.62 -39.41 0.25 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 6.2 Cg_exo -59.89 -38.57 78.41 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 N-CA-C 107.95 -1.596 . . . . 0.0 107.95 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 10.2 mt -63.89 -29.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 6.8 m -65.4 -23.77 67.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 59.8 t -70.21 -29.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -67.37 -39.26 85.66 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 23.0 mmtt -71.04 -29.85 65.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' HB2' ' A' ' 60' ' ' ALA . . . -63.76 -43.65 95.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.76 -0.588 . . . . 0.0 110.367 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -74.84 -36.23 62.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.022 . . . . 0.0 109.451 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.402 ' HA ' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.31 -19.85 65.7 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.4 mptp? -115.21 1.76 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.171 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 12.0 p -52.64 -40.66 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER 165.0 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.425 -0.797 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -99.49 5.96 58.96 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.06 -1.067 . . . . 0.0 110.752 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.497 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 8.1 p -39.49 129.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -1.077 . . . . 0.0 110.189 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.5 t -108.53 -10.99 15.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.469 0.652 . . . . 0.0 109.665 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -164.63 168.22 18.35 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.014 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 34' ' ' VAL . 10.2 p -165.5 152.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.962 . . . . 0.0 110.953 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' HG11 ' A' ' 44' ' ' VAL . 28.1 t0 -163.32 93.69 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG11 ' CA ' ' A' ' 43' ' ' ALA . 20.8 t -108.11 174.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 111.746 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.16 121.44 3.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.597 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 16.3 p90 -55.89 -145.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.56 ' C ' ' O ' ' A' ' 38' ' ' PHE . 14.1 tp10 1.13 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -36.01 -63.1 0.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.318 -0.864 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.689 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.2 tmm_? 103.98 77.47 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 C-N-CA 123.306 0.642 . . . . 0.0 111.17 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' O ' HG11 ' A' ' 36' ' ' VAL . 4.0 tm-20 -168.51 117.56 0.72 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.508 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -112.15 118.93 36.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.108 . . . . 0.0 111.329 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 35' ' ' ASP . 4.2 p -107.35 121.93 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.78 -1.2 . . . . 0.0 108.017 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.544 ' CG1' HD12 ' A' ' 57' ' ' LEU . 3.5 p -129.41 159.02 41.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.79 -1.164 . . . . 0.0 113.184 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -118.01 154.69 31.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' ' 3' ' ' GLN . 38.5 p90 -171.83 179.61 2.71 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.232 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 3.4 m-20 -106.79 117.16 33.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.5 t70 -64.15 -7.14 8.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.883 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.22 -26.2 61.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.935 -1.103 . . . . 0.0 110.196 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -0.54 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.197 -0.94 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -159.41 -166.39 1.78 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.572 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.44 159.16 0.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 8.0 p -41.08 -42.44 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.599 -0.688 . . . . 0.0 110.0 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -60.79 -46.78 89.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.256 -0.902 . . . . 0.0 109.682 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.87 -23.54 67.26 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 35.3 mt -72.49 -52.89 13.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.667 -1.271 . . . . 0.0 108.265 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 69' ' ' SER . 2.1 m -63.94 -21.1 66.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 9.5 ttpt -81.47 -26.58 35.13 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HB2' ' C ' ' A' ' 24' ' ' ALA . . . -71.07 -43.46 67.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.209 -0.932 . . . . 0.0 108.94 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 62' ' ' ALA . 9.4 t -74.23 -38.7 63.46 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 61' ' ' THR . . . -60.15 -27.14 66.85 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -90.21 -19.68 23.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.172 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -16.16 60.72 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 112.03 27.26 4.05 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.84 97.89 8.81 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.617 -0.931 . . . . 0.0 110.515 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.52 96.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.59 1.311 . . . . 0.0 109.4 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.91 -167.19 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 111.536 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -156.56 -172.22 3.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.8 p -133.63 161.8 40.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.595 -1.315 . . . . 0.0 111.444 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -148.07 54.76 1.04 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.721 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 110.238 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.44 87.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -127.08 153.02 46.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.05 -1.032 . . . . 0.0 111.624 -177.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -118.29 154.27 32.57 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.407 0.622 . . . . 0.0 109.634 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.545 ' CG2' HD11 ' A' ' 57' ' ' LEU . 17.5 m -145.76 170.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.342 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.542 ' OG1' ' CG2' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.55 156.48 19.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.1 mp -133.61 147.92 51.52 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.938 -1.505 . . . . 0.0 111.308 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -116.99 112.16 20.58 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG ' ' A' ' 41' ' ' ARG . 71.6 t -109.6 73.4 0.63 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.97 -1.081 . . . . 0.0 111.782 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 68' ' ' SER . 1.9 Cg_endo -58.6 -13.46 17.55 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.477 1.251 . . . . 0.0 110.073 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.64 15.24 31.7 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.571 ' HG2' ' CG ' ' A' ' 41' ' ' ARG . 2.2 ppp? -96.71 -164.71 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -1.221 . . . . 0.0 109.435 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.554 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.6 t 178.5 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.838 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 2.1 p -158.59 -154.16 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.536 -1.352 . . . . 0.0 110.673 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.93 42.5 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.951 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -145.81 -36.83 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.906 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.594 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 13.8 m -89.95 -44.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 0.0 111.757 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.0 Cg_endo -75.96 -43.94 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 N-CA-C 107.902 -1.615 . . . . 0.0 107.902 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.586 HG13 ' CD1' ' A' ' 38' ' ' PHE . 2.9 tt -55.66 -38.3 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.904 0.859 . . . . 0.0 109.635 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 5.2 m -62.8 -23.83 67.44 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.943 0.878 . . . . 0.0 108.636 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 32.6 t -69.32 -31.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.576 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 3.8 tttt -67.65 -41.78 83.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.55 -24.86 65.58 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.378 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -70.63 -54.7 10.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.803 -0.561 . . . . 0.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -59.66 -35.94 75.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.069 -1.02 . . . . 0.0 109.812 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -22.71 60.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.504 -0.748 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.81 -5.7 25.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.895 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.9 t -46.61 -81.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 4.0 tt0 169.93 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.348 -0.845 . . . . 0.0 109.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -104.95 -21.33 9.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 74.1 t -42.2 126.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -1.068 . . . . 0.0 109.79 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -113.13 -9.82 13.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -147.85 156.33 42.6 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.008 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 6.1 p -154.86 129.69 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.683 0.754 . . . . 0.0 111.01 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.68 89.66 1.57 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.2 m -108.32 -160.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.962 0.887 . . . . 0.0 111.47 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -144.57 110.06 0.55 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 4.9 m-30 -52.7 -98.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.019 -0.695 . . . . 0.0 109.927 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HA ' ' HE3' ' A' ' 12' ' ' MET . 1.2 mm-40 -54.42 -12.7 0.74 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.606 -1.309 . . . . 0.0 111.643 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.3 mptt -81.85 -24.83 35.57 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.194 . . . . 0.0 111.002 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' CG ' ' HG2' ' A' ' 12' ' ' MET . 7.4 tmm_? 68.41 63.52 0.35 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.581 -0.699 . . . . 0.0 110.655 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.7 tt0 -162.06 113.95 1.69 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.229 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.73 113.6 26.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.96 -1.087 . . . . 0.0 110.834 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' CG2' ' OG1' ' A' ' 6' ' ' THR . 89.2 t -114.31 121.76 67.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.631 -1.293 . . . . 0.0 108.967 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 4' ' ' THR . 25.8 m -137.66 -179.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 118.234 -1.386 . . . . 0.0 113.789 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.597 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.8 m -127.74 158.41 37.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 30.8 p90 -171.49 178.94 3.04 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.143 -1.423 . . . . 0.0 111.097 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.5 m-20 -107.41 117.7 34.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -63.25 -8.64 8.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 110.958 -177.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.474 HG21 ' N ' ' A' ' 51' ' ' LYS . 4.8 t -74.06 -26.73 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.629 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' N ' HG21 ' A' ' 50' ' ' THR . 1.0 OUTLIER -121.33 -13.22 8.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.498 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -148.14 -165.68 2.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.473 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.48 159.07 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG2' HG23 ' A' ' 70' ' ' VAL . 10.9 p -43.64 -37.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.773 . . . . 0.0 109.763 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -64.85 -44.22 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -0.856 . . . . 0.0 109.357 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 10.2 mtpt -67.68 -22.4 65.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.413 -0.805 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.586 HD13 ' CE2' ' A' ' 47' ' ' PHE . 23.8 mt -74.36 -58.51 3.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.664 -1.273 . . . . 0.0 108.413 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.451 HG22 ' CA ' ' A' ' 69' ' ' SER . 1.3 m -63.07 -21.53 66.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 8.4 ttmt -80.27 -27.97 38.49 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.13 79.41 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.306 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 62' ' ' ALA . 9.4 t -74.19 -38.01 63.76 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 61' ' ' THR . . . -58.72 -27.71 65.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -86.34 -23.4 26.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.3 -14.5 61.32 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.74 30.22 4.1 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.4 m-85 -135.82 94.96 14.27 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.703 -0.88 . . . . 0.0 110.514 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.09 93.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.7 1.369 . . . . 0.0 109.758 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -108.75 -169.06 1.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 111.139 -179.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.451 ' CA ' HG22 ' A' ' 58' ' ' THR . 0.5 OUTLIER -146.48 -174.99 4.61 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.568 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 4.8 p -139.86 150.44 22.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.705 -1.247 . . . . 0.0 112.654 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -134.14 77.62 1.71 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.435 0.636 . . . . 0.0 109.513 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.328 0.585 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -150.4 88.4 1.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 21.6 mm-40 -120.98 155.83 33.45 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.623 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.608 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 5.2 t -136.39 144.23 44.42 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 57' ' ' LEU . 28.3 m -136.46 174.31 12.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.664 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' A' ' 71' ' ' LYS . 12.1 t -107.98 153.49 23.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.57 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -130.41 150.26 51.71 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.444 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.479 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -118.25 115.94 25.76 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -110.99 76.18 1.2 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.019 -1.051 . . . . 0.0 111.49 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.2 Cg_endo -62.8 -15.23 45.61 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.466 1.245 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -55.65 -21.78 30.04 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.636 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.79 -174.5 4.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.955 . . . . 0.0 109.691 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 178.58 75.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 110.724 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.89 -178.61 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.888 -1.133 . . . . 0.0 110.047 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' HB1' ' A' ' 16' ' ' ALA . . . -79.37 75.48 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 109.822 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.53 -45.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.118 -0.989 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 5.3 m -96.84 -45.03 0.25 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.959 -1.088 . . . . 0.0 113.145 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -59.23 -38.23 86.91 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 N-CA-C 108.231 -1.488 . . . . 0.0 108.231 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 19' ' ' ILE . 2.2 tt -63.62 -35.23 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.18 0.99 . . . . 0.0 108.575 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 6.8 m -62.65 -20.75 65.12 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.575 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.9 t -73.81 -32.65 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 18.6 tttm -64.61 -36.13 83.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 26' ' ' SER . 0.1 OUTLIER -66.4 -37.54 85.47 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.25 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . . . -57.56 -59.6 4.92 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.821 -0.55 . . . . 0.0 110.357 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.31 -26.78 68.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 109.572 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 12.9 t -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.93 7.3 7.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.666 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 7.2 p -49.86 -49.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.826 -1.171 . . . . 0.0 110.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.9 -86.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.263 -0.898 . . . . 0.0 111.318 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -84.1 1.95 88.22 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.046 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 6.5 p -43.99 131.18 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.835 -1.391 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.57 -15.43 13.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -164.35 160.1 20.47 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.916 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 ' CG2' ' C ' ' A' ' 33' ' ' LYS . 14.1 t -150.96 151.99 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 110.318 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -169.95 96.24 0.28 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.591 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.2 m -107.88 -154.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.025 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 36' ' ' VAL . . . -144.87 109.5 0.52 Allowed Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.621 ' O ' ' CD2' ' A' ' 38' ' ' PHE . 49.0 p90 -83.46 57.81 4.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.829 . . . . 0.0 110.437 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -179.01 -60.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.27 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -78.99 2.65 19.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 8.7 tmm_? 60.46 84.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.771 -0.581 . . . . 0.0 111.252 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' GLY . 22.5 tt0 -167.17 120.38 0.97 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.977 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -113.65 118.21 33.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.022 -1.049 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.3 t -107.94 124.45 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.748 -1.22 . . . . 0.0 107.825 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' A' ' 57' ' ' LEU . 8.7 p -134.49 150.07 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.478 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.608 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.95 157.68 21.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 33.3 p90 -171.44 -176.16 1.78 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.346 -1.342 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -106.79 113.52 27.07 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -59.72 -10.09 3.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.192 -177.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 51' ' ' LYS . 10.0 t -70.6 -28.01 64.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 110.643 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' N ' HG21 ' A' ' 50' ' ' THR . 11.1 mtpt -124.13 -14.08 7.12 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.88 -1.137 . . . . 0.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -141.24 -170.64 3.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.42 160.14 0.73 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.162 -0.961 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 70' ' ' VAL . 3.9 p -41.01 -44.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.563 -0.711 . . . . 0.0 109.914 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 32.5 tt0 -57.37 -47.77 80.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -27.09 68.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.571 -0.705 . . . . 0.0 110.894 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 45' ' ' VAL . 52.5 mt -70.43 -55.55 8.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.798 -1.189 . . . . 0.0 108.718 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.445 ' N ' HD23 ' A' ' 7' ' ' LEU . 6.5 m -64.34 -20.72 66.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -83.37 -24.85 31.85 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.42 -41.3 69.69 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.62 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 10.7 t -75.16 -39.4 60.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -56.09 -32.27 64.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -86.27 -21.78 27.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.528 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.98 60.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.212 -0.93 . . . . 0.0 108.734 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 104.24 31.77 4.55 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.434 -1.867 . . . . 0.0 108.434 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 24.5 m-85 -138.77 89.75 12.96 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 122.015 -0.697 . . . . 0.0 110.488 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -54.85 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.634 1.333 . . . . 0.0 109.642 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.04 -168.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 111.254 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.99 -179.19 7.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 7.4 p -134.32 156.25 40.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 120.371 -1.456 . . . . 0.0 111.863 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HD2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.65 43.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.129 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' OXT' ' N ' ' A' ' 6' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.906 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.199 0.523 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.5 87.5 1.58 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 25.6 mm-40 -109.83 157.04 19.6 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.001 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.473 HG21 ' OG1' ' A' ' 46' ' ' THR . 13.8 m -135.77 115.28 12.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 57' ' ' LEU . 11.4 m -121.84 168.05 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -107.98 159.01 16.88 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mp -131.89 152.08 51.28 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.324 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -122.74 106.1 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.584 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 10.6 p -112.24 88.56 10.76 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.026 -1.046 . . . . 0.0 111.937 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.9 Cg_endo -68.64 -1.19 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.592 1.312 . . . . 0.0 111.338 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.92 12.67 47.83 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -106.99 -164.45 0.99 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.336 -1.097 . . . . 0.0 110.338 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.52 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.7 t 179.77 -4.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 13.8 p -172.2 -158.77 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 119.72 -1.863 . . . . 0.0 110.273 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 62.57 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.203 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -162.27 -42.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 111.333 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 10.3 p -108.09 -25.05 0.17 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.5 Cg_endo -78.28 -37.76 0.7 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 N-CA-C 106.75 -2.058 . . . . 0.0 106.75 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.554 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 72.0 mt -63.88 -29.93 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.151 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.521 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 9.4 m -65.91 -20.65 66.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 58.1 t -69.53 -33.23 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' CD ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -67.92 -37.46 81.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -32.17 73.14 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.103 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -62.68 -56.3 18.98 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.76 -0.588 . . . . 0.0 110.543 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.74 -24.1 67.45 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -76.68 -21.41 55.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.48 1.06 16.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.483 -0.761 . . . . 0.0 109.91 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.6 t -46.61 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.084 -1.01 . . . . 0.0 109.418 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 10.4 pt-20 179.44 -41.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 110.802 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -112.54 -10.26 17.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.52 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 9.6 t -50.45 125.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 110.028 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.61 14.86 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.628 0.727 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -154.93 160.51 41.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 7.3 p -155.8 163.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.84 -1.163 . . . . 0.0 111.938 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.69 143.59 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.543 HG23 ' CD ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -108.95 127.88 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.042 . . . . 0.0 112.08 -177.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -114.75 49.73 0.83 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.603 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -25.76 -118.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.2 tp10 -41.32 -35.82 0.71 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.55 -1.344 . . . . 0.0 110.718 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -86.43 38.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.0 110.529 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 8.31 86.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 5.8 tt0 -162.07 110.87 1.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.014 -1.054 . . . . 0.0 110.715 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.58 120.23 41.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 110.248 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.6 t -107.94 122.03 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.861 -1.15 . . . . 0.0 108.037 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG2' HG21 ' A' ' 34' ' ' VAL . 24.6 t -132.94 152.66 36.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 118.141 -1.424 . . . . 0.0 113.332 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -114.59 155.31 26.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.62 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 48.7 p90 -172.51 -178.86 2.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.595 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -106.75 117.13 33.23 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 178.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 24.7 t0 -70.78 0.54 6.91 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.255 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 51' ' ' LYS . 14.0 t -64.62 -16.68 63.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.93 -1.107 . . . . 0.0 109.599 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' N ' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -138.32 -43.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.05 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -104.5 -169.34 1.61 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.766 -0.584 . . . . 0.0 109.721 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.5 t -178.35 158.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.553 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 2.7 p -41.94 -42.72 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -60.61 -45.83 92.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 108.957 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.415 -0.803 . . . . 0.0 111.075 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 34.8 mt -73.04 -55.82 5.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.586 -1.321 . . . . 0.0 108.302 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 54.4 m -62.76 -20.56 65.09 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -81.49 -28.86 33.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.548 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -69.05 -39.96 78.85 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.283 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 62' ' ' ALA . 13.1 t -75.46 -41.0 56.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' N ' HG22 ' A' ' 61' ' ' THR . . . -58.07 -26.49 62.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.53 -21.84 21.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.857 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.21 -17.49 61.35 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.159 -0.963 . . . . 0.0 108.649 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.51 24.85 4.24 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.3 m-85 -138.66 88.66 13.94 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.631 -0.923 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.84 95.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.853 1.449 . . . . 0.0 110.194 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.522 ' HB3' ' CA ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.5 -163.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 110.861 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -149.04 -171.44 3.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.0 p -139.1 153.44 24.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 111.826 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.53 ' HG3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -155.83 39.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.585 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 71' ' ' LYS . 79.1 mt-30 . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.392 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 88.22 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -110.01 156.66 20.21 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.683 -177.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.552 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 23.4 m -135.1 137.24 42.64 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.597 -0.689 . . . . 0.0 109.258 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 27.9 m -146.77 175.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.538 ' CG2' ' CG ' ' A' ' 71' ' ' LYS . 12.2 t -109.59 162.85 14.01 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.3 mp -130.68 138.99 50.3 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.074 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -112.91 93.8 4.59 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -115.73 101.47 54.13 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.178 -0.952 . . . . 0.0 111.262 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 9.7 Cg_endo -76.36 5.37 4.7 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.628 1.331 . . . . 0.0 111.066 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -82.08 8.29 60.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.609 ' CE ' ' HA ' ' A' ' 18' ' ' PRO . 3.8 ptm -139.87 156.97 46.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.4 -1.059 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.14 39.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -170.46 -178.27 2.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.5 76.26 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.722 -1.236 . . . . 0.0 109.807 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.88 -51.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.055 -1.028 . . . . 0.0 111.357 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.643 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.0 m -90.35 -45.8 0.39 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.894 -1.129 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 17.6 Cg_exo -59.43 -64.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 122.838 0.915 . . . . 0.0 110.759 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 38' ' ' PHE . 26.6 mt -45.48 -27.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.925 -1.109 . . . . 0.0 110.296 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 90.4 m -70.44 -38.17 74.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.801 -1.187 . . . . 0.0 108.771 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 19.7 t -60.01 -26.5 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' CD ' HG23 ' A' ' 36' ' ' VAL . 9.9 tptm -71.83 -43.76 65.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -66.21 -26.91 67.6 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.703 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 27' ' ' LYS . . . -66.63 -48.68 68.69 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.657 -0.652 . . . . 0.0 110.811 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -72.91 -41.49 64.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -0.996 . . . . 0.0 110.345 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.21 -24.07 67.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.538 -0.726 . . . . 0.0 109.276 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -122.24 7.62 9.68 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.434 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.573 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.1 p -50.89 -48.13 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.478 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.26 -84.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.398 -0.814 . . . . 0.0 110.778 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -85.23 0.07 88.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.843 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 14.6 p -44.14 127.93 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.888 -1.36 . . . . 0.0 110.0 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.29 -14.39 14.16 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.669 0.747 . . . . 0.0 109.116 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 2.9 tttm -162.57 161.63 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 9.2 p -150.65 154.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 110.725 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 15.0 t70 -168.99 82.91 0.14 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.7 m -109.23 -163.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.001 0.905 . . . . 0.0 111.475 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.15 93.19 0.15 Allowed Glycine 0 C--N 1.298 -1.552 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.627 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 p90 -54.93 -54.66 39.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.877 . . . . 0.0 109.675 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.14 -24.75 65.04 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.025 -1.047 . . . . 0.0 110.183 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 0.27 57.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' CE ' ' A' ' 12' ' ' MET . 0.2 OUTLIER 46.69 70.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.371 -0.831 . . . . 0.0 111.079 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.49 119.79 0.79 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.41 -0.806 . . . . 0.0 109.981 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -108.19 119.1 38.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.798 -1.188 . . . . 0.0 112.356 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 1.0 OUTLIER -110.13 110.22 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 HG11 ' N ' ' A' ' 46' ' ' THR . 60.2 t -130.45 150.79 34.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.309 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.4 m -109.68 159.43 17.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 54.0 p90 -171.81 -174.86 1.41 Allowed 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.055 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 4.2 m-20 -106.61 126.82 52.75 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 5.9 p-10 -75.01 10.75 1.33 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.61 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.472 HG21 ' HB2' ' A' ' 1' ' ' ALA . 61.5 p -87.28 -36.34 17.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -118.68 -11.27 9.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.088 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -135.7 -174.36 3.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.613 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 3.7 t -178.44 154.48 0.8 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.895 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 34.3 m -42.59 -38.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.253 -0.904 . . . . 0.0 109.488 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.6 tt0 -64.01 -47.25 81.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -62.0 -26.91 68.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.586 HD13 ' CE2' ' A' ' 47' ' ' PHE . 45.7 mt -69.65 -54.68 12.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.856 -1.152 . . . . 0.0 108.306 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.546 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.0 OUTLIER -65.55 -17.34 64.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.6 ttpt -86.15 -21.64 27.46 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.474 -0.766 . . . . 0.0 109.183 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.15 50.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.576 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.556 HG22 ' CB ' ' A' ' 68' ' ' SER . 1.9 t -79.94 -36.26 36.49 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -64.46 -27.72 69.18 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 m-20 -84.76 -20.29 31.3 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -19.56 60.66 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.36 28.76 2.93 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.624 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 21.6 m-85 -134.83 105.0 10.64 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.717 -0.872 . . . . 0.0 110.642 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 7.6 Cg_exo -49.39 101.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 61' ' ' THR . 53.0 p -107.82 158.22 17.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 112.05 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.495 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.3 t -126.84 -178.15 4.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.9 p -142.91 150.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 120.761 -1.212 . . . . 0.0 111.069 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' CG ' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -168.26 51.09 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.801 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.5 tt0 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 117.955 -1.022 . . . . 0.0 111.368 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.58 86.07 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.92 153.6 23.32 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.231 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.521 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 19.0 m -135.15 132.26 37.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.539 -0.725 . . . . 0.0 109.918 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' CG1' ' A' ' 54' ' ' VAL . 21.5 m -135.51 171.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.603 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.44 154.98 20.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.2 mp -130.01 157.12 43.22 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.155 -1.418 . . . . 0.0 111.214 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.462 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -127.31 112.15 14.72 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.358 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 62.0 t -116.85 74.56 6.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.923 -1.11 . . . . 0.0 111.408 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HG3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 Cg_endo -67.27 -5.52 14.02 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.591 1.311 . . . . 0.0 111.226 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -54.39 -23.16 25.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.617 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.5 -178.8 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 109.279 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 12' ' ' MET . 0.9 OUTLIER 177.91 75.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.021 -1.05 . . . . 0.0 110.721 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -149.33 -55.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 117.893 -1.523 . . . . 0.0 111.603 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . 176.67 -27.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.413 -1.429 . . . . 0.0 111.363 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -115.24 -40.42 3.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.611 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 7.6 m -66.3 -47.45 59.99 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.124 -0.985 . . . . 0.0 111.202 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 2.1 Cg_endo -62.54 -37.86 55.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.57 -24.6 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 21.6 m -62.97 -20.12 64.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 41.6 t -74.18 -33.45 35.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -62.48 -35.5 79.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' CE ' ' HE3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -67.14 -44.51 79.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.987 0.899 . . . . 0.0 109.837 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -57.35 -52.35 65.7 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -63.74 -41.22 98.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.017 -1.052 . . . . 0.0 109.854 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -63.11 -21.41 66.17 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HE3' ' CE ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -108.44 -2.11 19.3 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.414 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -46.01 -53.16 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -0.915 . . . . 0.0 109.541 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER 153.62 -72.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.79 0.805 . . . . 0.0 109.562 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -83.55 -16.72 67.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 14.4 p -38.75 122.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 110.348 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 m -112.68 -12.7 13.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.612 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 1.2 tttt -143.62 155.64 44.33 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.206 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.502 ' CG2' ' C ' ' A' ' 33' ' ' LYS . 4.3 t -151.23 129.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.662 0.744 . . . . 0.0 110.707 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 65.3 m-20 -155.02 89.2 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 2.4 m -109.42 -159.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 122.15 0.976 . . . . 0.0 111.816 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' CG ' ' A' ' 40' ' ' LYS . . . -149.93 113.93 0.63 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -49.99 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.731 -0.864 . . . . 0.0 111.825 -178.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -33.59 -33.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.337 -0.852 . . . . 0.0 111.372 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 41' ' ' ARG . 16.2 ptmt -89.6 51.41 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.501 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -13.42 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.411 0.624 . . . . 0.0 112.557 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' LYS . 18.3 mt-10 -152.22 112.79 4.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 110.156 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.21 115.67 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.903 -1.123 . . . . 0.0 111.095 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 8.2 t -107.53 116.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.642 -1.286 . . . . 0.0 108.298 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 4' ' ' THR . 11.8 m -132.43 162.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.245 -1.382 . . . . 0.0 113.354 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.612 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.6 m -119.07 162.35 18.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 3' ' ' GLN . 38.7 p90 -172.17 -175.22 1.39 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.959 -1.496 . . . . 0.0 111.815 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.29 116.95 32.82 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 7.8 p-10 -67.91 -2.07 6.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.373 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -24.74 44.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.008 -1.058 . . . . 0.0 110.614 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -125.72 -3.33 7.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.048 -1.033 . . . . 0.0 110.463 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.43 -168.42 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 109.882 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.6 p 179.7 164.71 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.555 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 4.1 m -43.2 -33.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.361 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.401 ' N ' ' CG2' ' A' ' 54' ' ' VAL . 3.0 tt0 -65.77 -47.87 73.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.472 -0.768 . . . . 0.0 109.148 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.67 -24.08 66.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.645 -0.66 . . . . 0.0 110.763 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 47' ' ' PHE . 41.7 mt -71.98 -55.82 6.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.814 -1.179 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.2 m -63.96 -19.89 65.47 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 1.6 ttmt -80.81 -27.37 36.6 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -69.73 -43.15 72.93 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.656 -0.817 . . . . 0.0 109.274 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 62' ' ' ALA . 14.8 t -75.66 -37.38 59.68 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.25 -26.52 66.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.39 -21.63 22.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 61' ' ' THR . . . -72.81 -15.86 61.62 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.613 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 108.28 30.94 3.68 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.617 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 23.3 m-85 -138.29 102.74 8.06 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.639 -0.918 . . . . 0.0 110.603 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.09 98.92 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.564 1.297 . . . . 0.0 109.396 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.48 ' OG ' ' CG2' ' A' ' 58' ' ' THR . 12.4 p -107.95 -166.39 1.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.235 -0.916 . . . . 0.0 111.604 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.6 t -163.84 126.74 2.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.552 ' HA ' HD13 ' A' ' 7' ' ' LEU . 6.6 p -91.69 161.84 2.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.868 -1.145 . . . . 0.0 110.958 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLN . 3.9 ptmt -145.86 42.22 1.22 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.563 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 71' ' ' LYS . 8.2 mp0 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -147.45 89.72 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 3.9 mm100 -109.61 158.28 18.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.76 0.79 . . . . 0.0 111.627 -177.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.47 ' OG1' ' OG1' ' A' ' 46' ' ' THR . 96.9 m -137.08 141.74 42.36 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.659 -0.651 . . . . 0.0 109.398 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.538 ' CG2' HD11 ' A' ' 57' ' ' LEU . 4.7 m -146.1 165.54 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.001 . . . . 0.0 109.766 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 71' ' ' LYS . 13.6 t -107.42 151.84 25.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.577 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.4 mp -125.95 156.81 39.2 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 120.957 -1.09 . . . . 0.0 110.668 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -137.24 107.47 6.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.994 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 1.9 t -108.22 102.41 46.31 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.176 -0.952 . . . . 0.0 110.776 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.0 Cg_endo -71.11 9.95 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.366 1.377 . . . . 0.0 112.4 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.51 -5.71 42.15 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.508 -1.37 . . . . 0.0 110.167 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.584 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 4.2 mmm -93.39 151.25 19.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.207 -1.172 . . . . 0.0 110.179 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 12' ' ' MET . 9.3 t -179.04 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.134 -0.979 . . . . 0.0 111.543 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 179.03 162.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.678 -1.264 . . . . 0.0 109.536 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.16 79.86 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.708 -1.245 . . . . 0.0 110.483 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 178.13 -56.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.007 -1.058 . . . . 0.0 111.007 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.604 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.0 m -86.92 -45.15 0.54 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.236 -0.915 . . . . 0.0 111.873 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 21.1 Cg_exo -54.8 -52.19 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.51 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 27.6 mt -59.17 -23.82 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.632 -0.667 . . . . 0.0 110.105 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 37.2 m -65.75 -26.74 67.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 108.544 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 25' ' ' LEU . 33.1 t -69.89 -26.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HB2' HG23 ' A' ' 36' ' ' VAL . 14.2 tttt -68.58 -44.42 74.44 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 mptp? -67.45 -29.61 69.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.363 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 28' ' ' VAL . . . -59.29 -45.08 92.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.278 0.561 . . . . 0.0 109.891 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -66.9 -47.87 70.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.861 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.412 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 8.3 t -66.12 -11.46 49.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.479 -0.763 . . . . 0.0 109.006 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -110.58 -9.3 14.56 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.069 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.594 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.0 t -48.79 -58.34 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.106 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 154.79 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.606 0.717 . . . . 0.0 110.072 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.01 -8.07 87.97 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' LEU . 2.5 t -43.72 122.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 109.38 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.37 -11.17 15.23 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -156.23 161.17 40.3 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' A' ' 33' ' ' LYS . 12.9 t -150.0 152.27 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.028 -1.045 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 6.4 t0 -167.69 82.8 0.2 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.2 m -109.24 -165.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 111.773 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -152.07 95.35 0.16 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -46.06 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.707 -0.878 . . . . 0.0 111.666 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.2 mm-40 1.53 -75.31 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.201 0.524 . . . . 0.0 112.035 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -62.49 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 108.734 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 143.49 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 122.864 0.466 . . . . 0.0 109.91 178.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 19.5 mt-10 -134.29 116.78 15.67 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.18 115.38 29.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 0.0 111.606 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 3.0 t -106.83 124.16 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.713 -1.242 . . . . 0.0 107.71 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 3.9 p -139.34 161.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.457 -1.297 . . . . 0.0 113.536 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.8 m -121.39 157.66 29.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 47.9 p90 -171.63 -174.39 1.37 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.922 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 82.3 m-20 -106.76 123.46 48.17 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -71.88 1.9 6.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.032 -177.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.427 HG21 ' CB ' ' A' ' 1' ' ' ALA . 24.7 p -78.87 -27.33 44.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.961 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -122.58 -18.04 6.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -138.38 -169.9 2.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.372 -0.83 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -177.99 159.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 11.7 m -42.8 -42.58 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' N ' ' CG2' ' A' ' 54' ' ' VAL . 6.3 tt0 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.065 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -65.49 -24.17 67.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.57 -0.706 . . . . 0.0 111.011 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.552 HD12 ' CG1' ' A' ' 45' ' ' VAL . 23.0 mt -75.5 -52.83 9.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 0.0 108.289 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.504 ' N ' HD22 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -66.66 -18.76 65.54 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -84.15 -25.72 29.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.536 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -70.98 -42.34 69.8 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.944 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 21' ' ' VAL . 11.7 t -77.17 -38.78 51.0 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -60.34 -25.27 65.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.52 -25.93 28.44 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -13.29 60.88 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.66 32.69 3.3 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -135.16 84.17 37.09 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.691 -0.888 . . . . 0.0 110.21 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -54.19 97.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.781 1.411 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.518 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 49.5 p -107.8 -165.59 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.889 0.852 . . . . 0.0 111.886 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -153.44 126.19 8.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.577 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 6.7 p -95.05 159.72 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.93 -1.106 . . . . 0.0 110.431 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.542 ' HG2' ' CG2' ' A' ' 6' ' ' THR . 0.4 OUTLIER -151.3 51.49 0.84 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.224 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.482 ' O ' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.24 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.29 89.21 1.7 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 152.35 44.75 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.926 0.87 . . . . 0.0 111.943 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -121.0 152.66 38.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.446 0.641 . . . . 0.0 109.873 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 54' ' ' VAL . 16.0 m -142.51 174.34 5.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 11.1 t -108.17 160.97 15.41 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.4 mp -130.68 141.77 50.42 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.878 -1.529 . . . . 0.0 111.707 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.491 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -110.39 101.21 9.95 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 13.3 p -112.55 79.64 3.22 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 111.051 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.7 Cg_endo -68.11 -3.38 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.766 1.403 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -56.24 -17.28 17.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.561 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -154.18 -171.25 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 110.027 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 12' ' ' MET . 7.0 t 179.93 58.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -160.31 173.64 15.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.305 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -73.89 78.72 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 110.59 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . 179.16 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.189 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 2.6 m -91.77 -44.7 0.36 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 4.9 Cg_exo -61.03 -44.59 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.581 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 85.4 mt -57.67 -29.66 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.967 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 14.6 m -65.46 -28.43 69.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 108.695 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' HD13 ' A' ' 25' ' ' LEU . 98.0 t -68.31 -27.42 36.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' CD ' ' HB ' ' A' ' 36' ' ' VAL . 5.9 tttt -69.84 -43.2 72.43 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.4 mptt -64.99 -25.01 67.68 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.351 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 60' ' ' ALA . . . -68.48 -43.27 77.28 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.777 -0.577 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -69.19 -41.89 76.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.055 -1.028 . . . . 0.0 109.64 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.52 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 2.9 p -67.4 -18.17 65.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -99.75 -9.65 22.77 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.903 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.5 t -45.32 -63.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.039 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 1.4 tt0 160.28 -64.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.355 0.597 . . . . 0.0 109.782 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -93.4 -6.91 62.37 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.565 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 26' ' ' SER . 13.7 p -41.77 129.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 109.732 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 m -108.24 -10.85 15.32 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.369 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -164.93 159.54 18.28 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.296 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 33' ' ' LYS . 60.4 t -147.49 160.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.838 -1.164 . . . . 0.0 111.581 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 44' ' ' VAL . 8.3 t70 -136.84 135.65 38.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' HB ' ' CD ' ' A' ' 22' ' ' LYS . 1.6 p -109.39 127.31 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.888 -1.133 . . . . 0.0 112.07 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -109.45 59.34 0.36 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' HB3' ' CG1' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -28.77 -110.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.373 0.606 . . . . 0.0 112.498 -177.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -50.9 -50.18 57.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.572 -1.33 . . . . 0.0 112.134 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.2 tmmm? -55.21 -14.04 1.54 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.0 111.506 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 tmm_? 61.45 84.01 0.14 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.432 -0.792 . . . . 0.0 111.216 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -171.8 120.51 0.46 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.398 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -114.04 119.55 37.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 110.487 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -107.36 123.62 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 57' ' ' LEU . 14.8 p -133.96 152.07 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.664 -1.214 . . . . 0.0 113.752 -176.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -113.16 152.33 29.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 35.0 p90 -170.45 -179.91 3.15 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 5.8 m-20 -107.11 123.69 48.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -67.34 -2.45 6.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.285 -177.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -81.57 -23.43 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 110.154 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -125.52 -5.84 7.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.155 -0.965 . . . . 0.0 110.479 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.15 -170.07 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.573 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.71 158.93 0.71 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 5' ' ' VAL . 17.4 m -41.84 -41.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' N ' HG22 ' A' ' 54' ' ' VAL . 22.2 tp60 -60.59 -45.61 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.392 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.61 -25.97 67.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.639 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.535 HD12 ' CG1' ' A' ' 45' ' ' VAL . 39.5 mt -72.62 -56.32 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.893 -1.129 . . . . 0.0 108.346 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 3.2 m -64.45 -17.74 64.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 4.2 ttmm -81.73 -27.95 33.63 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -71.41 -43.61 66.45 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.071 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.528 HG21 ' N ' ' A' ' 62' ' ' ALA . 9.9 t -74.29 -36.25 63.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' N ' HG21 ' A' ' 61' ' ' THR . . . -60.9 -29.77 69.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -90.28 -15.51 31.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.28 178.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.9 -18.82 58.06 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 117.48 23.91 3.62 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -142.13 90.56 8.25 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.571 -0.958 . . . . 0.0 109.993 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.71 97.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.63 1.332 . . . . 0.0 110.103 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.5 p -108.5 -163.21 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.874 . . . . 0.0 111.036 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -147.3 -175.37 4.81 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.585 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.2 p -139.56 142.08 33.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.817 -1.177 . . . . 0.0 112.184 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' CD ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -131.77 79.95 1.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.457 0.646 . . . . 0.0 109.595 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.436 ' HG3' HG13 ' A' ' 5' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -157.44 90.79 1.12 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -114.54 158.0 22.24 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.6 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.535 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 50.0 m -136.64 121.57 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.665 -0.647 . . . . 0.0 109.321 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.539 ' CG2' HD11 ' A' ' 57' ' ' LEU . 5.1 m -131.97 172.8 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.477 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 7' ' ' LEU . 10.6 t -108.48 157.33 18.54 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.576 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.6 mp -126.17 156.56 39.97 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.002 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -132.33 103.33 6.15 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' CG ' ' A' ' 12' ' ' MET . 1.6 t -108.71 102.76 49.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.526 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 4.6 Cg_endo -71.37 2.19 4.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.198 1.265 . . . . 0.0 111.8 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.41 -1.0 60.87 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.598 ' HE3' ' CD1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -107.16 161.2 14.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -1.22 . . . . 0.0 110.055 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 179.01 32.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.102 -0.999 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -173.19 170.37 4.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.739 -1.226 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 78.31 3.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 19' ' ' ILE . . . -179.8 -48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.588 ' CB ' ' HE2' ' A' ' 12' ' ' MET . 6.1 m -93.66 -44.72 0.31 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.978 -1.076 . . . . 0.0 112.048 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 1.5 Cg_endo -65.45 -38.11 27.27 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 107.661 -1.707 . . . . 0.0 107.661 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG13 ' CE1' ' A' ' 38' ' ' PHE 0.267 6.7 tt -59.21 -36.16 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.402 1.096 . . . . 0.0 108.711 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 49.9 m -63.44 -21.31 66.23 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.5 t -69.77 -33.09 54.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 27.5 tttm -66.16 -41.23 90.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -25.65 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.182 179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB3' ' C ' ' A' ' 60' ' ' ALA . . . -69.51 -55.6 9.75 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.687 -0.633 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.565 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -60.95 -37.23 81.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -70.37 -20.49 62.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 108.978 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -112.88 10.72 19.07 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.18 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 11.6 p -66.35 -44.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.457 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.44 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.476 -0.765 . . . . 0.0 111.269 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -90.27 0.98 79.07 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.271 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 7.3 p -42.86 128.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.922 -1.34 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -113.87 -14.87 12.45 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.596 0.713 . . . . 0.0 109.58 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -156.7 159.77 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.435 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 45' ' ' VAL . 13.4 p -152.65 157.4 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 111.08 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t0 -170.54 87.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.569 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 6.1 m -108.02 -159.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.885 . . . . 0.0 111.783 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.12 115.19 0.82 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.638 ' CE1' HG13 ' A' ' 19' ' ' ILE . 2.6 m-30 -56.6 -105.66 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 O-C-N 122.216 -0.579 . . . . 0.0 109.713 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 9.3 tt0 -47.87 -34.21 8.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.358 -1.464 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 33.4 tttt -52.78 -41.97 64.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.077 -1.014 . . . . 0.0 110.7 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER 81.37 70.03 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.425 0.631 . . . . 0.0 110.989 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -170.83 120.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.755 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -111.99 115.62 29.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.949 -1.094 . . . . 0.0 111.993 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.3 t -107.97 117.16 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 33' ' ' LYS . 21.8 t -137.3 155.5 32.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.228 -1.389 . . . . 0.0 113.09 -177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.8 m -114.9 160.55 19.39 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 3' ' ' GLN . 53.4 p90 -171.82 -176.52 1.75 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.796 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.63 114.78 29.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -62.67 -9.01 7.65 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.59 -177.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.4 t -67.59 -26.92 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.013 -1.054 . . . . 0.0 109.574 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -0.9 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.456 -0.778 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -148.35 -168.81 3.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 179.73 156.15 0.59 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.846 . . . . 0.0 109.62 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 8.2 m -44.74 -39.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.347 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.499 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.02 -43.74 97.87 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.327 -0.858 . . . . 0.0 109.105 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.24 -25.17 67.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.443 -0.786 . . . . 0.0 110.736 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.545 HD13 ' CE1' ' A' ' 47' ' ' PHE . 54.4 mt -69.57 -56.1 8.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.861 -1.149 . . . . 0.0 108.704 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.487 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 3.0 m -64.65 -21.43 66.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 27.3 mttp -81.43 -23.85 37.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 28' ' ' VAL . . . -73.47 -44.18 58.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.325 -0.86 . . . . 0.0 108.933 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 62' ' ' ALA . 11.5 t -75.59 -35.34 60.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -62.12 -29.78 70.57 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 40.3 t0 -79.21 -23.73 43.61 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.28 59.97 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.618 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.71 32.94 3.21 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.618 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 25.2 m-85 -137.35 84.62 23.33 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.681 -0.894 . . . . 0.0 110.262 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.19 97.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.67 1.353 . . . . 0.0 109.235 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.534 ' OG ' ' CG2' ' A' ' 9' ' ' VAL . 12.6 t -108.03 -172.03 1.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.887 0.851 . . . . 0.0 112.12 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.58 121.55 8.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -92.86 156.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.808 -1.182 . . . . 0.0 110.572 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -154.78 45.43 0.52 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.339 -1.344 . . . . 0.0 110.841 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.523 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.838 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.3 t -178.05 107.65 0.05 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.289 1.042 . . . . 0.0 108.725 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.656 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.7 pt20 -130.24 173.62 10.61 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.158 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.486 ' CG2' ' O ' ' A' ' 45' ' ' VAL . 7.0 m -126.37 137.82 53.49 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.578 -0.701 . . . . 0.0 109.737 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' HD11 ' A' ' 57' ' ' LEU . 33.7 m -133.13 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.91 157.01 18.1 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.59 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.47 152.4 50.51 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.814 -178.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.477 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.39 117.26 23.32 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.632 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.551 ' CG1' HG23 ' A' ' 21' ' ' VAL . 98.9 t -112.56 75.94 1.93 Allowed Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 120.845 -1.159 . . . . 0.0 112.184 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 68' ' ' SER . 5.9 Cg_endo -69.27 -13.95 36.79 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.222 1.117 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -43.89 -42.19 6.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.533 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . 83.5 mmm -153.39 140.14 19.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -1.067 . . . . 0.0 110.044 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.487 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 2.4 t -134.6 78.36 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 110.878 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -147.68 -142.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.035 -1.04 . . . . 0.0 108.881 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.11 64.81 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.805 -1.184 . . . . 0.0 109.335 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -179.04 -54.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.048 -1.032 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.641 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.1 m -77.29 -48.38 2.45 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 120.835 -1.165 . . . . 0.0 111.601 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 27.3 Cg_exo -51.02 -56.19 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.082 1.043 . . . . 0.0 109.776 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -57.66 -27.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.767 -0.583 . . . . 0.0 110.42 179.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 67.8 m -66.43 -24.54 66.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.741 -1.225 . . . . 0.0 108.717 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 57.3 t -69.17 -31.72 51.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HA ' HD11 ' A' ' 25' ' ' LEU . 17.4 tttm -70.51 -40.16 73.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -68.51 -21.05 64.61 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.451 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -72.51 -53.47 11.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.706 -0.621 . . . . 0.0 110.321 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.574 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.55 -30.13 70.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.0 109.373 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.8 -27.43 61.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.502 -0.749 . . . . 0.0 109.16 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.44 6.89 37.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.264 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 2.5 t -56.13 -77.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' N ' HG13 ' A' ' 28' ' ' VAL . 1.0 OUTLIER 177.89 -81.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.3 -1.06 87.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 ' CG2' HG22 ' A' ' 34' ' ' VAL . 5.4 p -42.11 133.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.206 -1.173 . . . . 0.0 110.582 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -110.15 -17.94 13.43 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 3.5 tttt -167.63 158.63 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.165 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.509 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 24.4 t -154.64 145.12 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.773 -1.204 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -141.66 154.67 45.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 35' ' ' ASP . 46.6 t -155.29 158.48 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.352 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -124.3 81.94 0.35 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -35.93 -101.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 122.276 -0.544 . . . . 0.0 111.812 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -28.8 -44.03 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.474 -0.766 . . . . 0.0 111.025 -179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -89.8 50.8 1.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -10.38 76.84 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' LYS . 5.6 tm-20 -149.82 109.6 4.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' CB ' HG21 ' A' ' 36' ' ' VAL . . . -110.17 126.79 54.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.815 -1.178 . . . . 0.0 111.431 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.47 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 1.0 OUTLIER -108.08 120.84 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG1' HD12 ' A' ' 57' ' ' LEU . 9.9 p -126.02 156.06 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.589 1.185 . . . . 0.0 113.955 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -121.43 153.31 38.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.692 ' O ' ' HA ' ' A' ' 2' ' ' THR . 43.9 p90 -172.31 179.86 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 117.879 -1.528 . . . . 0.0 111.294 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 8.0 m-20 -106.54 112.33 25.28 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -62.45 -8.22 5.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.985 -177.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 t -71.6 -10.26 59.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.996 -1.065 . . . . 0.0 110.155 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -132.39 -39.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -123.79 -169.96 2.04 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.724 -0.61 . . . . 0.0 109.696 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' ' C ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.28 154.28 5.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p -41.07 -30.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.844 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' N ' HG11 ' A' ' 54' ' ' VAL . 22.3 tt0 -70.08 -50.03 45.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -22.38 65.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.557 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 42.3 mt -72.27 -51.56 20.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.641 -1.287 . . . . 0.0 108.155 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -65.91 -19.31 65.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -82.57 -24.05 34.15 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . . . -72.7 -43.05 63.53 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.94 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.531 HG21 ' N ' ' A' ' 62' ' ' ALA . 8.3 t -76.46 -38.29 55.63 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' N ' HG21 ' A' ' 61' ' ' THR . . . -61.93 -26.08 67.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.55 -24.24 29.36 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.97 -19.08 62.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 113.03 28.56 3.32 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 17.3 m-85 -134.82 87.55 30.14 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 121.499 -1.0 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.25 100.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.795 1.418 . . . . 0.0 109.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 11.4 p -107.66 -167.91 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.59 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -150.47 129.64 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 6.9 p -99.14 158.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.889 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -137.7 45.58 2.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.657 -1.217 . . . . 0.0 110.915 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.582 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.212 0.53 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -158.94 92.95 1.13 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -118.36 161.27 20.23 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.757 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -137.68 122.56 18.89 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 72' ' ' GLN . 34.2 m -132.99 174.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.988 HG22 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.28 163.71 12.79 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.005 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -135.45 143.74 46.07 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.277 -1.369 . . . . 0.0 111.604 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.581 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -114.22 99.3 7.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.861 ' O ' ' HE3' ' A' ' 12' ' ' MET . 7.4 p -112.34 80.08 3.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.117 -0.989 . . . . 0.0 111.932 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.5 Cg_endo -68.54 -1.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.508 1.268 . . . . 0.0 111.221 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.37 -26.52 3.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.861 ' HE3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -149.05 -165.19 2.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -1.234 . . . . 0.0 110.215 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 13' ' ' THR . 5.3 t -179.75 67.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.127 -0.983 . . . . 0.0 111.093 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -166.17 177.32 7.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.05 -1.031 . . . . 0.0 109.334 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.69 74.69 5.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 110.078 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.09 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 111.377 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.4 m -89.77 -42.6 0.42 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.98 -1.075 . . . . 0.0 112.88 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 5.5 Cg_endo -65.18 -41.22 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 38' ' ' PHE . 4.0 mt -61.47 -27.35 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 29.6 m -67.03 -27.98 67.85 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.101 -0.999 . . . . 0.0 108.334 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.741 ' O ' HD12 ' A' ' 25' ' ' LEU . 84.6 t -64.58 -32.15 56.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 tttm -65.28 -39.26 92.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -68.92 -24.89 64.34 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.885 0.85 . . . . 0.0 109.149 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.656 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.89 -56.14 6.92 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.72 -0.612 . . . . 0.0 110.514 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.46 -30.65 70.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.1 t -72.81 -25.36 61.12 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -108.07 7.13 27.55 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.684 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.3 p -61.81 -48.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.95 -1.093 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 165.45 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.0 -1.062 . . . . 0.0 111.238 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -91.82 4.67 78.99 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.124 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 28' ' ' VAL . 7.5 p -41.03 129.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.167 -1.196 . . . . 0.0 110.17 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -16.49 13.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.9 156.03 21.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.676 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.737 HG13 ' CG2' ' A' ' 45' ' ' VAL . 45.6 t -150.64 145.49 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.893 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -162.3 92.99 0.84 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 22' ' ' LYS . 2.3 m -108.39 -164.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.025 -1.047 . . . . 0.0 111.185 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -140.99 118.94 1.44 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -47.53 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.4 tt0 -35.45 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.019 -1.051 . . . . 0.0 111.538 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.19 30.58 0.46 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.893 -1.13 . . . . 0.0 110.898 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 6.14 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' LYS . 10.0 tt0 -145.79 112.75 6.06 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.669 -1.27 . . . . 0.0 110.593 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.71 120.65 43.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.874 -1.141 . . . . 0.0 111.979 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.988 HG23 HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -108.52 115.67 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.737 ' CG2' HG13 ' A' ' 34' ' ' VAL . 14.5 t -132.04 154.15 39.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.131 -1.428 . . . . 0.0 113.132 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -115.29 158.17 22.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.7 p90 -171.91 -177.7 2.0 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.562 -1.255 . . . . 0.0 110.918 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.0 m-20 -107.29 110.64 22.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.17 -12.96 4.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.449 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 14.4 t -60.44 -32.3 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 110.154 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 -3.73 6.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -142.67 -168.02 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 22.0 t 179.42 154.8 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.935 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HD12 ' A' ' 57' ' ' LEU . 15.2 m -43.61 -35.47 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.189 -0.944 . . . . 0.0 109.614 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' VAL . 10.6 tt0 -65.77 -46.38 78.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.007 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 2.4 mmtp -63.1 -25.37 68.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.547 -0.72 . . . . 0.0 110.271 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 54' ' ' VAL . 61.4 mt -69.88 -55.61 9.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.873 -1.142 . . . . 0.0 108.733 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.592 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -62.94 -22.38 66.75 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -81.37 -27.15 34.97 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.49 -0.756 . . . . 0.0 109.213 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.656 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.18 -42.93 71.78 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.161 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.715 ' CB ' HG13 ' A' ' 21' ' ' VAL . 12.4 t -75.32 -38.02 60.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.26 66.47 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.17 -23.76 26.4 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.87 -16.85 60.66 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.07 27.56 3.4 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.7 m-85 -138.05 82.61 24.6 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.567 -0.961 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.85 97.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.672 1.354 . . . . 0.0 109.974 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.9 p -108.49 -161.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.781 0.801 . . . . 0.0 111.316 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.5 t -146.32 -170.32 3.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -138.98 153.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 O-C-N 120.831 -1.168 . . . . 0.0 111.294 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -157.89 61.72 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.75 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.727 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.2 pt20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.425 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.28 0.562 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -160.03 91.72 0.97 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.3 pm0 -127.7 163.15 24.93 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.059 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 12.0 m -125.69 133.97 51.97 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.327 0.584 . . . . 0.0 109.718 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 ' HG3' ' A' ' 72' ' ' GLN . 7.0 m -135.75 169.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.859 ' O ' HD12 ' A' ' 7' ' ' LEU . 13.5 t -108.5 161.99 14.54 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.032 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -133.79 154.64 50.85 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.487 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -121.48 100.37 6.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.3 p -111.67 89.23 10.65 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.176 -0.952 . . . . 0.0 111.522 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.7 Cg_endo -68.69 -7.77 21.42 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.596 1.314 . . . . 0.0 110.713 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.82 0.45 57.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.565 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -92.34 176.67 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -1.204 . . . . 0.0 109.987 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.9 -9.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -163.5 -156.75 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.766 -1.834 . . . . 0.0 111.112 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.43 60.21 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.844 -1.16 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.94 -40.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 111.09 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m -93.79 -45.82 0.3 Allowed Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.69 -1.256 . . . . 0.0 111.962 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.6 Cg_exo -62.01 -57.88 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 122.965 0.981 . . . . 0.0 109.897 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -54.72 -29.44 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.711 . . . . 0.0 110.76 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.648 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 17.9 m -64.28 -27.15 68.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.805 -1.184 . . . . 0.0 109.055 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.885 HG22 ' OG1' ' A' ' 61' ' ' THR . 73.4 t -67.12 -30.23 48.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.599 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.8 tttt -70.55 -44.64 67.03 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.02 -23.15 64.04 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.884 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.93 -49.03 50.16 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.701 -0.624 . . . . 0.0 110.468 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.795 ' CB ' HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -61.62 -42.41 98.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 0.0 109.625 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.469 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.8 p -70.4 -20.19 62.95 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.225 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.03 -7.85 41.53 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.503 -0.748 . . . . 0.0 109.699 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.79 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 3.8 t -52.17 -76.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.643 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 167.76 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.521 0.677 . . . . 0.0 109.768 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.36 -8.19 49.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.9 p -48.59 126.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -1.171 . . . . 0.0 109.907 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.39 -14.6 14.4 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -162.2 160.5 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.56 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 45' ' ' VAL . 67.0 t -149.78 149.58 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.13 -0.981 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 30.3 t0 -167.4 91.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.0 m -108.39 -156.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.003 0.906 . . . . 0.0 111.345 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -154.37 91.6 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.623 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -38.2 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.936 -0.743 . . . . 0.0 111.17 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 13.0 tp10 -34.34 -40.82 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.454 -0.779 . . . . 0.0 110.731 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' GLU . 1.2 tmtp? -87.25 46.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 109.571 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -6.15 72.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -149.82 117.17 6.07 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.838 -1.163 . . . . 0.0 110.321 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.88 116.99 33.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.399 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -108.94 109.53 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 25' ' ' LEU . 40.1 t -129.14 151.16 35.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.98 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m -109.8 157.57 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.9 p90 -172.5 -179.03 2.1 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.335 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 7.9 m-20 -107.92 113.98 27.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.555 ' HB2' ' NE2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -59.84 -9.89 3.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.937 -178.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -64.95 -25.42 67.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.899 -1.126 . . . . 0.0 110.404 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -126.78 -32.91 2.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -117.71 -167.64 1.37 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.641 -0.662 . . . . 0.0 109.917 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.613 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.54 153.04 0.86 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 57' ' ' LEU . 24.4 m -43.02 -36.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.754 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.5 tt0 -67.58 -45.08 76.56 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -60.94 -27.03 67.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 54' ' ' VAL . 44.8 mt -69.17 -52.58 26.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.242 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.5 m -65.52 -17.62 64.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -83.81 -24.5 30.97 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.03 -42.3 66.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.829 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.885 ' OG1' HG22 ' A' ' 21' ' ' VAL . 11.5 t -76.61 -38.7 54.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.37 -28.24 66.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.1 m-20 -84.46 -24.44 29.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.648 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.37 -16.45 62.42 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.51 27.81 4.27 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.4 m-85 -135.99 97.13 12.51 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.482 -1.011 . . . . 0.0 110.401 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.2 Cg_exo -58.11 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.619 1.326 . . . . 0.0 110.054 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.527 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.4 p -108.43 -165.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 110.788 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.699 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 84.9 p -148.55 -171.91 3.96 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.032 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.8 p -139.23 152.08 23.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 110.983 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.27 42.68 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.169 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.825 ' HG3' HG12 ' A' ' 5' ' ' VAL . 1.4 mt-30 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.018 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.81 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.174 0.512 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.79 95.92 1.93 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 2.1 mt-30 -108.74 159.03 17.09 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.627 0.727 . . . . 0.0 110.987 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.527 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 m -139.31 127.74 22.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.912 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 54' ' ' VAL . 5.3 m -133.32 169.72 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 7' ' ' LEU . 14.8 t -108.2 160.33 15.91 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.988 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.52 145.64 50.32 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.483 -178.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -117.54 100.49 7.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.817 HG11 HG21 ' A' ' 21' ' ' VAL . 6.5 p -109.66 80.02 1.52 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.123 . . . . 0.0 112.552 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.1 Cg_endo -67.58 -3.78 10.85 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.467 1.246 . . . . 0.0 110.811 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -41.84 -32.17 0.9 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 99.2 mmm -146.62 -160.65 1.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.478 -1.013 . . . . 0.0 109.372 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.7 t 179.92 71.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -169.49 -178.91 3.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.186 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.79 73.64 5.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.049 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.22 -51.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 m -86.84 -43.99 0.54 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.9 -1.125 . . . . 0.0 112.894 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 2.2 Cg_endo -63.51 -44.57 13.84 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 8.7 mt -64.41 -25.29 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.674 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 62.3 m -64.18 -23.68 67.4 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.738 -1.226 . . . . 0.0 108.059 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' HB ' ' A' ' 61' ' ' THR . 45.0 t -71.0 -32.79 49.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.651 ' HE3' HG13 ' A' ' 34' ' ' VAL . 3.4 tttt -63.43 -38.43 91.1 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.3 -32.14 72.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.189 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -62.86 -51.57 66.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.746 HD22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -70.62 -27.54 64.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.358 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -66.94 -25.34 66.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.75 17.37 6.85 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.119 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -60.58 -47.24 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 175.27 -84.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 110.928 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.766 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -100.6 8.41 58.32 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.657 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.1 p -40.26 130.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -1.111 . . . . 0.0 110.445 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -110.12 -16.9 13.68 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.748 0.785 . . . . 0.0 108.925 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.896 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.42 158.82 27.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.546 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.811 HG23 HG22 ' A' ' 45' ' ' VAL . 7.1 p -157.74 151.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.52 ' OD1' HG12 ' A' ' 44' ' ' VAL . 7.1 p-10 -169.38 98.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.0 m -109.04 -157.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 112.005 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.2 122.98 1.67 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.25 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.147 -0.619 . . . . 0.0 111.562 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -23.53 -38.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.557 -0.714 . . . . 0.0 112.912 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 38' ' ' PHE . 2.5 ttpt -81.24 32.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.737 -1.227 . . . . 0.0 111.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 7.5 87.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.599 ' OE2' HG23 ' A' ' 44' ' ' VAL . 4.6 tm-20 -156.43 110.15 2.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.055 . . . . 0.0 110.21 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -114.02 117.4 31.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.754 -1.216 . . . . 0.0 111.661 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.599 HG23 ' OE2' ' A' ' 42' ' ' GLU . 2.2 t -108.45 121.23 61.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 33' ' ' LYS . 52.8 t -139.83 152.16 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.079 -1.448 . . . . 0.0 113.144 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -111.49 162.4 15.14 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.4 p90 -172.69 -176.95 1.59 Allowed 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.489 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 72.6 m-20 -106.58 122.21 45.87 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.81 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -65.62 -4.5 6.27 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.929 -177.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.631 HG23 ' HB1' ' A' ' 1' ' ' ALA . 30.7 p -76.15 -26.84 56.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 2.2 mmmt -125.61 -6.49 6.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.766 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -147.28 -168.45 3.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 35.4 t -178.17 152.54 0.72 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 57' ' ' LEU . 3.6 p -41.76 -39.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.469 -0.77 . . . . 0.0 109.377 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.62 -45.7 82.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 53' ' ' SER . 1.3 mttt -60.66 -23.64 64.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.465 -0.772 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 54' ' ' VAL . 32.5 mt -74.4 -51.96 13.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.729 -1.232 . . . . 0.0 108.35 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 1.8 m -64.02 -18.84 64.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.06 -26.79 33.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.14 -41.46 70.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.034 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.917 ' HB ' HG13 ' A' ' 21' ' ' VAL . 13.0 t -76.0 -39.51 55.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.69 -26.37 67.07 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.64 -19.81 23.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.07 61.14 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.83 28.42 3.94 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -137.15 101.47 9.27 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.98 . . . . 0.0 110.746 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.53 95.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.662 1.348 . . . . 0.0 109.773 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 9' ' ' VAL . 12.6 t -108.94 -168.6 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.14 178.35 7.76 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.988 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.4 p -138.29 148.0 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.725 -1.235 . . . . 0.0 112.511 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.04 77.47 1.66 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.603 -0.686 . . . . 0.0 109.825 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.915 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.209 0.528 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -155.9 93.22 1.43 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -113.81 -171.23 1.86 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.035 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.553 HG23 ' OG1' ' A' ' 46' ' ' THR . 20.4 m -153.0 156.92 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.44 169.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.27 1.033 . . . . 0.0 110.34 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 t -109.73 165.16 11.91 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 1.0 OUTLIER -133.55 145.63 50.27 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.624 -1.23 . . . . 0.0 111.664 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.998 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -110.56 100.1 8.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 3.4 p -112.03 79.52 2.75 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.04 -1.037 . . . . 0.0 111.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 4.2 Cg_endo -67.17 -4.66 12.04 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.608 1.32 . . . . 0.0 110.917 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -42.1 -43.49 4.49 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.704 ' HA ' ' HE3' ' A' ' 12' ' ' MET . 0.0 OUTLIER -139.06 -159.03 0.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -1.077 . . . . 0.0 109.604 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 13' ' ' THR . 3.8 t -179.04 79.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.03 -1.044 . . . . 0.0 110.628 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.6 -177.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.418 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -81.62 70.96 8.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.056 . . . . 0.0 110.292 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -177.31 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 111.679 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 8.3 m -93.93 -43.42 0.31 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 120.803 -1.186 . . . . 0.0 112.646 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.4 Cg_endo -65.64 -37.6 28.16 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 N-CA-C 108.577 -1.355 . . . . 0.0 108.577 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 tt -65.28 -33.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.953 0.882 . . . . 0.0 108.973 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 76.0 m -60.74 -20.24 60.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.04 HG13 ' HB ' ' A' ' 61' ' ' THR . 62.3 t -74.82 -36.12 38.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.855 ' HD3' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -60.48 -33.92 73.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -68.34 -46.68 69.5 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.483 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -52.77 -57.55 9.79 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.164 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.031 -1.043 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.62 ' CA ' HG21 ' A' ' 34' ' ' VAL . 7.4 t -63.44 -20.06 65.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.6 16.32 5.91 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.598 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.006 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.8 p -55.25 -56.59 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 0.0 110.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 1.006 ' HG2' HG22 ' A' ' 28' ' ' VAL . 5.7 pt-20 170.86 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.92 3.62 16.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 25' ' ' LEU . 3.6 p -50.3 134.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.4 -8.63 11.59 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.981 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.8 ttmm -155.24 160.87 41.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.855 HG11 ' HD3' ' A' ' 22' ' ' LYS . 54.6 t -152.62 137.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.501 0.667 . . . . 0.0 110.337 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.2 m-20 -167.92 92.43 0.36 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 22' ' ' LYS . 3.7 m -107.97 -153.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 111.845 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.77 111.99 0.57 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -82.22 65.03 7.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.959 0.885 . . . . 0.0 110.502 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -178.66 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.317 -0.865 . . . . 0.0 108.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -89.88 42.06 1.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.998 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.7 ppt_? 23.46 84.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.114 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 tt0 -150.42 116.16 5.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.464 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -111.16 117.59 33.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.115 . . . . 0.0 111.222 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -110.01 114.62 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 33' ' ' LYS . 56.5 t -138.07 151.07 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.445 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.5 m -109.43 166.26 11.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 57' ' ' LEU . 53.2 p90 -172.85 -171.05 0.72 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.885 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -107.28 111.28 23.58 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -61.98 -9.65 7.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 -177.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.915 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -75.99 -30.37 58.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.877 -1.14 . . . . 0.0 109.662 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 1.3 10.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.979 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -155.1 -169.37 3.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.62 155.68 0.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.755 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.41 -37.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 54' ' ' VAL . 6.1 tt0 -64.04 -46.91 82.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.251 -0.906 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -61.49 -29.75 70.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.452 -0.78 . . . . 0.0 110.027 179.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 54' ' ' VAL . 68.0 mt -65.51 -52.9 49.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 69' ' ' SER . 5.5 m -64.35 -18.36 64.58 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 20.1 ttpt -80.58 -27.89 37.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.6 -43.51 66.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.91 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.04 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.2 t -73.23 -35.61 66.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -58.8 -31.46 68.46 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.52 -16.44 28.85 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.573 -0.704 . . . . 0.0 109.466 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.46 -18.98 61.06 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.48 23.96 4.58 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -139.34 93.26 10.11 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.614 -0.933 . . . . 0.0 110.557 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_exo -54.91 95.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.705 1.371 . . . . 0.0 109.432 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 61' ' ' THR . 5.4 p -108.39 -159.09 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.853 0.835 . . . . 0.0 111.391 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.659 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -151.53 -167.08 2.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 7' ' ' LEU 0.258 3.3 p -139.4 146.39 25.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.191 -0.943 . . . . 0.0 110.749 -178.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.708 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -160.6 50.22 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.825 -178.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.52 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 4.9 pp0? . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.494 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.824 ' HB3' ' CG ' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.208 0.528 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.52 86.99 1.84 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 47' ' ' PHE . 4.4 pt20 -120.44 149.37 42.48 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.589 -0.844 . . . . 0.0 112.17 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.577 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -119.16 138.98 52.56 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.646 0.736 . . . . 0.0 110.194 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 54' ' ' VAL . 35.1 m -130.92 169.76 20.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.588 -0.695 . . . . 0.0 109.171 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.021 HG22 ' HB2' ' A' ' 72' ' ' GLN . 12.0 t -107.49 159.79 16.15 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -133.58 153.33 51.74 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.466 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -124.01 106.06 10.09 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.998 HG11 HG21 ' A' ' 21' ' ' VAL . 7.2 p -115.69 78.05 6.65 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.931 -1.106 . . . . 0.0 111.518 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.523 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 8.6 Cg_endo -72.53 2.73 4.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.744 1.392 . . . . 0.0 111.351 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -55.36 -29.79 53.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -172.72 119.91 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.676 -0.896 . . . . 0.0 109.4 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 13' ' ' THR . 2.9 t -143.49 110.0 5.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 13' ' ' THR . 1.8 m -148.55 -61.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.0 109.082 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.76 27.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.613 -0.679 . . . . 0.0 109.871 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -168.68 -40.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 111.646 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 8.2 m -67.2 -44.86 49.95 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.128 . . . . 0.0 112.035 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 4.3 Cg_endo -64.14 -41.65 21.31 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.619 HD12 ' CG ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -63.4 -31.92 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.652 0.739 . . . . 0.0 109.317 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 30.8 m -61.7 -23.08 65.88 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.066 HG13 ' HB ' ' A' ' 61' ' ' THR . 60.7 t -73.18 -33.66 42.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.672 ' HA ' HG21 ' A' ' 36' ' ' VAL . 65.2 tttt -62.1 -35.08 77.63 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -65.86 -43.02 89.66 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.567 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -55.77 -59.29 5.08 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.75 -0.594 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -64.65 -29.29 70.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.001 -1.062 . . . . 0.0 109.924 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 20.0 m -59.5 -30.3 68.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -135.28 21.93 3.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.792 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HB ' ' A' ' 31' ' ' VAL . 10.7 p -54.18 -45.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.72 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 110.557 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -97.1 1.69 61.03 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -42.72 128.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.059 -1.26 . . . . 0.0 110.159 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.01 -9.17 15.09 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.432 0.634 . . . . 0.0 109.657 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.645 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -166.67 163.03 16.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.361 -0.837 . . . . 0.0 109.549 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 22' ' ' LYS . 92.2 t -150.71 162.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.3 t0 -170.72 85.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 22' ' ' LYS . 23.8 t -106.94 176.29 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.741 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -131.8 118.36 2.3 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CG ' HD12 ' A' ' 19' ' ' ILE . 17.9 p90 -87.24 63.82 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.945 0.878 . . . . 0.0 109.858 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 2.1 tt0 179.58 -63.88 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.2 mtmt -73.26 -2.69 22.89 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CB ' ' A' ' 13' ' ' THR . 8.2 tmm_? 59.5 75.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.7 -0.625 . . . . 0.0 110.879 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -156.88 122.35 4.7 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.736 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -109.21 115.58 30.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.098 -1.001 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.0 t -109.2 119.37 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.7 t -135.64 156.88 38.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.017 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.577 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.62 154.34 26.19 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.3 p90 -170.88 177.88 3.65 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.22 -1.392 . . . . 0.0 111.668 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.37 123.74 48.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.824 ' CG ' ' HB3' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -69.17 -0.74 6.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.311 -177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.7 p -73.18 -33.29 65.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -121.32 -13.7 8.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.068 -1.02 . . . . 0.0 110.557 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -140.87 -169.25 2.77 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.914 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.8 p 179.76 158.26 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.941 ' HA ' HD12 ' A' ' 57' ' ' LEU . 5.5 m -41.3 -40.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.769 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.549 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.97 -49.05 79.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.081 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -25.46 68.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.676 -0.64 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' HA ' ' A' ' 54' ' ' VAL . 39.2 mt -71.63 -52.87 15.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.775 -1.203 . . . . 0.0 108.621 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.676 HG21 ' HA ' ' A' ' 69' ' ' SER . 83.8 m -66.05 -19.2 65.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.27 -24.56 34.68 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -72.07 -42.07 66.65 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.989 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.066 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.72 -38.71 58.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.74 -30.29 68.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.5 t70 -86.31 -20.68 28.01 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.03 -19.33 62.52 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 116.78 24.36 3.69 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.614 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 18.1 m-85 -138.42 99.39 8.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.441 -1.035 . . . . 0.0 110.391 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 4.9 Cg_exo -56.76 95.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.65 1.342 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.0 p -109.49 -162.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.858 . . . . 0.0 111.375 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.676 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.6 p -156.2 -173.2 4.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.5 p -135.8 156.15 37.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.848 -1.158 . . . . 0.0 110.958 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.741 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.94 54.36 0.41 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.415 -1.314 . . . . 0.0 111.766 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 1.021 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.291 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.693 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.083 0.468 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -145.35 86.26 1.75 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 26.8 mm-40 -115.45 141.9 47.42 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.136 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.544 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -125.52 122.31 36.22 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.481 0.658 . . . . 0.0 109.719 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 ' HB ' ' A' ' 54' ' ' VAL . 14.9 m -117.41 170.93 6.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.456 -0.777 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.779 HG23 ' HG2' ' A' ' 71' ' ' LYS . 14.8 t -107.64 154.3 21.65 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.741 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -131.29 159.66 37.2 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.255 -1.378 . . . . 0.0 110.922 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -126.83 123.91 38.42 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.969 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 21' ' ' VAL . 3.7 t -112.48 76.7 2.08 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.02 -1.05 . . . . 0.0 111.542 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 9.4 Cg_endo -73.65 -23.04 17.36 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.111 1.208 . . . . 0.0 111.016 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -46.8 -50.33 15.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.8 mmm -147.17 158.83 44.08 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.312 -1.111 . . . . 0.0 110.159 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 1.1 t -178.78 112.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.618 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.4 p -166.66 -42.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 110.641 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 178.83 30.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.894 -1.129 . . . . 0.0 110.668 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.707 ' N ' HD12 ' A' ' 19' ' ' ILE . . . 179.26 -32.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 110.65 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 50.8 m -70.05 -43.39 19.24 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.974 -1.079 . . . . 0.0 112.003 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.7 Cg_endo -72.72 -47.41 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 N-CA-C 107.126 -1.913 . . . . 0.0 107.126 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 16' ' ' ALA 0.259 3.5 mt -54.95 -33.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 177.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 24.6 m -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 109.158 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 9' ' ' VAL . 22.2 t -67.7 -31.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -67.9 -41.82 82.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.0 tmtt? -62.17 -37.95 87.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.567 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -59.54 -58.05 10.29 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.896 -0.503 . . . . 0.0 111.461 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.979 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -62.31 -33.98 75.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.041 -1.037 . . . . 0.0 109.831 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.492 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -63.35 -24.75 67.99 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -125.29 15.25 8.35 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.404 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.979 HG12 ' O ' ' A' ' 25' ' ' LEU . 2.2 p -58.75 -63.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.168 -0.958 . . . . 0.0 111.276 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.766 ' H ' HG13 ' A' ' 28' ' ' VAL . 3.1 mt-10 -165.47 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.713 -1.242 . . . . 0.0 110.721 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -98.67 6.15 60.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.7 p -39.73 132.17 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.421 -1.046 . . . . 0.0 110.479 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -109.47 -13.03 14.64 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.564 0.697 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' C ' HG23 ' A' ' 34' ' ' VAL . 2.9 tttt -165.83 160.58 17.13 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.799 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.664 HG13 HG22 ' A' ' 45' ' ' VAL . 61.2 t -152.28 151.19 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.452 ' OD2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p-10 -168.34 95.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.1 m -107.85 -158.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.113 0.958 . . . . 0.0 111.824 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -142.95 115.72 0.95 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 19' ' ' ILE . 3.2 m-30 -52.69 -114.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.045 -0.68 . . . . 0.0 110.257 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.7 mt-10 -36.65 -30.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.044 -1.035 . . . . 0.0 110.548 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.4 mtpt -88.91 50.28 1.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.561 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.918 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.1 ppt_? -16.37 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.544 0.687 . . . . 0.0 112.569 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 40' ' ' LYS . 15.4 tt0 -154.38 111.27 3.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.436 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -110.18 115.24 29.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.769 -1.207 . . . . 0.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 24.2 t -107.23 120.45 58.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.645 -1.285 . . . . 0.0 107.552 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.87 HG21 ' CB ' ' A' ' 25' ' ' LEU . 19.0 t -131.73 150.84 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.837 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -110.0 156.09 20.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.758 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.6 p90 -170.88 -177.27 2.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.14 -1.424 . . . . 0.0 111.797 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.0 m-20 -106.21 112.61 25.71 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -66.37 -6.04 12.91 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.656 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.693 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -63.32 -18.46 63.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -138.25 -38.2 0.55 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.939 . . . . 0.0 110.479 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -108.15 -168.94 1.43 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.981 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER 179.26 160.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 110.412 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.065 HG23 HG21 ' A' ' 70' ' ' VAL . 3.8 p -41.78 -43.73 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.135 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -61.38 -44.24 97.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -0.956 . . . . 0.0 109.316 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 mtpp -64.15 -25.79 68.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.432 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 54' ' ' VAL . 28.4 mt -72.79 -50.51 23.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.858 -1.151 . . . . 0.0 108.101 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 59.4 m -64.34 -18.14 64.36 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 3.2 ttpp -80.01 -28.88 39.35 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -69.47 -43.85 72.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.325 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.73 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.1 t -74.42 -36.99 63.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.06 -28.52 67.86 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.99 -19.43 25.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.138 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.5 -14.06 60.4 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.612 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 102.6 35.08 3.91 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.2 m-85 -138.15 96.19 10.24 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.946 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.9 Cg_exo -55.34 97.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.636 1.335 . . . . 0.0 108.912 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -108.02 -177.91 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 111.794 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.16 133.31 17.29 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.065 HG21 HG23 ' A' ' 54' ' ' VAL . 7.3 p -99.79 158.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.611 -1.306 . . . . 0.0 111.207 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -154.47 50.73 0.63 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.645 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.1 pp0? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.784 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.133 0.492 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.77 91.09 1.35 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 4.3 mm100 -114.12 153.93 28.66 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.649 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.4 m -131.67 129.65 41.04 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 72' ' ' GLN . 31.5 m -133.93 170.85 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.968 -1.082 . . . . 0.0 110.273 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.871 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.2 159.33 16.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.31 154.1 50.97 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.337 -177.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -130.11 108.97 10.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.075 HG11 HG21 ' A' ' 21' ' ' VAL . 12.2 p -113.18 83.32 6.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.991 . . . . 0.0 111.203 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.9 Cg_endo -70.87 -6.61 19.54 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.624 1.329 . . . . 0.0 110.662 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -46.45 -40.03 10.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.567 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.6 mmm -156.56 132.19 9.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.539 -0.977 . . . . 0.0 109.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.529 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -133.75 93.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 110.234 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -149.55 -71.45 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.825 -1.172 . . . . 0.0 110.258 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . 179.92 49.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 109.467 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.39 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.413 -0.805 . . . . 0.0 110.43 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.6 m -71.16 -50.63 11.23 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -57.68 -43.12 53.02 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 N-CA-C 107.927 -1.605 . . . . 0.0 107.927 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.22 -28.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.723 0.773 . . . . 0.0 109.816 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 42.6 m -66.47 -23.72 66.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.924 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.075 HG21 HG11 ' A' ' 9' ' ' VAL . 25.2 t -68.88 -28.63 40.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.2 tttt -64.15 -45.6 87.75 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 17.9 mmtt -69.58 -20.92 63.64 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.38 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -40.23 65.84 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.683 -0.635 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.87 ' HB3' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -77.97 -34.47 51.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 0.0 109.357 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.579 ' C ' HG11 ' A' ' 31' ' ' VAL . 23.8 t -71.23 -21.82 62.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -110.38 -0.51 17.54 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.297 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -49.04 -45.16 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.91 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 2.2 mt-10 161.09 -83.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.735 -0.603 . . . . 0.0 111.275 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.29 7.39 72.2 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.579 HG11 ' C ' ' A' ' 26' ' ' SER . 4.0 p -41.04 134.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.198 -1.178 . . . . 0.0 110.293 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -14.82 14.26 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.813 0.816 . . . . 0.0 108.9 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -161.25 158.69 27.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -150.11 162.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 111.192 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t0 -156.61 151.47 26.0 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 22' ' ' LYS . 1.6 p -154.37 161.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.201 -1.399 . . . . 0.0 111.982 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -137.91 111.48 0.82 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' LYS . 26.1 p90 -54.29 -155.78 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' PHE . 35.2 tt0 5.88 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -38.97 -24.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.496 -1.377 . . . . 0.0 111.737 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.7 tmm_? 62.94 76.97 0.35 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.121 -0.987 . . . . 0.0 111.358 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -165.38 126.41 1.94 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.051 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -125.77 128.36 47.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.8 -1.187 . . . . 0.0 110.245 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.871 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -109.11 140.34 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.823 -1.173 . . . . 0.0 108.312 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.884 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -149.32 156.01 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.418 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.9 m -125.56 156.74 38.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.1 p90 -172.62 -179.61 2.2 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.823 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -107.33 123.48 48.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -65.21 -5.52 7.15 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.85 -177.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.784 HG23 ' HB1' ' A' ' 1' ' ' ALA . 6.9 p -62.73 -37.59 87.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.168 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.84 23.27 5.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.507 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -169.53 -171.61 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.42 155.59 0.52 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.011 HG23 HG21 ' A' ' 70' ' ' VAL . 5.6 p -43.43 -34.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.533 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.7 tt0 -65.3 -46.91 78.49 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.353 -0.842 . . . . 0.0 108.983 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -64.64 -24.64 67.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.62 -0.675 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.884 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.5 mt -72.06 -56.12 6.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.688 -1.258 . . . . 0.0 108.299 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' HA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -63.68 -19.74 65.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 ttpt -81.71 -26.21 34.8 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -72.35 -41.72 66.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.096 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.762 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.3 t -75.86 -36.85 59.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.43 -30.94 69.95 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -90.27 -15.58 31.0 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.47 -21.03 61.28 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 118.27 23.63 3.45 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.3 m-85 -139.39 105.28 7.11 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 0.0 110.561 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 6.3 Cg_exo -57.62 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.517 1.272 . . . . 0.0 109.34 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 9' ' ' VAL . 3.8 t -110.49 -176.26 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.784 . . . . 0.0 111.158 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.571 ' HA ' HG21 ' A' ' 58' ' ' THR . 3.4 t -147.24 -176.43 5.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 7' ' ' LEU . 9.5 p -134.81 159.68 41.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.681 -1.262 . . . . 0.0 111.657 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.91 47.04 1.01 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.061 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.7 mp0 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.239 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.07 88.93 1.48 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 mm-40 -114.0 154.76 27.08 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.582 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.495 HG23 ' OG1' ' A' ' 46' ' ' THR . 16.0 m -127.61 160.32 31.97 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 109.539 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.95 HG11 HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -166.94 170.69 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.979 0.895 . . . . 0.0 109.798 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -109.27 163.72 13.12 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.964 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -135.66 144.2 45.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.93 -1.106 . . . . 0.0 111.303 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -113.82 99.52 7.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 109.487 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 5.4 p -111.19 85.47 5.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.038 -1.039 . . . . 0.0 111.962 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 1.7 Cg_endo -64.77 -6.3 12.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.629 1.331 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.85 2.06 56.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.596 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.33 173.76 6.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 110.613 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 14' ' ' CYS . 3.1 t -179.22 15.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.996 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 179.61 -162.16 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.281 -1.512 . . . . 0.0 110.197 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.83 52.72 2.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 110.28 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 17' ' ' CYS . . . -172.75 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 111.177 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.709 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 51.8 m -152.62 -50.83 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.325 -0.859 . . . . 0.0 111.48 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 9.8 Cg_endo -73.98 -50.31 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 N-CA-C 108.267 -1.474 . . . . 0.0 108.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.2 mt -65.7 -25.38 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.928 0.87 . . . . 0.0 108.692 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.471 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 2.7 m -62.81 -23.93 67.5 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.5 t -72.77 -32.98 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 15.1 tttt -59.77 -35.45 74.67 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.4 -37.61 77.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.816 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -61.17 -56.1 24.59 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.612 -0.68 . . . . 0.0 111.042 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -63.49 -32.93 74.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.055 . . . . 0.0 110.176 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' HG11 ' A' ' 31' ' ' VAL . 8.2 p -68.52 -20.19 64.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -120.07 6.85 10.79 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.6 p -55.6 -49.31 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.123 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.6 OUTLIER 171.64 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 111.152 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.54 10.44 70.96 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.561 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.61 HG21 ' CG2' ' A' ' 34' ' ' VAL . 10.6 p -41.89 133.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.126 . . . . 0.0 110.089 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.26 -18.05 13.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' HG23 ' A' ' 34' ' ' VAL . 10.6 tttm -163.61 158.39 20.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 45' ' ' VAL . 71.4 t -156.15 142.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 111.918 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -141.93 158.68 43.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 9.8 p -154.09 168.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 117.623 -1.631 . . . . 0.0 112.794 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.07 110.65 1.06 Allowed Glycine 0 N--CA 1.48 1.588 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.65 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.429 -0.453 . . . . 0.0 111.742 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 1.1 tt0 -28.68 -31.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.432 -0.793 . . . . 0.0 112.293 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 38' ' ' PHE . 55.2 mttt -80.38 27.81 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.734 -1.228 . . . . 0.0 110.996 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER 13.49 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.5 tt0 -165.67 109.65 0.83 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.419 -1.426 . . . . 0.0 111.107 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.08 125.25 53.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.068 -1.02 . . . . 0.0 111.424 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.7 p -109.59 114.26 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' CB ' ' A' ' 25' ' ' LEU . 22.3 t -128.42 150.03 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.468 -1.293 . . . . 0.0 113.113 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -112.42 160.38 17.8 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.3 p90 -171.68 -171.46 0.91 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.186 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.4 m-20 -106.57 123.56 48.28 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -71.85 3.54 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.442 -177.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.507 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -85.23 -33.24 22.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.912 -1.118 . . . . 0.0 109.64 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 -4.42 10.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.098 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . . . -145.77 -172.7 3.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 179.68 153.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.822 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.95 HG12 HG11 ' A' ' 5' ' ' VAL . 26.7 m -43.35 -32.72 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.025 -1.047 . . . . 0.0 109.858 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.9 tt0 -68.18 -46.94 69.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 108.874 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 5.0 mttm -63.34 -25.5 68.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.544 -0.722 . . . . 0.0 110.297 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 54' ' ' VAL . 46.2 mt -71.05 -53.11 15.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.846 -1.159 . . . . 0.0 108.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.441 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 5.1 m -62.27 -24.23 67.16 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.23 -28.73 42.49 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.39 -45.42 76.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.882 ' HB ' HG13 ' A' ' 21' ' ' VAL . 12.9 t -72.29 -38.18 68.83 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.64 -27.89 65.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 2.5 t70 -90.29 -20.69 22.64 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.554 -0.716 . . . . 0.0 109.413 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.09 -17.38 62.0 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.605 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 111.53 27.19 4.22 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.8 m-85 -138.6 92.38 11.6 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.555 -0.968 . . . . 0.0 110.166 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.4 Cg_exo -54.22 96.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.583 1.307 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.531 ' HB3' HG21 ' A' ' 61' ' ' THR . 8.6 t -108.85 -167.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.392 -0.818 . . . . 0.0 111.34 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -142.87 -167.68 2.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.964 HG23 ' CD1' ' A' ' 7' ' ' LEU . 1.6 p -142.9 155.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.944 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.68 53.77 0.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.4 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.489 ' N ' HG23 ' A' ' 5' ' ' VAL . 15.7 tm0? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.446 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.254 0.55 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 90.3 1.59 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mm-40 -109.97 169.33 8.8 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.016 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.7 m -144.02 125.58 14.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.506 -0.746 . . . . 0.0 109.553 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.845 HG21 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -130.28 169.65 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.803 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.1 t -108.73 159.25 16.91 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.965 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -133.58 152.03 51.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.208 -1.397 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.528 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.0 102.1 7.36 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 12' ' ' MET . 2.6 p -110.37 91.32 11.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.851 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.1 Cg_endo -66.29 -11.02 29.63 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.679 1.357 . . . . 0.0 110.305 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.84 48.8 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -136.42 158.16 45.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -1.154 . . . . 0.0 110.568 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 12' ' ' MET . 10.7 t 179.47 33.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.578 0.704 . . . . 0.0 109.161 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -160.93 127.05 3.92 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -35.68 83.49 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.64 -0.663 . . . . 0.0 111.615 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 177.83 -67.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.194 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 m -82.17 -44.16 1.01 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.945 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 38' ' ' PHE . 23.7 Cg_exo -54.1 -55.94 3.0 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' HB3' ' A' ' 38' ' ' PHE . 37.9 mt -53.9 -27.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.828 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 22.6 m -69.08 -30.96 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.003 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.809 HG22 ' OG1' ' A' ' 61' ' ' THR . 55.5 t -65.95 -33.24 62.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HA ' HD12 ' A' ' 25' ' ' LEU . 8.0 tttt -70.05 -33.19 71.63 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mmtp -74.37 -29.01 61.37 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.264 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.8 -46.47 87.82 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.324 0.583 . . . . 0.0 109.804 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.697 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -72.7 -33.69 66.64 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.754 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.481 ' HA ' HG11 ' A' ' 31' ' ' VAL . 23.3 t -64.6 -18.62 65.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.62 8.58 6.41 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.774 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.624 HG22 ' OE2' ' A' ' 29' ' ' GLU . 14.6 p -49.52 -52.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 110.509 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 3.9 pt-20 165.17 -48.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.195 -0.941 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -125.1 2.12 8.38 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.739 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.71 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 t -42.82 130.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.29 . . . . 0.0 109.562 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.51 -13.48 14.56 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -163.6 164.15 24.22 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.47 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 45' ' ' VAL . 7.2 p -152.82 162.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 111.179 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' N ' HG22 ' A' ' 34' ' ' VAL . 2.1 m-20 -168.63 80.14 0.14 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' CA ' ' A' ' 43' ' ' ALA . 33.0 t -108.32 164.99 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.904 0.859 . . . . 0.0 111.556 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -126.42 107.34 0.91 Allowed Glycine 0 N--CA 1.48 1.611 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.46 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.605 -0.938 . . . . 0.0 111.764 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 38' ' ' PHE . 63.3 mt-10 -22.54 -67.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.8 -0.563 . . . . 0.0 112.273 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.638 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 19.5 tptp -42.1 -55.36 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.041 -1.037 . . . . 0.0 110.235 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.638 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.1 tmm_? 99.39 76.5 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 C-N-CA 123.493 0.717 . . . . 0.0 110.815 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -169.0 115.13 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 0.0 110.439 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.721 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -108.12 119.95 40.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.636 -1.29 . . . . 0.0 111.502 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.5 t -108.76 118.58 56.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.71 ' CG1' HG22 ' A' ' 31' ' ' VAL . 9.3 t -133.82 157.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.697 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.6 m -116.82 160.94 20.07 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.9 p90 -171.99 -175.23 1.44 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.906 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 14.1 p-10 -106.88 112.31 25.22 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -63.61 -9.65 14.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 0.0 110.718 -177.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.499 ' CG2' ' OD2' ' A' ' 48' ' ' ASP . 5.9 t -62.1 -23.72 66.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.01 -1.056 . . . . 0.0 109.776 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -38.5 1.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 110.317 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -108.0 -168.94 1.44 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.643 -0.66 . . . . 0.0 109.961 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.616 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 31.4 t -179.5 155.68 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.045 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.052 ' CG2' HG21 ' A' ' 70' ' ' VAL . 6.7 p -42.94 -40.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.624 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.508 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.4 tt0 -61.88 -44.72 96.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.361 -0.837 . . . . 0.0 109.451 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 38.0 mttp -67.34 -23.27 65.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 54' ' ' VAL . 40.0 mt -71.14 -51.57 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.619 -1.301 . . . . 0.0 108.492 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -64.99 -19.77 66.16 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 7.2 mttt -82.49 -25.47 33.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -70.65 -44.06 67.9 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.438 -0.789 . . . . 0.0 109.134 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.809 ' OG1' HG22 ' A' ' 21' ' ' VAL . 10.2 t -75.84 -38.73 57.73 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.21 66.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.22 -21.92 24.26 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -17.02 60.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.608 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.47 27.94 3.17 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -136.59 91.18 16.17 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.621 -0.929 . . . . 0.0 110.633 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.93 93.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 0.0 110.055 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.548 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -108.99 -163.85 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 110.942 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.609 ' HA ' HG21 ' A' ' 58' ' ' THR . 2.5 t -150.09 -170.86 3.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.052 HG21 ' CG2' ' A' ' 54' ' ' VAL . 7.5 p -139.9 160.06 26.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.993 -1.067 . . . . 0.0 111.452 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.601 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -172.07 48.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.408 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 71' ' ' LYS . 38.3 tt0 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.957 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.35 94.11 1.46 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 9.2 mm-40 -110.91 150.22 29.52 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.165 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.451 HG23 ' OG1' ' A' ' 46' ' ' THR . 38.4 m -129.51 120.68 25.8 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 54' ' ' VAL . 33.4 m -127.7 170.42 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.881 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -108.14 157.6 18.15 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.857 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -132.48 152.37 51.56 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.104 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.543 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -120.88 109.19 14.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.725 HG22 ' CB ' ' A' ' 68' ' ' SER . 12.4 t -111.47 73.91 1.11 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.725 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 6.6 Cg_endo -67.35 -7.52 19.32 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.317 1.167 . . . . 0.0 111.389 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' O ' ' SD ' ' A' ' 12' ' ' MET . . . -50.08 -42.34 39.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 65.4 mmm -152.2 163.38 39.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.446 -1.032 . . . . 0.0 109.134 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.519 ' O ' HG23 ' A' ' 13' ' ' THR . 2.3 t -174.14 108.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 111.181 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 1.3 p -167.26 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 110.347 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 177.2 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.748 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -123.76 22.79 8.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 81.8 m -121.23 -66.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.002 -1.061 . . . . 0.0 110.25 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 5.2 Cg_exo -52.87 -39.04 79.34 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -61.36 -38.3 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.641 0.734 . . . . 0.0 109.182 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 23.7 m -61.56 -22.08 64.86 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.032 HG13 ' HB ' ' A' ' 61' ' ' THR . 11.9 t -77.11 -31.61 18.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.716 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.17 -36.83 85.44 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -74.01 -33.94 63.97 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.539 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -62.31 -49.86 73.96 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 110.794 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -65.45 -47.01 77.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 109.863 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.604 ' HB2' HG21 ' A' ' 34' ' ' VAL . 8.8 t -61.1 -17.54 53.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 108.676 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -103.51 -13.22 16.67 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.46 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.784 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.8 t -47.54 -57.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.448 -0.782 . . . . 0.0 109.602 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 154.67 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.616 0.722 . . . . 0.0 110.248 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.47 -22.75 73.34 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 25' ' ' LEU . 22.9 t -42.63 121.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.41 -1.053 . . . . 0.0 109.703 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -109.53 -14.8 14.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.571 0.701 . . . . 0.0 109.782 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.695 ' O ' HG13 ' A' ' 45' ' ' VAL . 21.5 tttt -154.3 155.69 35.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.451 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.964 HG13 HG22 ' A' ' 45' ' ' VAL . 3.7 t -149.33 153.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -170.45 94.81 0.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -107.63 -152.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.967 0.889 . . . . 0.0 111.742 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -146.59 108.73 0.46 Allowed Glycine 0 N--CA 1.48 1.582 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -81.92 62.25 5.62 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.535 0.683 . . . . 0.0 110.749 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.8 tp10 179.31 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.22 40.51 2.05 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 25.08 79.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.922 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 37' ' ' GLY . 4.3 tp10 -146.09 113.01 6.08 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.395 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -112.32 115.06 28.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.716 -1.24 . . . . 0.0 110.969 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.2 t -108.65 121.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 107.756 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.964 HG22 HG13 ' A' ' 34' ' ' VAL . 75.2 t -136.97 155.03 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.226 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.92 157.21 24.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' THR . 49.0 p90 -172.8 178.84 2.5 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 117.891 -1.524 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 70.2 m-20 -106.69 120.52 42.21 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -62.75 -8.37 6.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.689 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 1' ' ' ALA . 2.4 p -66.93 -27.27 67.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.01 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -128.07 -8.39 5.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.001 -1.062 . . . . 0.0 111.129 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -146.02 -167.67 2.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 110.021 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.629 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -178.24 155.53 0.92 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 110.033 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.047 ' CG1' HG21 ' A' ' 70' ' ' VAL . 24.9 t -43.05 -39.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.7 tt0 -60.9 -46.07 92.1 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.506 -0.746 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.07 -22.04 65.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.412 -0.805 . . . . 0.0 111.028 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 54' ' ' VAL . 33.8 mt -73.99 -56.75 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.653 -1.279 . . . . 0.0 108.319 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.619 ' N ' HD21 ' A' ' 7' ' ' LEU . 2.5 m -65.1 -20.45 66.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.69 -28.34 33.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.784 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.5 -41.87 79.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.905 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.032 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -74.77 -36.67 62.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.44 -27.19 67.32 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.1 -19.44 24.31 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.99 -18.74 61.32 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.17 27.31 3.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 21.0 m-85 -138.2 98.41 9.29 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 110.856 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -58.08 93.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.611 1.322 . . . . 0.0 109.658 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.725 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -108.45 -161.44 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 111.317 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.525 ' HA ' HG21 ' A' ' 58' ' ' THR . 45.5 p -156.95 -169.48 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 ' CG1' ' A' ' 54' ' ' VAL . 5.7 p -135.61 158.87 40.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.886 -1.134 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.881 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.7 OUTLIER -171.54 47.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.756 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' N ' HG22 ' A' ' 6' ' ' THR . 1.4 pp0? . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.112 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.902 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.09 0.471 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.7 89.94 1.44 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.673 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 12.3 pt20 -122.21 165.16 16.59 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.792 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 45' ' ' VAL . 11.9 m -128.81 136.1 50.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.681 -0.637 . . . . 0.0 109.694 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 57' ' ' LEU . 21.0 m -130.32 167.46 25.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.531 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -106.51 157.15 17.87 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.92 149.27 51.28 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.355 -1.338 . . . . 0.0 111.219 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.513 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -119.94 113.98 21.37 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.756 -0.59 . . . . 0.0 109.45 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.991 HG22 ' HB2' ' A' ' 68' ' ' SER . 2.3 t -117.06 78.11 9.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.026 -1.046 . . . . 0.0 111.062 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 13.6 Cg_endo -80.7 40.52 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.234 1.289 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.36 2.46 10.45 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -159.49 21.2 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.076 -1.249 . . . . 0.0 110.579 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 39' ' ' GLU . 15.5 m -47.19 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -179.8 112.15 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 108.55 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -26.17 77.01 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 174.74 -49.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.221 -0.925 . . . . 0.0 110.593 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 32.7 m -97.62 -39.41 0.25 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.644 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 6.2 Cg_exo -59.89 -38.57 78.41 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 N-CA-C 107.95 -1.596 . . . . 0.0 107.95 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 10.2 mt -63.89 -29.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 6.8 m -65.4 -23.77 67.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.925 HG11 HG21 ' A' ' 9' ' ' VAL . 59.8 t -70.21 -29.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.37 -39.26 85.66 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 23.0 mmtt -71.04 -29.85 65.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -43.65 95.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.76 -0.588 . . . . 0.0 110.367 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -74.84 -36.23 62.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.022 . . . . 0.0 109.451 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.798 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.31 -19.85 65.7 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.4 mptp? -115.21 1.76 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.171 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.0 p -52.64 -40.66 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.8 OUTLIER 165.0 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.425 -0.797 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -99.49 5.96 58.96 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.06 -1.067 . . . . 0.0 110.752 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.798 HG11 ' C ' ' A' ' 26' ' ' SER . 8.1 p -39.49 129.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -1.077 . . . . 0.0 110.189 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.5 t -108.53 -10.99 15.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.469 0.652 . . . . 0.0 109.665 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.63 168.22 18.35 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.014 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 10.2 p -165.5 152.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.962 . . . . 0.0 110.953 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 44' ' ' VAL . 28.1 t0 -163.32 93.69 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.665 HG13 ' CA ' ' A' ' 43' ' ' ALA . 20.8 t -108.11 174.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 111.746 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.554 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -130.16 121.44 3.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 16.3 p90 -55.89 -145.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 1.033 ' O ' HG23 ' A' ' 13' ' ' THR . 14.1 tp10 1.13 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -36.01 -63.1 0.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.318 -0.864 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.689 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.2 tmm_? 103.98 77.47 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 C-N-CA 123.306 0.642 . . . . 0.0 111.17 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.0 tm-20 -168.51 117.56 0.72 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.508 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.665 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -112.15 118.93 36.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.108 . . . . 0.0 111.329 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 35' ' ' ASP . 4.2 p -107.35 121.93 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.78 -1.2 . . . . 0.0 108.017 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 4' ' ' THR . 3.5 p -129.41 159.02 41.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.79 -1.164 . . . . 0.0 113.184 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -118.01 154.69 31.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -171.83 179.61 2.71 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.232 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 3.4 m-20 -106.79 117.16 33.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 1.5 t70 -64.15 -7.14 8.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.883 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.22 -26.2 61.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.935 -1.103 . . . . 0.0 110.196 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -0.54 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.197 -0.94 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -159.41 -166.39 1.78 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.44 159.16 0.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.094 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.0 p -41.08 -42.44 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.599 -0.688 . . . . 0.0 110.0 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.576 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -60.79 -46.78 89.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.256 -0.902 . . . . 0.0 109.682 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.87 -23.54 67.26 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.974 HD12 ' HA ' ' A' ' 54' ' ' VAL . 35.3 mt -72.49 -52.89 13.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.667 -1.271 . . . . 0.0 108.265 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 69' ' ' SER . 2.1 m -63.94 -21.1 66.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 ttpt -81.47 -26.58 35.13 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.07 -43.46 67.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.209 -0.932 . . . . 0.0 108.94 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.23 -38.7 63.46 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.15 -27.14 66.85 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -90.21 -19.68 23.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.172 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -16.16 60.72 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 112.03 27.26 4.05 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.84 97.89 8.81 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.617 -0.931 . . . . 0.0 110.515 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.3 Cg_exo -55.52 96.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.59 1.311 . . . . 0.0 109.4 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.991 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.91 -167.19 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 111.536 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.6 OUTLIER -156.56 -172.22 3.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.094 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.8 p -133.63 161.8 40.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.595 -1.315 . . . . 0.0 111.444 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -148.07 54.76 1.04 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.721 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 5' ' ' VAL . 2.4 tt0 . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 110.238 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.44 87.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -127.08 153.02 46.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.05 -1.032 . . . . 0.0 111.624 -177.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -118.29 154.27 32.57 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.407 0.622 . . . . 0.0 109.634 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 72' ' ' GLN . 17.5 m -145.76 170.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.342 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.913 ' OG1' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.55 156.48 19.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.051 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.61 147.92 51.52 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.938 -1.505 . . . . 0.0 111.308 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.514 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -116.99 112.16 20.58 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.733 HG21 HG11 ' A' ' 21' ' ' VAL . 71.6 t -109.6 73.4 0.63 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.97 -1.081 . . . . 0.0 111.782 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.9 Cg_endo -58.6 -13.46 17.55 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.477 1.251 . . . . 0.0 110.073 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.64 15.24 31.7 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.604 ' HG2' ' CG ' ' A' ' 41' ' ' ARG . 2.2 ppp? -96.71 -164.71 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -1.221 . . . . 0.0 109.435 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.554 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.6 t 178.5 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.838 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 2.1 p -158.59 -154.16 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.536 -1.352 . . . . 0.0 110.673 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.93 42.5 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.951 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.81 -36.83 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.906 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 13.8 m -89.95 -44.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 0.0 111.757 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.63 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 14.0 Cg_endo -75.96 -43.94 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 N-CA-C 107.902 -1.615 . . . . 0.0 107.902 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.61 HG13 ' CE1' ' A' ' 38' ' ' PHE . 2.9 tt -55.66 -38.3 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.904 0.859 . . . . 0.0 109.635 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 5.2 m -62.8 -23.83 67.44 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.943 0.878 . . . . 0.0 108.636 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG13 ' HB ' ' A' ' 61' ' ' THR . 32.6 t -69.32 -31.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB2' HG21 ' A' ' 36' ' ' VAL . 3.8 tttt -67.65 -41.78 83.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.55 -24.86 65.58 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.378 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -70.63 -54.7 10.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.803 -0.561 . . . . 0.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -59.66 -35.94 75.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.069 -1.02 . . . . 0.0 109.812 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -22.71 60.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.504 -0.748 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.81 -5.7 25.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.895 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -46.61 -81.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.749 ' N ' HG12 ' A' ' 28' ' ' VAL . 4.0 tt0 169.93 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.348 -0.845 . . . . 0.0 109.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.582 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -104.95 -21.33 9.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 25' ' ' LEU . 74.1 t -42.2 126.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -1.068 . . . . 0.0 109.79 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -113.13 -9.82 13.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -147.85 156.33 42.6 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.008 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 45' ' ' VAL . 6.1 p -154.86 129.69 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.683 0.754 . . . . 0.0 111.01 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.68 89.66 1.57 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 22' ' ' LYS . 2.2 m -108.32 -160.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.962 0.887 . . . . 0.0 111.47 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.57 110.06 0.55 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 4.9 m-30 -52.7 -98.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.019 -0.695 . . . . 0.0 109.927 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 1.2 mm-40 -54.42 -12.7 0.74 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.606 -1.309 . . . . 0.0 111.643 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.3 mptt -81.85 -24.83 35.57 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.194 . . . . 0.0 111.002 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.604 ' CG ' ' HG2' ' A' ' 12' ' ' MET . 7.4 tmm_? 68.41 63.52 0.35 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.581 -0.699 . . . . 0.0 110.655 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.7 tt0 -162.06 113.95 1.69 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.229 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.73 113.6 26.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.96 -1.087 . . . . 0.0 110.834 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.913 HG22 ' OG1' ' A' ' 6' ' ' THR . 89.2 t -114.31 121.76 67.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.631 -1.293 . . . . 0.0 108.967 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 34' ' ' VAL . 25.8 m -137.66 -179.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 118.234 -1.386 . . . . 0.0 113.789 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.61 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.8 m -127.74 158.41 37.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.8 p90 -171.49 178.94 3.04 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.143 -1.423 . . . . 0.0 111.097 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.5 m-20 -107.41 117.7 34.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -63.25 -8.64 8.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 110.958 -177.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -74.06 -26.73 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.629 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -121.33 -13.22 8.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.498 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.582 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.14 -165.68 2.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.473 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.48 159.07 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 57' ' ' LEU . 10.9 p -43.64 -37.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.773 . . . . 0.0 109.763 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -64.85 -44.22 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -0.856 . . . . 0.0 109.357 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 10.2 mtpt -67.68 -22.4 65.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.413 -0.805 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.8 mt -74.36 -58.51 3.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.664 -1.273 . . . . 0.0 108.413 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.612 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.3 m -63.07 -21.53 66.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 8.4 ttmt -80.27 -27.97 38.49 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -68.04 -43.13 79.41 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.306 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.761 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.19 -38.01 63.76 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.72 -27.71 65.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -86.34 -23.4 26.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -73.3 -14.5 61.32 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.74 30.22 4.1 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.4 m-85 -135.82 94.96 14.27 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.703 -0.88 . . . . 0.0 110.514 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.09 93.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.7 1.369 . . . . 0.0 109.758 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.537 ' CB ' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -108.75 -169.06 1.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 111.139 -179.139 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.438 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -146.48 -174.99 4.61 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.051 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.8 p -139.86 150.44 22.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.705 -1.247 . . . . 0.0 112.654 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB3' HG22 ' A' ' 6' ' ' THR . 0.6 OUTLIER -134.14 77.62 1.71 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.435 0.636 . . . . 0.0 109.513 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.8 pt20 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.328 0.585 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -150.4 88.4 1.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 21.6 mm-40 -120.98 155.83 33.45 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.623 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.638 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 5.2 t -136.39 144.23 44.42 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.46 174.31 12.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.664 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 72' ' ' GLN . 12.1 t -107.98 153.49 23.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -130.41 150.26 51.71 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.444 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -118.25 115.94 25.76 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.62 HG13 ' CB ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -110.99 76.18 1.2 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.019 -1.051 . . . . 0.0 111.49 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.2 Cg_endo -62.8 -15.23 45.61 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.466 1.245 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -55.65 -21.78 30.04 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.79 -174.5 4.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.955 . . . . 0.0 109.691 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 178.58 75.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 110.724 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.89 -178.61 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.888 -1.133 . . . . 0.0 110.047 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.37 75.48 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 109.822 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.53 -45.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.118 -0.989 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 5.3 m -96.84 -45.03 0.25 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.959 -1.088 . . . . 0.0 113.145 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -59.23 -38.23 86.91 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 N-CA-C 108.231 -1.488 . . . . 0.0 108.231 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.447 HG13 ' HB3' ' A' ' 38' ' ' PHE . 2.2 tt -63.62 -35.23 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.18 0.99 . . . . 0.0 108.575 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 6.8 m -62.65 -20.75 65.12 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.804 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.9 t -73.81 -32.65 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HG3' HG12 ' A' ' 34' ' ' VAL . 18.6 tttm -64.61 -36.13 83.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 26' ' ' SER . 0.1 OUTLIER -66.4 -37.54 85.47 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.25 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.505 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . . . -57.56 -59.6 4.92 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.821 -0.55 . . . . 0.0 110.357 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.31 -26.78 68.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 109.572 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 12.9 t -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.93 7.3 7.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.666 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.2 p -49.86 -49.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.826 -1.171 . . . . 0.0 110.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.9 -86.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.263 -0.898 . . . . 0.0 111.318 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -84.1 1.95 88.22 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.046 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 25' ' ' LEU . 6.5 p -43.99 131.18 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.835 -1.391 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.57 -15.43 13.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -164.35 160.1 20.47 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.916 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.624 HG12 ' HG3' ' A' ' 22' ' ' LYS . 14.1 t -150.96 151.99 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 110.318 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -169.95 96.24 0.28 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 22' ' ' LYS . 3.2 m -107.88 -154.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.025 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.87 109.5 0.52 Allowed Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.621 ' O ' ' CD2' ' A' ' 38' ' ' PHE . 49.0 p90 -83.46 57.81 4.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.829 . . . . 0.0 110.437 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -179.01 -60.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.27 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -78.99 2.65 19.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 9' ' ' VAL . 8.7 tmm_? 60.46 84.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.771 -0.581 . . . . 0.0 111.252 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' GLY . 22.5 tt0 -167.17 120.38 0.97 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.977 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -113.65 118.21 33.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.022 -1.049 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.3 t -107.94 124.45 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.748 -1.22 . . . . 0.0 107.825 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 57' ' ' LEU . 8.7 p -134.49 150.07 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.478 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.638 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.95 157.68 21.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.3 p90 -171.44 -176.16 1.78 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.346 -1.342 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -106.79 113.52 27.07 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -59.72 -10.09 3.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.192 -177.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 48' ' ' ASP . 10.0 t -70.6 -28.01 64.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 110.643 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 11.1 mtpt -124.13 -14.08 7.12 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.88 -1.137 . . . . 0.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -141.24 -170.64 3.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.42 160.14 0.73 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.162 -0.961 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.047 HG23 HG21 ' A' ' 70' ' ' VAL . 3.9 p -41.01 -44.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.563 -0.711 . . . . 0.0 109.914 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.547 ' N ' HG13 ' A' ' 54' ' ' VAL . 32.5 tt0 -57.37 -47.77 80.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -64.11 -27.09 68.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.571 -0.705 . . . . 0.0 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.5 mt -70.43 -55.55 8.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.798 -1.189 . . . . 0.0 108.718 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' SER . 6.5 m -64.34 -20.72 66.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -83.37 -24.85 31.85 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.42 -41.3 69.69 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.62 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.544 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.7 t -75.16 -39.4 60.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.539 ' N ' HG23 ' A' ' 61' ' ' THR . . . -56.09 -32.27 64.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -86.27 -21.78 27.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.528 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.98 60.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.212 -0.93 . . . . 0.0 108.734 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 104.24 31.77 4.55 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.434 -1.867 . . . . 0.0 108.434 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.666 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 24.5 m-85 -138.77 89.75 12.96 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 122.015 -0.697 . . . . 0.0 110.488 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -54.85 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.634 1.333 . . . . 0.0 109.642 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.04 -168.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 111.254 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.541 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -152.99 -179.19 7.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 54' ' ' VAL . 7.4 p -134.32 156.25 40.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 120.371 -1.456 . . . . 0.0 111.863 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.681 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.65 43.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.129 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.701 ' C ' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.906 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.199 0.523 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.5 87.5 1.58 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 25.6 mm-40 -109.83 157.04 19.6 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.001 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.511 HG23 ' OG1' ' A' ' 46' ' ' THR . 13.8 m -135.77 115.28 12.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.648 HG11 ' HB ' ' A' ' 54' ' ' VAL . 11.4 m -121.84 168.05 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.85 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -107.98 159.01 16.88 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.016 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -131.89 152.08 51.28 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.324 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -122.74 106.1 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.901 HG11 HG21 ' A' ' 21' ' ' VAL . 10.6 p -112.24 88.56 10.76 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.026 -1.046 . . . . 0.0 111.937 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.9 Cg_endo -68.64 -1.19 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.592 1.312 . . . . 0.0 111.338 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.92 12.67 47.83 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.604 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -106.99 -164.45 0.99 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.336 -1.097 . . . . 0.0 110.338 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.794 HG22 ' SG ' ' A' ' 17' ' ' CYS . 1.7 t 179.77 -4.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 13.8 p -172.2 -158.77 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 119.72 -1.863 . . . . 0.0 110.273 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 62.57 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.203 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -162.27 -42.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 111.333 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 13' ' ' THR . 10.3 p -108.09 -25.05 0.17 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.657 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 12.5 Cg_endo -78.28 -37.76 0.7 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 N-CA-C 106.75 -2.058 . . . . 0.0 106.75 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.576 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 72.0 mt -63.88 -29.93 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.151 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 9.4 m -65.91 -20.65 66.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.982 HG13 ' OG1' ' A' ' 61' ' ' THR . 58.1 t -69.53 -33.23 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -67.92 -37.46 81.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -62.61 -32.17 73.14 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.103 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.68 -56.3 18.98 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.76 -0.588 . . . . 0.0 110.543 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -64.74 -24.1 67.45 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -76.68 -21.41 55.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.48 1.06 16.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.483 -0.761 . . . . 0.0 109.91 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.6 t -46.61 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.084 -1.01 . . . . 0.0 109.418 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.796 ' N ' HG12 ' A' ' 28' ' ' VAL . 10.4 pt-20 179.44 -41.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 110.802 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 29' ' ' GLU . . . -112.54 -10.26 17.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -50.45 125.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 110.028 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.61 14.86 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.628 0.727 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.93 160.51 41.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 22' ' ' LYS . 7.3 p -155.8 163.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.84 -1.163 . . . . 0.0 111.938 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.69 143.59 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.89 HG13 ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -108.95 127.88 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.042 . . . . 0.0 112.08 -177.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -114.75 49.73 0.83 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -25.76 -118.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.2 tp10 -41.32 -35.82 0.71 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.55 -1.344 . . . . 0.0 110.718 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -86.43 38.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.0 110.529 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.562 ' HB3' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 8.31 86.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 5.8 tt0 -162.07 110.87 1.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.014 -1.054 . . . . 0.0 110.715 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.58 120.23 41.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 110.248 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.6 t -107.94 122.03 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.861 -1.15 . . . . 0.0 108.037 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.6 t -132.94 152.66 36.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 118.141 -1.424 . . . . 0.0 113.332 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -114.59 155.31 26.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 57' ' ' LEU . 48.7 p90 -172.51 -178.86 2.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.595 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -106.75 117.13 33.23 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 178.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 24.7 t0 -70.78 0.54 6.91 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.255 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' HG3' ' A' ' 51' ' ' LYS . 14.0 t -64.62 -16.68 63.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.93 -1.107 . . . . 0.0 109.599 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG3' HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -138.32 -43.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.05 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -104.5 -169.34 1.61 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.766 -0.584 . . . . 0.0 109.721 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.639 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.5 t -178.35 158.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.926 ' HA ' HD12 ' A' ' 57' ' ' LEU . 2.7 p -41.94 -42.72 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.506 ' N ' HG13 ' A' ' 54' ' ' VAL . 38.0 tt0 -60.61 -45.83 92.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 108.957 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.415 -0.803 . . . . 0.0 111.075 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 54' ' ' VAL . 34.8 mt -73.04 -55.82 5.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.586 -1.321 . . . . 0.0 108.302 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.553 ' N ' HD21 ' A' ' 7' ' ' LEU . 54.4 m -62.76 -20.56 65.09 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -81.49 -28.86 33.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.899 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -69.05 -39.96 78.85 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.283 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.982 ' OG1' HG13 ' A' ' 21' ' ' VAL . 13.1 t -75.46 -41.0 56.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.07 -26.49 62.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.53 -21.84 21.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.857 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.21 -17.49 61.35 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.159 -0.963 . . . . 0.0 108.649 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.51 24.85 4.24 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.618 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 20.3 m-85 -138.66 88.66 13.94 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.631 -0.923 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.3 Cg_exo -54.84 95.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.853 1.449 . . . . 0.0 110.194 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.5 -163.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 110.861 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -149.04 -171.44 3.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.016 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.0 p -139.1 153.44 24.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 111.826 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -155.83 39.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.585 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 71' ' ' LYS . 79.1 mt-30 . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.392 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 88.22 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -110.01 156.66 20.21 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.683 -177.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.552 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 23.4 m -135.1 137.24 42.64 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.597 -0.689 . . . . 0.0 109.258 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' CG1' ' A' ' 54' ' ' VAL . 27.9 m -146.77 175.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.84 ' O ' HD12 ' A' ' 7' ' ' LEU . 12.2 t -109.59 162.85 14.01 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.864 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.3 mp -130.68 138.99 50.3 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.074 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -112.91 93.8 4.59 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.789 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 ' SD ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -115.73 101.47 54.13 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.178 -0.952 . . . . 0.0 111.262 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 9.7 Cg_endo -76.36 5.37 4.7 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.628 1.331 . . . . 0.0 111.066 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -82.08 8.29 60.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.932 ' SD ' HG21 ' A' ' 21' ' ' VAL . 3.8 ptm -139.87 156.97 46.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.4 -1.059 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.14 39.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -170.46 -178.27 2.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.5 76.26 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.722 -1.236 . . . . 0.0 109.807 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.88 -51.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.055 -1.028 . . . . 0.0 111.357 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.66 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.0 m -90.35 -45.8 0.39 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.894 -1.129 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.676 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 17.6 Cg_exo -59.43 -64.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 122.838 0.915 . . . . 0.0 110.759 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 38' ' ' PHE . 26.6 mt -45.48 -27.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.925 -1.109 . . . . 0.0 110.296 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 90.4 m -70.44 -38.17 74.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.801 -1.187 . . . . 0.0 108.771 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.978 HG22 ' OG1' ' A' ' 61' ' ' THR . 19.7 t -60.01 -26.5 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 36' ' ' VAL . 9.9 tptm -71.83 -43.76 65.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -66.21 -26.91 67.6 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.703 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . . . -66.63 -48.68 68.69 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.657 -0.652 . . . . 0.0 110.811 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.677 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -72.91 -41.49 64.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -0.996 . . . . 0.0 110.345 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -62.21 -24.07 67.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.538 -0.726 . . . . 0.0 109.276 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -122.24 7.62 9.68 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.434 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.1 p -50.89 -48.13 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.478 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.598 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.26 -84.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.398 -0.814 . . . . 0.0 110.778 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.572 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -85.23 0.07 88.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.843 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.571 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.6 p -44.14 127.93 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.888 -1.36 . . . . 0.0 110.0 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.29 -14.39 14.16 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.669 0.747 . . . . 0.0 109.116 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 2.9 tttm -162.57 161.63 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.713 HG23 HG22 ' A' ' 45' ' ' VAL . 9.2 p -150.65 154.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 110.725 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 15.0 t70 -168.99 82.91 0.14 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 22' ' ' LYS . 4.7 m -109.23 -163.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.001 0.905 . . . . 0.0 111.475 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.15 93.19 0.15 Allowed Glycine 0 C--N 1.298 -1.552 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.676 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 p90 -54.93 -54.66 39.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.877 . . . . 0.0 109.675 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.14 -24.75 65.04 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.025 -1.047 . . . . 0.0 110.183 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 0.27 57.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HA ' ' CE ' ' A' ' 12' ' ' MET . 0.2 OUTLIER 46.69 70.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.371 -0.831 . . . . 0.0 111.079 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.49 119.79 0.79 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.41 -0.806 . . . . 0.0 109.981 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.19 119.1 38.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.798 -1.188 . . . . 0.0 112.356 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -110.13 110.22 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.713 HG22 HG23 ' A' ' 34' ' ' VAL . 60.2 t -130.45 150.79 34.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.309 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.4 m -109.68 159.43 17.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.752 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.0 p90 -171.81 -174.86 1.41 Allowed 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.055 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 4.2 m-20 -106.61 126.82 52.75 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 5.9 p-10 -75.01 10.75 1.33 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.61 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.776 HG23 ' HB1' ' A' ' 1' ' ' ALA . 61.5 p -87.28 -36.34 17.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -118.68 -11.27 9.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.088 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -135.7 -174.36 3.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 3.7 t -178.44 154.48 0.8 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.895 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.901 ' HA ' HD12 ' A' ' 57' ' ' LEU . 34.3 m -42.59 -38.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.253 -0.904 . . . . 0.0 109.488 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.513 ' N ' HG23 ' A' ' 54' ' ' VAL . 2.6 tt0 -64.01 -47.25 81.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -62.0 -26.91 68.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 54' ' ' VAL . 45.7 mt -69.65 -54.68 12.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.856 -1.152 . . . . 0.0 108.306 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.75 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.0 OUTLIER -65.55 -17.34 64.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.24 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.6 ttpt -86.15 -21.64 27.46 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.474 -0.766 . . . . 0.0 109.183 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -76.63 -40.15 50.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.576 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.978 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.9 t -79.94 -36.26 36.49 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.46 -27.72 69.18 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 m-20 -84.76 -20.29 31.3 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -19.56 60.66 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.36 28.76 2.93 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 21.6 m-85 -134.83 105.0 10.64 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.717 -0.872 . . . . 0.0 110.642 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 7.6 Cg_exo -49.39 101.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.75 ' OG ' HG22 ' A' ' 58' ' ' THR . 53.0 p -107.82 158.22 17.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 112.05 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 1.3 t -126.84 -178.15 4.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.864 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.9 p -142.91 150.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 120.761 -1.212 . . . . 0.0 111.069 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.759 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -168.26 51.09 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.801 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.5 tt0 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 117.955 -1.022 . . . . 0.0 111.368 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.58 86.07 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.92 153.6 23.32 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.231 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.521 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 19.0 m -135.15 132.26 37.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.539 -0.725 . . . . 0.0 109.918 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.838 HG11 HG12 ' A' ' 54' ' ' VAL . 21.5 m -135.51 171.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.13 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.44 154.98 20.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 ' HB ' ' A' ' 70' ' ' VAL . 1.2 mp -130.01 157.12 43.22 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.155 -1.418 . . . . 0.0 111.214 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -127.31 112.15 14.72 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.358 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.854 HG21 HG11 ' A' ' 21' ' ' VAL . 62.0 t -116.85 74.56 6.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.923 -1.11 . . . . 0.0 111.408 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 Cg_endo -67.27 -5.52 14.02 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.591 1.311 . . . . 0.0 111.226 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -54.39 -23.16 25.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.862 ' HE1' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -144.5 -178.8 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 109.279 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 12' ' ' MET . 0.9 OUTLIER 177.91 75.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.021 -1.05 . . . . 0.0 110.721 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -149.33 -55.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 117.893 -1.523 . . . . 0.0 111.603 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 176.67 -27.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.413 -1.429 . . . . 0.0 111.363 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -115.24 -40.42 3.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.611 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' C ' ' HE2' ' A' ' 12' ' ' MET . 7.6 m -66.3 -47.45 59.99 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.124 -0.985 . . . . 0.0 111.202 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 2.1 Cg_endo -62.54 -37.86 55.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.72 HD12 ' HB3' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -68.57 -24.6 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 21.6 m -62.97 -20.12 64.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 9' ' ' VAL . 41.6 t -74.18 -33.45 35.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -62.48 -35.5 79.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' CE ' ' HE3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -67.14 -44.51 79.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.987 0.899 . . . . 0.0 109.837 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -57.35 -52.35 65.7 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -63.74 -41.22 98.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.017 -1.052 . . . . 0.0 109.854 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.527 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -63.11 -21.41 66.17 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' CE ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -108.44 -2.11 19.3 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.414 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.04 HG23 ' HB2' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -46.01 -53.16 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -0.915 . . . . 0.0 109.541 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 153.62 -72.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.79 0.805 . . . . 0.0 109.562 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -83.55 -16.72 67.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.4 p -38.75 122.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 110.348 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 m -112.68 -12.7 13.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.627 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 1.2 tttt -143.62 155.64 44.33 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.206 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.686 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.3 t -151.23 129.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.662 0.744 . . . . 0.0 110.707 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 65.3 m-20 -155.02 89.2 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 43' ' ' ALA . 2.4 m -109.42 -159.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 122.15 0.976 . . . . 0.0 111.816 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 40' ' ' LYS . . . -149.93 113.93 0.63 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HB3' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -49.99 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.731 -0.864 . . . . 0.0 111.825 -178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -33.59 -33.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.337 -0.852 . . . . 0.0 111.372 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 41' ' ' ARG . 16.2 ptmt -89.6 51.41 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.501 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.761 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -13.42 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.411 0.624 . . . . 0.0 112.557 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' LYS . 18.3 mt-10 -152.22 112.79 4.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 110.156 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.21 115.67 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.903 -1.123 . . . . 0.0 111.095 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.13 ' CG2' HG22 ' A' ' 6' ' ' THR . 8.2 t -107.53 116.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.642 -1.286 . . . . 0.0 108.298 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CB ' ' A' ' 25' ' ' LEU . 11.8 m -132.43 162.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.245 -1.382 . . . . 0.0 113.354 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.627 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.6 m -119.07 162.35 18.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -172.17 -175.22 1.39 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.959 -1.496 . . . . 0.0 111.815 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.29 116.95 32.82 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 7.8 p-10 -67.91 -2.07 6.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.373 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -24.74 44.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.008 -1.058 . . . . 0.0 110.614 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -125.72 -3.33 7.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.048 -1.033 . . . . 0.0 110.463 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -156.43 -168.42 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.634 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.6 p 179.7 164.71 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 m -43.2 -33.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.361 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' N ' HG23 ' A' ' 54' ' ' VAL . 3.0 tt0 -65.77 -47.87 73.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.472 -0.768 . . . . 0.0 109.148 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.67 -24.08 66.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.645 -0.66 . . . . 0.0 110.763 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 54' ' ' VAL . 41.7 mt -71.98 -55.82 6.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.814 -1.179 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.2 m -63.96 -19.89 65.47 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 1.6 ttmt -80.81 -27.37 36.6 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.04 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -69.73 -43.15 72.93 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.656 -0.817 . . . . 0.0 109.274 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.585 ' HB ' HG13 ' A' ' 21' ' ' VAL . 14.8 t -75.66 -37.38 59.68 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.25 -26.52 66.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.39 -21.63 22.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.81 -15.86 61.62 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.613 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 108.28 30.94 3.68 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 23.3 m-85 -138.29 102.74 8.06 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.639 -0.918 . . . . 0.0 110.603 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.09 98.92 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.564 1.297 . . . . 0.0 109.396 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.791 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -107.95 -166.39 1.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.235 -0.916 . . . . 0.0 111.604 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.6 t -163.84 126.74 2.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 7' ' ' LEU . 6.6 p -91.69 161.84 2.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.868 -1.145 . . . . 0.0 110.958 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLN . 3.9 ptmt -145.86 42.22 1.22 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.563 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.2 mp0 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.839 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -147.45 89.72 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 3.9 mm100 -109.61 158.28 18.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.76 0.79 . . . . 0.0 111.627 -177.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 45' ' ' VAL . 96.9 m -137.08 141.74 42.36 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.659 -0.651 . . . . 0.0 109.398 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.807 HG11 ' CG1' ' A' ' 54' ' ' VAL . 4.7 m -146.1 165.54 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.001 . . . . 0.0 109.766 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.958 HG22 ' O ' ' A' ' 72' ' ' GLN . 13.6 t -107.42 151.84 25.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.733 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -125.95 156.81 39.2 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 120.957 -1.09 . . . . 0.0 110.668 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -137.24 107.47 6.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.994 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 68' ' ' SER . 1.9 t -108.22 102.41 46.31 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.176 -0.952 . . . . 0.0 110.776 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.0 Cg_endo -71.11 9.95 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.366 1.377 . . . . 0.0 112.4 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.51 -5.71 42.15 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.508 -1.37 . . . . 0.0 110.167 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.712 ' HE1' ' HB3' ' A' ' 17' ' ' CYS . 4.2 mmm -93.39 151.25 19.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.207 -1.172 . . . . 0.0 110.179 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 12' ' ' MET . 9.3 t -179.04 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.134 -0.979 . . . . 0.0 111.543 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 179.03 162.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.678 -1.264 . . . . 0.0 109.536 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -71.16 79.86 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.708 -1.245 . . . . 0.0 110.483 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 178.13 -56.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.007 -1.058 . . . . 0.0 111.007 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 5.0 m -86.92 -45.15 0.54 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.236 -0.915 . . . . 0.0 111.873 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.634 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 21.1 Cg_exo -54.8 -52.19 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 27.6 mt -59.17 -23.82 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.632 -0.667 . . . . 0.0 110.105 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 37.2 m -65.75 -26.74 67.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 108.544 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 61' ' ' THR . 33.1 t -69.89 -26.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.738 ' HD2' HG22 ' A' ' 36' ' ' VAL . 14.2 tttt -68.58 -44.42 74.44 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 mptp? -67.45 -29.61 69.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.363 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -59.29 -45.08 92.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.278 0.561 . . . . 0.0 109.891 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.79 HD22 ' HB ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -66.9 -47.87 70.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.861 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.44 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 8.3 t -66.12 -11.46 49.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.479 -0.763 . . . . 0.0 109.006 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -110.58 -9.3 14.56 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.069 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.0 t -48.79 -58.34 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.106 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 154.79 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.606 0.717 . . . . 0.0 110.072 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.01 -8.07 87.97 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 25' ' ' LEU . 2.5 t -43.72 122.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 109.38 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.37 -11.17 15.23 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.668 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -156.23 161.17 40.3 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.564 HG13 HD13 ' A' ' 25' ' ' LEU . 12.9 t -150.0 152.27 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.028 -1.045 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 6.4 t0 -167.69 82.8 0.2 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 22' ' ' LYS . 3.2 m -109.24 -165.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 111.773 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -152.07 95.35 0.16 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -46.06 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.707 -0.878 . . . . 0.0 111.666 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.2 mm-40 1.53 -75.31 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.201 0.524 . . . . 0.0 112.035 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -62.49 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 108.734 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 143.49 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 122.864 0.466 . . . . 0.0 109.91 178.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 19.5 mt-10 -134.29 116.78 15.67 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -110.18 115.38 29.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 0.0 111.606 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.0 t -106.83 124.16 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.713 -1.242 . . . . 0.0 107.71 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.79 ' HB ' HD22 ' A' ' 25' ' ' LEU . 3.9 p -139.34 161.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.457 -1.297 . . . . 0.0 113.536 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.8 m -121.39 157.66 29.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.835 ' CE2' HD11 ' A' ' 57' ' ' LEU . 47.9 p90 -171.63 -174.39 1.37 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.922 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 82.3 m-20 -106.76 123.46 48.17 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -71.88 1.9 6.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.032 -177.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.839 HG23 ' CB ' ' A' ' 1' ' ' ALA . 24.7 p -78.87 -27.33 44.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.961 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -122.58 -18.04 6.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -138.38 -169.9 2.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.372 -0.83 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.637 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -177.99 159.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.868 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.8 -42.58 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.598 ' N ' HG23 ' A' ' 54' ' ' VAL . 37.2 tt0 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.065 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -65.49 -24.17 67.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.57 -0.706 . . . . 0.0 111.011 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.0 mt -75.5 -52.83 9.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 0.0 108.289 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.534 HG22 ' OG ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -66.66 -18.76 65.54 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -84.15 -25.72 29.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.052 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -70.98 -42.34 69.8 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.944 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.53 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.7 t -77.17 -38.78 51.0 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -60.34 -25.27 65.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.52 -25.93 28.44 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -13.29 60.88 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.66 32.69 3.3 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.835 ' HB3' HG11 ' A' ' 9' ' ' VAL . 24.0 m-85 -135.16 84.17 37.09 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.691 -0.888 . . . . 0.0 110.21 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -54.19 97.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.781 1.411 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.868 ' HB3' HG13 ' A' ' 9' ' ' VAL . 49.5 p -107.8 -165.59 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.889 0.852 . . . . 0.0 111.886 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -153.44 126.19 8.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.733 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.7 p -95.05 159.72 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.93 -1.106 . . . . 0.0 110.431 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.4 OUTLIER -151.3 51.49 0.84 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.224 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.958 ' O ' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.24 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.734 HG23 ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -148.29 89.21 1.7 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 152.35 44.75 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.926 0.87 . . . . 0.0 111.943 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -121.0 152.66 38.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.446 0.641 . . . . 0.0 109.873 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 54' ' ' VAL . 16.0 m -142.51 174.34 5.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.821 ' O ' HD12 ' A' ' 7' ' ' LEU . 11.1 t -108.17 160.97 15.41 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.007 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -130.68 141.77 50.42 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.878 -1.529 . . . . 0.0 111.707 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -110.39 101.21 9.95 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.3 p -112.55 79.64 3.22 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 111.051 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.7 Cg_endo -68.11 -3.38 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.766 1.403 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -56.24 -17.28 17.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.715 ' SD ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -154.18 -171.25 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 110.027 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 12' ' ' MET . 7.0 t 179.93 58.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -160.31 173.64 15.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.305 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -73.89 78.72 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 110.59 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.16 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.189 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB2' ' CB ' ' A' ' 12' ' ' MET . 2.6 m -91.77 -44.7 0.36 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.639 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 4.9 Cg_exo -61.03 -44.59 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.651 ' HA ' HG23 ' A' ' 36' ' ' VAL . 85.4 mt -57.67 -29.66 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.967 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 14.6 m -65.46 -28.43 69.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 108.695 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.901 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.0 t -68.31 -27.42 36.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.826 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.9 tttt -69.84 -43.2 72.43 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.4 mptt -64.99 -25.01 67.68 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.351 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.48 -43.27 77.28 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.777 -0.577 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -69.19 -41.89 76.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.055 -1.028 . . . . 0.0 109.64 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.828 ' HA ' HG11 ' A' ' 31' ' ' VAL . 2.9 p -67.4 -18.17 65.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -99.75 -9.65 22.77 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.903 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.5 t -45.32 -63.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.039 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 1.4 tt0 160.28 -64.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.355 0.597 . . . . 0.0 109.782 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -93.4 -6.91 62.37 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.565 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 26' ' ' SER . 13.7 p -41.77 129.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 109.732 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 m -108.24 -10.85 15.32 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.369 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.93 159.54 18.28 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.296 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 25' ' ' LEU . 60.4 t -147.49 160.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.838 -1.164 . . . . 0.0 111.581 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 44' ' ' VAL . 8.3 t70 -136.84 135.65 38.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG23 ' HA ' ' A' ' 19' ' ' ILE . 1.6 p -109.39 127.31 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.888 -1.133 . . . . 0.0 112.07 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -109.45 59.34 0.36 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -28.77 -110.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.373 0.606 . . . . 0.0 112.498 -177.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -50.9 -50.18 57.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.572 -1.33 . . . . 0.0 112.134 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.2 tmmm? -55.21 -14.04 1.54 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.0 111.506 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' VAL . 7.7 tmm_? 61.45 84.01 0.14 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.432 -0.792 . . . . 0.0 111.216 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -171.8 120.51 0.46 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.398 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -114.04 119.55 37.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 110.487 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -107.36 123.62 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.8 p -133.96 152.07 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.664 -1.214 . . . . 0.0 113.752 -176.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -113.16 152.33 29.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.807 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.0 p90 -170.45 -179.91 3.15 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.734 ' OD2' HG23 ' A' ' 2' ' ' THR . 5.8 m-20 -107.11 123.69 48.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.686 ' OD1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -67.34 -2.45 6.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.285 -177.244 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 48' ' ' ASP . 6.0 t -81.57 -23.43 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 110.154 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -125.52 -5.84 7.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.155 -0.965 . . . . 0.0 110.479 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.15 -170.07 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.71 158.93 0.71 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.817 ' HA ' HD12 ' A' ' 57' ' ' LEU . 17.4 m -41.84 -41.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.579 ' N ' HG23 ' A' ' 54' ' ' VAL . 22.2 tp60 -60.59 -45.61 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.392 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.61 -25.97 67.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.639 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 45' ' ' VAL . 39.5 mt -72.62 -56.32 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.893 -1.129 . . . . 0.0 108.346 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 ' OG ' ' A' ' 68' ' ' SER . 3.2 m -64.45 -17.74 64.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 4.2 ttmm -81.73 -27.95 33.63 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.41 -43.61 66.45 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.071 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.901 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.9 t -74.29 -36.25 63.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -60.9 -29.77 69.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -90.28 -15.51 31.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.28 178.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.9 -18.82 58.06 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 117.48 23.91 3.62 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -142.13 90.56 8.25 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.571 -0.958 . . . . 0.0 109.993 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.5 Cg_exo -55.71 97.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.63 1.332 . . . . 0.0 110.103 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.679 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.5 p -108.5 -163.21 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.874 . . . . 0.0 111.036 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.656 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -147.3 -175.37 4.81 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.007 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.56 142.08 33.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.817 -1.177 . . . . 0.0 112.184 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -131.77 79.95 1.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.457 0.646 . . . . 0.0 109.595 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 5' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -157.44 90.79 1.12 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -114.54 158.0 22.24 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.6 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.535 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 50.0 m -136.64 121.57 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.665 -0.647 . . . . 0.0 109.321 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' A' ' 72' ' ' GLN . 5.1 m -131.97 172.8 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.477 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.707 ' O ' HD12 ' A' ' 7' ' ' LEU . 10.6 t -108.48 157.33 18.54 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -126.17 156.56 39.97 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.002 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -132.33 103.33 6.15 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.0 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.6 t -108.71 102.76 49.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.526 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 4.6 Cg_endo -71.37 2.19 4.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.198 1.265 . . . . 0.0 111.8 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.41 -1.0 60.87 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -107.16 161.2 14.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -1.22 . . . . 0.0 110.055 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 179.01 32.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.102 -0.999 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -173.19 170.37 4.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.739 -1.226 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -77.05 78.31 3.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.8 -48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 6.1 m -93.66 -44.72 0.31 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.978 -1.076 . . . . 0.0 112.048 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 1.5 Cg_endo -65.45 -38.11 27.27 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 107.661 -1.707 . . . . 0.0 107.661 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.66 HG13 ' CE1' ' A' ' 38' ' ' PHE 0.267 6.7 tt -59.21 -36.16 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.402 1.096 . . . . 0.0 108.711 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 49.9 m -63.44 -21.31 66.23 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.72 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.5 t -69.77 -33.09 54.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.774 ' HB2' HG21 ' A' ' 36' ' ' VAL . 27.5 tttm -66.16 -41.23 90.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -25.65 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.182 179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' VAL . . . -69.51 -55.6 9.75 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.687 -0.633 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.875 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.95 -37.23 81.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.606 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -70.37 -20.49 62.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 108.978 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -112.88 10.72 19.07 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.18 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.6 p -66.35 -44.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.457 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.44 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.476 -0.765 . . . . 0.0 111.269 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.703 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -90.27 0.98 79.07 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.271 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG11 ' C ' ' A' ' 26' ' ' SER . 7.3 p -42.86 128.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.922 -1.34 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -113.87 -14.87 12.45 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.596 0.713 . . . . 0.0 109.58 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.816 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -156.7 159.77 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.435 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 45' ' ' VAL . 13.4 p -152.65 157.4 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 111.08 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t0 -170.54 87.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 22' ' ' LYS . 6.1 m -108.02 -159.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.885 . . . . 0.0 111.783 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.12 115.19 0.82 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.68 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 m-30 -56.6 -105.66 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 O-C-N 122.216 -0.579 . . . . 0.0 109.713 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -47.87 -34.21 8.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.358 -1.464 . . . . 0.0 110.476 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 33.4 tttt -52.78 -41.97 64.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.077 -1.014 . . . . 0.0 110.7 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER 81.37 70.03 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.425 0.631 . . . . 0.0 110.989 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -170.83 120.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.755 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.99 115.62 29.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.949 -1.094 . . . . 0.0 111.993 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.3 t -107.97 117.16 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.875 HG21 HD22 ' A' ' 25' ' ' LEU . 21.8 t -137.3 155.5 32.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.228 -1.389 . . . . 0.0 113.09 -177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.8 m -114.9 160.55 19.39 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.753 ' CE1' HD11 ' A' ' 57' ' ' LEU . 53.4 p90 -171.82 -176.52 1.75 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.796 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.63 114.78 29.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -62.67 -9.01 7.65 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.59 -177.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 7.4 t -67.59 -26.92 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.013 -1.054 . . . . 0.0 109.574 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -0.9 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.456 -0.778 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.35 -168.81 3.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 179.73 156.15 0.59 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.846 . . . . 0.0 109.62 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.794 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.2 m -44.74 -39.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.347 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.02 -43.74 97.87 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.327 -0.858 . . . . 0.0 109.105 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.24 -25.17 67.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.443 -0.786 . . . . 0.0 110.736 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 54' ' ' VAL . 54.4 mt -69.57 -56.1 8.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.861 -1.149 . . . . 0.0 108.704 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 3.0 m -64.65 -21.43 66.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mttp -81.43 -23.85 37.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -73.47 -44.18 58.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.325 -0.86 . . . . 0.0 108.933 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.632 ' OG1' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.59 -35.34 60.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.12 -29.78 70.57 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 40.3 t0 -79.21 -23.73 43.61 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.28 59.97 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.618 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.71 32.94 3.21 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG11 ' A' ' 9' ' ' VAL . 25.2 m-85 -137.35 84.62 23.33 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.681 -0.894 . . . . 0.0 110.262 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.19 97.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.67 1.353 . . . . 0.0 109.235 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.0 ' OG ' HG22 ' A' ' 9' ' ' VAL . 12.6 t -108.03 -172.03 1.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.887 0.851 . . . . 0.0 112.12 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.58 121.55 8.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -92.86 156.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.808 -1.182 . . . . 0.0 110.572 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.621 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -154.78 45.43 0.52 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.339 -1.344 . . . . 0.0 110.841 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.635 ' HB3' HG12 ' A' ' 5' ' ' VAL . 2.7 pp0? . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.838 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.938 ' HB1' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.3 t -178.05 107.65 0.05 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.289 1.042 . . . . 0.0 108.725 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.656 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.7 pt20 -130.24 173.62 10.61 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.158 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 45' ' ' VAL . 7.0 m -126.37 137.82 53.49 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.578 -0.701 . . . . 0.0 109.737 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.763 HG21 HG23 ' A' ' 54' ' ' VAL . 33.7 m -133.13 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.834 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.91 157.01 18.1 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.79 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.47 152.4 50.51 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.814 -178.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.39 117.26 23.32 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.632 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.9 HG21 HG11 ' A' ' 21' ' ' VAL . 98.9 t -112.56 75.94 1.93 Allowed Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 120.845 -1.159 . . . . 0.0 112.184 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 5.9 Cg_endo -69.27 -13.95 36.79 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.222 1.117 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -43.89 -42.19 6.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 83.5 mmm -153.39 140.14 19.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -1.067 . . . . 0.0 110.044 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.558 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 2.4 t -134.6 78.36 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 110.878 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -147.68 -142.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.035 -1.04 . . . . 0.0 108.881 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -110.11 64.81 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.805 -1.184 . . . . 0.0 109.335 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.04 -54.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.048 -1.032 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.1 m -77.29 -48.38 2.45 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 120.835 -1.165 . . . . 0.0 111.601 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 27.3 Cg_exo -51.02 -56.19 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.082 1.043 . . . . 0.0 109.776 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -57.66 -27.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.767 -0.583 . . . . 0.0 110.42 179.239 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 67.8 m -66.43 -24.54 66.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.741 -1.225 . . . . 0.0 108.717 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.9 HG11 HG21 ' A' ' 9' ' ' VAL . 57.3 t -69.17 -31.72 51.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.671 ' CA ' HG21 ' A' ' 36' ' ' VAL . 17.4 tttm -70.51 -40.16 73.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -68.51 -21.05 64.61 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.451 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -72.51 -53.47 11.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.706 -0.621 . . . . 0.0 110.321 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -61.55 -30.13 70.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.0 109.373 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.8 -27.43 61.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.502 -0.749 . . . . 0.0 109.16 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.44 6.89 37.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.264 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.5 t -56.13 -77.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.731 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER 177.89 -81.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.3 -1.06 87.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 25' ' ' LEU . 5.4 p -42.11 133.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.206 -1.173 . . . . 0.0 110.582 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -110.15 -17.94 13.43 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.593 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.5 tttt -167.63 158.63 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.165 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 45' ' ' VAL . 24.4 t -154.64 145.12 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.773 -1.204 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -141.66 154.67 45.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.671 HG21 ' CA ' ' A' ' 22' ' ' LYS . 46.6 t -155.29 158.48 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.352 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -124.3 81.94 0.35 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -35.93 -101.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 122.276 -0.544 . . . . 0.0 111.812 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -28.8 -44.03 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.474 -0.766 . . . . 0.0 111.025 -179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -89.8 50.8 1.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -10.38 76.84 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' LYS . 5.6 tm-20 -149.82 109.6 4.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.627 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -110.17 126.79 54.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.815 -1.178 . . . . 0.0 111.431 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.834 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -108.08 120.84 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.902 ' CG1' HD13 ' A' ' 57' ' ' LEU . 9.9 p -126.02 156.06 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.589 1.185 . . . . 0.0 113.955 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -121.43 153.31 38.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 2' ' ' THR . 43.9 p90 -172.31 179.86 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 117.879 -1.528 . . . . 0.0 111.294 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.54 112.33 25.28 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.938 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -62.45 -8.22 5.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.985 -177.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 t -71.6 -10.26 59.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.996 -1.065 . . . . 0.0 110.155 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -132.39 -39.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -123.79 -169.96 2.04 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.724 -0.61 . . . . 0.0 109.696 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' ' C ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.28 154.28 5.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.939 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.3 p -41.07 -30.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.844 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 22.3 tt0 -70.08 -50.03 45.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -22.38 65.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 54' ' ' VAL . 42.3 mt -72.27 -51.56 20.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.641 -1.287 . . . . 0.0 108.155 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -65.91 -19.31 65.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -82.57 -24.05 34.15 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.838 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -72.7 -43.05 63.53 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.94 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.612 ' HB ' HG13 ' A' ' 21' ' ' VAL . 8.3 t -76.46 -38.29 55.63 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -61.93 -26.08 67.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.55 -24.24 29.36 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.97 -19.08 62.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 113.03 28.56 3.32 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 17.3 m-85 -134.82 87.55 30.14 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 121.499 -1.0 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.25 100.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.795 1.418 . . . . 0.0 109.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 9' ' ' VAL . 11.4 p -107.66 -167.91 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.59 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -150.47 129.64 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.915 HG21 HG22 ' A' ' 54' ' ' VAL . 6.9 p -99.14 158.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.889 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.7 OUTLIER -137.7 45.58 2.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.657 -1.217 . . . . 0.0 110.915 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.582 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.212 0.53 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -158.94 92.95 1.13 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -118.36 161.27 20.23 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.757 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -137.68 122.56 18.89 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 72' ' ' GLN . 34.2 m -132.99 174.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.988 HG22 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.28 163.71 12.79 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.005 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -135.45 143.74 46.07 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.277 -1.369 . . . . 0.0 111.604 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -114.22 99.3 7.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.861 ' O ' ' HE3' ' A' ' 12' ' ' MET . 7.4 p -112.34 80.08 3.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.117 -0.989 . . . . 0.0 111.932 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.5 Cg_endo -68.54 -1.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.508 1.268 . . . . 0.0 111.221 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.37 -26.52 3.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.861 ' HE3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -149.05 -165.19 2.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -1.234 . . . . 0.0 110.215 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 13' ' ' THR . 5.3 t -179.75 67.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.127 -0.983 . . . . 0.0 111.093 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -166.17 177.32 7.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.05 -1.031 . . . . 0.0 109.334 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.69 74.69 5.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 110.078 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.09 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 111.377 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.4 m -89.77 -42.6 0.42 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.98 -1.075 . . . . 0.0 112.88 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 5.5 Cg_endo -65.18 -41.22 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 38' ' ' PHE . 4.0 mt -61.47 -27.35 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 29.6 m -67.03 -27.98 67.85 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.101 -0.999 . . . . 0.0 108.334 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.741 ' O ' HD12 ' A' ' 25' ' ' LEU . 84.6 t -64.58 -32.15 56.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 tttm -65.28 -39.26 92.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -68.92 -24.89 64.34 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.885 0.85 . . . . 0.0 109.149 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.656 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.89 -56.14 6.92 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.72 -0.612 . . . . 0.0 110.514 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.46 -30.65 70.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.1 t -72.81 -25.36 61.12 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -108.07 7.13 27.55 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.684 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.3 p -61.81 -48.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.95 -1.093 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 165.45 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.0 -1.062 . . . . 0.0 111.238 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -91.82 4.67 78.99 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.124 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 28' ' ' VAL . 7.5 p -41.03 129.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.167 -1.196 . . . . 0.0 110.17 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -16.49 13.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.9 156.03 21.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.676 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.737 HG13 ' CG2' ' A' ' 45' ' ' VAL . 45.6 t -150.64 145.49 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.893 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -162.3 92.99 0.84 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 22' ' ' LYS . 2.3 m -108.39 -164.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.025 -1.047 . . . . 0.0 111.185 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -140.99 118.94 1.44 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -47.53 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.4 tt0 -35.45 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.019 -1.051 . . . . 0.0 111.538 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.19 30.58 0.46 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.893 -1.13 . . . . 0.0 110.898 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 6.14 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' LYS . 10.0 tt0 -145.79 112.75 6.06 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.669 -1.27 . . . . 0.0 110.593 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.71 120.65 43.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.874 -1.141 . . . . 0.0 111.979 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.988 HG23 HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -108.52 115.67 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.737 ' CG2' HG13 ' A' ' 34' ' ' VAL . 14.5 t -132.04 154.15 39.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.131 -1.428 . . . . 0.0 113.132 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -115.29 158.17 22.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.7 p90 -171.91 -177.7 2.0 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.562 -1.255 . . . . 0.0 110.918 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.0 m-20 -107.29 110.64 22.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.17 -12.96 4.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.449 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 14.4 t -60.44 -32.3 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 110.154 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 -3.73 6.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -142.67 -168.02 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 22.0 t 179.42 154.8 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.935 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HD12 ' A' ' 57' ' ' LEU . 15.2 m -43.61 -35.47 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.189 -0.944 . . . . 0.0 109.614 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' VAL . 10.6 tt0 -65.77 -46.38 78.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.007 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 2.4 mmtp -63.1 -25.37 68.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.547 -0.72 . . . . 0.0 110.271 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 54' ' ' VAL . 61.4 mt -69.88 -55.61 9.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.873 -1.142 . . . . 0.0 108.733 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.592 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -62.94 -22.38 66.75 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -81.37 -27.15 34.97 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.49 -0.756 . . . . 0.0 109.213 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.656 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.18 -42.93 71.78 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.161 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.715 ' CB ' HG13 ' A' ' 21' ' ' VAL . 12.4 t -75.32 -38.02 60.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.26 66.47 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.17 -23.76 26.4 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.87 -16.85 60.66 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.07 27.56 3.4 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.7 m-85 -138.05 82.61 24.6 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.567 -0.961 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.85 97.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.672 1.354 . . . . 0.0 109.974 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.9 p -108.49 -161.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.781 0.801 . . . . 0.0 111.316 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.5 t -146.32 -170.32 3.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -138.98 153.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 O-C-N 120.831 -1.168 . . . . 0.0 111.294 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -157.89 61.72 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.75 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.727 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.2 pt20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.425 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.28 0.562 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -160.03 91.72 0.97 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.3 pm0 -127.7 163.15 24.93 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.059 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 12.0 m -125.69 133.97 51.97 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.327 0.584 . . . . 0.0 109.718 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 ' HG3' ' A' ' 72' ' ' GLN . 7.0 m -135.75 169.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.859 ' O ' HD12 ' A' ' 7' ' ' LEU . 13.5 t -108.5 161.99 14.54 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.032 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -133.79 154.64 50.85 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.487 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -121.48 100.37 6.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.3 p -111.67 89.23 10.65 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.176 -0.952 . . . . 0.0 111.522 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.7 Cg_endo -68.69 -7.77 21.42 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.596 1.314 . . . . 0.0 110.713 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.82 0.45 57.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.565 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -92.34 176.67 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -1.204 . . . . 0.0 109.987 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.9 -9.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -163.5 -156.75 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.766 -1.834 . . . . 0.0 111.112 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.43 60.21 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.844 -1.16 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.94 -40.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 111.09 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m -93.79 -45.82 0.3 Allowed Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.69 -1.256 . . . . 0.0 111.962 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.6 Cg_exo -62.01 -57.88 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 122.965 0.981 . . . . 0.0 109.897 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -54.72 -29.44 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.711 . . . . 0.0 110.76 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.648 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 17.9 m -64.28 -27.15 68.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.805 -1.184 . . . . 0.0 109.055 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.885 HG22 ' OG1' ' A' ' 61' ' ' THR . 73.4 t -67.12 -30.23 48.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.599 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.8 tttt -70.55 -44.64 67.03 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.02 -23.15 64.04 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.884 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.93 -49.03 50.16 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.701 -0.624 . . . . 0.0 110.468 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.795 ' CB ' HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -61.62 -42.41 98.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 0.0 109.625 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.469 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.8 p -70.4 -20.19 62.95 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.225 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.03 -7.85 41.53 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.503 -0.748 . . . . 0.0 109.699 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.79 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 3.8 t -52.17 -76.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.643 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 167.76 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.521 0.677 . . . . 0.0 109.768 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.36 -8.19 49.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.9 p -48.59 126.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -1.171 . . . . 0.0 109.907 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.39 -14.6 14.4 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -162.2 160.5 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.56 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 45' ' ' VAL . 67.0 t -149.78 149.58 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.13 -0.981 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 30.3 t0 -167.4 91.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.0 m -108.39 -156.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.003 0.906 . . . . 0.0 111.345 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -154.37 91.6 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.623 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -38.2 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.936 -0.743 . . . . 0.0 111.17 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 13.0 tp10 -34.34 -40.82 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.454 -0.779 . . . . 0.0 110.731 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' GLU . 1.2 tmtp? -87.25 46.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 109.571 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -6.15 72.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -149.82 117.17 6.07 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.838 -1.163 . . . . 0.0 110.321 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.88 116.99 33.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.399 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -108.94 109.53 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 25' ' ' LEU . 40.1 t -129.14 151.16 35.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.98 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m -109.8 157.57 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.9 p90 -172.5 -179.03 2.1 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.335 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 7.9 m-20 -107.92 113.98 27.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.555 ' HB2' ' NE2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -59.84 -9.89 3.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.937 -178.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -64.95 -25.42 67.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.899 -1.126 . . . . 0.0 110.404 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -126.78 -32.91 2.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -117.71 -167.64 1.37 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.641 -0.662 . . . . 0.0 109.917 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.613 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.54 153.04 0.86 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 57' ' ' LEU . 24.4 m -43.02 -36.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.754 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.5 tt0 -67.58 -45.08 76.56 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -60.94 -27.03 67.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 54' ' ' VAL . 44.8 mt -69.17 -52.58 26.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.242 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.5 m -65.52 -17.62 64.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -83.81 -24.5 30.97 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.03 -42.3 66.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.829 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.885 ' OG1' HG22 ' A' ' 21' ' ' VAL . 11.5 t -76.61 -38.7 54.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.37 -28.24 66.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.1 m-20 -84.46 -24.44 29.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.648 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.37 -16.45 62.42 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.51 27.81 4.27 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.4 m-85 -135.99 97.13 12.51 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.482 -1.011 . . . . 0.0 110.401 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.2 Cg_exo -58.11 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.619 1.326 . . . . 0.0 110.054 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.527 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.4 p -108.43 -165.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 110.788 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.699 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 84.9 p -148.55 -171.91 3.96 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.032 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.8 p -139.23 152.08 23.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 110.983 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.27 42.68 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.169 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.825 ' HG3' HG12 ' A' ' 5' ' ' VAL . 1.4 mt-30 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.018 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.81 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.174 0.512 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.79 95.92 1.93 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 2.1 mt-30 -108.74 159.03 17.09 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.627 0.727 . . . . 0.0 110.987 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.527 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 m -139.31 127.74 22.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.912 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 54' ' ' VAL . 5.3 m -133.32 169.72 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 7' ' ' LEU . 14.8 t -108.2 160.33 15.91 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.988 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.52 145.64 50.32 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.483 -178.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -117.54 100.49 7.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.817 HG11 HG21 ' A' ' 21' ' ' VAL . 6.5 p -109.66 80.02 1.52 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.123 . . . . 0.0 112.552 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.1 Cg_endo -67.58 -3.78 10.85 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.467 1.246 . . . . 0.0 110.811 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -41.84 -32.17 0.9 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 99.2 mmm -146.62 -160.65 1.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.478 -1.013 . . . . 0.0 109.372 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.7 t 179.92 71.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -169.49 -178.91 3.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.186 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.79 73.64 5.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.049 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.22 -51.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 m -86.84 -43.99 0.54 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.9 -1.125 . . . . 0.0 112.894 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 2.2 Cg_endo -63.51 -44.57 13.84 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 8.7 mt -64.41 -25.29 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.674 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 62.3 m -64.18 -23.68 67.4 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.738 -1.226 . . . . 0.0 108.059 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' HB ' ' A' ' 61' ' ' THR . 45.0 t -71.0 -32.79 49.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.651 ' HE3' HG13 ' A' ' 34' ' ' VAL . 3.4 tttt -63.43 -38.43 91.1 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.3 -32.14 72.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.189 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -62.86 -51.57 66.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.746 HD22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -70.62 -27.54 64.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.358 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -66.94 -25.34 66.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.75 17.37 6.85 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.119 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -60.58 -47.24 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 175.27 -84.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 110.928 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.766 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -100.6 8.41 58.32 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.657 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.1 p -40.26 130.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -1.111 . . . . 0.0 110.445 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -110.12 -16.9 13.68 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.748 0.785 . . . . 0.0 108.925 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.896 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.42 158.82 27.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.546 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.811 HG23 HG22 ' A' ' 45' ' ' VAL . 7.1 p -157.74 151.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.52 ' OD1' HG12 ' A' ' 44' ' ' VAL . 7.1 p-10 -169.38 98.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.0 m -109.04 -157.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 112.005 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.2 122.98 1.67 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.25 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.147 -0.619 . . . . 0.0 111.562 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -23.53 -38.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.557 -0.714 . . . . 0.0 112.912 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 38' ' ' PHE . 2.5 ttpt -81.24 32.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.737 -1.227 . . . . 0.0 111.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 7.5 87.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.599 ' OE2' HG23 ' A' ' 44' ' ' VAL . 4.6 tm-20 -156.43 110.15 2.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.055 . . . . 0.0 110.21 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -114.02 117.4 31.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.754 -1.216 . . . . 0.0 111.661 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.599 HG23 ' OE2' ' A' ' 42' ' ' GLU . 2.2 t -108.45 121.23 61.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 33' ' ' LYS . 52.8 t -139.83 152.16 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.079 -1.448 . . . . 0.0 113.144 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -111.49 162.4 15.14 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.4 p90 -172.69 -176.95 1.59 Allowed 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.489 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 72.6 m-20 -106.58 122.21 45.87 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.81 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -65.62 -4.5 6.27 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.929 -177.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.631 HG23 ' HB1' ' A' ' 1' ' ' ALA . 30.7 p -76.15 -26.84 56.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 2.2 mmmt -125.61 -6.49 6.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.766 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -147.28 -168.45 3.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 35.4 t -178.17 152.54 0.72 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 57' ' ' LEU . 3.6 p -41.76 -39.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.469 -0.77 . . . . 0.0 109.377 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.62 -45.7 82.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 53' ' ' SER . 1.3 mttt -60.66 -23.64 64.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.465 -0.772 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 54' ' ' VAL . 32.5 mt -74.4 -51.96 13.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.729 -1.232 . . . . 0.0 108.35 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 1.8 m -64.02 -18.84 64.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.06 -26.79 33.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.14 -41.46 70.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.034 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.917 ' HB ' HG13 ' A' ' 21' ' ' VAL . 13.0 t -76.0 -39.51 55.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.69 -26.37 67.07 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.64 -19.81 23.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.07 61.14 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.83 28.42 3.94 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -137.15 101.47 9.27 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.98 . . . . 0.0 110.746 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.53 95.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.662 1.348 . . . . 0.0 109.773 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 9' ' ' VAL . 12.6 t -108.94 -168.6 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.14 178.35 7.76 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.988 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.4 p -138.29 148.0 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.725 -1.235 . . . . 0.0 112.511 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.04 77.47 1.66 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.603 -0.686 . . . . 0.0 109.825 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.915 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.209 0.528 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -155.9 93.22 1.43 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -113.81 -171.23 1.86 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.035 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.553 HG23 ' OG1' ' A' ' 46' ' ' THR . 20.4 m -153.0 156.92 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.44 169.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.27 1.033 . . . . 0.0 110.34 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 t -109.73 165.16 11.91 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 1.0 OUTLIER -133.55 145.63 50.27 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.624 -1.23 . . . . 0.0 111.664 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.998 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -110.56 100.1 8.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 3.4 p -112.03 79.52 2.75 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.04 -1.037 . . . . 0.0 111.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 4.2 Cg_endo -67.17 -4.66 12.04 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.608 1.32 . . . . 0.0 110.917 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -42.1 -43.49 4.49 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.704 ' HA ' ' HE3' ' A' ' 12' ' ' MET . 0.0 OUTLIER -139.06 -159.03 0.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -1.077 . . . . 0.0 109.604 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 13' ' ' THR . 3.8 t -179.04 79.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.03 -1.044 . . . . 0.0 110.628 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.6 -177.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.418 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -81.62 70.96 8.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.056 . . . . 0.0 110.292 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -177.31 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 111.679 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 8.3 m -93.93 -43.42 0.31 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 120.803 -1.186 . . . . 0.0 112.646 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.4 Cg_endo -65.64 -37.6 28.16 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 N-CA-C 108.577 -1.355 . . . . 0.0 108.577 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 tt -65.28 -33.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.953 0.882 . . . . 0.0 108.973 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 76.0 m -60.74 -20.24 60.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.04 HG13 ' HB ' ' A' ' 61' ' ' THR . 62.3 t -74.82 -36.12 38.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.855 ' HD3' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -60.48 -33.92 73.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -68.34 -46.68 69.5 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.483 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -52.77 -57.55 9.79 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.164 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.031 -1.043 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.62 ' CA ' HG21 ' A' ' 34' ' ' VAL . 7.4 t -63.44 -20.06 65.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.6 16.32 5.91 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.598 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.006 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.8 p -55.25 -56.59 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 0.0 110.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 1.006 ' HG2' HG22 ' A' ' 28' ' ' VAL . 5.7 pt-20 170.86 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.92 3.62 16.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 25' ' ' LEU . 3.6 p -50.3 134.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.4 -8.63 11.59 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.981 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.8 ttmm -155.24 160.87 41.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.855 HG11 ' HD3' ' A' ' 22' ' ' LYS . 54.6 t -152.62 137.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.501 0.667 . . . . 0.0 110.337 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.2 m-20 -167.92 92.43 0.36 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 22' ' ' LYS . 3.7 m -107.97 -153.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 111.845 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.77 111.99 0.57 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -82.22 65.03 7.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.959 0.885 . . . . 0.0 110.502 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -178.66 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.317 -0.865 . . . . 0.0 108.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -89.88 42.06 1.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.998 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.7 ppt_? 23.46 84.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.114 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 tt0 -150.42 116.16 5.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.464 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -111.16 117.59 33.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.115 . . . . 0.0 111.222 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -110.01 114.62 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 33' ' ' LYS . 56.5 t -138.07 151.07 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.445 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.5 m -109.43 166.26 11.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 57' ' ' LEU . 53.2 p90 -172.85 -171.05 0.72 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.885 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -107.28 111.28 23.58 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -61.98 -9.65 7.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 -177.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.915 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -75.99 -30.37 58.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.877 -1.14 . . . . 0.0 109.662 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 1.3 10.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.979 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -155.1 -169.37 3.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.62 155.68 0.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.755 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.41 -37.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 54' ' ' VAL . 6.1 tt0 -64.04 -46.91 82.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.251 -0.906 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -61.49 -29.75 70.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.452 -0.78 . . . . 0.0 110.027 179.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 54' ' ' VAL . 68.0 mt -65.51 -52.9 49.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 69' ' ' SER . 5.5 m -64.35 -18.36 64.58 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 20.1 ttpt -80.58 -27.89 37.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.6 -43.51 66.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.91 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.04 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.2 t -73.23 -35.61 66.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -58.8 -31.46 68.46 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.52 -16.44 28.85 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.573 -0.704 . . . . 0.0 109.466 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.46 -18.98 61.06 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.48 23.96 4.58 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -139.34 93.26 10.11 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.614 -0.933 . . . . 0.0 110.557 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_exo -54.91 95.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.705 1.371 . . . . 0.0 109.432 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 61' ' ' THR . 5.4 p -108.39 -159.09 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.853 0.835 . . . . 0.0 111.391 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.659 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -151.53 -167.08 2.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 7' ' ' LEU 0.258 3.3 p -139.4 146.39 25.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.191 -0.943 . . . . 0.0 110.749 -178.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.708 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -160.6 50.22 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.825 -178.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.52 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 4.9 pp0? . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.494 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.824 ' HB3' ' CG ' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.208 0.528 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.52 86.99 1.84 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 47' ' ' PHE . 4.4 pt20 -120.44 149.37 42.48 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.589 -0.844 . . . . 0.0 112.17 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.577 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -119.16 138.98 52.56 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.646 0.736 . . . . 0.0 110.194 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 54' ' ' VAL . 35.1 m -130.92 169.76 20.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.588 -0.695 . . . . 0.0 109.171 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.021 HG22 ' HB2' ' A' ' 72' ' ' GLN . 12.0 t -107.49 159.79 16.15 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -133.58 153.33 51.74 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.466 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -124.01 106.06 10.09 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.998 HG11 HG21 ' A' ' 21' ' ' VAL . 7.2 p -115.69 78.05 6.65 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.931 -1.106 . . . . 0.0 111.518 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.523 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 8.6 Cg_endo -72.53 2.73 4.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.744 1.392 . . . . 0.0 111.351 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -55.36 -29.79 53.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -172.72 119.91 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.676 -0.896 . . . . 0.0 109.4 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 13' ' ' THR . 2.9 t -143.49 110.0 5.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 13' ' ' THR . 1.8 m -148.55 -61.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.0 109.082 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.76 27.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.613 -0.679 . . . . 0.0 109.871 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -168.68 -40.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 111.646 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 8.2 m -67.2 -44.86 49.95 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.128 . . . . 0.0 112.035 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 4.3 Cg_endo -64.14 -41.65 21.31 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.619 HD12 ' CG ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -63.4 -31.92 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.652 0.739 . . . . 0.0 109.317 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 30.8 m -61.7 -23.08 65.88 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.066 HG13 ' HB ' ' A' ' 61' ' ' THR . 60.7 t -73.18 -33.66 42.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.672 ' HA ' HG21 ' A' ' 36' ' ' VAL . 65.2 tttt -62.1 -35.08 77.63 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -65.86 -43.02 89.66 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.567 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -55.77 -59.29 5.08 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.75 -0.594 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -64.65 -29.29 70.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.001 -1.062 . . . . 0.0 109.924 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 20.0 m -59.5 -30.3 68.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -135.28 21.93 3.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.792 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HB ' ' A' ' 31' ' ' VAL . 10.7 p -54.18 -45.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.72 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 110.557 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -97.1 1.69 61.03 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -42.72 128.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.059 -1.26 . . . . 0.0 110.159 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.01 -9.17 15.09 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.432 0.634 . . . . 0.0 109.657 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.645 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -166.67 163.03 16.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.361 -0.837 . . . . 0.0 109.549 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 22' ' ' LYS . 92.2 t -150.71 162.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.3 t0 -170.72 85.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 22' ' ' LYS . 23.8 t -106.94 176.29 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.741 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -131.8 118.36 2.3 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CG ' HD12 ' A' ' 19' ' ' ILE . 17.9 p90 -87.24 63.82 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.945 0.878 . . . . 0.0 109.858 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 2.1 tt0 179.58 -63.88 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.2 mtmt -73.26 -2.69 22.89 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CB ' ' A' ' 13' ' ' THR . 8.2 tmm_? 59.5 75.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.7 -0.625 . . . . 0.0 110.879 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -156.88 122.35 4.7 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.736 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -109.21 115.58 30.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.098 -1.001 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.0 t -109.2 119.37 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.7 t -135.64 156.88 38.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.017 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.577 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.62 154.34 26.19 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.3 p90 -170.88 177.88 3.65 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.22 -1.392 . . . . 0.0 111.668 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.37 123.74 48.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.824 ' CG ' ' HB3' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -69.17 -0.74 6.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.311 -177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.7 p -73.18 -33.29 65.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -121.32 -13.7 8.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.068 -1.02 . . . . 0.0 110.557 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -140.87 -169.25 2.77 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.914 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.8 p 179.76 158.26 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.941 ' HA ' HD12 ' A' ' 57' ' ' LEU . 5.5 m -41.3 -40.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.769 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.549 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.97 -49.05 79.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.081 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -25.46 68.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.676 -0.64 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' HA ' ' A' ' 54' ' ' VAL . 39.2 mt -71.63 -52.87 15.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.775 -1.203 . . . . 0.0 108.621 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.676 HG21 ' HA ' ' A' ' 69' ' ' SER . 83.8 m -66.05 -19.2 65.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.27 -24.56 34.68 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -72.07 -42.07 66.65 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.989 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.066 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.72 -38.71 58.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.74 -30.29 68.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.5 t70 -86.31 -20.68 28.01 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.03 -19.33 62.52 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 116.78 24.36 3.69 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.614 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 18.1 m-85 -138.42 99.39 8.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.441 -1.035 . . . . 0.0 110.391 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 4.9 Cg_exo -56.76 95.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.65 1.342 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.0 p -109.49 -162.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.858 . . . . 0.0 111.375 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.676 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.6 p -156.2 -173.2 4.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.5 p -135.8 156.15 37.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.848 -1.158 . . . . 0.0 110.958 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.741 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.94 54.36 0.41 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.415 -1.314 . . . . 0.0 111.766 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 1.021 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.291 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.693 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.083 0.468 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -145.35 86.26 1.75 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 26.8 mm-40 -115.45 141.9 47.42 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.136 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -125.52 122.31 36.22 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.481 0.658 . . . . 0.0 109.719 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 ' HB ' ' A' ' 54' ' ' VAL . 14.9 m -117.41 170.93 6.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.456 -0.777 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.779 HG23 ' HG2' ' A' ' 71' ' ' LYS . 14.8 t -107.64 154.3 21.65 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.741 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -131.29 159.66 37.2 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.255 -1.378 . . . . 0.0 110.922 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -126.83 123.91 38.42 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.969 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 21' ' ' VAL . 3.7 t -112.48 76.7 2.08 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.02 -1.05 . . . . 0.0 111.542 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 9.4 Cg_endo -73.65 -23.04 17.36 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.111 1.208 . . . . 0.0 111.016 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -46.8 -50.33 15.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.8 mmm -147.17 158.83 44.08 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.312 -1.111 . . . . 0.0 110.159 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 1.1 t -178.78 112.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.618 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.4 p -166.66 -42.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 110.641 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 178.83 30.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.894 -1.129 . . . . 0.0 110.668 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' N ' HD12 ' A' ' 19' ' ' ILE . . . 179.26 -32.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 110.65 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 50.8 m -70.05 -43.39 19.24 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.974 -1.079 . . . . 0.0 112.003 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.7 Cg_endo -72.72 -47.41 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 N-CA-C 107.126 -1.913 . . . . 0.0 107.126 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 16' ' ' ALA 0.259 3.5 mt -54.95 -33.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 177.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 24.6 m -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 109.158 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 9' ' ' VAL . 22.2 t -67.7 -31.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -67.9 -41.82 82.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.0 tmtt? -62.17 -37.95 87.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.567 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -59.54 -58.05 10.29 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.896 -0.503 . . . . 0.0 111.461 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.979 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -62.31 -33.98 75.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.041 -1.037 . . . . 0.0 109.831 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.492 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -63.35 -24.75 67.99 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -125.29 15.25 8.35 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.404 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.979 HG12 ' O ' ' A' ' 25' ' ' LEU . 2.2 p -58.75 -63.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.168 -0.958 . . . . 0.0 111.276 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.766 ' H ' HG13 ' A' ' 28' ' ' VAL . 3.1 mt-10 -165.47 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.713 -1.242 . . . . 0.0 110.721 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -98.67 6.15 60.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.7 p -39.73 132.17 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.421 -1.046 . . . . 0.0 110.479 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -109.47 -13.03 14.64 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.564 0.697 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' C ' HG23 ' A' ' 34' ' ' VAL . 2.9 tttt -165.83 160.58 17.13 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.799 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.664 HG13 HG22 ' A' ' 45' ' ' VAL . 61.2 t -152.28 151.19 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.452 ' OD2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p-10 -168.34 95.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.1 m -107.85 -158.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.113 0.958 . . . . 0.0 111.824 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -142.95 115.72 0.95 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 19' ' ' ILE . 3.2 m-30 -52.69 -114.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.045 -0.68 . . . . 0.0 110.257 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.7 mt-10 -36.65 -30.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.044 -1.035 . . . . 0.0 110.548 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.4 mtpt -88.91 50.28 1.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.561 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.918 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.1 ppt_? -16.37 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.544 0.687 . . . . 0.0 112.569 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 40' ' ' LYS . 15.4 tt0 -154.38 111.27 3.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.436 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -110.18 115.24 29.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.769 -1.207 . . . . 0.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 24.2 t -107.23 120.45 58.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.645 -1.285 . . . . 0.0 107.552 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.87 HG21 ' CB ' ' A' ' 25' ' ' LEU . 19.0 t -131.73 150.84 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.837 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -110.0 156.09 20.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.758 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.6 p90 -170.88 -177.27 2.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.14 -1.424 . . . . 0.0 111.797 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.0 m-20 -106.21 112.61 25.71 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -66.37 -6.04 12.91 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.656 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.693 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -63.32 -18.46 63.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -138.25 -38.2 0.55 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.939 . . . . 0.0 110.479 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -108.15 -168.94 1.43 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.981 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER 179.26 160.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 110.412 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.065 HG23 HG21 ' A' ' 70' ' ' VAL . 3.8 p -41.78 -43.73 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.135 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -61.38 -44.24 97.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -0.956 . . . . 0.0 109.316 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 mtpp -64.15 -25.79 68.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.432 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 54' ' ' VAL . 28.4 mt -72.79 -50.51 23.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.858 -1.151 . . . . 0.0 108.101 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 59.4 m -64.34 -18.14 64.36 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 3.2 ttpp -80.01 -28.88 39.35 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -69.47 -43.85 72.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.325 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.73 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.1 t -74.42 -36.99 63.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.06 -28.52 67.86 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.99 -19.43 25.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.138 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.5 -14.06 60.4 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.612 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 102.6 35.08 3.91 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.2 m-85 -138.15 96.19 10.24 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.946 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.9 Cg_exo -55.34 97.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.636 1.335 . . . . 0.0 108.912 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -108.02 -177.91 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 111.794 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.16 133.31 17.29 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.065 HG21 HG23 ' A' ' 54' ' ' VAL . 7.3 p -99.79 158.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.611 -1.306 . . . . 0.0 111.207 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -154.47 50.73 0.63 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.645 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.1 pp0? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.784 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.133 0.492 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.77 91.09 1.35 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 4.3 mm100 -114.12 153.93 28.66 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.649 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.4 m -131.67 129.65 41.04 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 72' ' ' GLN . 31.5 m -133.93 170.85 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.968 -1.082 . . . . 0.0 110.273 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.871 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.2 159.33 16.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.31 154.1 50.97 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.337 -177.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -130.11 108.97 10.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.075 HG11 HG21 ' A' ' 21' ' ' VAL . 12.2 p -113.18 83.32 6.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.991 . . . . 0.0 111.203 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.9 Cg_endo -70.87 -6.61 19.54 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.624 1.329 . . . . 0.0 110.662 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -46.45 -40.03 10.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.567 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.6 mmm -156.56 132.19 9.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.539 -0.977 . . . . 0.0 109.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.529 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -133.75 93.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 110.234 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -149.55 -71.45 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.825 -1.172 . . . . 0.0 110.258 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . 179.92 49.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 109.467 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.39 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.413 -0.805 . . . . 0.0 110.43 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.6 m -71.16 -50.63 11.23 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -57.68 -43.12 53.02 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 N-CA-C 107.927 -1.605 . . . . 0.0 107.927 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.22 -28.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.723 0.773 . . . . 0.0 109.816 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 42.6 m -66.47 -23.72 66.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.924 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.075 HG21 HG11 ' A' ' 9' ' ' VAL . 25.2 t -68.88 -28.63 40.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.2 tttt -64.15 -45.6 87.75 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 17.9 mmtt -69.58 -20.92 63.64 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.38 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -40.23 65.84 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.683 -0.635 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.87 ' HB3' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -77.97 -34.47 51.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 0.0 109.357 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.579 ' C ' HG11 ' A' ' 31' ' ' VAL . 23.8 t -71.23 -21.82 62.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -110.38 -0.51 17.54 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.297 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -49.04 -45.16 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.91 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 2.2 mt-10 161.09 -83.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.735 -0.603 . . . . 0.0 111.275 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.29 7.39 72.2 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.579 HG11 ' C ' ' A' ' 26' ' ' SER . 4.0 p -41.04 134.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.198 -1.178 . . . . 0.0 110.293 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -14.82 14.26 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.813 0.816 . . . . 0.0 108.9 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -161.25 158.69 27.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -150.11 162.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 111.192 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t0 -156.61 151.47 26.0 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 22' ' ' LYS . 1.6 p -154.37 161.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.201 -1.399 . . . . 0.0 111.982 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -137.91 111.48 0.82 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' LYS . 26.1 p90 -54.29 -155.78 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' PHE . 35.2 tt0 5.88 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -38.97 -24.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.496 -1.377 . . . . 0.0 111.737 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.7 tmm_? 62.94 76.97 0.35 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.121 -0.987 . . . . 0.0 111.358 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -165.38 126.41 1.94 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.051 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -125.77 128.36 47.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.8 -1.187 . . . . 0.0 110.245 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.871 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -109.11 140.34 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.823 -1.173 . . . . 0.0 108.312 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.884 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -149.32 156.01 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.418 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.9 m -125.56 156.74 38.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.1 p90 -172.62 -179.61 2.2 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.823 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -107.33 123.48 48.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -65.21 -5.52 7.15 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.85 -177.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.784 HG23 ' HB1' ' A' ' 1' ' ' ALA . 6.9 p -62.73 -37.59 87.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.168 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.84 23.27 5.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.507 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -169.53 -171.61 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.42 155.59 0.52 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.011 HG23 HG21 ' A' ' 70' ' ' VAL . 5.6 p -43.43 -34.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.533 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.7 tt0 -65.3 -46.91 78.49 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.353 -0.842 . . . . 0.0 108.983 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -64.64 -24.64 67.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.62 -0.675 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.884 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.5 mt -72.06 -56.12 6.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.688 -1.258 . . . . 0.0 108.299 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' HA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -63.68 -19.74 65.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 ttpt -81.71 -26.21 34.8 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -72.35 -41.72 66.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.096 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.762 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.3 t -75.86 -36.85 59.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.43 -30.94 69.95 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -90.27 -15.58 31.0 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.47 -21.03 61.28 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 118.27 23.63 3.45 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.3 m-85 -139.39 105.28 7.11 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 0.0 110.561 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 6.3 Cg_exo -57.62 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.517 1.272 . . . . 0.0 109.34 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 9' ' ' VAL . 3.8 t -110.49 -176.26 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.784 . . . . 0.0 111.158 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.571 ' HA ' HG21 ' A' ' 58' ' ' THR . 3.4 t -147.24 -176.43 5.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 7' ' ' LEU . 9.5 p -134.81 159.68 41.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.681 -1.262 . . . . 0.0 111.657 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.91 47.04 1.01 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.061 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.7 mp0 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.239 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.07 88.93 1.48 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 mm-40 -114.0 154.76 27.08 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.582 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.495 HG23 ' OG1' ' A' ' 46' ' ' THR . 16.0 m -127.61 160.32 31.97 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 109.539 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.95 HG11 HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -166.94 170.69 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.979 0.895 . . . . 0.0 109.798 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -109.27 163.72 13.12 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.964 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -135.66 144.2 45.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.93 -1.106 . . . . 0.0 111.303 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -113.82 99.52 7.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 109.487 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 5.4 p -111.19 85.47 5.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.038 -1.039 . . . . 0.0 111.962 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 1.7 Cg_endo -64.77 -6.3 12.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.629 1.331 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.85 2.06 56.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.596 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.33 173.76 6.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 110.613 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 14' ' ' CYS . 3.1 t -179.22 15.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.996 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 179.61 -162.16 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.281 -1.512 . . . . 0.0 110.197 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.83 52.72 2.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 110.28 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 17' ' ' CYS . . . -172.75 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 111.177 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.709 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 51.8 m -152.62 -50.83 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.325 -0.859 . . . . 0.0 111.48 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 9.8 Cg_endo -73.98 -50.31 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 N-CA-C 108.267 -1.474 . . . . 0.0 108.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.2 mt -65.7 -25.38 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.928 0.87 . . . . 0.0 108.692 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.471 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 2.7 m -62.81 -23.93 67.5 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.5 t -72.77 -32.98 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 15.1 tttt -59.77 -35.45 74.67 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.4 -37.61 77.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.816 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -61.17 -56.1 24.59 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.612 -0.68 . . . . 0.0 111.042 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -63.49 -32.93 74.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.055 . . . . 0.0 110.176 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' HG11 ' A' ' 31' ' ' VAL . 8.2 p -68.52 -20.19 64.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -120.07 6.85 10.79 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.6 p -55.6 -49.31 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.123 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.6 OUTLIER 171.64 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 111.152 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.54 10.44 70.96 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.561 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.61 HG21 ' CG2' ' A' ' 34' ' ' VAL . 10.6 p -41.89 133.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.126 . . . . 0.0 110.089 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.26 -18.05 13.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' HG23 ' A' ' 34' ' ' VAL . 10.6 tttm -163.61 158.39 20.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 45' ' ' VAL . 71.4 t -156.15 142.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 111.918 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -141.93 158.68 43.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 9.8 p -154.09 168.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 117.623 -1.631 . . . . 0.0 112.794 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.07 110.65 1.06 Allowed Glycine 0 N--CA 1.48 1.588 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.65 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.429 -0.453 . . . . 0.0 111.742 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 1.1 tt0 -28.68 -31.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.432 -0.793 . . . . 0.0 112.293 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 38' ' ' PHE . 55.2 mttt -80.38 27.81 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.734 -1.228 . . . . 0.0 110.996 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER 13.49 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.5 tt0 -165.67 109.65 0.83 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.419 -1.426 . . . . 0.0 111.107 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.08 125.25 53.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.068 -1.02 . . . . 0.0 111.424 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.7 p -109.59 114.26 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' CB ' ' A' ' 25' ' ' LEU . 22.3 t -128.42 150.03 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.468 -1.293 . . . . 0.0 113.113 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -112.42 160.38 17.8 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.3 p90 -171.68 -171.46 0.91 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.186 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.4 m-20 -106.57 123.56 48.28 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -71.85 3.54 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.442 -177.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.507 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -85.23 -33.24 22.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.912 -1.118 . . . . 0.0 109.64 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 -4.42 10.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.098 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . . . -145.77 -172.7 3.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 179.68 153.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.822 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.95 HG12 HG11 ' A' ' 5' ' ' VAL . 26.7 m -43.35 -32.72 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.025 -1.047 . . . . 0.0 109.858 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.9 tt0 -68.18 -46.94 69.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 108.874 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 5.0 mttm -63.34 -25.5 68.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.544 -0.722 . . . . 0.0 110.297 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 54' ' ' VAL . 46.2 mt -71.05 -53.11 15.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.846 -1.159 . . . . 0.0 108.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.441 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 5.1 m -62.27 -24.23 67.16 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.23 -28.73 42.49 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.39 -45.42 76.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.882 ' HB ' HG13 ' A' ' 21' ' ' VAL . 12.9 t -72.29 -38.18 68.83 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.64 -27.89 65.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 2.5 t70 -90.29 -20.69 22.64 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.554 -0.716 . . . . 0.0 109.413 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.09 -17.38 62.0 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.605 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 111.53 27.19 4.22 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.8 m-85 -138.6 92.38 11.6 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.555 -0.968 . . . . 0.0 110.166 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.4 Cg_exo -54.22 96.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.583 1.307 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.531 ' HB3' HG21 ' A' ' 61' ' ' THR . 8.6 t -108.85 -167.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.392 -0.818 . . . . 0.0 111.34 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -142.87 -167.68 2.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.964 HG23 ' CD1' ' A' ' 7' ' ' LEU . 1.6 p -142.9 155.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.944 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.68 53.77 0.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.4 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.489 ' N ' HG23 ' A' ' 5' ' ' VAL . 15.7 tm0? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.446 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.254 0.55 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 90.3 1.59 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mm-40 -109.97 169.33 8.8 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.016 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.7 m -144.02 125.58 14.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.506 -0.746 . . . . 0.0 109.553 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.845 HG21 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -130.28 169.65 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.803 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.1 t -108.73 159.25 16.91 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.965 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -133.58 152.03 51.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.208 -1.397 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.528 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.0 102.1 7.36 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 12' ' ' MET . 2.6 p -110.37 91.32 11.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.851 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.1 Cg_endo -66.29 -11.02 29.63 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.679 1.357 . . . . 0.0 110.305 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.84 48.8 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -136.42 158.16 45.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -1.154 . . . . 0.0 110.568 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 12' ' ' MET . 10.7 t 179.47 33.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.578 0.704 . . . . 0.0 109.161 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -160.93 127.05 3.92 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -35.68 83.49 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.64 -0.663 . . . . 0.0 111.615 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 177.83 -67.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.194 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 m -82.17 -44.16 1.01 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.945 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 38' ' ' PHE . 23.7 Cg_exo -54.1 -55.94 3.0 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' HB3' ' A' ' 38' ' ' PHE . 37.9 mt -53.9 -27.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.828 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 22.6 m -69.08 -30.96 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.003 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.809 HG22 ' OG1' ' A' ' 61' ' ' THR . 55.5 t -65.95 -33.24 62.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HA ' HD12 ' A' ' 25' ' ' LEU . 8.0 tttt -70.05 -33.19 71.63 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mmtp -74.37 -29.01 61.37 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.264 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.8 -46.47 87.82 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.324 0.583 . . . . 0.0 109.804 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.697 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -72.7 -33.69 66.64 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.754 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.481 ' HA ' HG11 ' A' ' 31' ' ' VAL . 23.3 t -64.6 -18.62 65.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.62 8.58 6.41 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.774 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.624 HG22 ' OE2' ' A' ' 29' ' ' GLU . 14.6 p -49.52 -52.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 110.509 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 3.9 pt-20 165.17 -48.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.195 -0.941 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -125.1 2.12 8.38 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.739 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.71 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 t -42.82 130.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.29 . . . . 0.0 109.562 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.51 -13.48 14.56 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -163.6 164.15 24.22 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.47 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 45' ' ' VAL . 7.2 p -152.82 162.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 111.179 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' N ' HG22 ' A' ' 34' ' ' VAL . 2.1 m-20 -168.63 80.14 0.14 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' CA ' ' A' ' 43' ' ' ALA . 33.0 t -108.32 164.99 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.904 0.859 . . . . 0.0 111.556 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -126.42 107.34 0.91 Allowed Glycine 0 N--CA 1.48 1.611 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.46 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.605 -0.938 . . . . 0.0 111.764 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 38' ' ' PHE . 63.3 mt-10 -22.54 -67.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.8 -0.563 . . . . 0.0 112.273 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.638 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 19.5 tptp -42.1 -55.36 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.041 -1.037 . . . . 0.0 110.235 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.638 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.1 tmm_? 99.39 76.5 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 C-N-CA 123.493 0.717 . . . . 0.0 110.815 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -169.0 115.13 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 0.0 110.439 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.721 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -108.12 119.95 40.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.636 -1.29 . . . . 0.0 111.502 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.5 t -108.76 118.58 56.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.71 ' CG1' HG22 ' A' ' 31' ' ' VAL . 9.3 t -133.82 157.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.697 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.6 m -116.82 160.94 20.07 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.9 p90 -171.99 -175.23 1.44 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.906 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 14.1 p-10 -106.88 112.31 25.22 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -63.61 -9.65 14.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 0.0 110.718 -177.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.499 ' CG2' ' OD2' ' A' ' 48' ' ' ASP . 5.9 t -62.1 -23.72 66.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.01 -1.056 . . . . 0.0 109.776 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -38.5 1.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 110.317 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -108.0 -168.94 1.44 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.643 -0.66 . . . . 0.0 109.961 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.616 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 31.4 t -179.5 155.68 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.045 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.052 ' CG2' HG21 ' A' ' 70' ' ' VAL . 6.7 p -42.94 -40.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.624 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.508 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.4 tt0 -61.88 -44.72 96.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.361 -0.837 . . . . 0.0 109.451 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 38.0 mttp -67.34 -23.27 65.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 54' ' ' VAL . 40.0 mt -71.14 -51.57 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.619 -1.301 . . . . 0.0 108.492 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -64.99 -19.77 66.16 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 7.2 mttt -82.49 -25.47 33.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -70.65 -44.06 67.9 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.438 -0.789 . . . . 0.0 109.134 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.809 ' OG1' HG22 ' A' ' 21' ' ' VAL . 10.2 t -75.84 -38.73 57.73 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.21 66.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.22 -21.92 24.26 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -17.02 60.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.608 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.47 27.94 3.17 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -136.59 91.18 16.17 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.621 -0.929 . . . . 0.0 110.633 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.93 93.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 0.0 110.055 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.548 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -108.99 -163.85 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 110.942 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.609 ' HA ' HG21 ' A' ' 58' ' ' THR . 2.5 t -150.09 -170.86 3.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.052 HG21 ' CG2' ' A' ' 54' ' ' VAL . 7.5 p -139.9 160.06 26.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.993 -1.067 . . . . 0.0 111.452 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.601 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -172.07 48.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.408 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 71' ' ' LYS . 38.3 tt0 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.957 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.35 94.11 1.46 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 9.2 mm-40 -110.91 150.22 29.52 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.165 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.451 HG23 ' OG1' ' A' ' 46' ' ' THR . 38.4 m -129.51 120.68 25.8 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 54' ' ' VAL . 33.4 m -127.7 170.42 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.881 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -108.14 157.6 18.15 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.857 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -132.48 152.37 51.56 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.104 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.543 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -120.88 109.19 14.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.725 HG22 ' CB ' ' A' ' 68' ' ' SER . 12.4 t -111.47 73.91 1.11 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.725 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 6.6 Cg_endo -67.35 -7.52 19.32 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.317 1.167 . . . . 0.0 111.389 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' O ' ' SD ' ' A' ' 12' ' ' MET . . . -50.08 -42.34 39.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 65.4 mmm -152.2 163.38 39.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.446 -1.032 . . . . 0.0 109.134 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.519 ' O ' HG23 ' A' ' 13' ' ' THR . 2.3 t -174.14 108.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 111.181 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 1.3 p -167.26 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 110.347 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 177.2 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.748 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -123.76 22.79 8.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 81.8 m -121.23 -66.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.002 -1.061 . . . . 0.0 110.25 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 5.2 Cg_exo -52.87 -39.04 79.34 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -61.36 -38.3 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.641 0.734 . . . . 0.0 109.182 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 23.7 m -61.56 -22.08 64.86 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.032 HG13 ' HB ' ' A' ' 61' ' ' THR . 11.9 t -77.11 -31.61 18.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.716 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.17 -36.83 85.44 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -74.01 -33.94 63.97 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.539 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -62.31 -49.86 73.96 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 110.794 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -65.45 -47.01 77.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 109.863 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.604 ' HB2' HG21 ' A' ' 34' ' ' VAL . 8.8 t -61.1 -17.54 53.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 108.676 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -103.51 -13.22 16.67 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.46 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.784 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.8 t -47.54 -57.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.448 -0.782 . . . . 0.0 109.602 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 154.67 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.616 0.722 . . . . 0.0 110.248 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.47 -22.75 73.34 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 25' ' ' LEU . 22.9 t -42.63 121.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.41 -1.053 . . . . 0.0 109.703 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -109.53 -14.8 14.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.571 0.701 . . . . 0.0 109.782 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.695 ' O ' HG13 ' A' ' 45' ' ' VAL . 21.5 tttt -154.3 155.69 35.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.451 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.964 HG13 HG22 ' A' ' 45' ' ' VAL . 3.7 t -149.33 153.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -170.45 94.81 0.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -107.63 -152.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.967 0.889 . . . . 0.0 111.742 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -146.59 108.73 0.46 Allowed Glycine 0 N--CA 1.48 1.582 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -81.92 62.25 5.62 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.535 0.683 . . . . 0.0 110.749 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.8 tp10 179.31 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.22 40.51 2.05 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 25.08 79.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.922 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 37' ' ' GLY . 4.3 tp10 -146.09 113.01 6.08 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.395 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -112.32 115.06 28.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.716 -1.24 . . . . 0.0 110.969 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.2 t -108.65 121.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 107.756 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.964 HG22 HG13 ' A' ' 34' ' ' VAL . 75.2 t -136.97 155.03 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.226 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.92 157.21 24.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' THR . 49.0 p90 -172.8 178.84 2.5 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 117.891 -1.524 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 70.2 m-20 -106.69 120.52 42.21 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -62.75 -8.37 6.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.689 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 1' ' ' ALA . 2.4 p -66.93 -27.27 67.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.01 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -128.07 -8.39 5.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.001 -1.062 . . . . 0.0 111.129 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -146.02 -167.67 2.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 110.021 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.629 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -178.24 155.53 0.92 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 110.033 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.047 ' CG1' HG21 ' A' ' 70' ' ' VAL . 24.9 t -43.05 -39.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.7 tt0 -60.9 -46.07 92.1 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.506 -0.746 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.07 -22.04 65.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.412 -0.805 . . . . 0.0 111.028 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 54' ' ' VAL . 33.8 mt -73.99 -56.75 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.653 -1.279 . . . . 0.0 108.319 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.619 ' N ' HD21 ' A' ' 7' ' ' LEU . 2.5 m -65.1 -20.45 66.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.69 -28.34 33.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.784 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.5 -41.87 79.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.905 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.032 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -74.77 -36.67 62.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.44 -27.19 67.32 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.1 -19.44 24.31 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.99 -18.74 61.32 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.17 27.31 3.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 21.0 m-85 -138.2 98.41 9.29 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 110.856 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -58.08 93.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.611 1.322 . . . . 0.0 109.658 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.725 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -108.45 -161.44 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 111.317 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.525 ' HA ' HG21 ' A' ' 58' ' ' THR . 45.5 p -156.95 -169.48 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 ' CG1' ' A' ' 54' ' ' VAL . 5.7 p -135.61 158.87 40.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.886 -1.134 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.881 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.7 OUTLIER -171.54 47.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.756 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' N ' HG22 ' A' ' 6' ' ' THR . 1.4 pp0? . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.112 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.902 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.09 0.471 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.7 89.94 1.44 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.673 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 12.3 pt20 -122.21 165.16 16.59 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.792 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 45' ' ' VAL . 11.9 m -128.81 136.1 50.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.681 -0.637 . . . . 0.0 109.694 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 57' ' ' LEU . 21.0 m -130.32 167.46 25.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.531 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -106.51 157.15 17.87 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.92 149.27 51.28 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.355 -1.338 . . . . 0.0 111.219 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -119.94 113.98 21.37 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.756 -0.59 . . . . 0.0 109.45 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.991 HG22 ' HB2' ' A' ' 68' ' ' SER . 2.3 t -117.06 78.11 9.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.026 -1.046 . . . . 0.0 111.062 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 13.6 Cg_endo -80.7 40.52 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.234 1.289 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.36 2.46 10.45 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -159.49 21.2 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.076 -1.249 . . . . 0.0 110.579 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 39' ' ' GLU . 15.5 m -47.19 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -179.8 112.15 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 108.55 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -26.17 77.01 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 174.74 -49.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.221 -0.925 . . . . 0.0 110.593 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 32.7 m -97.62 -39.41 0.25 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.644 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 6.2 Cg_exo -59.89 -38.57 78.41 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 N-CA-C 107.95 -1.596 . . . . 0.0 107.95 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 10.2 mt -63.89 -29.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 6.8 m -65.4 -23.77 67.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.925 HG11 HG21 ' A' ' 9' ' ' VAL . 59.8 t -70.21 -29.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.37 -39.26 85.66 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 23.0 mmtt -71.04 -29.85 65.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -43.65 95.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.76 -0.588 . . . . 0.0 110.367 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -74.84 -36.23 62.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.022 . . . . 0.0 109.451 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.798 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.31 -19.85 65.7 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.4 mptp? -115.21 1.76 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.171 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.0 p -52.64 -40.66 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.8 OUTLIER 165.0 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.425 -0.797 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -99.49 5.96 58.96 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.06 -1.067 . . . . 0.0 110.752 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.798 HG11 ' C ' ' A' ' 26' ' ' SER . 8.1 p -39.49 129.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -1.077 . . . . 0.0 110.189 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.5 t -108.53 -10.99 15.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.469 0.652 . . . . 0.0 109.665 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.63 168.22 18.35 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.014 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 10.2 p -165.5 152.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.962 . . . . 0.0 110.953 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 44' ' ' VAL . 28.1 t0 -163.32 93.69 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.665 HG13 ' CA ' ' A' ' 43' ' ' ALA . 20.8 t -108.11 174.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 111.746 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.554 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -130.16 121.44 3.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 16.3 p90 -55.89 -145.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 1.033 ' O ' HG23 ' A' ' 13' ' ' THR . 14.1 tp10 1.13 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -36.01 -63.1 0.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.318 -0.864 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.689 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.2 tmm_? 103.98 77.47 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 C-N-CA 123.306 0.642 . . . . 0.0 111.17 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.0 tm-20 -168.51 117.56 0.72 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.508 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.665 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -112.15 118.93 36.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.108 . . . . 0.0 111.329 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 35' ' ' ASP . 4.2 p -107.35 121.93 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.78 -1.2 . . . . 0.0 108.017 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 4' ' ' THR . 3.5 p -129.41 159.02 41.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.79 -1.164 . . . . 0.0 113.184 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -118.01 154.69 31.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -171.83 179.61 2.71 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.232 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.605 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 3.4 m-20 -106.79 117.16 33.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 1.5 t70 -64.15 -7.14 8.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.883 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.22 -26.2 61.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.935 -1.103 . . . . 0.0 110.196 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -0.54 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.197 -0.94 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -159.41 -166.39 1.78 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.44 159.16 0.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.094 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.0 p -41.08 -42.44 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.599 -0.688 . . . . 0.0 110.0 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -60.79 -46.78 89.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.256 -0.902 . . . . 0.0 109.682 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.87 -23.54 67.26 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.974 HD12 ' HA ' ' A' ' 54' ' ' VAL . 35.3 mt -72.49 -52.89 13.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.667 -1.271 . . . . 0.0 108.265 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 69' ' ' SER . 2.1 m -63.94 -21.1 66.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 ttpt -81.47 -26.58 35.13 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.07 -43.46 67.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.209 -0.932 . . . . 0.0 108.94 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.23 -38.7 63.46 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.15 -27.14 66.85 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -90.21 -19.68 23.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.172 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -16.16 60.72 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 112.03 27.26 4.05 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.84 97.89 8.81 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.617 -0.931 . . . . 0.0 110.515 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.3 Cg_exo -55.52 96.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.59 1.311 . . . . 0.0 109.4 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.991 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.91 -167.19 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 111.536 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.6 OUTLIER -156.56 -172.22 3.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.094 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.8 p -133.63 161.8 40.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.595 -1.315 . . . . 0.0 111.444 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -148.07 54.76 1.04 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.721 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 5' ' ' VAL . 2.4 tt0 . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 110.238 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.44 87.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -127.08 153.02 46.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.05 -1.032 . . . . 0.0 111.624 -177.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -118.29 154.27 32.57 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.407 0.622 . . . . 0.0 109.634 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 72' ' ' GLN . 17.5 m -145.76 170.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.342 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.913 ' OG1' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.55 156.48 19.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.051 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.61 147.92 51.52 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.938 -1.505 . . . . 0.0 111.308 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -116.99 112.16 20.58 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.733 HG21 HG11 ' A' ' 21' ' ' VAL . 71.6 t -109.6 73.4 0.63 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.97 -1.081 . . . . 0.0 111.782 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.9 Cg_endo -58.6 -13.46 17.55 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.477 1.251 . . . . 0.0 110.073 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.64 15.24 31.7 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.604 ' HG2' ' CG ' ' A' ' 41' ' ' ARG . 2.2 ppp? -96.71 -164.71 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -1.221 . . . . 0.0 109.435 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.554 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.6 t 178.5 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.838 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 2.1 p -158.59 -154.16 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.536 -1.352 . . . . 0.0 110.673 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.93 42.5 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.951 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.81 -36.83 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.906 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 13.8 m -89.95 -44.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 0.0 111.757 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.63 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 14.0 Cg_endo -75.96 -43.94 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 N-CA-C 107.902 -1.615 . . . . 0.0 107.902 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.61 HG13 ' CE1' ' A' ' 38' ' ' PHE . 2.9 tt -55.66 -38.3 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.904 0.859 . . . . 0.0 109.635 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 5.2 m -62.8 -23.83 67.44 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.943 0.878 . . . . 0.0 108.636 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG13 ' HB ' ' A' ' 61' ' ' THR . 32.6 t -69.32 -31.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB2' HG21 ' A' ' 36' ' ' VAL . 3.8 tttt -67.65 -41.78 83.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.55 -24.86 65.58 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.378 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -70.63 -54.7 10.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.803 -0.561 . . . . 0.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -59.66 -35.94 75.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.069 -1.02 . . . . 0.0 109.812 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -22.71 60.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.504 -0.748 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.81 -5.7 25.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.895 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -46.61 -81.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.749 ' N ' HG12 ' A' ' 28' ' ' VAL . 4.0 tt0 169.93 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.348 -0.845 . . . . 0.0 109.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.582 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -104.95 -21.33 9.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 25' ' ' LEU . 74.1 t -42.2 126.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -1.068 . . . . 0.0 109.79 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -113.13 -9.82 13.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -147.85 156.33 42.6 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.008 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 45' ' ' VAL . 6.1 p -154.86 129.69 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.683 0.754 . . . . 0.0 111.01 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.68 89.66 1.57 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 22' ' ' LYS . 2.2 m -108.32 -160.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.962 0.887 . . . . 0.0 111.47 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.57 110.06 0.55 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 4.9 m-30 -52.7 -98.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.019 -0.695 . . . . 0.0 109.927 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 1.2 mm-40 -54.42 -12.7 0.74 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.606 -1.309 . . . . 0.0 111.643 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.3 mptt -81.85 -24.83 35.57 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.194 . . . . 0.0 111.002 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.604 ' CG ' ' HG2' ' A' ' 12' ' ' MET . 7.4 tmm_? 68.41 63.52 0.35 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.581 -0.699 . . . . 0.0 110.655 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.7 tt0 -162.06 113.95 1.69 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.229 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.73 113.6 26.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.96 -1.087 . . . . 0.0 110.834 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.913 HG22 ' OG1' ' A' ' 6' ' ' THR . 89.2 t -114.31 121.76 67.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.631 -1.293 . . . . 0.0 108.967 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 34' ' ' VAL . 25.8 m -137.66 -179.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 118.234 -1.386 . . . . 0.0 113.789 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.61 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.8 m -127.74 158.41 37.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.8 p90 -171.49 178.94 3.04 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.143 -1.423 . . . . 0.0 111.097 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.5 m-20 -107.41 117.7 34.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -63.25 -8.64 8.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 110.958 -177.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -74.06 -26.73 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.629 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -121.33 -13.22 8.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.498 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.582 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.14 -165.68 2.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.473 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.48 159.07 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 57' ' ' LEU . 10.9 p -43.64 -37.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.773 . . . . 0.0 109.763 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -64.85 -44.22 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -0.856 . . . . 0.0 109.357 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 10.2 mtpt -67.68 -22.4 65.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.413 -0.805 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.8 mt -74.36 -58.51 3.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.664 -1.273 . . . . 0.0 108.413 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.612 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.3 m -63.07 -21.53 66.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 8.4 ttmt -80.27 -27.97 38.49 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -68.04 -43.13 79.41 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.306 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.761 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.19 -38.01 63.76 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.72 -27.71 65.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -86.34 -23.4 26.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -73.3 -14.5 61.32 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.74 30.22 4.1 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.4 m-85 -135.82 94.96 14.27 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.703 -0.88 . . . . 0.0 110.514 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.09 93.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.7 1.369 . . . . 0.0 109.758 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.537 ' CB ' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -108.75 -169.06 1.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 111.139 -179.139 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.438 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -146.48 -174.99 4.61 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.051 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.8 p -139.86 150.44 22.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.705 -1.247 . . . . 0.0 112.654 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB3' HG22 ' A' ' 6' ' ' THR . 0.6 OUTLIER -134.14 77.62 1.71 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.435 0.636 . . . . 0.0 109.513 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.8 pt20 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.328 0.585 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -150.4 88.4 1.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 21.6 mm-40 -120.98 155.83 33.45 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.623 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.638 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 5.2 t -136.39 144.23 44.42 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.46 174.31 12.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.664 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 72' ' ' GLN . 12.1 t -107.98 153.49 23.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -130.41 150.26 51.71 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.444 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -118.25 115.94 25.76 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.62 HG13 ' CB ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -110.99 76.18 1.2 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.019 -1.051 . . . . 0.0 111.49 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.2 Cg_endo -62.8 -15.23 45.61 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.466 1.245 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -55.65 -21.78 30.04 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.79 -174.5 4.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.955 . . . . 0.0 109.691 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 178.58 75.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 110.724 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.89 -178.61 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.888 -1.133 . . . . 0.0 110.047 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.37 75.48 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 109.822 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.53 -45.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.118 -0.989 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 5.3 m -96.84 -45.03 0.25 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.959 -1.088 . . . . 0.0 113.145 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -59.23 -38.23 86.91 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 N-CA-C 108.231 -1.488 . . . . 0.0 108.231 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.447 HG13 ' HB3' ' A' ' 38' ' ' PHE . 2.2 tt -63.62 -35.23 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.18 0.99 . . . . 0.0 108.575 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 6.8 m -62.65 -20.75 65.12 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.804 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.9 t -73.81 -32.65 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HG3' HG12 ' A' ' 34' ' ' VAL . 18.6 tttm -64.61 -36.13 83.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 26' ' ' SER . 0.1 OUTLIER -66.4 -37.54 85.47 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.25 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.505 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . . . -57.56 -59.6 4.92 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.821 -0.55 . . . . 0.0 110.357 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.31 -26.78 68.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 109.572 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 12.9 t -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.93 7.3 7.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.666 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.2 p -49.86 -49.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.826 -1.171 . . . . 0.0 110.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.9 -86.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.263 -0.898 . . . . 0.0 111.318 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -84.1 1.95 88.22 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.046 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 25' ' ' LEU . 6.5 p -43.99 131.18 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.835 -1.391 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.57 -15.43 13.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -164.35 160.1 20.47 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.916 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.624 HG12 ' HG3' ' A' ' 22' ' ' LYS . 14.1 t -150.96 151.99 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 110.318 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -169.95 96.24 0.28 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 22' ' ' LYS . 3.2 m -107.88 -154.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.025 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.87 109.5 0.52 Allowed Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.621 ' O ' ' CD2' ' A' ' 38' ' ' PHE . 49.0 p90 -83.46 57.81 4.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.829 . . . . 0.0 110.437 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -179.01 -60.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.27 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -78.99 2.65 19.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 9' ' ' VAL . 8.7 tmm_? 60.46 84.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.771 -0.581 . . . . 0.0 111.252 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' GLY . 22.5 tt0 -167.17 120.38 0.97 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.977 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -113.65 118.21 33.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.022 -1.049 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.3 t -107.94 124.45 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.748 -1.22 . . . . 0.0 107.825 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 57' ' ' LEU . 8.7 p -134.49 150.07 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.478 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.638 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.95 157.68 21.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.3 p90 -171.44 -176.16 1.78 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.346 -1.342 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -106.79 113.52 27.07 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -59.72 -10.09 3.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.192 -177.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 48' ' ' ASP . 10.0 t -70.6 -28.01 64.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 110.643 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 11.1 mtpt -124.13 -14.08 7.12 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.88 -1.137 . . . . 0.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -141.24 -170.64 3.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.42 160.14 0.73 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.162 -0.961 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.047 HG23 HG21 ' A' ' 70' ' ' VAL . 3.9 p -41.01 -44.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.563 -0.711 . . . . 0.0 109.914 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.547 ' N ' HG13 ' A' ' 54' ' ' VAL . 32.5 tt0 -57.37 -47.77 80.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -64.11 -27.09 68.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.571 -0.705 . . . . 0.0 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.5 mt -70.43 -55.55 8.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.798 -1.189 . . . . 0.0 108.718 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' SER . 6.5 m -64.34 -20.72 66.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -83.37 -24.85 31.85 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.42 -41.3 69.69 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.62 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.544 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.7 t -75.16 -39.4 60.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.539 ' N ' HG23 ' A' ' 61' ' ' THR . . . -56.09 -32.27 64.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -86.27 -21.78 27.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.528 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.98 60.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.212 -0.93 . . . . 0.0 108.734 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 104.24 31.77 4.55 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.434 -1.867 . . . . 0.0 108.434 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.666 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 24.5 m-85 -138.77 89.75 12.96 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 122.015 -0.697 . . . . 0.0 110.488 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -54.85 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.634 1.333 . . . . 0.0 109.642 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.04 -168.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 111.254 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.541 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -152.99 -179.19 7.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 54' ' ' VAL . 7.4 p -134.32 156.25 40.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 120.371 -1.456 . . . . 0.0 111.863 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.681 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.65 43.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.129 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.701 ' C ' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.906 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.199 0.523 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.5 87.5 1.58 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 25.6 mm-40 -109.83 157.04 19.6 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.001 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.511 HG23 ' OG1' ' A' ' 46' ' ' THR . 13.8 m -135.77 115.28 12.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.648 HG11 ' HB ' ' A' ' 54' ' ' VAL . 11.4 m -121.84 168.05 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.85 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -107.98 159.01 16.88 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.016 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -131.89 152.08 51.28 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.324 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -122.74 106.1 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.901 HG11 HG21 ' A' ' 21' ' ' VAL . 10.6 p -112.24 88.56 10.76 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.026 -1.046 . . . . 0.0 111.937 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.9 Cg_endo -68.64 -1.19 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.592 1.312 . . . . 0.0 111.338 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.92 12.67 47.83 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.604 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -106.99 -164.45 0.99 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.336 -1.097 . . . . 0.0 110.338 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.794 HG22 ' SG ' ' A' ' 17' ' ' CYS . 1.7 t 179.77 -4.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 13.8 p -172.2 -158.77 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 119.72 -1.863 . . . . 0.0 110.273 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 62.57 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.203 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -162.27 -42.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 111.333 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 13' ' ' THR . 10.3 p -108.09 -25.05 0.17 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.657 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 12.5 Cg_endo -78.28 -37.76 0.7 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 N-CA-C 106.75 -2.058 . . . . 0.0 106.75 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.576 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 72.0 mt -63.88 -29.93 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.151 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 9.4 m -65.91 -20.65 66.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.982 HG13 ' OG1' ' A' ' 61' ' ' THR . 58.1 t -69.53 -33.23 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -67.92 -37.46 81.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -62.61 -32.17 73.14 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.103 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.68 -56.3 18.98 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.76 -0.588 . . . . 0.0 110.543 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -64.74 -24.1 67.45 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -76.68 -21.41 55.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.48 1.06 16.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.483 -0.761 . . . . 0.0 109.91 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.6 t -46.61 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.084 -1.01 . . . . 0.0 109.418 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.796 ' N ' HG12 ' A' ' 28' ' ' VAL . 10.4 pt-20 179.44 -41.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 110.802 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 29' ' ' GLU . . . -112.54 -10.26 17.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -50.45 125.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 110.028 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.61 14.86 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.628 0.727 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.93 160.51 41.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 22' ' ' LYS . 7.3 p -155.8 163.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.84 -1.163 . . . . 0.0 111.938 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.69 143.59 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.89 HG13 ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -108.95 127.88 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.042 . . . . 0.0 112.08 -177.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -114.75 49.73 0.83 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -25.76 -118.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.2 tp10 -41.32 -35.82 0.71 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.55 -1.344 . . . . 0.0 110.718 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -86.43 38.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.0 110.529 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.562 ' HB3' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 8.31 86.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 5.8 tt0 -162.07 110.87 1.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.014 -1.054 . . . . 0.0 110.715 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.58 120.23 41.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 110.248 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.6 t -107.94 122.03 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.861 -1.15 . . . . 0.0 108.037 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.6 t -132.94 152.66 36.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 118.141 -1.424 . . . . 0.0 113.332 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -114.59 155.31 26.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 57' ' ' LEU . 48.7 p90 -172.51 -178.86 2.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.595 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -106.75 117.13 33.23 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 178.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 24.7 t0 -70.78 0.54 6.91 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.255 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' HG3' ' A' ' 51' ' ' LYS . 14.0 t -64.62 -16.68 63.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.93 -1.107 . . . . 0.0 109.599 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG3' HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -138.32 -43.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.05 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -104.5 -169.34 1.61 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.766 -0.584 . . . . 0.0 109.721 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.639 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.5 t -178.35 158.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.926 ' HA ' HD12 ' A' ' 57' ' ' LEU . 2.7 p -41.94 -42.72 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.506 ' N ' HG13 ' A' ' 54' ' ' VAL . 38.0 tt0 -60.61 -45.83 92.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 108.957 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.415 -0.803 . . . . 0.0 111.075 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 54' ' ' VAL . 34.8 mt -73.04 -55.82 5.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.586 -1.321 . . . . 0.0 108.302 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.553 ' N ' HD21 ' A' ' 7' ' ' LEU . 54.4 m -62.76 -20.56 65.09 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -81.49 -28.86 33.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.899 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -69.05 -39.96 78.85 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.283 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.982 ' OG1' HG13 ' A' ' 21' ' ' VAL . 13.1 t -75.46 -41.0 56.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.07 -26.49 62.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.53 -21.84 21.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.857 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.21 -17.49 61.35 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.159 -0.963 . . . . 0.0 108.649 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.51 24.85 4.24 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.618 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 20.3 m-85 -138.66 88.66 13.94 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.631 -0.923 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.3 Cg_exo -54.84 95.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.853 1.449 . . . . 0.0 110.194 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.5 -163.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 110.861 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -149.04 -171.44 3.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.016 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.0 p -139.1 153.44 24.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 111.826 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -155.83 39.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.585 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 71' ' ' LYS . 79.1 mt-30 . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.392 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 88.22 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -110.01 156.66 20.21 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.683 -177.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.552 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 23.4 m -135.1 137.24 42.64 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.597 -0.689 . . . . 0.0 109.258 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' CG1' ' A' ' 54' ' ' VAL . 27.9 m -146.77 175.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.84 ' O ' HD12 ' A' ' 7' ' ' LEU . 12.2 t -109.59 162.85 14.01 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.864 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.3 mp -130.68 138.99 50.3 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.074 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -112.91 93.8 4.59 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.789 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 ' SD ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -115.73 101.47 54.13 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.178 -0.952 . . . . 0.0 111.262 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 9.7 Cg_endo -76.36 5.37 4.7 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.628 1.331 . . . . 0.0 111.066 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -82.08 8.29 60.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.932 ' SD ' HG21 ' A' ' 21' ' ' VAL . 3.8 ptm -139.87 156.97 46.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.4 -1.059 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.14 39.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -170.46 -178.27 2.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.5 76.26 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.722 -1.236 . . . . 0.0 109.807 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.88 -51.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.055 -1.028 . . . . 0.0 111.357 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.66 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.0 m -90.35 -45.8 0.39 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.894 -1.129 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.676 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 17.6 Cg_exo -59.43 -64.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 122.838 0.915 . . . . 0.0 110.759 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 38' ' ' PHE . 26.6 mt -45.48 -27.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.925 -1.109 . . . . 0.0 110.296 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 90.4 m -70.44 -38.17 74.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.801 -1.187 . . . . 0.0 108.771 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.978 HG22 ' OG1' ' A' ' 61' ' ' THR . 19.7 t -60.01 -26.5 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 36' ' ' VAL . 9.9 tptm -71.83 -43.76 65.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -66.21 -26.91 67.6 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.703 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . . . -66.63 -48.68 68.69 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.657 -0.652 . . . . 0.0 110.811 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.677 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -72.91 -41.49 64.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -0.996 . . . . 0.0 110.345 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -62.21 -24.07 67.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.538 -0.726 . . . . 0.0 109.276 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -122.24 7.62 9.68 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.434 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.1 p -50.89 -48.13 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.478 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.26 -84.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.398 -0.814 . . . . 0.0 110.778 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.572 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -85.23 0.07 88.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.843 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.571 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.6 p -44.14 127.93 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.888 -1.36 . . . . 0.0 110.0 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.29 -14.39 14.16 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.669 0.747 . . . . 0.0 109.116 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 2.9 tttm -162.57 161.63 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.713 HG23 HG22 ' A' ' 45' ' ' VAL . 9.2 p -150.65 154.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 110.725 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 15.0 t70 -168.99 82.91 0.14 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 22' ' ' LYS . 4.7 m -109.23 -163.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.001 0.905 . . . . 0.0 111.475 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.15 93.19 0.15 Allowed Glycine 0 C--N 1.298 -1.552 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.676 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 p90 -54.93 -54.66 39.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.877 . . . . 0.0 109.675 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.14 -24.75 65.04 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.025 -1.047 . . . . 0.0 110.183 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 0.27 57.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HA ' ' CE ' ' A' ' 12' ' ' MET . 0.2 OUTLIER 46.69 70.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.371 -0.831 . . . . 0.0 111.079 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.49 119.79 0.79 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.41 -0.806 . . . . 0.0 109.981 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.19 119.1 38.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.798 -1.188 . . . . 0.0 112.356 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -110.13 110.22 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.713 HG22 HG23 ' A' ' 34' ' ' VAL . 60.2 t -130.45 150.79 34.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.309 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.4 m -109.68 159.43 17.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.752 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.0 p90 -171.81 -174.86 1.41 Allowed 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.055 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 4.2 m-20 -106.61 126.82 52.75 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 5.9 p-10 -75.01 10.75 1.33 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.61 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.776 HG23 ' HB1' ' A' ' 1' ' ' ALA . 61.5 p -87.28 -36.34 17.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -118.68 -11.27 9.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.088 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -135.7 -174.36 3.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 3.7 t -178.44 154.48 0.8 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.895 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.901 ' HA ' HD12 ' A' ' 57' ' ' LEU . 34.3 m -42.59 -38.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.253 -0.904 . . . . 0.0 109.488 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' N ' HG23 ' A' ' 54' ' ' VAL . 2.6 tt0 -64.01 -47.25 81.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -62.0 -26.91 68.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 54' ' ' VAL . 45.7 mt -69.65 -54.68 12.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.856 -1.152 . . . . 0.0 108.306 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.75 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.0 OUTLIER -65.55 -17.34 64.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.6 ttpt -86.15 -21.64 27.46 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.474 -0.766 . . . . 0.0 109.183 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -76.63 -40.15 50.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.576 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.978 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.9 t -79.94 -36.26 36.49 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.46 -27.72 69.18 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 m-20 -84.76 -20.29 31.3 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -19.56 60.66 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.36 28.76 2.93 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 21.6 m-85 -134.83 105.0 10.64 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.717 -0.872 . . . . 0.0 110.642 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 7.6 Cg_exo -49.39 101.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.75 ' OG ' HG22 ' A' ' 58' ' ' THR . 53.0 p -107.82 158.22 17.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 112.05 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 1.3 t -126.84 -178.15 4.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.864 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.9 p -142.91 150.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 120.761 -1.212 . . . . 0.0 111.069 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.759 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -168.26 51.09 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.801 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.5 tt0 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 117.955 -1.022 . . . . 0.0 111.368 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.58 86.07 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.92 153.6 23.32 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.231 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.521 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 19.0 m -135.15 132.26 37.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.539 -0.725 . . . . 0.0 109.918 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.838 HG11 HG12 ' A' ' 54' ' ' VAL . 21.5 m -135.51 171.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.13 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.44 154.98 20.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 ' HB ' ' A' ' 70' ' ' VAL . 1.2 mp -130.01 157.12 43.22 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.155 -1.418 . . . . 0.0 111.214 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -127.31 112.15 14.72 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.358 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.854 HG21 HG11 ' A' ' 21' ' ' VAL . 62.0 t -116.85 74.56 6.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.923 -1.11 . . . . 0.0 111.408 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 Cg_endo -67.27 -5.52 14.02 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.591 1.311 . . . . 0.0 111.226 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -54.39 -23.16 25.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.862 ' HE1' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -144.5 -178.8 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 109.279 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 12' ' ' MET . 0.9 OUTLIER 177.91 75.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.021 -1.05 . . . . 0.0 110.721 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -149.33 -55.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 117.893 -1.523 . . . . 0.0 111.603 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 176.67 -27.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.413 -1.429 . . . . 0.0 111.363 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -115.24 -40.42 3.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.611 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' C ' ' HE2' ' A' ' 12' ' ' MET . 7.6 m -66.3 -47.45 59.99 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.124 -0.985 . . . . 0.0 111.202 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 2.1 Cg_endo -62.54 -37.86 55.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.72 HD12 ' HB3' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -68.57 -24.6 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 21.6 m -62.97 -20.12 64.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 9' ' ' VAL . 41.6 t -74.18 -33.45 35.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -62.48 -35.5 79.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' CE ' ' HE3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -67.14 -44.51 79.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.987 0.899 . . . . 0.0 109.837 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -57.35 -52.35 65.7 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -63.74 -41.22 98.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.017 -1.052 . . . . 0.0 109.854 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.527 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -63.11 -21.41 66.17 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' CE ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -108.44 -2.11 19.3 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.414 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.04 HG23 ' HB2' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -46.01 -53.16 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -0.915 . . . . 0.0 109.541 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 153.62 -72.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.79 0.805 . . . . 0.0 109.562 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -83.55 -16.72 67.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.4 p -38.75 122.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 110.348 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 m -112.68 -12.7 13.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.627 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 1.2 tttt -143.62 155.64 44.33 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.206 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.686 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.3 t -151.23 129.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.662 0.744 . . . . 0.0 110.707 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 65.3 m-20 -155.02 89.2 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 43' ' ' ALA . 2.4 m -109.42 -159.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 122.15 0.976 . . . . 0.0 111.816 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 40' ' ' LYS . . . -149.93 113.93 0.63 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HB3' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -49.99 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.731 -0.864 . . . . 0.0 111.825 -178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -33.59 -33.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.337 -0.852 . . . . 0.0 111.372 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 41' ' ' ARG . 16.2 ptmt -89.6 51.41 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.501 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.761 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -13.42 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.411 0.624 . . . . 0.0 112.557 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' LYS . 18.3 mt-10 -152.22 112.79 4.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 110.156 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.21 115.67 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.903 -1.123 . . . . 0.0 111.095 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.13 ' CG2' HG22 ' A' ' 6' ' ' THR . 8.2 t -107.53 116.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.642 -1.286 . . . . 0.0 108.298 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CB ' ' A' ' 25' ' ' LEU . 11.8 m -132.43 162.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.245 -1.382 . . . . 0.0 113.354 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.627 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.6 m -119.07 162.35 18.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -172.17 -175.22 1.39 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.959 -1.496 . . . . 0.0 111.815 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.29 116.95 32.82 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 7.8 p-10 -67.91 -2.07 6.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.373 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -24.74 44.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.008 -1.058 . . . . 0.0 110.614 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -125.72 -3.33 7.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.048 -1.033 . . . . 0.0 110.463 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -156.43 -168.42 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.634 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.6 p 179.7 164.71 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 m -43.2 -33.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.361 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' N ' HG23 ' A' ' 54' ' ' VAL . 3.0 tt0 -65.77 -47.87 73.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.472 -0.768 . . . . 0.0 109.148 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.67 -24.08 66.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.645 -0.66 . . . . 0.0 110.763 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 54' ' ' VAL . 41.7 mt -71.98 -55.82 6.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.814 -1.179 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.2 m -63.96 -19.89 65.47 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 1.6 ttmt -80.81 -27.37 36.6 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.04 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -69.73 -43.15 72.93 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.656 -0.817 . . . . 0.0 109.274 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.585 ' HB ' HG13 ' A' ' 21' ' ' VAL . 14.8 t -75.66 -37.38 59.68 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.25 -26.52 66.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.39 -21.63 22.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.81 -15.86 61.62 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.613 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 108.28 30.94 3.68 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 23.3 m-85 -138.29 102.74 8.06 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.639 -0.918 . . . . 0.0 110.603 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.09 98.92 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.564 1.297 . . . . 0.0 109.396 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.791 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -107.95 -166.39 1.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.235 -0.916 . . . . 0.0 111.604 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.6 t -163.84 126.74 2.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 7' ' ' LEU . 6.6 p -91.69 161.84 2.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.868 -1.145 . . . . 0.0 110.958 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLN . 3.9 ptmt -145.86 42.22 1.22 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.563 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.2 mp0 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.839 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -147.45 89.72 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 3.9 mm100 -109.61 158.28 18.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.76 0.79 . . . . 0.0 111.627 -177.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 45' ' ' VAL . 96.9 m -137.08 141.74 42.36 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.659 -0.651 . . . . 0.0 109.398 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.807 HG11 ' CG1' ' A' ' 54' ' ' VAL . 4.7 m -146.1 165.54 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.001 . . . . 0.0 109.766 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.958 HG22 ' O ' ' A' ' 72' ' ' GLN . 13.6 t -107.42 151.84 25.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.733 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -125.95 156.81 39.2 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 120.957 -1.09 . . . . 0.0 110.668 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -137.24 107.47 6.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.994 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 68' ' ' SER . 1.9 t -108.22 102.41 46.31 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.176 -0.952 . . . . 0.0 110.776 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.0 Cg_endo -71.11 9.95 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.366 1.377 . . . . 0.0 112.4 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.51 -5.71 42.15 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.508 -1.37 . . . . 0.0 110.167 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.712 ' HE1' ' HB3' ' A' ' 17' ' ' CYS . 4.2 mmm -93.39 151.25 19.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.207 -1.172 . . . . 0.0 110.179 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 12' ' ' MET . 9.3 t -179.04 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.134 -0.979 . . . . 0.0 111.543 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 179.03 162.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.678 -1.264 . . . . 0.0 109.536 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -71.16 79.86 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.708 -1.245 . . . . 0.0 110.483 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 178.13 -56.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.007 -1.058 . . . . 0.0 111.007 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 5.0 m -86.92 -45.15 0.54 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.236 -0.915 . . . . 0.0 111.873 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.634 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 21.1 Cg_exo -54.8 -52.19 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 27.6 mt -59.17 -23.82 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.632 -0.667 . . . . 0.0 110.105 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 37.2 m -65.75 -26.74 67.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 108.544 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 61' ' ' THR . 33.1 t -69.89 -26.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.738 ' HD2' HG22 ' A' ' 36' ' ' VAL . 14.2 tttt -68.58 -44.42 74.44 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 mptp? -67.45 -29.61 69.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.363 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -59.29 -45.08 92.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.278 0.561 . . . . 0.0 109.891 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.79 HD22 ' HB ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -66.9 -47.87 70.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.861 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.44 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 8.3 t -66.12 -11.46 49.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.479 -0.763 . . . . 0.0 109.006 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -110.58 -9.3 14.56 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.069 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.0 t -48.79 -58.34 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.106 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 154.79 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.606 0.717 . . . . 0.0 110.072 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.01 -8.07 87.97 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 25' ' ' LEU . 2.5 t -43.72 122.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 109.38 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.37 -11.17 15.23 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.668 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -156.23 161.17 40.3 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.564 HG13 HD13 ' A' ' 25' ' ' LEU . 12.9 t -150.0 152.27 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.028 -1.045 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 6.4 t0 -167.69 82.8 0.2 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 22' ' ' LYS . 3.2 m -109.24 -165.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 111.773 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -152.07 95.35 0.16 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -46.06 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.707 -0.878 . . . . 0.0 111.666 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.2 mm-40 1.53 -75.31 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.201 0.524 . . . . 0.0 112.035 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -62.49 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 108.734 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 143.49 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 122.864 0.466 . . . . 0.0 109.91 178.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 19.5 mt-10 -134.29 116.78 15.67 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -110.18 115.38 29.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 0.0 111.606 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.0 t -106.83 124.16 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.713 -1.242 . . . . 0.0 107.71 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.79 ' HB ' HD22 ' A' ' 25' ' ' LEU . 3.9 p -139.34 161.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.457 -1.297 . . . . 0.0 113.536 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.8 m -121.39 157.66 29.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.835 ' CE2' HD11 ' A' ' 57' ' ' LEU . 47.9 p90 -171.63 -174.39 1.37 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.922 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 82.3 m-20 -106.76 123.46 48.17 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -71.88 1.9 6.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.032 -177.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.839 HG23 ' CB ' ' A' ' 1' ' ' ALA . 24.7 p -78.87 -27.33 44.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.961 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -122.58 -18.04 6.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -138.38 -169.9 2.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.372 -0.83 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.637 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -177.99 159.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.868 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.8 -42.58 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.598 ' N ' HG23 ' A' ' 54' ' ' VAL . 37.2 tt0 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.065 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -65.49 -24.17 67.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.57 -0.706 . . . . 0.0 111.011 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.0 mt -75.5 -52.83 9.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 0.0 108.289 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.534 HG22 ' OG ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -66.66 -18.76 65.54 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -84.15 -25.72 29.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.052 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -70.98 -42.34 69.8 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.944 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.53 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.7 t -77.17 -38.78 51.0 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -60.34 -25.27 65.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.52 -25.93 28.44 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -13.29 60.88 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.66 32.69 3.3 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.835 ' HB3' HG11 ' A' ' 9' ' ' VAL . 24.0 m-85 -135.16 84.17 37.09 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.691 -0.888 . . . . 0.0 110.21 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -54.19 97.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.781 1.411 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.868 ' HB3' HG13 ' A' ' 9' ' ' VAL . 49.5 p -107.8 -165.59 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.889 0.852 . . . . 0.0 111.886 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -153.44 126.19 8.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.733 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.7 p -95.05 159.72 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.93 -1.106 . . . . 0.0 110.431 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.4 OUTLIER -151.3 51.49 0.84 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.224 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.958 ' O ' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.24 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.734 HG23 ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -148.29 89.21 1.7 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 152.35 44.75 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.926 0.87 . . . . 0.0 111.943 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -121.0 152.66 38.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.446 0.641 . . . . 0.0 109.873 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 54' ' ' VAL . 16.0 m -142.51 174.34 5.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.821 ' O ' HD12 ' A' ' 7' ' ' LEU . 11.1 t -108.17 160.97 15.41 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.007 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -130.68 141.77 50.42 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.878 -1.529 . . . . 0.0 111.707 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -110.39 101.21 9.95 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.3 p -112.55 79.64 3.22 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 111.051 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.7 Cg_endo -68.11 -3.38 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.766 1.403 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -56.24 -17.28 17.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.715 ' SD ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -154.18 -171.25 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 110.027 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 12' ' ' MET . 7.0 t 179.93 58.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -160.31 173.64 15.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.305 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -73.89 78.72 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 110.59 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.16 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.189 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB2' ' CB ' ' A' ' 12' ' ' MET . 2.6 m -91.77 -44.7 0.36 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.639 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 4.9 Cg_exo -61.03 -44.59 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.651 ' HA ' HG23 ' A' ' 36' ' ' VAL . 85.4 mt -57.67 -29.66 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.967 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 14.6 m -65.46 -28.43 69.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 108.695 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.901 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.0 t -68.31 -27.42 36.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.826 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.9 tttt -69.84 -43.2 72.43 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.4 mptt -64.99 -25.01 67.68 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.351 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.48 -43.27 77.28 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.777 -0.577 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -69.19 -41.89 76.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.055 -1.028 . . . . 0.0 109.64 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.828 ' HA ' HG11 ' A' ' 31' ' ' VAL . 2.9 p -67.4 -18.17 65.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -99.75 -9.65 22.77 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.903 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.5 t -45.32 -63.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.039 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 1.4 tt0 160.28 -64.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.355 0.597 . . . . 0.0 109.782 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -93.4 -6.91 62.37 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.565 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 26' ' ' SER . 13.7 p -41.77 129.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 109.732 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 m -108.24 -10.85 15.32 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.369 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.93 159.54 18.28 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.296 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 25' ' ' LEU . 60.4 t -147.49 160.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.838 -1.164 . . . . 0.0 111.581 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 44' ' ' VAL . 8.3 t70 -136.84 135.65 38.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG23 ' HA ' ' A' ' 19' ' ' ILE . 1.6 p -109.39 127.31 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.888 -1.133 . . . . 0.0 112.07 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -109.45 59.34 0.36 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -28.77 -110.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.373 0.606 . . . . 0.0 112.498 -177.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -50.9 -50.18 57.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.572 -1.33 . . . . 0.0 112.134 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.2 tmmm? -55.21 -14.04 1.54 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.0 111.506 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' VAL . 7.7 tmm_? 61.45 84.01 0.14 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.432 -0.792 . . . . 0.0 111.216 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -171.8 120.51 0.46 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.398 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -114.04 119.55 37.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 110.487 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -107.36 123.62 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.8 p -133.96 152.07 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.664 -1.214 . . . . 0.0 113.752 -176.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -113.16 152.33 29.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.807 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.0 p90 -170.45 -179.91 3.15 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.734 ' OD2' HG23 ' A' ' 2' ' ' THR . 5.8 m-20 -107.11 123.69 48.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.686 ' OD1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -67.34 -2.45 6.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.285 -177.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 48' ' ' ASP . 6.0 t -81.57 -23.43 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 110.154 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -125.52 -5.84 7.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.155 -0.965 . . . . 0.0 110.479 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.15 -170.07 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.71 158.93 0.71 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.817 ' HA ' HD12 ' A' ' 57' ' ' LEU . 17.4 m -41.84 -41.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.579 ' N ' HG23 ' A' ' 54' ' ' VAL . 22.2 tp60 -60.59 -45.61 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.392 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.61 -25.97 67.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.639 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 45' ' ' VAL . 39.5 mt -72.62 -56.32 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.893 -1.129 . . . . 0.0 108.346 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 ' OG ' ' A' ' 68' ' ' SER . 3.2 m -64.45 -17.74 64.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 4.2 ttmm -81.73 -27.95 33.63 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.41 -43.61 66.45 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.071 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.901 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.9 t -74.29 -36.25 63.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -60.9 -29.77 69.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -90.28 -15.51 31.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.28 178.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.9 -18.82 58.06 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 117.48 23.91 3.62 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -142.13 90.56 8.25 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.571 -0.958 . . . . 0.0 109.993 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.5 Cg_exo -55.71 97.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.63 1.332 . . . . 0.0 110.103 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.679 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.5 p -108.5 -163.21 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.874 . . . . 0.0 111.036 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.656 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -147.3 -175.37 4.81 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.007 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.56 142.08 33.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.817 -1.177 . . . . 0.0 112.184 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -131.77 79.95 1.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.457 0.646 . . . . 0.0 109.595 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 5' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -157.44 90.79 1.12 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -114.54 158.0 22.24 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.6 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.535 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 50.0 m -136.64 121.57 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.665 -0.647 . . . . 0.0 109.321 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' A' ' 72' ' ' GLN . 5.1 m -131.97 172.8 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.477 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.707 ' O ' HD12 ' A' ' 7' ' ' LEU . 10.6 t -108.48 157.33 18.54 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -126.17 156.56 39.97 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.002 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -132.33 103.33 6.15 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.0 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.6 t -108.71 102.76 49.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.526 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 4.6 Cg_endo -71.37 2.19 4.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.198 1.265 . . . . 0.0 111.8 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.41 -1.0 60.87 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -107.16 161.2 14.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -1.22 . . . . 0.0 110.055 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 179.01 32.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.102 -0.999 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -173.19 170.37 4.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.739 -1.226 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -77.05 78.31 3.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.8 -48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 6.1 m -93.66 -44.72 0.31 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.978 -1.076 . . . . 0.0 112.048 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 1.5 Cg_endo -65.45 -38.11 27.27 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 107.661 -1.707 . . . . 0.0 107.661 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.66 HG13 ' CE1' ' A' ' 38' ' ' PHE 0.267 6.7 tt -59.21 -36.16 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.402 1.096 . . . . 0.0 108.711 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 49.9 m -63.44 -21.31 66.23 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.72 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.5 t -69.77 -33.09 54.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.774 ' HB2' HG21 ' A' ' 36' ' ' VAL . 27.5 tttm -66.16 -41.23 90.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -25.65 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.182 179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' VAL . . . -69.51 -55.6 9.75 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.687 -0.633 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.875 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.95 -37.23 81.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.606 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -70.37 -20.49 62.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 108.978 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -112.88 10.72 19.07 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.18 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.6 p -66.35 -44.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.457 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.44 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.476 -0.765 . . . . 0.0 111.269 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.703 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -90.27 0.98 79.07 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.271 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG11 ' C ' ' A' ' 26' ' ' SER . 7.3 p -42.86 128.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.922 -1.34 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -113.87 -14.87 12.45 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.596 0.713 . . . . 0.0 109.58 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.816 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -156.7 159.77 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.435 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 45' ' ' VAL . 13.4 p -152.65 157.4 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 111.08 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t0 -170.54 87.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 22' ' ' LYS . 6.1 m -108.02 -159.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.885 . . . . 0.0 111.783 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.12 115.19 0.82 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.68 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 m-30 -56.6 -105.66 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 O-C-N 122.216 -0.579 . . . . 0.0 109.713 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -47.87 -34.21 8.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.358 -1.464 . . . . 0.0 110.476 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 33.4 tttt -52.78 -41.97 64.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.077 -1.014 . . . . 0.0 110.7 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER 81.37 70.03 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.425 0.631 . . . . 0.0 110.989 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -170.83 120.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.755 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.99 115.62 29.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.949 -1.094 . . . . 0.0 111.993 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.3 t -107.97 117.16 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.875 HG21 HD22 ' A' ' 25' ' ' LEU . 21.8 t -137.3 155.5 32.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.228 -1.389 . . . . 0.0 113.09 -177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.8 m -114.9 160.55 19.39 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.753 ' CE1' HD11 ' A' ' 57' ' ' LEU . 53.4 p90 -171.82 -176.52 1.75 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.796 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.63 114.78 29.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -62.67 -9.01 7.65 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.59 -177.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 7.4 t -67.59 -26.92 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.013 -1.054 . . . . 0.0 109.574 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -0.9 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.456 -0.778 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.35 -168.81 3.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 179.73 156.15 0.59 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.846 . . . . 0.0 109.62 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.794 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.2 m -44.74 -39.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.347 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.02 -43.74 97.87 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.327 -0.858 . . . . 0.0 109.105 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.24 -25.17 67.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.443 -0.786 . . . . 0.0 110.736 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 54' ' ' VAL . 54.4 mt -69.57 -56.1 8.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.861 -1.149 . . . . 0.0 108.704 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 3.0 m -64.65 -21.43 66.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mttp -81.43 -23.85 37.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -73.47 -44.18 58.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.325 -0.86 . . . . 0.0 108.933 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.632 ' OG1' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.59 -35.34 60.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.12 -29.78 70.57 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 40.3 t0 -79.21 -23.73 43.61 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.28 59.97 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.618 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.71 32.94 3.21 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG11 ' A' ' 9' ' ' VAL . 25.2 m-85 -137.35 84.62 23.33 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.681 -0.894 . . . . 0.0 110.262 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.19 97.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.67 1.353 . . . . 0.0 109.235 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.0 ' OG ' HG22 ' A' ' 9' ' ' VAL . 12.6 t -108.03 -172.03 1.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.887 0.851 . . . . 0.0 112.12 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.58 121.55 8.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -92.86 156.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.808 -1.182 . . . . 0.0 110.572 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.621 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -154.78 45.43 0.52 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.339 -1.344 . . . . 0.0 110.841 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.635 ' HB3' HG12 ' A' ' 5' ' ' VAL . 2.7 pp0? . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.838 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.938 ' HB1' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.3 t -178.05 107.65 0.05 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.289 1.042 . . . . 0.0 108.725 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.656 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.7 pt20 -130.24 173.62 10.61 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.158 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 45' ' ' VAL . 7.0 m -126.37 137.82 53.49 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.578 -0.701 . . . . 0.0 109.737 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.763 HG21 HG23 ' A' ' 54' ' ' VAL . 33.7 m -133.13 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.834 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.91 157.01 18.1 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.79 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.47 152.4 50.51 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.814 -178.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.39 117.26 23.32 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.632 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.9 HG21 HG11 ' A' ' 21' ' ' VAL . 98.9 t -112.56 75.94 1.93 Allowed Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 120.845 -1.159 . . . . 0.0 112.184 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 5.9 Cg_endo -69.27 -13.95 36.79 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.222 1.117 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -43.89 -42.19 6.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 83.5 mmm -153.39 140.14 19.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -1.067 . . . . 0.0 110.044 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.558 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 2.4 t -134.6 78.36 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 110.878 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -147.68 -142.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.035 -1.04 . . . . 0.0 108.881 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -110.11 64.81 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.805 -1.184 . . . . 0.0 109.335 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.04 -54.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.048 -1.032 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.1 m -77.29 -48.38 2.45 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 120.835 -1.165 . . . . 0.0 111.601 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 27.3 Cg_exo -51.02 -56.19 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.082 1.043 . . . . 0.0 109.776 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -57.66 -27.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.767 -0.583 . . . . 0.0 110.42 179.239 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 67.8 m -66.43 -24.54 66.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.741 -1.225 . . . . 0.0 108.717 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.9 HG11 HG21 ' A' ' 9' ' ' VAL . 57.3 t -69.17 -31.72 51.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.671 ' CA ' HG21 ' A' ' 36' ' ' VAL . 17.4 tttm -70.51 -40.16 73.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -68.51 -21.05 64.61 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.451 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -72.51 -53.47 11.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.706 -0.621 . . . . 0.0 110.321 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -61.55 -30.13 70.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.0 109.373 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.8 -27.43 61.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.502 -0.749 . . . . 0.0 109.16 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.44 6.89 37.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.264 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.5 t -56.13 -77.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.731 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER 177.89 -81.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.3 -1.06 87.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 25' ' ' LEU . 5.4 p -42.11 133.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.206 -1.173 . . . . 0.0 110.582 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -110.15 -17.94 13.43 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.5 tttt -167.63 158.63 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.165 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 45' ' ' VAL . 24.4 t -154.64 145.12 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.773 -1.204 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -141.66 154.67 45.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.671 HG21 ' CA ' ' A' ' 22' ' ' LYS . 46.6 t -155.29 158.48 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.352 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -124.3 81.94 0.35 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -35.93 -101.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 122.276 -0.544 . . . . 0.0 111.812 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -28.8 -44.03 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.474 -0.766 . . . . 0.0 111.025 -179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -89.8 50.8 1.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -10.38 76.84 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' LYS . 5.6 tm-20 -149.82 109.6 4.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.627 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -110.17 126.79 54.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.815 -1.178 . . . . 0.0 111.431 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.834 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -108.08 120.84 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.902 ' CG1' HD13 ' A' ' 57' ' ' LEU . 9.9 p -126.02 156.06 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.589 1.185 . . . . 0.0 113.955 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -121.43 153.31 38.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 2' ' ' THR . 43.9 p90 -172.31 179.86 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 117.879 -1.528 . . . . 0.0 111.294 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.54 112.33 25.28 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.938 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -62.45 -8.22 5.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.985 -177.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 t -71.6 -10.26 59.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.996 -1.065 . . . . 0.0 110.155 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -132.39 -39.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -123.79 -169.96 2.04 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.724 -0.61 . . . . 0.0 109.696 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' ' C ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.28 154.28 5.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.939 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.3 p -41.07 -30.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.844 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 22.3 tt0 -70.08 -50.03 45.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -22.38 65.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 54' ' ' VAL . 42.3 mt -72.27 -51.56 20.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.641 -1.287 . . . . 0.0 108.155 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -65.91 -19.31 65.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -82.57 -24.05 34.15 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.838 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -72.7 -43.05 63.53 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.94 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.612 ' HB ' HG13 ' A' ' 21' ' ' VAL . 8.3 t -76.46 -38.29 55.63 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -61.93 -26.08 67.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.55 -24.24 29.36 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.97 -19.08 62.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 113.03 28.56 3.32 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 17.3 m-85 -134.82 87.55 30.14 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 121.499 -1.0 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.25 100.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.795 1.418 . . . . 0.0 109.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 9' ' ' VAL . 11.4 p -107.66 -167.91 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.59 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -150.47 129.64 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.915 HG21 HG22 ' A' ' 54' ' ' VAL . 6.9 p -99.14 158.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.889 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.7 OUTLIER -137.7 45.58 2.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.657 -1.217 . . . . 0.0 110.915 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.582 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.212 0.53 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -158.94 92.95 1.13 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -118.36 161.27 20.23 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.757 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -137.68 122.56 18.89 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 72' ' ' GLN . 34.2 m -132.99 174.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.988 HG22 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.28 163.71 12.79 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.005 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -135.45 143.74 46.07 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.277 -1.369 . . . . 0.0 111.604 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.581 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -114.22 99.3 7.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.861 ' O ' ' HE3' ' A' ' 12' ' ' MET . 7.4 p -112.34 80.08 3.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.117 -0.989 . . . . 0.0 111.932 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.5 Cg_endo -68.54 -1.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.508 1.268 . . . . 0.0 111.221 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.37 -26.52 3.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.861 ' HE3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -149.05 -165.19 2.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -1.234 . . . . 0.0 110.215 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 13' ' ' THR . 5.3 t -179.75 67.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.127 -0.983 . . . . 0.0 111.093 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -166.17 177.32 7.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.05 -1.031 . . . . 0.0 109.334 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.69 74.69 5.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 110.078 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.09 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 111.377 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.4 m -89.77 -42.6 0.42 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.98 -1.075 . . . . 0.0 112.88 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 5.5 Cg_endo -65.18 -41.22 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 38' ' ' PHE . 4.0 mt -61.47 -27.35 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 29.6 m -67.03 -27.98 67.85 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.101 -0.999 . . . . 0.0 108.334 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.741 ' O ' HD12 ' A' ' 25' ' ' LEU . 84.6 t -64.58 -32.15 56.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 tttm -65.28 -39.26 92.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -68.92 -24.89 64.34 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.885 0.85 . . . . 0.0 109.149 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.656 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.89 -56.14 6.92 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.72 -0.612 . . . . 0.0 110.514 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.46 -30.65 70.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.1 t -72.81 -25.36 61.12 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -108.07 7.13 27.55 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.684 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.3 p -61.81 -48.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.95 -1.093 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 165.45 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.0 -1.062 . . . . 0.0 111.238 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -91.82 4.67 78.99 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.124 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 28' ' ' VAL . 7.5 p -41.03 129.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.167 -1.196 . . . . 0.0 110.17 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -16.49 13.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.9 156.03 21.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.676 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.737 HG13 ' CG2' ' A' ' 45' ' ' VAL . 45.6 t -150.64 145.49 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.893 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -162.3 92.99 0.84 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 22' ' ' LYS . 2.3 m -108.39 -164.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.025 -1.047 . . . . 0.0 111.185 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -140.99 118.94 1.44 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -47.53 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.4 tt0 -35.45 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.019 -1.051 . . . . 0.0 111.538 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.19 30.58 0.46 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.893 -1.13 . . . . 0.0 110.898 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 6.14 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' LYS . 10.0 tt0 -145.79 112.75 6.06 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.669 -1.27 . . . . 0.0 110.593 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.71 120.65 43.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.874 -1.141 . . . . 0.0 111.979 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.988 HG23 HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -108.52 115.67 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.737 ' CG2' HG13 ' A' ' 34' ' ' VAL . 14.5 t -132.04 154.15 39.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.131 -1.428 . . . . 0.0 113.132 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -115.29 158.17 22.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.7 p90 -171.91 -177.7 2.0 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.562 -1.255 . . . . 0.0 110.918 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.0 m-20 -107.29 110.64 22.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.17 -12.96 4.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.449 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 14.4 t -60.44 -32.3 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 110.154 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 -3.73 6.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -142.67 -168.02 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 22.0 t 179.42 154.8 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.935 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HD12 ' A' ' 57' ' ' LEU . 15.2 m -43.61 -35.47 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.189 -0.944 . . . . 0.0 109.614 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' VAL . 10.6 tt0 -65.77 -46.38 78.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.007 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 2.4 mmtp -63.1 -25.37 68.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.547 -0.72 . . . . 0.0 110.271 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 54' ' ' VAL . 61.4 mt -69.88 -55.61 9.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.873 -1.142 . . . . 0.0 108.733 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.592 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -62.94 -22.38 66.75 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -81.37 -27.15 34.97 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.49 -0.756 . . . . 0.0 109.213 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.656 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.18 -42.93 71.78 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.161 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.715 ' CB ' HG13 ' A' ' 21' ' ' VAL . 12.4 t -75.32 -38.02 60.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.26 66.47 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.17 -23.76 26.4 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.87 -16.85 60.66 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.07 27.56 3.4 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.7 m-85 -138.05 82.61 24.6 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.567 -0.961 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.85 97.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.672 1.354 . . . . 0.0 109.974 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.9 p -108.49 -161.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.781 0.801 . . . . 0.0 111.316 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.5 t -146.32 -170.32 3.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -138.98 153.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 O-C-N 120.831 -1.168 . . . . 0.0 111.294 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -157.89 61.72 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.75 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.727 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.2 pt20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.425 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.28 0.562 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -160.03 91.72 0.97 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.3 pm0 -127.7 163.15 24.93 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.059 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 12.0 m -125.69 133.97 51.97 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.327 0.584 . . . . 0.0 109.718 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 ' HG3' ' A' ' 72' ' ' GLN . 7.0 m -135.75 169.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.859 ' O ' HD12 ' A' ' 7' ' ' LEU . 13.5 t -108.5 161.99 14.54 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.032 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -133.79 154.64 50.85 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.487 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -121.48 100.37 6.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.3 p -111.67 89.23 10.65 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.176 -0.952 . . . . 0.0 111.522 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.7 Cg_endo -68.69 -7.77 21.42 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.596 1.314 . . . . 0.0 110.713 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.82 0.45 57.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.565 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -92.34 176.67 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -1.204 . . . . 0.0 109.987 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.9 -9.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -163.5 -156.75 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.766 -1.834 . . . . 0.0 111.112 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.43 60.21 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.844 -1.16 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.94 -40.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 111.09 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m -93.79 -45.82 0.3 Allowed Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.69 -1.256 . . . . 0.0 111.962 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.6 Cg_exo -62.01 -57.88 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 122.965 0.981 . . . . 0.0 109.897 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -54.72 -29.44 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.711 . . . . 0.0 110.76 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.648 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 17.9 m -64.28 -27.15 68.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.805 -1.184 . . . . 0.0 109.055 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.885 HG22 ' OG1' ' A' ' 61' ' ' THR . 73.4 t -67.12 -30.23 48.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.599 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.8 tttt -70.55 -44.64 67.03 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.02 -23.15 64.04 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.884 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.93 -49.03 50.16 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.701 -0.624 . . . . 0.0 110.468 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.795 ' CB ' HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -61.62 -42.41 98.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 0.0 109.625 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.469 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.8 p -70.4 -20.19 62.95 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.225 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.03 -7.85 41.53 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.503 -0.748 . . . . 0.0 109.699 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.79 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 3.8 t -52.17 -76.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.643 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 167.76 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.521 0.677 . . . . 0.0 109.768 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.36 -8.19 49.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.9 p -48.59 126.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -1.171 . . . . 0.0 109.907 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.39 -14.6 14.4 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -162.2 160.5 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.56 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 45' ' ' VAL . 67.0 t -149.78 149.58 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.13 -0.981 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 30.3 t0 -167.4 91.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.0 m -108.39 -156.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.003 0.906 . . . . 0.0 111.345 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -154.37 91.6 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.623 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -38.2 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.936 -0.743 . . . . 0.0 111.17 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 13.0 tp10 -34.34 -40.82 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.454 -0.779 . . . . 0.0 110.731 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' GLU . 1.2 tmtp? -87.25 46.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 109.571 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -6.15 72.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -149.82 117.17 6.07 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.838 -1.163 . . . . 0.0 110.321 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.88 116.99 33.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.399 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -108.94 109.53 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 25' ' ' LEU . 40.1 t -129.14 151.16 35.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.98 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m -109.8 157.57 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.9 p90 -172.5 -179.03 2.1 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.335 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 7.9 m-20 -107.92 113.98 27.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.555 ' HB2' ' NE2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -59.84 -9.89 3.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.937 -178.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -64.95 -25.42 67.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.899 -1.126 . . . . 0.0 110.404 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -126.78 -32.91 2.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -117.71 -167.64 1.37 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.641 -0.662 . . . . 0.0 109.917 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.613 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.54 153.04 0.86 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 57' ' ' LEU . 24.4 m -43.02 -36.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.754 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.5 tt0 -67.58 -45.08 76.56 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -60.94 -27.03 67.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 54' ' ' VAL . 44.8 mt -69.17 -52.58 26.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.242 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.5 m -65.52 -17.62 64.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -83.81 -24.5 30.97 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.03 -42.3 66.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.829 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.885 ' OG1' HG22 ' A' ' 21' ' ' VAL . 11.5 t -76.61 -38.7 54.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.37 -28.24 66.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.1 m-20 -84.46 -24.44 29.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.648 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.37 -16.45 62.42 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.51 27.81 4.27 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.4 m-85 -135.99 97.13 12.51 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.482 -1.011 . . . . 0.0 110.401 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.2 Cg_exo -58.11 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.619 1.326 . . . . 0.0 110.054 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.527 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.4 p -108.43 -165.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 110.788 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.699 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 84.9 p -148.55 -171.91 3.96 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.032 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.8 p -139.23 152.08 23.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 110.983 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.27 42.68 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.169 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.825 ' HG3' HG12 ' A' ' 5' ' ' VAL . 1.4 mt-30 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.018 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.81 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.174 0.512 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.79 95.92 1.93 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 2.1 mt-30 -108.74 159.03 17.09 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.627 0.727 . . . . 0.0 110.987 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.527 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 m -139.31 127.74 22.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.912 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 54' ' ' VAL . 5.3 m -133.32 169.72 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 7' ' ' LEU . 14.8 t -108.2 160.33 15.91 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.988 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.52 145.64 50.32 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.483 -178.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -117.54 100.49 7.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.817 HG11 HG21 ' A' ' 21' ' ' VAL . 6.5 p -109.66 80.02 1.52 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.123 . . . . 0.0 112.552 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.1 Cg_endo -67.58 -3.78 10.85 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.467 1.246 . . . . 0.0 110.811 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -41.84 -32.17 0.9 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 99.2 mmm -146.62 -160.65 1.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.478 -1.013 . . . . 0.0 109.372 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.7 t 179.92 71.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -169.49 -178.91 3.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.186 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.79 73.64 5.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.049 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.22 -51.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 m -86.84 -43.99 0.54 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.9 -1.125 . . . . 0.0 112.894 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 2.2 Cg_endo -63.51 -44.57 13.84 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 8.7 mt -64.41 -25.29 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.674 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 62.3 m -64.18 -23.68 67.4 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.738 -1.226 . . . . 0.0 108.059 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' HB ' ' A' ' 61' ' ' THR . 45.0 t -71.0 -32.79 49.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.651 ' HE3' HG13 ' A' ' 34' ' ' VAL . 3.4 tttt -63.43 -38.43 91.1 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.3 -32.14 72.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.189 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -62.86 -51.57 66.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.746 HD22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -70.62 -27.54 64.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.358 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -66.94 -25.34 66.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.75 17.37 6.85 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.119 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -60.58 -47.24 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 175.27 -84.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 110.928 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.766 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -100.6 8.41 58.32 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.657 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.1 p -40.26 130.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -1.111 . . . . 0.0 110.445 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -110.12 -16.9 13.68 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.748 0.785 . . . . 0.0 108.925 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.896 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.42 158.82 27.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.546 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.811 HG23 HG22 ' A' ' 45' ' ' VAL . 7.1 p -157.74 151.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.52 ' OD1' HG12 ' A' ' 44' ' ' VAL . 7.1 p-10 -169.38 98.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.0 m -109.04 -157.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 112.005 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.2 122.98 1.67 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.25 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.147 -0.619 . . . . 0.0 111.562 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -23.53 -38.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.557 -0.714 . . . . 0.0 112.912 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 38' ' ' PHE . 2.5 ttpt -81.24 32.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.737 -1.227 . . . . 0.0 111.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 7.5 87.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.599 ' OE2' HG23 ' A' ' 44' ' ' VAL . 4.6 tm-20 -156.43 110.15 2.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.055 . . . . 0.0 110.21 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -114.02 117.4 31.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.754 -1.216 . . . . 0.0 111.661 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.599 HG23 ' OE2' ' A' ' 42' ' ' GLU . 2.2 t -108.45 121.23 61.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 33' ' ' LYS . 52.8 t -139.83 152.16 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.079 -1.448 . . . . 0.0 113.144 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -111.49 162.4 15.14 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.4 p90 -172.69 -176.95 1.59 Allowed 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.489 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 72.6 m-20 -106.58 122.21 45.87 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.81 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -65.62 -4.5 6.27 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.929 -177.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.631 HG23 ' HB1' ' A' ' 1' ' ' ALA . 30.7 p -76.15 -26.84 56.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 2.2 mmmt -125.61 -6.49 6.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.766 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -147.28 -168.45 3.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 35.4 t -178.17 152.54 0.72 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 57' ' ' LEU . 3.6 p -41.76 -39.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.469 -0.77 . . . . 0.0 109.377 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.62 -45.7 82.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 53' ' ' SER . 1.3 mttt -60.66 -23.64 64.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.465 -0.772 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 54' ' ' VAL . 32.5 mt -74.4 -51.96 13.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.729 -1.232 . . . . 0.0 108.35 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 1.8 m -64.02 -18.84 64.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.06 -26.79 33.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.14 -41.46 70.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.034 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.917 ' HB ' HG13 ' A' ' 21' ' ' VAL . 13.0 t -76.0 -39.51 55.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.69 -26.37 67.07 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.64 -19.81 23.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.07 61.14 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.83 28.42 3.94 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -137.15 101.47 9.27 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.98 . . . . 0.0 110.746 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.53 95.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.662 1.348 . . . . 0.0 109.773 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 9' ' ' VAL . 12.6 t -108.94 -168.6 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.14 178.35 7.76 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.988 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.4 p -138.29 148.0 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.725 -1.235 . . . . 0.0 112.511 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.04 77.47 1.66 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.603 -0.686 . . . . 0.0 109.825 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.915 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.209 0.528 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -155.9 93.22 1.43 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -113.81 -171.23 1.86 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.035 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.553 HG23 ' OG1' ' A' ' 46' ' ' THR . 20.4 m -153.0 156.92 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.44 169.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.27 1.033 . . . . 0.0 110.34 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 t -109.73 165.16 11.91 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 1.0 OUTLIER -133.55 145.63 50.27 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.624 -1.23 . . . . 0.0 111.664 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.998 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -110.56 100.1 8.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 3.4 p -112.03 79.52 2.75 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.04 -1.037 . . . . 0.0 111.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 4.2 Cg_endo -67.17 -4.66 12.04 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.608 1.32 . . . . 0.0 110.917 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -42.1 -43.49 4.49 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.704 ' HA ' ' HE3' ' A' ' 12' ' ' MET . 0.0 OUTLIER -139.06 -159.03 0.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -1.077 . . . . 0.0 109.604 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 13' ' ' THR . 3.8 t -179.04 79.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.03 -1.044 . . . . 0.0 110.628 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.6 -177.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.418 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -81.62 70.96 8.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.056 . . . . 0.0 110.292 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -177.31 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 111.679 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 8.3 m -93.93 -43.42 0.31 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 120.803 -1.186 . . . . 0.0 112.646 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.4 Cg_endo -65.64 -37.6 28.16 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 N-CA-C 108.577 -1.355 . . . . 0.0 108.577 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 tt -65.28 -33.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.953 0.882 . . . . 0.0 108.973 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 76.0 m -60.74 -20.24 60.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.04 HG13 ' HB ' ' A' ' 61' ' ' THR . 62.3 t -74.82 -36.12 38.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.855 ' HD3' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -60.48 -33.92 73.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -68.34 -46.68 69.5 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.483 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -52.77 -57.55 9.79 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.164 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.031 -1.043 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.62 ' CA ' HG21 ' A' ' 34' ' ' VAL . 7.4 t -63.44 -20.06 65.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.6 16.32 5.91 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.598 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.006 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.8 p -55.25 -56.59 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 0.0 110.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 1.006 ' HG2' HG22 ' A' ' 28' ' ' VAL . 5.7 pt-20 170.86 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.92 3.62 16.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 25' ' ' LEU . 3.6 p -50.3 134.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.4 -8.63 11.59 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.981 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.8 ttmm -155.24 160.87 41.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.855 HG11 ' HD3' ' A' ' 22' ' ' LYS . 54.6 t -152.62 137.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.501 0.667 . . . . 0.0 110.337 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.2 m-20 -167.92 92.43 0.36 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 22' ' ' LYS . 3.7 m -107.97 -153.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 111.845 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.77 111.99 0.57 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -82.22 65.03 7.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.959 0.885 . . . . 0.0 110.502 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -178.66 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.317 -0.865 . . . . 0.0 108.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -89.88 42.06 1.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.998 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.7 ppt_? 23.46 84.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.114 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 tt0 -150.42 116.16 5.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.464 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -111.16 117.59 33.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.115 . . . . 0.0 111.222 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -110.01 114.62 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 33' ' ' LYS . 56.5 t -138.07 151.07 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.445 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.5 m -109.43 166.26 11.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 57' ' ' LEU . 53.2 p90 -172.85 -171.05 0.72 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.885 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -107.28 111.28 23.58 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -61.98 -9.65 7.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 -177.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.915 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -75.99 -30.37 58.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.877 -1.14 . . . . 0.0 109.662 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 1.3 10.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.979 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -155.1 -169.37 3.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.62 155.68 0.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.755 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.41 -37.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 54' ' ' VAL . 6.1 tt0 -64.04 -46.91 82.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.251 -0.906 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -61.49 -29.75 70.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.452 -0.78 . . . . 0.0 110.027 179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 54' ' ' VAL . 68.0 mt -65.51 -52.9 49.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 69' ' ' SER . 5.5 m -64.35 -18.36 64.58 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 20.1 ttpt -80.58 -27.89 37.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.6 -43.51 66.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.91 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.04 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.2 t -73.23 -35.61 66.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -58.8 -31.46 68.46 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.52 -16.44 28.85 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.573 -0.704 . . . . 0.0 109.466 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.46 -18.98 61.06 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.48 23.96 4.58 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -139.34 93.26 10.11 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.614 -0.933 . . . . 0.0 110.557 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_exo -54.91 95.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.705 1.371 . . . . 0.0 109.432 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 61' ' ' THR . 5.4 p -108.39 -159.09 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.853 0.835 . . . . 0.0 111.391 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.659 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -151.53 -167.08 2.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 7' ' ' LEU 0.258 3.3 p -139.4 146.39 25.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.191 -0.943 . . . . 0.0 110.749 -178.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.708 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -160.6 50.22 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.825 -178.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.52 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 4.9 pp0? . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.494 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.824 ' HB3' ' CG ' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.208 0.528 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.52 86.99 1.84 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 47' ' ' PHE . 4.4 pt20 -120.44 149.37 42.48 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.589 -0.844 . . . . 0.0 112.17 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.577 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -119.16 138.98 52.56 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.646 0.736 . . . . 0.0 110.194 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 54' ' ' VAL . 35.1 m -130.92 169.76 20.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.588 -0.695 . . . . 0.0 109.171 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.021 HG22 ' HB2' ' A' ' 72' ' ' GLN . 12.0 t -107.49 159.79 16.15 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -133.58 153.33 51.74 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.466 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -124.01 106.06 10.09 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.998 HG11 HG21 ' A' ' 21' ' ' VAL . 7.2 p -115.69 78.05 6.65 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.931 -1.106 . . . . 0.0 111.518 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.523 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 8.6 Cg_endo -72.53 2.73 4.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.744 1.392 . . . . 0.0 111.351 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -55.36 -29.79 53.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -172.72 119.91 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.676 -0.896 . . . . 0.0 109.4 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 13' ' ' THR . 2.9 t -143.49 110.0 5.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 13' ' ' THR . 1.8 m -148.55 -61.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.0 109.082 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.76 27.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.613 -0.679 . . . . 0.0 109.871 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -168.68 -40.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 111.646 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 8.2 m -67.2 -44.86 49.95 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.128 . . . . 0.0 112.035 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 4.3 Cg_endo -64.14 -41.65 21.31 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.619 HD12 ' CG ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -63.4 -31.92 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.652 0.739 . . . . 0.0 109.317 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 30.8 m -61.7 -23.08 65.88 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.066 HG13 ' HB ' ' A' ' 61' ' ' THR . 60.7 t -73.18 -33.66 42.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.672 ' HA ' HG21 ' A' ' 36' ' ' VAL . 65.2 tttt -62.1 -35.08 77.63 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -65.86 -43.02 89.66 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.567 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -55.77 -59.29 5.08 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.75 -0.594 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -64.65 -29.29 70.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.001 -1.062 . . . . 0.0 109.924 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 20.0 m -59.5 -30.3 68.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -135.28 21.93 3.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.792 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HB ' ' A' ' 31' ' ' VAL . 10.7 p -54.18 -45.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.72 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 110.557 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -97.1 1.69 61.03 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -42.72 128.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.059 -1.26 . . . . 0.0 110.159 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.01 -9.17 15.09 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.432 0.634 . . . . 0.0 109.657 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.645 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -166.67 163.03 16.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.361 -0.837 . . . . 0.0 109.549 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 22' ' ' LYS . 92.2 t -150.71 162.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.3 t0 -170.72 85.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 22' ' ' LYS . 23.8 t -106.94 176.29 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.741 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -131.8 118.36 2.3 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CG ' HD12 ' A' ' 19' ' ' ILE . 17.9 p90 -87.24 63.82 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.945 0.878 . . . . 0.0 109.858 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 2.1 tt0 179.58 -63.88 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.2 mtmt -73.26 -2.69 22.89 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CB ' ' A' ' 13' ' ' THR . 8.2 tmm_? 59.5 75.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.7 -0.625 . . . . 0.0 110.879 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -156.88 122.35 4.7 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.736 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -109.21 115.58 30.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.098 -1.001 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.0 t -109.2 119.37 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.7 t -135.64 156.88 38.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.017 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.577 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.62 154.34 26.19 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.3 p90 -170.88 177.88 3.65 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.22 -1.392 . . . . 0.0 111.668 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.37 123.74 48.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.824 ' CG ' ' HB3' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -69.17 -0.74 6.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.311 -177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.7 p -73.18 -33.29 65.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -121.32 -13.7 8.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.068 -1.02 . . . . 0.0 110.557 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -140.87 -169.25 2.77 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.914 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.8 p 179.76 158.26 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.941 ' HA ' HD12 ' A' ' 57' ' ' LEU . 5.5 m -41.3 -40.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.769 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.549 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.97 -49.05 79.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -25.46 68.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.676 -0.64 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' HA ' ' A' ' 54' ' ' VAL . 39.2 mt -71.63 -52.87 15.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.775 -1.203 . . . . 0.0 108.621 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.676 HG21 ' HA ' ' A' ' 69' ' ' SER . 83.8 m -66.05 -19.2 65.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.27 -24.56 34.68 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -72.07 -42.07 66.65 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.989 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.066 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.72 -38.71 58.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.74 -30.29 68.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.5 t70 -86.31 -20.68 28.01 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.03 -19.33 62.52 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 116.78 24.36 3.69 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.614 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 18.1 m-85 -138.42 99.39 8.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.441 -1.035 . . . . 0.0 110.391 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 4.9 Cg_exo -56.76 95.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.65 1.342 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.0 p -109.49 -162.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.858 . . . . 0.0 111.375 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.676 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.6 p -156.2 -173.2 4.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.5 p -135.8 156.15 37.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.848 -1.158 . . . . 0.0 110.958 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.741 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.94 54.36 0.41 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.415 -1.314 . . . . 0.0 111.766 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 1.021 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.291 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.693 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.083 0.468 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -145.35 86.26 1.75 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 26.8 mm-40 -115.45 141.9 47.42 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.136 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.544 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -125.52 122.31 36.22 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.481 0.658 . . . . 0.0 109.719 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 ' HB ' ' A' ' 54' ' ' VAL . 14.9 m -117.41 170.93 6.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.456 -0.777 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.779 HG23 ' HG2' ' A' ' 71' ' ' LYS . 14.8 t -107.64 154.3 21.65 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.741 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -131.29 159.66 37.2 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.255 -1.378 . . . . 0.0 110.922 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -126.83 123.91 38.42 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.969 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 21' ' ' VAL . 3.7 t -112.48 76.7 2.08 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.02 -1.05 . . . . 0.0 111.542 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 9.4 Cg_endo -73.65 -23.04 17.36 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.111 1.208 . . . . 0.0 111.016 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -46.8 -50.33 15.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.8 mmm -147.17 158.83 44.08 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.312 -1.111 . . . . 0.0 110.159 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 1.1 t -178.78 112.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.618 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.4 p -166.66 -42.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 110.641 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 178.83 30.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.894 -1.129 . . . . 0.0 110.668 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.707 ' N ' HD12 ' A' ' 19' ' ' ILE . . . 179.26 -32.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 110.65 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 50.8 m -70.05 -43.39 19.24 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.974 -1.079 . . . . 0.0 112.003 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.7 Cg_endo -72.72 -47.41 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 N-CA-C 107.126 -1.913 . . . . 0.0 107.126 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 16' ' ' ALA 0.259 3.5 mt -54.95 -33.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 177.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 24.6 m -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 109.158 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 9' ' ' VAL . 22.2 t -67.7 -31.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -67.9 -41.82 82.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.0 tmtt? -62.17 -37.95 87.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.567 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -59.54 -58.05 10.29 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.896 -0.503 . . . . 0.0 111.461 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.979 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -62.31 -33.98 75.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.041 -1.037 . . . . 0.0 109.831 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.492 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -63.35 -24.75 67.99 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -125.29 15.25 8.35 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.404 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.979 HG12 ' O ' ' A' ' 25' ' ' LEU . 2.2 p -58.75 -63.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.168 -0.958 . . . . 0.0 111.276 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.766 ' H ' HG13 ' A' ' 28' ' ' VAL . 3.1 mt-10 -165.47 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.713 -1.242 . . . . 0.0 110.721 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -98.67 6.15 60.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.7 p -39.73 132.17 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.421 -1.046 . . . . 0.0 110.479 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -109.47 -13.03 14.64 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.564 0.697 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' C ' HG23 ' A' ' 34' ' ' VAL . 2.9 tttt -165.83 160.58 17.13 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.799 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.664 HG13 HG22 ' A' ' 45' ' ' VAL . 61.2 t -152.28 151.19 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.452 ' OD2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p-10 -168.34 95.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.1 m -107.85 -158.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.113 0.958 . . . . 0.0 111.824 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -142.95 115.72 0.95 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 19' ' ' ILE . 3.2 m-30 -52.69 -114.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.045 -0.68 . . . . 0.0 110.257 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.7 mt-10 -36.65 -30.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.044 -1.035 . . . . 0.0 110.548 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.4 mtpt -88.91 50.28 1.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.561 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.918 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.1 ppt_? -16.37 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.544 0.687 . . . . 0.0 112.569 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 40' ' ' LYS . 15.4 tt0 -154.38 111.27 3.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.436 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -110.18 115.24 29.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.769 -1.207 . . . . 0.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 24.2 t -107.23 120.45 58.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.645 -1.285 . . . . 0.0 107.552 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.87 HG21 ' CB ' ' A' ' 25' ' ' LEU . 19.0 t -131.73 150.84 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.837 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -110.0 156.09 20.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.758 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.6 p90 -170.88 -177.27 2.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.14 -1.424 . . . . 0.0 111.797 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.0 m-20 -106.21 112.61 25.71 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -66.37 -6.04 12.91 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.656 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.693 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -63.32 -18.46 63.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -138.25 -38.2 0.55 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.939 . . . . 0.0 110.479 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -108.15 -168.94 1.43 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.981 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER 179.26 160.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 110.412 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.065 HG23 HG21 ' A' ' 70' ' ' VAL . 3.8 p -41.78 -43.73 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.135 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -61.38 -44.24 97.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -0.956 . . . . 0.0 109.316 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 mtpp -64.15 -25.79 68.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.432 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 54' ' ' VAL . 28.4 mt -72.79 -50.51 23.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.858 -1.151 . . . . 0.0 108.101 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 59.4 m -64.34 -18.14 64.36 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 3.2 ttpp -80.01 -28.88 39.35 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -69.47 -43.85 72.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.325 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.73 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.1 t -74.42 -36.99 63.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.06 -28.52 67.86 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.99 -19.43 25.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.138 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.5 -14.06 60.4 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.612 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 102.6 35.08 3.91 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.2 m-85 -138.15 96.19 10.24 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.946 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.9 Cg_exo -55.34 97.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.636 1.335 . . . . 0.0 108.912 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -108.02 -177.91 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 111.794 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.16 133.31 17.29 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.065 HG21 HG23 ' A' ' 54' ' ' VAL . 7.3 p -99.79 158.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.611 -1.306 . . . . 0.0 111.207 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -154.47 50.73 0.63 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.645 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.1 pp0? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.784 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.133 0.492 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.77 91.09 1.35 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 4.3 mm100 -114.12 153.93 28.66 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.649 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.4 m -131.67 129.65 41.04 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 72' ' ' GLN . 31.5 m -133.93 170.85 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.968 -1.082 . . . . 0.0 110.273 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.871 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.2 159.33 16.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.31 154.1 50.97 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.337 -177.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -130.11 108.97 10.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.075 HG11 HG21 ' A' ' 21' ' ' VAL . 12.2 p -113.18 83.32 6.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.991 . . . . 0.0 111.203 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.9 Cg_endo -70.87 -6.61 19.54 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.624 1.329 . . . . 0.0 110.662 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -46.45 -40.03 10.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.567 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.6 mmm -156.56 132.19 9.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.539 -0.977 . . . . 0.0 109.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.529 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -133.75 93.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 110.234 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -149.55 -71.45 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.825 -1.172 . . . . 0.0 110.258 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . 179.92 49.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 109.467 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.39 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.413 -0.805 . . . . 0.0 110.43 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.6 m -71.16 -50.63 11.23 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -57.68 -43.12 53.02 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 N-CA-C 107.927 -1.605 . . . . 0.0 107.927 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.22 -28.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.723 0.773 . . . . 0.0 109.816 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 42.6 m -66.47 -23.72 66.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.924 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.075 HG21 HG11 ' A' ' 9' ' ' VAL . 25.2 t -68.88 -28.63 40.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.2 tttt -64.15 -45.6 87.75 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 17.9 mmtt -69.58 -20.92 63.64 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.38 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -40.23 65.84 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.683 -0.635 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.87 ' HB3' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -77.97 -34.47 51.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 0.0 109.357 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.579 ' C ' HG11 ' A' ' 31' ' ' VAL . 23.8 t -71.23 -21.82 62.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -110.38 -0.51 17.54 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.297 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -49.04 -45.16 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.91 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 2.2 mt-10 161.09 -83.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.735 -0.603 . . . . 0.0 111.275 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.29 7.39 72.2 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.579 HG11 ' C ' ' A' ' 26' ' ' SER . 4.0 p -41.04 134.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.198 -1.178 . . . . 0.0 110.293 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -14.82 14.26 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.813 0.816 . . . . 0.0 108.9 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -161.25 158.69 27.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -150.11 162.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 111.192 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t0 -156.61 151.47 26.0 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 22' ' ' LYS . 1.6 p -154.37 161.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.201 -1.399 . . . . 0.0 111.982 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -137.91 111.48 0.82 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' LYS . 26.1 p90 -54.29 -155.78 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' PHE . 35.2 tt0 5.88 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -38.97 -24.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.496 -1.377 . . . . 0.0 111.737 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.7 tmm_? 62.94 76.97 0.35 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.121 -0.987 . . . . 0.0 111.358 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -165.38 126.41 1.94 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.051 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -125.77 128.36 47.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.8 -1.187 . . . . 0.0 110.245 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.871 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -109.11 140.34 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.823 -1.173 . . . . 0.0 108.312 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.884 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -149.32 156.01 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.418 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.9 m -125.56 156.74 38.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.1 p90 -172.62 -179.61 2.2 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.823 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -107.33 123.48 48.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -65.21 -5.52 7.15 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.85 -177.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.784 HG23 ' HB1' ' A' ' 1' ' ' ALA . 6.9 p -62.73 -37.59 87.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.168 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.84 23.27 5.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.507 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -169.53 -171.61 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.42 155.59 0.52 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.011 HG23 HG21 ' A' ' 70' ' ' VAL . 5.6 p -43.43 -34.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.533 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.7 tt0 -65.3 -46.91 78.49 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.353 -0.842 . . . . 0.0 108.983 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -64.64 -24.64 67.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.62 -0.675 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.884 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.5 mt -72.06 -56.12 6.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.688 -1.258 . . . . 0.0 108.299 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' HA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -63.68 -19.74 65.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 ttpt -81.71 -26.21 34.8 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -72.35 -41.72 66.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.096 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.762 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.3 t -75.86 -36.85 59.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.43 -30.94 69.95 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -90.27 -15.58 31.0 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.47 -21.03 61.28 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 118.27 23.63 3.45 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.3 m-85 -139.39 105.28 7.11 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 0.0 110.561 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 6.3 Cg_exo -57.62 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.517 1.272 . . . . 0.0 109.34 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 9' ' ' VAL . 3.8 t -110.49 -176.26 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.784 . . . . 0.0 111.158 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.571 ' HA ' HG21 ' A' ' 58' ' ' THR . 3.4 t -147.24 -176.43 5.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 7' ' ' LEU . 9.5 p -134.81 159.68 41.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.681 -1.262 . . . . 0.0 111.657 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.91 47.04 1.01 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.061 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.7 mp0 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.239 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.07 88.93 1.48 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 mm-40 -114.0 154.76 27.08 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.582 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.495 HG23 ' OG1' ' A' ' 46' ' ' THR . 16.0 m -127.61 160.32 31.97 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 109.539 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.95 HG11 HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -166.94 170.69 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.979 0.895 . . . . 0.0 109.798 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -109.27 163.72 13.12 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.964 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -135.66 144.2 45.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.93 -1.106 . . . . 0.0 111.303 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -113.82 99.52 7.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 109.487 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 5.4 p -111.19 85.47 5.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.038 -1.039 . . . . 0.0 111.962 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 1.7 Cg_endo -64.77 -6.3 12.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.629 1.331 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.85 2.06 56.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.596 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.33 173.76 6.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 110.613 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 14' ' ' CYS . 3.1 t -179.22 15.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.996 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 179.61 -162.16 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.281 -1.512 . . . . 0.0 110.197 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.83 52.72 2.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 110.28 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 17' ' ' CYS . . . -172.75 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 111.177 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.709 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 51.8 m -152.62 -50.83 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.325 -0.859 . . . . 0.0 111.48 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 9.8 Cg_endo -73.98 -50.31 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 N-CA-C 108.267 -1.474 . . . . 0.0 108.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.2 mt -65.7 -25.38 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.928 0.87 . . . . 0.0 108.692 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.471 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 2.7 m -62.81 -23.93 67.5 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.5 t -72.77 -32.98 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 15.1 tttt -59.77 -35.45 74.67 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.4 -37.61 77.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.816 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -61.17 -56.1 24.59 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.612 -0.68 . . . . 0.0 111.042 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -63.49 -32.93 74.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.055 . . . . 0.0 110.176 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' HG11 ' A' ' 31' ' ' VAL . 8.2 p -68.52 -20.19 64.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -120.07 6.85 10.79 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.6 p -55.6 -49.31 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.123 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.6 OUTLIER 171.64 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 111.152 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.54 10.44 70.96 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.561 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.61 HG21 ' CG2' ' A' ' 34' ' ' VAL . 10.6 p -41.89 133.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.126 . . . . 0.0 110.089 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.26 -18.05 13.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' HG23 ' A' ' 34' ' ' VAL . 10.6 tttm -163.61 158.39 20.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 45' ' ' VAL . 71.4 t -156.15 142.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 111.918 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -141.93 158.68 43.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 9.8 p -154.09 168.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 117.623 -1.631 . . . . 0.0 112.794 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.07 110.65 1.06 Allowed Glycine 0 N--CA 1.48 1.588 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.65 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.429 -0.453 . . . . 0.0 111.742 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 1.1 tt0 -28.68 -31.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.432 -0.793 . . . . 0.0 112.293 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 38' ' ' PHE . 55.2 mttt -80.38 27.81 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.734 -1.228 . . . . 0.0 110.996 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER 13.49 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.5 tt0 -165.67 109.65 0.83 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.419 -1.426 . . . . 0.0 111.107 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.08 125.25 53.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.068 -1.02 . . . . 0.0 111.424 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.7 p -109.59 114.26 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' CB ' ' A' ' 25' ' ' LEU . 22.3 t -128.42 150.03 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.468 -1.293 . . . . 0.0 113.113 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -112.42 160.38 17.8 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.3 p90 -171.68 -171.46 0.91 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.186 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.4 m-20 -106.57 123.56 48.28 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -71.85 3.54 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.442 -177.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.507 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -85.23 -33.24 22.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.912 -1.118 . . . . 0.0 109.64 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 -4.42 10.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.098 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . . . -145.77 -172.7 3.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 179.68 153.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.822 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.95 HG12 HG11 ' A' ' 5' ' ' VAL . 26.7 m -43.35 -32.72 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.025 -1.047 . . . . 0.0 109.858 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.9 tt0 -68.18 -46.94 69.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 108.874 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 5.0 mttm -63.34 -25.5 68.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.544 -0.722 . . . . 0.0 110.297 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 54' ' ' VAL . 46.2 mt -71.05 -53.11 15.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.846 -1.159 . . . . 0.0 108.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.441 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 5.1 m -62.27 -24.23 67.16 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.23 -28.73 42.49 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.39 -45.42 76.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.882 ' HB ' HG13 ' A' ' 21' ' ' VAL . 12.9 t -72.29 -38.18 68.83 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.64 -27.89 65.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 2.5 t70 -90.29 -20.69 22.64 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.554 -0.716 . . . . 0.0 109.413 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.09 -17.38 62.0 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.605 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 111.53 27.19 4.22 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.8 m-85 -138.6 92.38 11.6 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.555 -0.968 . . . . 0.0 110.166 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.4 Cg_exo -54.22 96.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.583 1.307 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.531 ' HB3' HG21 ' A' ' 61' ' ' THR . 8.6 t -108.85 -167.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.392 -0.818 . . . . 0.0 111.34 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -142.87 -167.68 2.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.964 HG23 ' CD1' ' A' ' 7' ' ' LEU . 1.6 p -142.9 155.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.944 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.68 53.77 0.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.4 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.489 ' N ' HG23 ' A' ' 5' ' ' VAL . 1.4 tm0? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.446 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.254 0.55 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 90.3 1.59 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mm-40 -109.97 169.33 8.8 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.016 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.7 m -144.02 125.58 14.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.506 -0.746 . . . . 0.0 109.553 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.845 HG21 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -130.28 169.65 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.803 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.1 t -108.73 159.25 16.91 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.965 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -133.58 152.03 51.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.208 -1.397 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.528 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.0 102.1 7.36 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 12' ' ' MET . 2.6 p -110.37 91.32 11.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.851 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.1 Cg_endo -66.29 -11.02 29.63 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.679 1.357 . . . . 0.0 110.305 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.84 48.8 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -136.42 158.16 45.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -1.154 . . . . 0.0 110.568 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 12' ' ' MET . 10.7 t 179.47 33.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.578 0.704 . . . . 0.0 109.161 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -160.93 127.05 3.92 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -35.68 83.49 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.64 -0.663 . . . . 0.0 111.615 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 177.83 -67.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.194 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 m -82.17 -44.16 1.01 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.945 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 38' ' ' PHE . 23.7 Cg_exo -54.1 -55.94 3.0 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' HB3' ' A' ' 38' ' ' PHE . 37.9 mt -53.9 -27.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.828 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 22.6 m -69.08 -30.96 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.003 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.809 HG22 ' OG1' ' A' ' 61' ' ' THR . 55.5 t -65.95 -33.24 62.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HA ' HD12 ' A' ' 25' ' ' LEU . 8.0 tttt -70.05 -33.19 71.63 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mmtp -74.37 -29.01 61.37 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.264 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.8 -46.47 87.82 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.324 0.583 . . . . 0.0 109.804 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.697 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -72.7 -33.69 66.64 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.754 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.481 ' HA ' HG11 ' A' ' 31' ' ' VAL . 23.3 t -64.6 -18.62 65.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.62 8.58 6.41 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.774 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.624 HG22 ' OE2' ' A' ' 29' ' ' GLU . 14.6 p -49.52 -52.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 110.509 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 3.9 pt-20 165.17 -48.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.195 -0.941 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -125.1 2.12 8.38 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.739 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.71 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 t -42.82 130.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.29 . . . . 0.0 109.562 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.51 -13.48 14.56 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -163.6 164.15 24.22 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.47 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 45' ' ' VAL . 7.2 p -152.82 162.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 111.179 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' N ' HG22 ' A' ' 34' ' ' VAL . 2.1 m-20 -168.63 80.14 0.14 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' CA ' ' A' ' 43' ' ' ALA . 33.0 t -108.32 164.99 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.904 0.859 . . . . 0.0 111.556 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -126.42 107.34 0.91 Allowed Glycine 0 N--CA 1.48 1.611 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.46 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.605 -0.938 . . . . 0.0 111.764 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 38' ' ' PHE . 63.3 mt-10 -22.54 -67.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.8 -0.563 . . . . 0.0 112.273 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.638 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 19.5 tptp -42.1 -55.36 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.041 -1.037 . . . . 0.0 110.235 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.638 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.1 tmm_? 99.39 76.5 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 C-N-CA 123.493 0.717 . . . . 0.0 110.815 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -169.0 115.13 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 0.0 110.439 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.721 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -108.12 119.95 40.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.636 -1.29 . . . . 0.0 111.502 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.5 t -108.76 118.58 56.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.71 ' CG1' HG22 ' A' ' 31' ' ' VAL . 9.3 t -133.82 157.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.697 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.6 m -116.82 160.94 20.07 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.9 p90 -171.99 -175.23 1.44 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.906 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 14.1 p-10 -106.88 112.31 25.22 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -63.61 -9.65 14.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 0.0 110.718 -177.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.499 ' CG2' ' OD2' ' A' ' 48' ' ' ASP . 5.9 t -62.1 -23.72 66.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.01 -1.056 . . . . 0.0 109.776 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -38.5 1.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 110.317 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -108.0 -168.94 1.44 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.643 -0.66 . . . . 0.0 109.961 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.616 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 31.4 t -179.5 155.68 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.045 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.052 ' CG2' HG21 ' A' ' 70' ' ' VAL . 6.7 p -42.94 -40.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.624 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.508 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.4 tt0 -61.88 -44.72 96.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.361 -0.837 . . . . 0.0 109.451 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 38.0 mttp -67.34 -23.27 65.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 54' ' ' VAL . 40.0 mt -71.14 -51.57 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.619 -1.301 . . . . 0.0 108.492 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -64.99 -19.77 66.16 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 7.2 mttt -82.49 -25.47 33.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -70.65 -44.06 67.9 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.438 -0.789 . . . . 0.0 109.134 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.809 ' OG1' HG22 ' A' ' 21' ' ' VAL . 10.2 t -75.84 -38.73 57.73 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.21 66.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.22 -21.92 24.26 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -17.02 60.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.608 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.47 27.94 3.17 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -136.59 91.18 16.17 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.621 -0.929 . . . . 0.0 110.633 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.93 93.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 0.0 110.055 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.548 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -108.99 -163.85 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 110.942 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.609 ' HA ' HG21 ' A' ' 58' ' ' THR . 2.5 t -150.09 -170.86 3.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.052 HG21 ' CG2' ' A' ' 54' ' ' VAL . 7.5 p -139.9 160.06 26.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.993 -1.067 . . . . 0.0 111.452 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.601 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -172.07 48.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.408 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 71' ' ' LYS . 38.3 tt0 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.957 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.35 94.11 1.46 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 9.2 mm-40 -110.91 150.22 29.52 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.165 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.451 HG23 ' OG1' ' A' ' 46' ' ' THR . 38.4 m -129.51 120.68 25.8 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 54' ' ' VAL . 33.4 m -127.7 170.42 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.881 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -108.14 157.6 18.15 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.857 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -132.48 152.37 51.56 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.104 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.543 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -120.88 109.19 14.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.725 HG22 ' CB ' ' A' ' 68' ' ' SER . 12.4 t -111.47 73.91 1.11 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.725 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 6.6 Cg_endo -67.35 -7.52 19.32 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.317 1.167 . . . . 0.0 111.389 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' O ' ' SD ' ' A' ' 12' ' ' MET . . . -50.08 -42.34 39.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 65.4 mmm -152.2 163.38 39.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.446 -1.032 . . . . 0.0 109.134 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.519 ' O ' HG23 ' A' ' 13' ' ' THR . 2.3 t -174.14 108.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 111.181 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 1.3 p -167.26 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 110.347 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 177.2 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.748 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -123.76 22.79 8.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 81.8 m -121.23 -66.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.002 -1.061 . . . . 0.0 110.25 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 5.2 Cg_exo -52.87 -39.04 79.34 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -61.36 -38.3 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.641 0.734 . . . . 0.0 109.182 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 23.7 m -61.56 -22.08 64.86 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.032 HG13 ' HB ' ' A' ' 61' ' ' THR . 11.9 t -77.11 -31.61 18.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.716 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.17 -36.83 85.44 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -74.01 -33.94 63.97 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.539 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -62.31 -49.86 73.96 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 110.794 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -65.45 -47.01 77.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 109.863 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.604 ' HB2' HG21 ' A' ' 34' ' ' VAL . 8.8 t -61.1 -17.54 53.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 108.676 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -103.51 -13.22 16.67 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.46 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.784 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.8 t -47.54 -57.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.448 -0.782 . . . . 0.0 109.602 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 154.67 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.616 0.722 . . . . 0.0 110.248 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.47 -22.75 73.34 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 25' ' ' LEU . 22.9 t -42.63 121.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.41 -1.053 . . . . 0.0 109.703 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -109.53 -14.8 14.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.571 0.701 . . . . 0.0 109.782 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.695 ' O ' HG13 ' A' ' 45' ' ' VAL . 21.5 tttt -154.3 155.69 35.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.451 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.964 HG13 HG22 ' A' ' 45' ' ' VAL . 3.7 t -149.33 153.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -170.45 94.81 0.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -107.63 -152.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.967 0.889 . . . . 0.0 111.742 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -146.59 108.73 0.46 Allowed Glycine 0 N--CA 1.48 1.582 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -81.92 62.25 5.62 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.535 0.683 . . . . 0.0 110.749 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.8 tp10 179.31 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.22 40.51 2.05 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 25.08 79.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.922 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 37' ' ' GLY . 4.3 tp10 -146.09 113.01 6.08 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.395 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -112.32 115.06 28.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.716 -1.24 . . . . 0.0 110.969 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.2 t -108.65 121.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 107.756 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.964 HG22 HG13 ' A' ' 34' ' ' VAL . 75.2 t -136.97 155.03 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.226 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.92 157.21 24.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' THR . 49.0 p90 -172.8 178.84 2.5 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 117.891 -1.524 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 70.2 m-20 -106.69 120.52 42.21 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -62.75 -8.37 6.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.689 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 1' ' ' ALA . 2.4 p -66.93 -27.27 67.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.01 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -128.07 -8.39 5.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.001 -1.062 . . . . 0.0 111.129 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -146.02 -167.67 2.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 110.021 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.629 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -178.24 155.53 0.92 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 110.033 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.047 ' CG1' HG21 ' A' ' 70' ' ' VAL . 24.9 t -43.05 -39.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.7 tt0 -60.9 -46.07 92.1 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.506 -0.746 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.07 -22.04 65.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.412 -0.805 . . . . 0.0 111.028 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 54' ' ' VAL . 33.8 mt -73.99 -56.75 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.653 -1.279 . . . . 0.0 108.319 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.619 ' N ' HD21 ' A' ' 7' ' ' LEU . 2.5 m -65.1 -20.45 66.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.69 -28.34 33.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.784 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.5 -41.87 79.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.905 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.032 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -74.77 -36.67 62.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.44 -27.19 67.32 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.1 -19.44 24.31 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.99 -18.74 61.32 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.17 27.31 3.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 21.0 m-85 -138.2 98.41 9.29 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 110.856 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -58.08 93.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.611 1.322 . . . . 0.0 109.658 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.725 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -108.45 -161.44 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 111.317 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.525 ' HA ' HG21 ' A' ' 58' ' ' THR . 45.5 p -156.95 -169.48 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 ' CG1' ' A' ' 54' ' ' VAL . 5.7 p -135.61 158.87 40.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.886 -1.134 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.881 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.7 OUTLIER -171.54 47.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.756 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' N ' HG22 ' A' ' 6' ' ' THR . 1.4 pp0? . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.112 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.902 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.09 0.471 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.7 89.94 1.44 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.673 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 18.6 pt20 -122.21 165.16 16.59 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.792 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 45' ' ' VAL . 11.9 m -128.81 136.1 50.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.681 -0.637 . . . . 0.0 109.694 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 57' ' ' LEU . 21.0 m -130.32 167.46 25.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.531 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -106.51 157.15 17.87 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.92 149.27 51.28 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.355 -1.338 . . . . 0.0 111.219 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.513 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -119.94 113.98 21.37 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.756 -0.59 . . . . 0.0 109.45 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.991 HG22 ' HB2' ' A' ' 68' ' ' SER . 2.3 t -117.06 78.11 9.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.026 -1.046 . . . . 0.0 111.062 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 13.6 Cg_endo -80.7 40.52 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.234 1.289 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.36 2.46 10.45 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -159.49 21.2 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.076 -1.249 . . . . 0.0 110.579 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 39' ' ' GLU . 15.5 m -47.19 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -179.8 112.15 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 108.55 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -26.17 77.01 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 174.74 -49.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.221 -0.925 . . . . 0.0 110.593 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 32.7 m -97.62 -39.41 0.25 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.644 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 6.2 Cg_exo -59.89 -38.57 78.41 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 N-CA-C 107.95 -1.596 . . . . 0.0 107.95 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 10.2 mt -63.89 -29.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 6.8 m -65.4 -23.77 67.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.925 HG11 HG21 ' A' ' 9' ' ' VAL . 59.8 t -70.21 -29.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.37 -39.26 85.66 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 23.0 mmtt -71.04 -29.85 65.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -43.65 95.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.76 -0.588 . . . . 0.0 110.367 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -74.84 -36.23 62.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.022 . . . . 0.0 109.451 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.798 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.31 -19.85 65.7 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.4 mptp? -115.21 1.76 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.171 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.0 p -52.64 -40.66 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.8 OUTLIER 165.0 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.425 -0.797 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -99.49 5.96 58.96 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.06 -1.067 . . . . 0.0 110.752 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.798 HG11 ' C ' ' A' ' 26' ' ' SER . 8.1 p -39.49 129.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -1.077 . . . . 0.0 110.189 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.5 t -108.53 -10.99 15.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.469 0.652 . . . . 0.0 109.665 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.63 168.22 18.35 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.014 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 10.2 p -165.5 152.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.962 . . . . 0.0 110.953 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 44' ' ' VAL . 28.1 t0 -163.32 93.69 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.665 HG13 ' CA ' ' A' ' 43' ' ' ALA . 20.8 t -108.11 174.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 111.746 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.554 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -130.16 121.44 3.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 16.3 p90 -55.89 -145.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 1.033 ' O ' HG23 ' A' ' 13' ' ' THR . 14.1 tp10 1.13 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -36.01 -63.1 0.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.318 -0.864 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.689 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.2 tmm_? 103.98 77.47 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 C-N-CA 123.306 0.642 . . . . 0.0 111.17 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.0 tm-20 -168.51 117.56 0.72 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.508 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.665 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -112.15 118.93 36.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.108 . . . . 0.0 111.329 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 35' ' ' ASP . 4.2 p -107.35 121.93 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.78 -1.2 . . . . 0.0 108.017 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 4' ' ' THR . 3.5 p -129.41 159.02 41.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.79 -1.164 . . . . 0.0 113.184 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -118.01 154.69 31.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -171.83 179.61 2.71 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.232 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 3.4 m-20 -106.79 117.16 33.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 1.5 t70 -64.15 -7.14 8.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.883 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.22 -26.2 61.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.935 -1.103 . . . . 0.0 110.196 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -0.54 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.197 -0.94 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -159.41 -166.39 1.78 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.44 159.16 0.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.094 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.0 p -41.08 -42.44 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.599 -0.688 . . . . 0.0 110.0 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.576 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -60.79 -46.78 89.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.256 -0.902 . . . . 0.0 109.682 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.87 -23.54 67.26 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.974 HD12 ' HA ' ' A' ' 54' ' ' VAL . 35.3 mt -72.49 -52.89 13.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.667 -1.271 . . . . 0.0 108.265 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 69' ' ' SER . 2.1 m -63.94 -21.1 66.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 ttpt -81.47 -26.58 35.13 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.07 -43.46 67.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.209 -0.932 . . . . 0.0 108.94 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.23 -38.7 63.46 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.15 -27.14 66.85 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -90.21 -19.68 23.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.172 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -16.16 60.72 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 112.03 27.26 4.05 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.84 97.89 8.81 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.617 -0.931 . . . . 0.0 110.515 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.3 Cg_exo -55.52 96.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.59 1.311 . . . . 0.0 109.4 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.991 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.91 -167.19 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 111.536 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.6 OUTLIER -156.56 -172.22 3.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.094 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.8 p -133.63 161.8 40.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.595 -1.315 . . . . 0.0 111.444 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -148.07 54.76 1.04 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.721 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 110.238 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.44 87.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -127.08 153.02 46.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.05 -1.032 . . . . 0.0 111.624 -177.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -118.29 154.27 32.57 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.407 0.622 . . . . 0.0 109.634 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 72' ' ' GLN . 17.5 m -145.76 170.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.342 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.913 ' OG1' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.55 156.48 19.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.051 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.61 147.92 51.52 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.938 -1.505 . . . . 0.0 111.308 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.514 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -116.99 112.16 20.58 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.733 HG21 HG11 ' A' ' 21' ' ' VAL . 71.6 t -109.6 73.4 0.63 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.97 -1.081 . . . . 0.0 111.782 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.9 Cg_endo -58.6 -13.46 17.55 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.477 1.251 . . . . 0.0 110.073 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.64 15.24 31.7 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.604 ' HG2' ' CG ' ' A' ' 41' ' ' ARG . 2.2 ppp? -96.71 -164.71 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -1.221 . . . . 0.0 109.435 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.554 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.6 t 178.5 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.838 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 2.1 p -158.59 -154.16 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.536 -1.352 . . . . 0.0 110.673 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.93 42.5 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.951 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.81 -36.83 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.906 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 13.8 m -89.95 -44.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 0.0 111.757 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.63 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 14.0 Cg_endo -75.96 -43.94 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 N-CA-C 107.902 -1.615 . . . . 0.0 107.902 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.61 HG13 ' CE1' ' A' ' 38' ' ' PHE . 2.9 tt -55.66 -38.3 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.904 0.859 . . . . 0.0 109.635 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 5.2 m -62.8 -23.83 67.44 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.943 0.878 . . . . 0.0 108.636 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG13 ' HB ' ' A' ' 61' ' ' THR . 32.6 t -69.32 -31.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB2' HG21 ' A' ' 36' ' ' VAL . 3.8 tttt -67.65 -41.78 83.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.55 -24.86 65.58 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.378 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -70.63 -54.7 10.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.803 -0.561 . . . . 0.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -59.66 -35.94 75.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.069 -1.02 . . . . 0.0 109.812 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -22.71 60.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.504 -0.748 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.81 -5.7 25.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.895 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -46.61 -81.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.749 ' N ' HG12 ' A' ' 28' ' ' VAL . 4.0 tt0 169.93 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.348 -0.845 . . . . 0.0 109.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.582 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -104.95 -21.33 9.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 25' ' ' LEU . 74.1 t -42.2 126.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -1.068 . . . . 0.0 109.79 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -113.13 -9.82 13.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -147.85 156.33 42.6 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.008 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 45' ' ' VAL . 6.1 p -154.86 129.69 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.683 0.754 . . . . 0.0 111.01 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.68 89.66 1.57 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 22' ' ' LYS . 2.2 m -108.32 -160.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.962 0.887 . . . . 0.0 111.47 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.57 110.06 0.55 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 4.9 m-30 -52.7 -98.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.019 -0.695 . . . . 0.0 109.927 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 1.2 mm-40 -54.42 -12.7 0.74 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.606 -1.309 . . . . 0.0 111.643 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.3 mptt -81.85 -24.83 35.57 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.194 . . . . 0.0 111.002 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.604 ' CG ' ' HG2' ' A' ' 12' ' ' MET . 7.4 tmm_? 68.41 63.52 0.35 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.581 -0.699 . . . . 0.0 110.655 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.7 tt0 -162.06 113.95 1.69 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.229 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.73 113.6 26.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.96 -1.087 . . . . 0.0 110.834 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.913 HG22 ' OG1' ' A' ' 6' ' ' THR . 89.2 t -114.31 121.76 67.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.631 -1.293 . . . . 0.0 108.967 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 34' ' ' VAL . 25.8 m -137.66 -179.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 118.234 -1.386 . . . . 0.0 113.789 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.61 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.8 m -127.74 158.41 37.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.8 p90 -171.49 178.94 3.04 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.143 -1.423 . . . . 0.0 111.097 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.5 m-20 -107.41 117.7 34.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -63.25 -8.64 8.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 110.958 -177.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -74.06 -26.73 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.629 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -121.33 -13.22 8.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.498 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.582 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.14 -165.68 2.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.473 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.48 159.07 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 57' ' ' LEU . 10.9 p -43.64 -37.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.773 . . . . 0.0 109.763 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -64.85 -44.22 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -0.856 . . . . 0.0 109.357 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 10.2 mtpt -67.68 -22.4 65.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.413 -0.805 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.8 mt -74.36 -58.51 3.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.664 -1.273 . . . . 0.0 108.413 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.612 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.3 m -63.07 -21.53 66.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 8.4 ttmt -80.27 -27.97 38.49 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -68.04 -43.13 79.41 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.306 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.761 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.19 -38.01 63.76 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.72 -27.71 65.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -86.34 -23.4 26.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -73.3 -14.5 61.32 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.74 30.22 4.1 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.4 m-85 -135.82 94.96 14.27 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.703 -0.88 . . . . 0.0 110.514 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.09 93.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.7 1.369 . . . . 0.0 109.758 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.537 ' CB ' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -108.75 -169.06 1.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 111.139 -179.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.438 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -146.48 -174.99 4.61 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.051 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.8 p -139.86 150.44 22.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.705 -1.247 . . . . 0.0 112.654 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB3' HG22 ' A' ' 6' ' ' THR . 0.6 OUTLIER -134.14 77.62 1.71 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.435 0.636 . . . . 0.0 109.513 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.8 pt20 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.328 0.585 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -150.4 88.4 1.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 21.6 mm-40 -120.98 155.83 33.45 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.623 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.638 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 5.2 t -136.39 144.23 44.42 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.46 174.31 12.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.664 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 72' ' ' GLN . 12.1 t -107.98 153.49 23.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -130.41 150.26 51.71 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.444 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -118.25 115.94 25.76 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.62 HG13 ' CB ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -110.99 76.18 1.2 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.019 -1.051 . . . . 0.0 111.49 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.2 Cg_endo -62.8 -15.23 45.61 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.466 1.245 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -55.65 -21.78 30.04 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.79 -174.5 4.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.955 . . . . 0.0 109.691 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 178.58 75.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 110.724 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.89 -178.61 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.888 -1.133 . . . . 0.0 110.047 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.37 75.48 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 109.822 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.53 -45.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.118 -0.989 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 5.3 m -96.84 -45.03 0.25 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.959 -1.088 . . . . 0.0 113.145 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -59.23 -38.23 86.91 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 N-CA-C 108.231 -1.488 . . . . 0.0 108.231 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.447 HG13 ' HB3' ' A' ' 38' ' ' PHE . 2.2 tt -63.62 -35.23 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.18 0.99 . . . . 0.0 108.575 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 6.8 m -62.65 -20.75 65.12 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.804 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.9 t -73.81 -32.65 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HG3' HG12 ' A' ' 34' ' ' VAL . 18.6 tttm -64.61 -36.13 83.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 26' ' ' SER . 0.1 OUTLIER -66.4 -37.54 85.47 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.25 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.505 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . . . -57.56 -59.6 4.92 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.821 -0.55 . . . . 0.0 110.357 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.31 -26.78 68.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 109.572 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 12.9 t -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.93 7.3 7.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.666 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.2 p -49.86 -49.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.826 -1.171 . . . . 0.0 110.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.9 -86.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.263 -0.898 . . . . 0.0 111.318 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -84.1 1.95 88.22 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.046 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 25' ' ' LEU . 6.5 p -43.99 131.18 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.835 -1.391 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.57 -15.43 13.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -164.35 160.1 20.47 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.916 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.624 HG12 ' HG3' ' A' ' 22' ' ' LYS . 14.1 t -150.96 151.99 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 110.318 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -169.95 96.24 0.28 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 22' ' ' LYS . 3.2 m -107.88 -154.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.025 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.87 109.5 0.52 Allowed Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.621 ' O ' ' CD2' ' A' ' 38' ' ' PHE . 49.0 p90 -83.46 57.81 4.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.829 . . . . 0.0 110.437 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -179.01 -60.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.27 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -78.99 2.65 19.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 9' ' ' VAL . 8.7 tmm_? 60.46 84.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.771 -0.581 . . . . 0.0 111.252 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' GLY . 22.5 tt0 -167.17 120.38 0.97 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.977 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -113.65 118.21 33.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.022 -1.049 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.3 t -107.94 124.45 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.748 -1.22 . . . . 0.0 107.825 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 57' ' ' LEU . 8.7 p -134.49 150.07 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.478 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.638 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.95 157.68 21.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.3 p90 -171.44 -176.16 1.78 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.346 -1.342 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -106.79 113.52 27.07 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -59.72 -10.09 3.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.192 -177.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 48' ' ' ASP . 10.0 t -70.6 -28.01 64.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 110.643 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 11.1 mtpt -124.13 -14.08 7.12 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.88 -1.137 . . . . 0.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -141.24 -170.64 3.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.42 160.14 0.73 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.162 -0.961 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.047 HG23 HG21 ' A' ' 70' ' ' VAL . 3.9 p -41.01 -44.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.563 -0.711 . . . . 0.0 109.914 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.547 ' N ' HG13 ' A' ' 54' ' ' VAL . 32.5 tt0 -57.37 -47.77 80.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -64.11 -27.09 68.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.571 -0.705 . . . . 0.0 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.5 mt -70.43 -55.55 8.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.798 -1.189 . . . . 0.0 108.718 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' SER . 6.5 m -64.34 -20.72 66.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -83.37 -24.85 31.85 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.42 -41.3 69.69 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.62 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.544 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.7 t -75.16 -39.4 60.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.539 ' N ' HG23 ' A' ' 61' ' ' THR . . . -56.09 -32.27 64.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -86.27 -21.78 27.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.528 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.98 60.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.212 -0.93 . . . . 0.0 108.734 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 104.24 31.77 4.55 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.434 -1.867 . . . . 0.0 108.434 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.666 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 24.5 m-85 -138.77 89.75 12.96 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 122.015 -0.697 . . . . 0.0 110.488 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -54.85 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.634 1.333 . . . . 0.0 109.642 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.04 -168.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 111.254 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.541 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -152.99 -179.19 7.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 54' ' ' VAL . 7.4 p -134.32 156.25 40.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 120.371 -1.456 . . . . 0.0 111.863 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.681 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.65 43.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.129 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.701 ' C ' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.906 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.199 0.523 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.5 87.5 1.58 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 25.6 mm-40 -109.83 157.04 19.6 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.001 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.511 HG23 ' OG1' ' A' ' 46' ' ' THR . 13.8 m -135.77 115.28 12.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.648 HG11 ' HB ' ' A' ' 54' ' ' VAL . 11.4 m -121.84 168.05 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.85 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -107.98 159.01 16.88 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.016 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -131.89 152.08 51.28 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.324 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -122.74 106.1 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.901 HG11 HG21 ' A' ' 21' ' ' VAL . 10.6 p -112.24 88.56 10.76 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.026 -1.046 . . . . 0.0 111.937 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.9 Cg_endo -68.64 -1.19 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.592 1.312 . . . . 0.0 111.338 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.92 12.67 47.83 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.604 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -106.99 -164.45 0.99 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.336 -1.097 . . . . 0.0 110.338 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.794 HG22 ' SG ' ' A' ' 17' ' ' CYS . 1.7 t 179.77 -4.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 13.8 p -172.2 -158.77 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 119.72 -1.863 . . . . 0.0 110.273 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 62.57 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.203 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -162.27 -42.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 111.333 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 13' ' ' THR . 10.3 p -108.09 -25.05 0.17 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.657 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 12.5 Cg_endo -78.28 -37.76 0.7 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 N-CA-C 106.75 -2.058 . . . . 0.0 106.75 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.576 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 72.0 mt -63.88 -29.93 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.151 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 9.4 m -65.91 -20.65 66.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.982 HG13 ' OG1' ' A' ' 61' ' ' THR . 58.1 t -69.53 -33.23 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -67.92 -37.46 81.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -62.61 -32.17 73.14 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.103 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.68 -56.3 18.98 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.76 -0.588 . . . . 0.0 110.543 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -64.74 -24.1 67.45 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -76.68 -21.41 55.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.48 1.06 16.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.483 -0.761 . . . . 0.0 109.91 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.6 t -46.61 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.084 -1.01 . . . . 0.0 109.418 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.796 ' N ' HG12 ' A' ' 28' ' ' VAL . 10.4 pt-20 179.44 -41.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 110.802 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 29' ' ' GLU . . . -112.54 -10.26 17.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -50.45 125.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 110.028 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.61 14.86 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.628 0.727 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.93 160.51 41.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 22' ' ' LYS . 7.3 p -155.8 163.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.84 -1.163 . . . . 0.0 111.938 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.69 143.59 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.89 HG13 ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -108.95 127.88 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.042 . . . . 0.0 112.08 -177.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -114.75 49.73 0.83 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -25.76 -118.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.2 tp10 -41.32 -35.82 0.71 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.55 -1.344 . . . . 0.0 110.718 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -86.43 38.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.0 110.529 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.562 ' HB3' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 8.31 86.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 5.8 tt0 -162.07 110.87 1.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.014 -1.054 . . . . 0.0 110.715 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.58 120.23 41.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 110.248 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.6 t -107.94 122.03 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.861 -1.15 . . . . 0.0 108.037 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.6 t -132.94 152.66 36.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 118.141 -1.424 . . . . 0.0 113.332 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -114.59 155.31 26.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 57' ' ' LEU . 48.7 p90 -172.51 -178.86 2.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.595 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -106.75 117.13 33.23 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 178.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 24.7 t0 -70.78 0.54 6.91 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.255 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' HG3' ' A' ' 51' ' ' LYS . 14.0 t -64.62 -16.68 63.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.93 -1.107 . . . . 0.0 109.599 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG3' HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -138.32 -43.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.05 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -104.5 -169.34 1.61 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.766 -0.584 . . . . 0.0 109.721 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.639 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.5 t -178.35 158.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.926 ' HA ' HD12 ' A' ' 57' ' ' LEU . 2.7 p -41.94 -42.72 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.506 ' N ' HG13 ' A' ' 54' ' ' VAL . 38.0 tt0 -60.61 -45.83 92.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 108.957 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.415 -0.803 . . . . 0.0 111.075 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 54' ' ' VAL . 34.8 mt -73.04 -55.82 5.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.586 -1.321 . . . . 0.0 108.302 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.553 ' N ' HD21 ' A' ' 7' ' ' LEU . 54.4 m -62.76 -20.56 65.09 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -81.49 -28.86 33.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.899 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -69.05 -39.96 78.85 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.283 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.982 ' OG1' HG13 ' A' ' 21' ' ' VAL . 13.1 t -75.46 -41.0 56.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.07 -26.49 62.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.53 -21.84 21.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.857 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.21 -17.49 61.35 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.159 -0.963 . . . . 0.0 108.649 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.51 24.85 4.24 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.618 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 20.3 m-85 -138.66 88.66 13.94 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.631 -0.923 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.3 Cg_exo -54.84 95.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.853 1.449 . . . . 0.0 110.194 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.5 -163.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 110.861 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -149.04 -171.44 3.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.016 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.0 p -139.1 153.44 24.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 111.826 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -155.83 39.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.585 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 71' ' ' LYS . 79.1 mt-30 . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.392 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 88.22 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -110.01 156.66 20.21 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.683 -177.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.552 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 23.4 m -135.1 137.24 42.64 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.597 -0.689 . . . . 0.0 109.258 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' CG1' ' A' ' 54' ' ' VAL . 27.9 m -146.77 175.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.84 ' O ' HD12 ' A' ' 7' ' ' LEU . 12.2 t -109.59 162.85 14.01 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.864 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.3 mp -130.68 138.99 50.3 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.074 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -112.91 93.8 4.59 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.789 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 ' SD ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -115.73 101.47 54.13 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.178 -0.952 . . . . 0.0 111.262 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 9.7 Cg_endo -76.36 5.37 4.7 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.628 1.331 . . . . 0.0 111.066 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -82.08 8.29 60.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.932 ' SD ' HG21 ' A' ' 21' ' ' VAL . 3.8 ptm -139.87 156.97 46.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.4 -1.059 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.14 39.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -170.46 -178.27 2.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.5 76.26 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.722 -1.236 . . . . 0.0 109.807 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.88 -51.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.055 -1.028 . . . . 0.0 111.357 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.66 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.0 m -90.35 -45.8 0.39 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.894 -1.129 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.676 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 17.6 Cg_exo -59.43 -64.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 122.838 0.915 . . . . 0.0 110.759 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 38' ' ' PHE . 26.6 mt -45.48 -27.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.925 -1.109 . . . . 0.0 110.296 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 90.4 m -70.44 -38.17 74.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.801 -1.187 . . . . 0.0 108.771 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.978 HG22 ' OG1' ' A' ' 61' ' ' THR . 19.7 t -60.01 -26.5 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 36' ' ' VAL . 9.9 tptm -71.83 -43.76 65.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -66.21 -26.91 67.6 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.703 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . . . -66.63 -48.68 68.69 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.657 -0.652 . . . . 0.0 110.811 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.677 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -72.91 -41.49 64.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -0.996 . . . . 0.0 110.345 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -62.21 -24.07 67.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.538 -0.726 . . . . 0.0 109.276 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -122.24 7.62 9.68 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.434 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.1 p -50.89 -48.13 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.478 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.598 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.26 -84.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.398 -0.814 . . . . 0.0 110.778 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.572 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -85.23 0.07 88.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.843 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.571 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.6 p -44.14 127.93 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.888 -1.36 . . . . 0.0 110.0 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.29 -14.39 14.16 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.669 0.747 . . . . 0.0 109.116 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 2.9 tttm -162.57 161.63 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.713 HG23 HG22 ' A' ' 45' ' ' VAL . 9.2 p -150.65 154.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 110.725 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 15.0 t70 -168.99 82.91 0.14 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 22' ' ' LYS . 4.7 m -109.23 -163.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.001 0.905 . . . . 0.0 111.475 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.15 93.19 0.15 Allowed Glycine 0 C--N 1.298 -1.552 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.676 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 p90 -54.93 -54.66 39.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.877 . . . . 0.0 109.675 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.14 -24.75 65.04 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.025 -1.047 . . . . 0.0 110.183 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 0.27 57.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HA ' ' CE ' ' A' ' 12' ' ' MET . 0.2 OUTLIER 46.69 70.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.371 -0.831 . . . . 0.0 111.079 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.49 119.79 0.79 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.41 -0.806 . . . . 0.0 109.981 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.19 119.1 38.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.798 -1.188 . . . . 0.0 112.356 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -110.13 110.22 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.713 HG22 HG23 ' A' ' 34' ' ' VAL . 60.2 t -130.45 150.79 34.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.309 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.4 m -109.68 159.43 17.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.752 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.0 p90 -171.81 -174.86 1.41 Allowed 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.055 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 4.2 m-20 -106.61 126.82 52.75 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 5.9 p-10 -75.01 10.75 1.33 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.61 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.776 HG23 ' HB1' ' A' ' 1' ' ' ALA . 61.5 p -87.28 -36.34 17.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -118.68 -11.27 9.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.088 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -135.7 -174.36 3.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 3.7 t -178.44 154.48 0.8 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.895 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.901 ' HA ' HD12 ' A' ' 57' ' ' LEU . 34.3 m -42.59 -38.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.253 -0.904 . . . . 0.0 109.488 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.513 ' N ' HG23 ' A' ' 54' ' ' VAL . 2.6 tt0 -64.01 -47.25 81.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -62.0 -26.91 68.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 54' ' ' VAL . 45.7 mt -69.65 -54.68 12.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.856 -1.152 . . . . 0.0 108.306 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.75 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.0 OUTLIER -65.55 -17.34 64.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.6 ttpt -86.15 -21.64 27.46 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.474 -0.766 . . . . 0.0 109.183 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -76.63 -40.15 50.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.576 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.978 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.9 t -79.94 -36.26 36.49 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.46 -27.72 69.18 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 m-20 -84.76 -20.29 31.3 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -19.56 60.66 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.36 28.76 2.93 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 21.6 m-85 -134.83 105.0 10.64 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.717 -0.872 . . . . 0.0 110.642 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 7.6 Cg_exo -49.39 101.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.75 ' OG ' HG22 ' A' ' 58' ' ' THR . 53.0 p -107.82 158.22 17.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 112.05 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 1.3 t -126.84 -178.15 4.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.864 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.9 p -142.91 150.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 120.761 -1.212 . . . . 0.0 111.069 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.759 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -168.26 51.09 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.801 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.5 tt0 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 117.955 -1.022 . . . . 0.0 111.368 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.58 86.07 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.92 153.6 23.32 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.231 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.521 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 19.0 m -135.15 132.26 37.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.539 -0.725 . . . . 0.0 109.918 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.838 HG11 HG12 ' A' ' 54' ' ' VAL . 21.5 m -135.51 171.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.13 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.44 154.98 20.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 ' HB ' ' A' ' 70' ' ' VAL . 1.2 mp -130.01 157.12 43.22 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.155 -1.418 . . . . 0.0 111.214 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -127.31 112.15 14.72 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.358 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.854 HG21 HG11 ' A' ' 21' ' ' VAL . 62.0 t -116.85 74.56 6.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.923 -1.11 . . . . 0.0 111.408 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 Cg_endo -67.27 -5.52 14.02 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.591 1.311 . . . . 0.0 111.226 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -54.39 -23.16 25.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.862 ' HE1' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -144.5 -178.8 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 109.279 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 12' ' ' MET . 0.9 OUTLIER 177.91 75.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.021 -1.05 . . . . 0.0 110.721 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -149.33 -55.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 117.893 -1.523 . . . . 0.0 111.603 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 176.67 -27.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.413 -1.429 . . . . 0.0 111.363 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -115.24 -40.42 3.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.611 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' C ' ' HE2' ' A' ' 12' ' ' MET . 7.6 m -66.3 -47.45 59.99 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.124 -0.985 . . . . 0.0 111.202 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 2.1 Cg_endo -62.54 -37.86 55.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.72 HD12 ' HB3' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -68.57 -24.6 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 21.6 m -62.97 -20.12 64.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 9' ' ' VAL . 41.6 t -74.18 -33.45 35.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -62.48 -35.5 79.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' CE ' ' HE3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -67.14 -44.51 79.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.987 0.899 . . . . 0.0 109.837 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -57.35 -52.35 65.7 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -63.74 -41.22 98.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.017 -1.052 . . . . 0.0 109.854 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.527 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -63.11 -21.41 66.17 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' CE ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -108.44 -2.11 19.3 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.414 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.04 HG23 ' HB2' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -46.01 -53.16 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -0.915 . . . . 0.0 109.541 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 153.62 -72.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.79 0.805 . . . . 0.0 109.562 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -83.55 -16.72 67.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.4 p -38.75 122.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 110.348 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 m -112.68 -12.7 13.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.627 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 1.2 tttt -143.62 155.64 44.33 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.206 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.686 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.3 t -151.23 129.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.662 0.744 . . . . 0.0 110.707 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 65.3 m-20 -155.02 89.2 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 43' ' ' ALA . 2.4 m -109.42 -159.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 122.15 0.976 . . . . 0.0 111.816 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 40' ' ' LYS . . . -149.93 113.93 0.63 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HB3' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -49.99 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.731 -0.864 . . . . 0.0 111.825 -178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -33.59 -33.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.337 -0.852 . . . . 0.0 111.372 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 41' ' ' ARG . 16.2 ptmt -89.6 51.41 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.501 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.761 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -13.42 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.411 0.624 . . . . 0.0 112.557 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' LYS . 18.3 mt-10 -152.22 112.79 4.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 110.156 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.21 115.67 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.903 -1.123 . . . . 0.0 111.095 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.13 ' CG2' HG22 ' A' ' 6' ' ' THR . 8.2 t -107.53 116.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.642 -1.286 . . . . 0.0 108.298 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CB ' ' A' ' 25' ' ' LEU . 11.8 m -132.43 162.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.245 -1.382 . . . . 0.0 113.354 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.627 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.6 m -119.07 162.35 18.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -172.17 -175.22 1.39 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.959 -1.496 . . . . 0.0 111.815 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.29 116.95 32.82 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 7.8 p-10 -67.91 -2.07 6.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.373 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -24.74 44.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.008 -1.058 . . . . 0.0 110.614 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -125.72 -3.33 7.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.048 -1.033 . . . . 0.0 110.463 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -156.43 -168.42 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.634 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.6 p 179.7 164.71 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 m -43.2 -33.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.361 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' N ' HG23 ' A' ' 54' ' ' VAL . 3.0 tt0 -65.77 -47.87 73.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.472 -0.768 . . . . 0.0 109.148 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.67 -24.08 66.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.645 -0.66 . . . . 0.0 110.763 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 54' ' ' VAL . 41.7 mt -71.98 -55.82 6.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.814 -1.179 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.2 m -63.96 -19.89 65.47 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 1.6 ttmt -80.81 -27.37 36.6 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.04 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -69.73 -43.15 72.93 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.656 -0.817 . . . . 0.0 109.274 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.585 ' HB ' HG13 ' A' ' 21' ' ' VAL . 14.8 t -75.66 -37.38 59.68 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.25 -26.52 66.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.39 -21.63 22.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.81 -15.86 61.62 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.613 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 108.28 30.94 3.68 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 23.3 m-85 -138.29 102.74 8.06 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.639 -0.918 . . . . 0.0 110.603 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.09 98.92 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.564 1.297 . . . . 0.0 109.396 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.791 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -107.95 -166.39 1.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.235 -0.916 . . . . 0.0 111.604 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.6 t -163.84 126.74 2.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 7' ' ' LEU . 6.6 p -91.69 161.84 2.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.868 -1.145 . . . . 0.0 110.958 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLN . 3.9 ptmt -145.86 42.22 1.22 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.563 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.2 mp0 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.839 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -147.45 89.72 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 3.9 mm100 -109.61 158.28 18.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.76 0.79 . . . . 0.0 111.627 -177.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 45' ' ' VAL . 96.9 m -137.08 141.74 42.36 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.659 -0.651 . . . . 0.0 109.398 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.807 HG11 ' CG1' ' A' ' 54' ' ' VAL . 4.7 m -146.1 165.54 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.001 . . . . 0.0 109.766 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.958 HG22 ' O ' ' A' ' 72' ' ' GLN . 13.6 t -107.42 151.84 25.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.733 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -125.95 156.81 39.2 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 120.957 -1.09 . . . . 0.0 110.668 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -137.24 107.47 6.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.994 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 68' ' ' SER . 1.9 t -108.22 102.41 46.31 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.176 -0.952 . . . . 0.0 110.776 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.0 Cg_endo -71.11 9.95 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.366 1.377 . . . . 0.0 112.4 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.51 -5.71 42.15 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.508 -1.37 . . . . 0.0 110.167 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.712 ' HE1' ' HB3' ' A' ' 17' ' ' CYS . 4.2 mmm -93.39 151.25 19.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.207 -1.172 . . . . 0.0 110.179 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 12' ' ' MET . 9.3 t -179.04 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.134 -0.979 . . . . 0.0 111.543 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 179.03 162.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.678 -1.264 . . . . 0.0 109.536 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -71.16 79.86 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.708 -1.245 . . . . 0.0 110.483 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 178.13 -56.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.007 -1.058 . . . . 0.0 111.007 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 5.0 m -86.92 -45.15 0.54 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.236 -0.915 . . . . 0.0 111.873 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.634 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 21.1 Cg_exo -54.8 -52.19 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 27.6 mt -59.17 -23.82 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.632 -0.667 . . . . 0.0 110.105 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 37.2 m -65.75 -26.74 67.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 108.544 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 61' ' ' THR . 33.1 t -69.89 -26.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.738 ' HD2' HG22 ' A' ' 36' ' ' VAL . 14.2 tttt -68.58 -44.42 74.44 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 mptp? -67.45 -29.61 69.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.363 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -59.29 -45.08 92.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.278 0.561 . . . . 0.0 109.891 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.79 HD22 ' HB ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -66.9 -47.87 70.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.861 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.44 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 8.3 t -66.12 -11.46 49.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.479 -0.763 . . . . 0.0 109.006 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -110.58 -9.3 14.56 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.069 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.0 t -48.79 -58.34 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.106 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 154.79 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.606 0.717 . . . . 0.0 110.072 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.01 -8.07 87.97 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 25' ' ' LEU . 2.5 t -43.72 122.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 109.38 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.37 -11.17 15.23 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.668 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -156.23 161.17 40.3 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.564 HG13 HD13 ' A' ' 25' ' ' LEU . 12.9 t -150.0 152.27 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.028 -1.045 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 6.4 t0 -167.69 82.8 0.2 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 22' ' ' LYS . 3.2 m -109.24 -165.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 111.773 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -152.07 95.35 0.16 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -46.06 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.707 -0.878 . . . . 0.0 111.666 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.2 mm-40 1.53 -75.31 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.201 0.524 . . . . 0.0 112.035 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -62.49 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 108.734 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 143.49 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 122.864 0.466 . . . . 0.0 109.91 178.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 19.5 mt-10 -134.29 116.78 15.67 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -110.18 115.38 29.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 0.0 111.606 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.0 t -106.83 124.16 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.713 -1.242 . . . . 0.0 107.71 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.79 ' HB ' HD22 ' A' ' 25' ' ' LEU . 3.9 p -139.34 161.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.457 -1.297 . . . . 0.0 113.536 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.8 m -121.39 157.66 29.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.835 ' CE2' HD11 ' A' ' 57' ' ' LEU . 47.9 p90 -171.63 -174.39 1.37 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.922 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 82.3 m-20 -106.76 123.46 48.17 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -71.88 1.9 6.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.032 -177.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.839 HG23 ' CB ' ' A' ' 1' ' ' ALA . 24.7 p -78.87 -27.33 44.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.961 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -122.58 -18.04 6.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -138.38 -169.9 2.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.372 -0.83 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.637 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -177.99 159.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.868 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.8 -42.58 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.598 ' N ' HG23 ' A' ' 54' ' ' VAL . 6.3 tt0 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.065 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -65.49 -24.17 67.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.57 -0.706 . . . . 0.0 111.011 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.0 mt -75.5 -52.83 9.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 0.0 108.289 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.534 HG22 ' OG ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -66.66 -18.76 65.54 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -84.15 -25.72 29.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -70.98 -42.34 69.8 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.944 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.53 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.7 t -77.17 -38.78 51.0 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -60.34 -25.27 65.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.52 -25.93 28.44 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -13.29 60.88 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.66 32.69 3.3 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.835 ' HB3' HG11 ' A' ' 9' ' ' VAL . 24.0 m-85 -135.16 84.17 37.09 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.691 -0.888 . . . . 0.0 110.21 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -54.19 97.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.781 1.411 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.868 ' HB3' HG13 ' A' ' 9' ' ' VAL . 49.5 p -107.8 -165.59 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.889 0.852 . . . . 0.0 111.886 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -153.44 126.19 8.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.733 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.7 p -95.05 159.72 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.93 -1.106 . . . . 0.0 110.431 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.4 OUTLIER -151.3 51.49 0.84 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.224 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.958 ' O ' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.24 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.734 HG23 ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -148.29 89.21 1.7 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 152.35 44.75 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.926 0.87 . . . . 0.0 111.943 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -121.0 152.66 38.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.446 0.641 . . . . 0.0 109.873 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 54' ' ' VAL . 16.0 m -142.51 174.34 5.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.821 ' O ' HD12 ' A' ' 7' ' ' LEU . 11.1 t -108.17 160.97 15.41 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.007 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -130.68 141.77 50.42 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.878 -1.529 . . . . 0.0 111.707 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -110.39 101.21 9.95 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.3 p -112.55 79.64 3.22 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 111.051 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.7 Cg_endo -68.11 -3.38 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.766 1.403 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -56.24 -17.28 17.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.715 ' SD ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -154.18 -171.25 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 110.027 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 12' ' ' MET . 7.0 t 179.93 58.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -160.31 173.64 15.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.305 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -73.89 78.72 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 110.59 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.16 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.189 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB2' ' CB ' ' A' ' 12' ' ' MET . 2.6 m -91.77 -44.7 0.36 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.639 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 4.9 Cg_exo -61.03 -44.59 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.651 ' HA ' HG23 ' A' ' 36' ' ' VAL . 85.4 mt -57.67 -29.66 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.967 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 14.6 m -65.46 -28.43 69.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 108.695 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.901 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.0 t -68.31 -27.42 36.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.826 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.9 tttt -69.84 -43.2 72.43 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.4 mptt -64.99 -25.01 67.68 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.351 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.48 -43.27 77.28 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.777 -0.577 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -69.19 -41.89 76.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.055 -1.028 . . . . 0.0 109.64 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.828 ' HA ' HG11 ' A' ' 31' ' ' VAL . 2.9 p -67.4 -18.17 65.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -99.75 -9.65 22.77 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.903 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.5 t -45.32 -63.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.039 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 1.4 tt0 160.28 -64.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.355 0.597 . . . . 0.0 109.782 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -93.4 -6.91 62.37 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.565 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 26' ' ' SER . 13.7 p -41.77 129.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 109.732 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 m -108.24 -10.85 15.32 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.369 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.93 159.54 18.28 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.296 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 25' ' ' LEU . 60.4 t -147.49 160.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.838 -1.164 . . . . 0.0 111.581 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 44' ' ' VAL . 8.3 t70 -136.84 135.65 38.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG23 ' HA ' ' A' ' 19' ' ' ILE . 1.6 p -109.39 127.31 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.888 -1.133 . . . . 0.0 112.07 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -109.45 59.34 0.36 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -28.77 -110.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.373 0.606 . . . . 0.0 112.498 -177.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -50.9 -50.18 57.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.572 -1.33 . . . . 0.0 112.134 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.2 tmmm? -55.21 -14.04 1.54 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.0 111.506 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' VAL . 7.7 tmm_? 61.45 84.01 0.14 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.432 -0.792 . . . . 0.0 111.216 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -171.8 120.51 0.46 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.398 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -114.04 119.55 37.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 110.487 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -107.36 123.62 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.8 p -133.96 152.07 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.664 -1.214 . . . . 0.0 113.752 -176.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -113.16 152.33 29.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.807 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.0 p90 -170.45 -179.91 3.15 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.734 ' OD2' HG23 ' A' ' 2' ' ' THR . 5.8 m-20 -107.11 123.69 48.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.686 ' OD1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -67.34 -2.45 6.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.285 -177.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 48' ' ' ASP . 6.0 t -81.57 -23.43 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 110.154 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -125.52 -5.84 7.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.155 -0.965 . . . . 0.0 110.479 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.15 -170.07 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.71 158.93 0.71 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.817 ' HA ' HD12 ' A' ' 57' ' ' LEU . 17.4 m -41.84 -41.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.579 ' N ' HG23 ' A' ' 54' ' ' VAL . 22.2 tp60 -60.59 -45.61 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.392 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.61 -25.97 67.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.639 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 45' ' ' VAL . 39.5 mt -72.62 -56.32 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.893 -1.129 . . . . 0.0 108.346 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 ' OG ' ' A' ' 68' ' ' SER . 3.2 m -64.45 -17.74 64.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 4.2 ttmm -81.73 -27.95 33.63 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.41 -43.61 66.45 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.071 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.901 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.9 t -74.29 -36.25 63.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -60.9 -29.77 69.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -90.28 -15.51 31.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.28 178.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.9 -18.82 58.06 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 117.48 23.91 3.62 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -142.13 90.56 8.25 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.571 -0.958 . . . . 0.0 109.993 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.5 Cg_exo -55.71 97.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.63 1.332 . . . . 0.0 110.103 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.679 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.5 p -108.5 -163.21 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.874 . . . . 0.0 111.036 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.656 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -147.3 -175.37 4.81 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.007 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.56 142.08 33.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.817 -1.177 . . . . 0.0 112.184 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -131.77 79.95 1.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.457 0.646 . . . . 0.0 109.595 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 5' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -157.44 90.79 1.12 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -114.54 158.0 22.24 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.6 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.535 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 50.0 m -136.64 121.57 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.665 -0.647 . . . . 0.0 109.321 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' A' ' 72' ' ' GLN . 5.1 m -131.97 172.8 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.477 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.707 ' O ' HD12 ' A' ' 7' ' ' LEU . 10.6 t -108.48 157.33 18.54 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -126.17 156.56 39.97 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.002 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -132.33 103.33 6.15 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.0 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.6 t -108.71 102.76 49.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.526 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 4.6 Cg_endo -71.37 2.19 4.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.198 1.265 . . . . 0.0 111.8 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.41 -1.0 60.87 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -107.16 161.2 14.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -1.22 . . . . 0.0 110.055 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 179.01 32.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.102 -0.999 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -173.19 170.37 4.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.739 -1.226 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -77.05 78.31 3.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.8 -48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 6.1 m -93.66 -44.72 0.31 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.978 -1.076 . . . . 0.0 112.048 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 1.5 Cg_endo -65.45 -38.11 27.27 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 107.661 -1.707 . . . . 0.0 107.661 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.66 HG13 ' CE1' ' A' ' 38' ' ' PHE 0.267 6.7 tt -59.21 -36.16 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.402 1.096 . . . . 0.0 108.711 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 49.9 m -63.44 -21.31 66.23 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.72 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.5 t -69.77 -33.09 54.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.774 ' HB2' HG21 ' A' ' 36' ' ' VAL . 27.5 tttm -66.16 -41.23 90.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -25.65 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.182 179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' VAL . . . -69.51 -55.6 9.75 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.687 -0.633 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.875 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.95 -37.23 81.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.606 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -70.37 -20.49 62.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 108.978 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -112.88 10.72 19.07 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.18 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.6 p -66.35 -44.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.457 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.44 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.476 -0.765 . . . . 0.0 111.269 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.703 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -90.27 0.98 79.07 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.271 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG11 ' C ' ' A' ' 26' ' ' SER . 7.3 p -42.86 128.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.922 -1.34 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -113.87 -14.87 12.45 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.596 0.713 . . . . 0.0 109.58 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.816 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -156.7 159.77 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.435 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 45' ' ' VAL . 13.4 p -152.65 157.4 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 111.08 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t0 -170.54 87.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 22' ' ' LYS . 6.1 m -108.02 -159.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.885 . . . . 0.0 111.783 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.12 115.19 0.82 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.68 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 m-30 -56.6 -105.66 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 O-C-N 122.216 -0.579 . . . . 0.0 109.713 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -47.87 -34.21 8.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.358 -1.464 . . . . 0.0 110.476 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 33.4 tttt -52.78 -41.97 64.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.077 -1.014 . . . . 0.0 110.7 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER 81.37 70.03 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.425 0.631 . . . . 0.0 110.989 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -170.83 120.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.755 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.99 115.62 29.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.949 -1.094 . . . . 0.0 111.993 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.3 t -107.97 117.16 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.875 HG21 HD22 ' A' ' 25' ' ' LEU . 21.8 t -137.3 155.5 32.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.228 -1.389 . . . . 0.0 113.09 -177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.8 m -114.9 160.55 19.39 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.753 ' CE1' HD11 ' A' ' 57' ' ' LEU . 53.4 p90 -171.82 -176.52 1.75 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.796 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.63 114.78 29.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -62.67 -9.01 7.65 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.59 -177.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 7.4 t -67.59 -26.92 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.013 -1.054 . . . . 0.0 109.574 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -0.9 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.456 -0.778 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.35 -168.81 3.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 179.73 156.15 0.59 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.846 . . . . 0.0 109.62 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.794 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.2 m -44.74 -39.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.347 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.02 -43.74 97.87 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.327 -0.858 . . . . 0.0 109.105 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.24 -25.17 67.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.443 -0.786 . . . . 0.0 110.736 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 54' ' ' VAL . 54.4 mt -69.57 -56.1 8.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.861 -1.149 . . . . 0.0 108.704 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 3.0 m -64.65 -21.43 66.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mttp -81.43 -23.85 37.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -73.47 -44.18 58.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.325 -0.86 . . . . 0.0 108.933 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.632 ' OG1' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.59 -35.34 60.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.12 -29.78 70.57 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 40.3 t0 -79.21 -23.73 43.61 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.28 59.97 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.618 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.71 32.94 3.21 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG11 ' A' ' 9' ' ' VAL . 25.2 m-85 -137.35 84.62 23.33 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.681 -0.894 . . . . 0.0 110.262 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.19 97.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.67 1.353 . . . . 0.0 109.235 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.0 ' OG ' HG22 ' A' ' 9' ' ' VAL . 12.6 t -108.03 -172.03 1.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.887 0.851 . . . . 0.0 112.12 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.58 121.55 8.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -92.86 156.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.808 -1.182 . . . . 0.0 110.572 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -154.78 45.43 0.52 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.339 -1.344 . . . . 0.0 110.841 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.635 ' HB3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.838 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.938 ' HB1' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.3 t -178.05 107.65 0.05 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.289 1.042 . . . . 0.0 108.725 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.656 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.7 pt20 -130.24 173.62 10.61 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.158 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 45' ' ' VAL . 7.0 m -126.37 137.82 53.49 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.578 -0.701 . . . . 0.0 109.737 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.763 HG21 HG23 ' A' ' 54' ' ' VAL . 33.7 m -133.13 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.834 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.91 157.01 18.1 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.79 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.47 152.4 50.51 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.814 -178.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.39 117.26 23.32 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.632 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.9 HG21 HG11 ' A' ' 21' ' ' VAL . 98.9 t -112.56 75.94 1.93 Allowed Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 120.845 -1.159 . . . . 0.0 112.184 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 5.9 Cg_endo -69.27 -13.95 36.79 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.222 1.117 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -43.89 -42.19 6.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 83.5 mmm -153.39 140.14 19.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -1.067 . . . . 0.0 110.044 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.558 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 2.4 t -134.6 78.36 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 110.878 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -147.68 -142.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.035 -1.04 . . . . 0.0 108.881 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -110.11 64.81 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.805 -1.184 . . . . 0.0 109.335 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.04 -54.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.048 -1.032 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.1 m -77.29 -48.38 2.45 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 120.835 -1.165 . . . . 0.0 111.601 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 27.3 Cg_exo -51.02 -56.19 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.082 1.043 . . . . 0.0 109.776 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -57.66 -27.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.767 -0.583 . . . . 0.0 110.42 179.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 67.8 m -66.43 -24.54 66.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.741 -1.225 . . . . 0.0 108.717 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.9 HG11 HG21 ' A' ' 9' ' ' VAL . 57.3 t -69.17 -31.72 51.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.671 ' CA ' HG21 ' A' ' 36' ' ' VAL . 17.4 tttm -70.51 -40.16 73.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -68.51 -21.05 64.61 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.451 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -72.51 -53.47 11.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.706 -0.621 . . . . 0.0 110.321 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -61.55 -30.13 70.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.0 109.373 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.8 -27.43 61.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.502 -0.749 . . . . 0.0 109.16 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.44 6.89 37.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.264 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.5 t -56.13 -77.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.731 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER 177.89 -81.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.3 -1.06 87.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 25' ' ' LEU . 5.4 p -42.11 133.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.206 -1.173 . . . . 0.0 110.582 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -110.15 -17.94 13.43 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.593 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.5 tttt -167.63 158.63 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.165 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 45' ' ' VAL . 24.4 t -154.64 145.12 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.773 -1.204 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -141.66 154.67 45.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.671 HG21 ' CA ' ' A' ' 22' ' ' LYS . 46.6 t -155.29 158.48 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.352 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -124.3 81.94 0.35 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -35.93 -101.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 122.276 -0.544 . . . . 0.0 111.812 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -28.8 -44.03 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.474 -0.766 . . . . 0.0 111.025 -179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -89.8 50.8 1.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -10.38 76.84 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' LYS . 5.6 tm-20 -149.82 109.6 4.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.627 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -110.17 126.79 54.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.815 -1.178 . . . . 0.0 111.431 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.834 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -108.08 120.84 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.902 ' CG1' HD13 ' A' ' 57' ' ' LEU . 9.9 p -126.02 156.06 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.589 1.185 . . . . 0.0 113.955 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -121.43 153.31 38.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 2' ' ' THR . 43.9 p90 -172.31 179.86 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 117.879 -1.528 . . . . 0.0 111.294 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.54 112.33 25.28 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.938 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -62.45 -8.22 5.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.985 -177.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 t -71.6 -10.26 59.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.996 -1.065 . . . . 0.0 110.155 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -132.39 -39.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -123.79 -169.96 2.04 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.724 -0.61 . . . . 0.0 109.696 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' ' C ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.28 154.28 5.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.939 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.3 p -41.07 -30.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.844 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 22.3 tt0 -70.08 -50.03 45.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -22.38 65.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 54' ' ' VAL . 42.3 mt -72.27 -51.56 20.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.641 -1.287 . . . . 0.0 108.155 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -65.91 -19.31 65.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -82.57 -24.05 34.15 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.838 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -72.7 -43.05 63.53 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.94 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.612 ' HB ' HG13 ' A' ' 21' ' ' VAL . 8.3 t -76.46 -38.29 55.63 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -61.93 -26.08 67.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.55 -24.24 29.36 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.97 -19.08 62.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 113.03 28.56 3.32 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 17.3 m-85 -134.82 87.55 30.14 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 121.499 -1.0 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.25 100.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.795 1.418 . . . . 0.0 109.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 9' ' ' VAL . 11.4 p -107.66 -167.91 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.59 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -150.47 129.64 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.915 HG21 HG22 ' A' ' 54' ' ' VAL . 6.9 p -99.14 158.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.889 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.7 OUTLIER -137.7 45.58 2.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.657 -1.217 . . . . 0.0 110.915 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.582 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.212 0.53 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -158.94 92.95 1.13 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -118.36 161.27 20.23 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.757 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -137.68 122.56 18.89 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 72' ' ' GLN . 34.2 m -132.99 174.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.988 HG22 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.28 163.71 12.79 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.005 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -135.45 143.74 46.07 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.277 -1.369 . . . . 0.0 111.604 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -114.22 99.3 7.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.861 ' O ' ' HE3' ' A' ' 12' ' ' MET . 7.4 p -112.34 80.08 3.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.117 -0.989 . . . . 0.0 111.932 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.5 Cg_endo -68.54 -1.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.508 1.268 . . . . 0.0 111.221 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.37 -26.52 3.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.861 ' HE3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -149.05 -165.19 2.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -1.234 . . . . 0.0 110.215 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 13' ' ' THR . 5.3 t -179.75 67.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.127 -0.983 . . . . 0.0 111.093 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -166.17 177.32 7.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.05 -1.031 . . . . 0.0 109.334 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.69 74.69 5.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 110.078 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.09 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 111.377 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.4 m -89.77 -42.6 0.42 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.98 -1.075 . . . . 0.0 112.88 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.698 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 5.5 Cg_endo -65.18 -41.22 17.09 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 38' ' ' PHE . 4.0 mt -61.47 -27.35 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 29.6 m -67.03 -27.98 67.85 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.101 -0.999 . . . . 0.0 108.334 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.741 ' O ' HD12 ' A' ' 25' ' ' LEU . 84.6 t -64.58 -32.15 56.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 tttm -65.28 -39.26 92.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -68.92 -24.89 64.34 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.885 0.85 . . . . 0.0 109.149 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.656 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.89 -56.14 6.92 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.72 -0.612 . . . . 0.0 110.514 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -61.46 -30.65 70.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.1 t -72.81 -25.36 61.12 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -108.07 7.13 27.55 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.684 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.3 p -61.81 -48.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.95 -1.093 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 165.45 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.0 -1.062 . . . . 0.0 111.238 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -91.82 4.67 78.99 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.124 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 28' ' ' VAL . 7.5 p -41.03 129.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.167 -1.196 . . . . 0.0 110.17 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -16.49 13.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.9 156.03 21.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.676 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.737 HG13 ' CG2' ' A' ' 45' ' ' VAL . 45.6 t -150.64 145.49 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.893 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -162.3 92.99 0.84 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 22' ' ' LYS . 2.3 m -108.39 -164.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.025 -1.047 . . . . 0.0 111.185 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -140.99 118.94 1.44 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -47.53 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.4 tt0 -35.45 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.019 -1.051 . . . . 0.0 111.538 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.19 30.58 0.46 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.893 -1.13 . . . . 0.0 110.898 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 6.14 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' LYS . 10.0 tt0 -145.79 112.75 6.06 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.669 -1.27 . . . . 0.0 110.593 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -110.71 120.65 43.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.874 -1.141 . . . . 0.0 111.979 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.988 HG23 HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -108.52 115.67 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.737 ' CG2' HG13 ' A' ' 34' ' ' VAL . 14.5 t -132.04 154.15 39.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.131 -1.428 . . . . 0.0 113.132 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -115.29 158.17 22.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.7 p90 -171.91 -177.7 2.0 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.562 -1.255 . . . . 0.0 110.918 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.0 m-20 -107.29 110.64 22.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.17 -12.96 4.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.449 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 14.4 t -60.44 -32.3 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 110.154 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 -3.73 6.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -142.67 -168.02 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 22.0 t 179.42 154.8 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.935 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HD12 ' A' ' 57' ' ' LEU . 15.2 m -43.61 -35.47 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.189 -0.944 . . . . 0.0 109.614 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' VAL . 10.6 tt0 -65.77 -46.38 78.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.291 -0.881 . . . . 0.0 109.007 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 53' ' ' SER . 2.4 mmtp -63.1 -25.37 68.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.547 -0.72 . . . . 0.0 110.271 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 54' ' ' VAL . 61.4 mt -69.88 -55.61 9.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.873 -1.142 . . . . 0.0 108.733 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.592 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -62.94 -22.38 66.75 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -81.37 -27.15 34.97 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.49 -0.756 . . . . 0.0 109.213 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.656 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.18 -42.93 71.78 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.161 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.715 ' CB ' HG13 ' A' ' 21' ' ' VAL . 12.4 t -75.32 -38.02 60.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.26 66.47 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.17 -23.76 26.4 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.87 -16.85 60.66 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.07 27.56 3.4 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.7 m-85 -138.05 82.61 24.6 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.567 -0.961 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.85 97.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.672 1.354 . . . . 0.0 109.974 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.9 p -108.49 -161.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.781 0.801 . . . . 0.0 111.316 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.5 t -146.32 -170.32 3.47 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -138.98 153.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 O-C-N 120.831 -1.168 . . . . 0.0 111.294 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -157.89 61.72 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.75 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.727 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.2 pt20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.425 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.28 0.562 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -160.03 91.72 0.97 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.3 pm0 -127.7 163.15 24.93 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.059 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.49 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 12.0 m -125.69 133.97 51.97 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.327 0.584 . . . . 0.0 109.718 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 ' HG3' ' A' ' 72' ' ' GLN . 7.0 m -135.75 169.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.233 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.859 ' O ' HD12 ' A' ' 7' ' ' LEU . 13.5 t -108.5 161.99 14.54 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.032 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -133.79 154.64 50.85 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.487 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -121.48 100.37 6.99 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.3 p -111.67 89.23 10.65 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.176 -0.952 . . . . 0.0 111.522 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.7 Cg_endo -68.69 -7.77 21.42 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.596 1.314 . . . . 0.0 110.713 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.82 0.45 57.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.565 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -92.34 176.67 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -1.204 . . . . 0.0 109.987 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.9 -9.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -163.5 -156.75 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.766 -1.834 . . . . 0.0 111.112 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.43 60.21 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.844 -1.16 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.94 -40.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 111.09 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m -93.79 -45.82 0.3 Allowed Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.69 -1.256 . . . . 0.0 111.962 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 14.6 Cg_exo -62.01 -57.88 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 122.965 0.981 . . . . 0.0 109.897 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -54.72 -29.44 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.711 . . . . 0.0 110.76 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.648 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 17.9 m -64.28 -27.15 68.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.805 -1.184 . . . . 0.0 109.055 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.885 HG22 ' OG1' ' A' ' 61' ' ' THR . 73.4 t -67.12 -30.23 48.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.599 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.8 tttt -70.55 -44.64 67.03 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.02 -23.15 64.04 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.884 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.93 -49.03 50.16 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.701 -0.624 . . . . 0.0 110.468 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.795 ' CB ' HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -61.62 -42.41 98.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 0.0 109.625 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.469 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.8 p -70.4 -20.19 62.95 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.225 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.03 -7.85 41.53 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.503 -0.748 . . . . 0.0 109.699 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.79 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 3.8 t -52.17 -76.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.643 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 167.76 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.521 0.677 . . . . 0.0 109.768 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.36 -8.19 49.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.9 p -48.59 126.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -1.171 . . . . 0.0 109.907 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.39 -14.6 14.4 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -162.2 160.5 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.56 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 45' ' ' VAL . 67.0 t -149.78 149.58 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.13 -0.981 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 30.3 t0 -167.4 91.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.0 m -108.39 -156.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.003 0.906 . . . . 0.0 111.345 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -154.37 91.6 0.13 Allowed Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.623 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -38.2 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.936 -0.743 . . . . 0.0 111.17 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 13.0 tp10 -34.34 -40.82 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.454 -0.779 . . . . 0.0 110.731 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' GLU . 1.2 tmtp? -87.25 46.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 109.571 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -6.15 72.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -149.82 117.17 6.07 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.838 -1.163 . . . . 0.0 110.321 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.88 116.99 33.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.399 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -108.94 109.53 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 25' ' ' LEU . 40.1 t -129.14 151.16 35.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.98 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m -109.8 157.57 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.9 p90 -172.5 -179.03 2.1 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.335 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 7.9 m-20 -107.92 113.98 27.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.555 ' HB2' ' NE2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -59.84 -9.89 3.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.937 -178.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -64.95 -25.42 67.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.899 -1.126 . . . . 0.0 110.404 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -126.78 -32.91 2.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -117.71 -167.64 1.37 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.641 -0.662 . . . . 0.0 109.917 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.613 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.54 153.04 0.86 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 57' ' ' LEU . 24.4 m -43.02 -36.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.754 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.5 tt0 -67.58 -45.08 76.56 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -60.94 -27.03 67.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 54' ' ' VAL . 44.8 mt -69.17 -52.58 26.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.242 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.5 m -65.52 -17.62 64.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -83.81 -24.5 30.97 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.03 -42.3 66.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.829 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.885 ' OG1' HG22 ' A' ' 21' ' ' VAL . 11.5 t -76.61 -38.7 54.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.37 -28.24 66.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.1 m-20 -84.46 -24.44 29.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.648 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.37 -16.45 62.42 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.51 27.81 4.27 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 17.4 m-85 -135.99 97.13 12.51 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.482 -1.011 . . . . 0.0 110.401 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.2 Cg_exo -58.11 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.619 1.326 . . . . 0.0 110.054 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.527 ' HB2' ' CA ' ' A' ' 9' ' ' VAL . 3.4 p -108.43 -165.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 110.788 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.699 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 84.9 p -148.55 -171.91 3.96 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.032 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.8 p -139.23 152.08 23.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 110.983 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.27 42.68 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.169 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.825 ' HG3' HG12 ' A' ' 5' ' ' VAL . 1.4 mt-30 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.018 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.81 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.174 0.512 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.79 95.92 1.93 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 2.1 mt-30 -108.74 159.03 17.09 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.627 0.727 . . . . 0.0 110.987 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.527 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 m -139.31 127.74 22.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.547 -0.721 . . . . 0.0 109.912 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 54' ' ' VAL . 5.3 m -133.32 169.72 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 7' ' ' LEU . 14.8 t -108.2 160.33 15.91 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.988 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.52 145.64 50.32 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.483 -178.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -117.54 100.49 7.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.817 HG11 HG21 ' A' ' 21' ' ' VAL . 6.5 p -109.66 80.02 1.52 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.123 . . . . 0.0 112.552 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.1 Cg_endo -67.58 -3.78 10.85 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.467 1.246 . . . . 0.0 110.811 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -41.84 -32.17 0.9 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 17' ' ' CYS . 99.2 mmm -146.62 -160.65 1.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.478 -1.013 . . . . 0.0 109.372 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.7 t 179.92 71.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -169.49 -178.91 3.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.186 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -78.79 73.64 5.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.049 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.22 -51.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 m -86.84 -43.99 0.54 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.9 -1.125 . . . . 0.0 112.894 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 2.2 Cg_endo -63.51 -44.57 13.84 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 8.7 mt -64.41 -25.29 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.674 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 62.3 m -64.18 -23.68 67.4 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.738 -1.226 . . . . 0.0 108.059 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' HB ' ' A' ' 61' ' ' THR . 45.0 t -71.0 -32.79 49.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.651 ' HE3' HG13 ' A' ' 34' ' ' VAL . 3.4 tttt -63.43 -38.43 91.1 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.3 -32.14 72.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.189 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -62.86 -51.57 66.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.746 HD22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -70.62 -27.54 64.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.358 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -66.94 -25.34 66.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.75 17.37 6.85 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.119 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -60.58 -47.24 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 175.27 -84.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 110.928 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.766 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -100.6 8.41 58.32 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.657 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.1 p -40.26 130.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -1.111 . . . . 0.0 110.445 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -110.12 -16.9 13.68 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.748 0.785 . . . . 0.0 108.925 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.896 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.42 158.82 27.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.546 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.811 HG23 HG22 ' A' ' 45' ' ' VAL . 7.1 p -157.74 151.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.52 ' OD1' HG12 ' A' ' 44' ' ' VAL . 7.1 p-10 -169.38 98.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.0 m -109.04 -157.09 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 112.005 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.2 122.98 1.67 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.25 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.147 -0.619 . . . . 0.0 111.562 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -23.53 -38.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.557 -0.714 . . . . 0.0 112.912 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 38' ' ' PHE . 2.5 ttpt -81.24 32.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.737 -1.227 . . . . 0.0 111.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 7.5 87.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.599 ' OE2' HG23 ' A' ' 44' ' ' VAL . 4.6 tm-20 -156.43 110.15 2.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.055 . . . . 0.0 110.21 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -114.02 117.4 31.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.754 -1.216 . . . . 0.0 111.661 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.599 HG23 ' OE2' ' A' ' 42' ' ' GLU . 2.2 t -108.45 121.23 61.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 33' ' ' LYS . 52.8 t -139.83 152.16 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.079 -1.448 . . . . 0.0 113.144 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -111.49 162.4 15.14 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 57' ' ' LEU . 52.4 p90 -172.69 -176.95 1.59 Allowed 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.489 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 72.6 m-20 -106.58 122.21 45.87 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.81 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -65.62 -4.5 6.27 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.929 -177.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.631 HG23 ' HB1' ' A' ' 1' ' ' ALA . 30.7 p -76.15 -26.84 56.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 2.2 mmmt -125.61 -6.49 6.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.766 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -147.28 -168.45 3.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.636 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 35.4 t -178.17 152.54 0.72 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 57' ' ' LEU . 3.6 p -41.76 -39.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.469 -0.77 . . . . 0.0 109.377 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.62 -45.7 82.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 53' ' ' SER . 1.3 mttt -60.66 -23.64 64.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.465 -0.772 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 54' ' ' VAL . 32.5 mt -74.4 -51.96 13.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.729 -1.232 . . . . 0.0 108.35 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 1.8 m -64.02 -18.84 64.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.06 -26.79 33.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.14 -41.46 70.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.034 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.917 ' HB ' HG13 ' A' ' 21' ' ' VAL . 13.0 t -76.0 -39.51 55.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.69 -26.37 67.07 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.64 -19.81 23.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.07 61.14 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 110.83 28.42 3.94 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -137.15 101.47 9.27 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.98 . . . . 0.0 110.746 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.53 95.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.662 1.348 . . . . 0.0 109.773 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 9' ' ' VAL . 12.6 t -108.94 -168.6 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.14 178.35 7.76 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.988 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.4 p -138.29 148.0 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.725 -1.235 . . . . 0.0 112.511 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.04 77.47 1.66 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.603 -0.686 . . . . 0.0 109.825 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.915 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.209 0.528 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -155.9 93.22 1.43 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -113.81 -171.23 1.86 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.035 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.553 HG23 ' OG1' ' A' ' 46' ' ' THR . 20.4 m -153.0 156.92 39.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -170.44 169.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.27 1.033 . . . . 0.0 110.34 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 t -109.73 165.16 11.91 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 1.0 OUTLIER -133.55 145.63 50.27 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.624 -1.23 . . . . 0.0 111.664 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.998 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -110.56 100.1 8.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 3.4 p -112.03 79.52 2.75 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.04 -1.037 . . . . 0.0 111.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 4.2 Cg_endo -67.17 -4.66 12.04 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.608 1.32 . . . . 0.0 110.917 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -42.1 -43.49 4.49 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.704 ' HA ' ' HE3' ' A' ' 12' ' ' MET . 0.0 OUTLIER -139.06 -159.03 0.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -1.077 . . . . 0.0 109.604 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 13' ' ' THR . 3.8 t -179.04 79.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.03 -1.044 . . . . 0.0 110.628 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.6 -177.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.418 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -81.62 70.96 8.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.056 . . . . 0.0 110.292 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -177.31 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 111.679 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 8.3 m -93.93 -43.42 0.31 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 120.803 -1.186 . . . . 0.0 112.646 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.4 Cg_endo -65.64 -37.6 28.16 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 N-CA-C 108.577 -1.355 . . . . 0.0 108.577 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 tt -65.28 -33.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.953 0.882 . . . . 0.0 108.973 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 76.0 m -60.74 -20.24 60.83 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.04 HG13 ' HB ' ' A' ' 61' ' ' THR . 62.3 t -74.82 -36.12 38.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.855 ' HD3' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -60.48 -33.92 73.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -68.34 -46.68 69.5 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.483 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -52.77 -57.55 9.79 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.164 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.031 -1.043 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.62 ' CA ' HG21 ' A' ' 34' ' ' VAL . 7.4 t -63.44 -20.06 65.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.6 16.32 5.91 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.598 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.006 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.8 p -55.25 -56.59 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 0.0 110.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 1.006 ' HG2' HG22 ' A' ' 28' ' ' VAL . 5.7 pt-20 170.86 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.92 3.62 16.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 25' ' ' LEU . 3.6 p -50.3 134.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.4 -8.63 11.59 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.981 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.8 ttmm -155.24 160.87 41.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.855 HG11 ' HD3' ' A' ' 22' ' ' LYS . 54.6 t -152.62 137.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.501 0.667 . . . . 0.0 110.337 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.2 m-20 -167.92 92.43 0.36 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 22' ' ' LYS . 3.7 m -107.97 -153.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 111.845 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -147.77 111.99 0.57 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -82.22 65.03 7.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.959 0.885 . . . . 0.0 110.502 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -178.66 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.317 -0.865 . . . . 0.0 108.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -89.88 42.06 1.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.998 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.7 ppt_? 23.46 84.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.114 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 tt0 -150.42 116.16 5.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.464 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -111.16 117.59 33.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.115 . . . . 0.0 111.222 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -110.01 114.62 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 33' ' ' LYS . 56.5 t -138.07 151.07 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.445 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.5 m -109.43 166.26 11.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 57' ' ' LEU . 53.2 p90 -172.85 -171.05 0.72 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.885 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -107.28 111.28 23.58 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -61.98 -9.65 7.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 -177.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.915 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -75.99 -30.37 58.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.877 -1.14 . . . . 0.0 109.662 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 1.3 10.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.979 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -155.1 -169.37 3.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.62 155.68 0.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.755 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.41 -37.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.22 -0.925 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 54' ' ' VAL . 6.1 tt0 -64.04 -46.91 82.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.251 -0.906 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -61.49 -29.75 70.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.452 -0.78 . . . . 0.0 110.027 179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 54' ' ' VAL . 68.0 mt -65.51 -52.9 49.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 69' ' ' SER . 5.5 m -64.35 -18.36 64.58 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 20.1 ttpt -80.58 -27.89 37.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -71.6 -43.51 66.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.91 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.04 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.2 t -73.23 -35.61 66.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -58.8 -31.46 68.46 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.52 -16.44 28.85 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.573 -0.704 . . . . 0.0 109.466 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.46 -18.98 61.06 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.48 23.96 4.58 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -139.34 93.26 10.11 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.614 -0.933 . . . . 0.0 110.557 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_exo -54.91 95.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.705 1.371 . . . . 0.0 109.432 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 61' ' ' THR . 5.4 p -108.39 -159.09 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.853 0.835 . . . . 0.0 111.391 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.659 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -151.53 -167.08 2.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 7' ' ' LEU 0.258 3.3 p -139.4 146.39 25.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.191 -0.943 . . . . 0.0 110.749 -178.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.708 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -160.6 50.22 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.825 -178.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.52 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 4.9 pp0? . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.494 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.824 ' HB3' ' CG ' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.208 0.528 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.52 86.99 1.84 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 47' ' ' PHE . 4.4 pt20 -120.44 149.37 42.48 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.589 -0.844 . . . . 0.0 112.17 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.577 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -119.16 138.98 52.56 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.646 0.736 . . . . 0.0 110.194 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 54' ' ' VAL . 35.1 m -130.92 169.76 20.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.588 -0.695 . . . . 0.0 109.171 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.021 HG22 ' HB2' ' A' ' 72' ' ' GLN . 12.0 t -107.49 159.79 16.15 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -133.58 153.33 51.74 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.466 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -124.01 106.06 10.09 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.998 HG11 HG21 ' A' ' 21' ' ' VAL . 7.2 p -115.69 78.05 6.65 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.931 -1.106 . . . . 0.0 111.518 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.523 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 8.6 Cg_endo -72.53 2.73 4.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.744 1.392 . . . . 0.0 111.351 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -55.36 -29.79 53.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -172.72 119.91 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.676 -0.896 . . . . 0.0 109.4 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 13' ' ' THR . 2.9 t -143.49 110.0 5.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 13' ' ' THR . 1.8 m -148.55 -61.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.0 109.082 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.76 27.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.613 -0.679 . . . . 0.0 109.871 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -168.68 -40.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 111.646 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 8.2 m -67.2 -44.86 49.95 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.128 . . . . 0.0 112.035 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 4.3 Cg_endo -64.14 -41.65 21.31 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.619 HD12 ' CG ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -63.4 -31.92 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.652 0.739 . . . . 0.0 109.317 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 30.8 m -61.7 -23.08 65.88 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.066 HG13 ' HB ' ' A' ' 61' ' ' THR . 60.7 t -73.18 -33.66 42.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.672 ' HA ' HG21 ' A' ' 36' ' ' VAL . 65.2 tttt -62.1 -35.08 77.63 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -65.86 -43.02 89.66 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.567 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -55.77 -59.29 5.08 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.75 -0.594 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -64.65 -29.29 70.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.001 -1.062 . . . . 0.0 109.924 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 20.0 m -59.5 -30.3 68.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -135.28 21.93 3.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.792 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HB ' ' A' ' 31' ' ' VAL . 10.7 p -54.18 -45.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.72 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 110.557 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -97.1 1.69 61.03 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -42.72 128.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.059 -1.26 . . . . 0.0 110.159 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.01 -9.17 15.09 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.432 0.634 . . . . 0.0 109.657 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.645 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -166.67 163.03 16.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.361 -0.837 . . . . 0.0 109.549 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 22' ' ' LYS . 92.2 t -150.71 162.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 2.3 t0 -170.72 85.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 22' ' ' LYS . 23.8 t -106.94 176.29 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 111.741 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -131.8 118.36 2.3 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CG ' HD12 ' A' ' 19' ' ' ILE . 17.9 p90 -87.24 63.82 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.945 0.878 . . . . 0.0 109.858 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 2.1 tt0 179.58 -63.88 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.2 mtmt -73.26 -2.69 22.89 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CB ' ' A' ' 13' ' ' THR . 8.2 tmm_? 59.5 75.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.7 -0.625 . . . . 0.0 110.879 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -156.88 122.35 4.7 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.736 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -109.21 115.58 30.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.098 -1.001 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.0 t -109.2 119.37 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.7 t -135.64 156.88 38.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.017 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.577 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.62 154.34 26.19 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.3 p90 -170.88 177.88 3.65 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.22 -1.392 . . . . 0.0 111.668 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.37 123.74 48.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.824 ' CG ' ' HB3' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -69.17 -0.74 6.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.311 -177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.7 p -73.18 -33.29 65.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -121.32 -13.7 8.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.068 -1.02 . . . . 0.0 110.557 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -140.87 -169.25 2.77 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.914 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.8 p 179.76 158.26 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.941 ' HA ' HD12 ' A' ' 57' ' ' LEU . 5.5 m -41.3 -40.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.573 -0.705 . . . . 0.0 109.769 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.549 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.97 -49.05 79.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -25.46 68.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.676 -0.64 . . . . 0.0 111.023 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' HA ' ' A' ' 54' ' ' VAL . 39.2 mt -71.63 -52.87 15.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.775 -1.203 . . . . 0.0 108.621 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.676 HG21 ' HA ' ' A' ' 69' ' ' SER . 83.8 m -66.05 -19.2 65.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.27 -24.56 34.68 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -72.07 -42.07 66.65 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.989 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.066 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.72 -38.71 58.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 61' ' ' THR . . . -59.74 -30.29 68.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 5.5 t70 -86.31 -20.68 28.01 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.03 -19.33 62.52 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 116.78 24.36 3.69 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.614 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 18.1 m-85 -138.42 99.39 8.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.441 -1.035 . . . . 0.0 110.391 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 4.9 Cg_exo -56.76 95.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.65 1.342 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.0 p -109.49 -162.55 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.858 . . . . 0.0 111.375 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.676 ' HA ' HG21 ' A' ' 58' ' ' THR . 1.6 p -156.2 -173.2 4.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.5 p -135.8 156.15 37.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.848 -1.158 . . . . 0.0 110.958 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.741 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.94 54.36 0.41 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.415 -1.314 . . . . 0.0 111.766 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 1.021 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.291 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.693 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.083 0.468 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -145.35 86.26 1.75 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 26.8 mm-40 -115.45 141.9 47.42 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.136 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -125.52 122.31 36.22 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.481 0.658 . . . . 0.0 109.719 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 ' HB ' ' A' ' 54' ' ' VAL . 14.9 m -117.41 170.93 6.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.456 -0.777 . . . . 0.0 109.473 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.779 HG23 ' HG2' ' A' ' 71' ' ' LYS . 14.8 t -107.64 154.3 21.65 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.741 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -131.29 159.66 37.2 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.255 -1.378 . . . . 0.0 110.922 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -126.83 123.91 38.42 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.969 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 21' ' ' VAL . 3.7 t -112.48 76.7 2.08 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.02 -1.05 . . . . 0.0 111.542 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 9.4 Cg_endo -73.65 -23.04 17.36 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.111 1.208 . . . . 0.0 111.016 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -46.8 -50.33 15.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.8 mmm -147.17 158.83 44.08 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.312 -1.111 . . . . 0.0 110.159 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 1.1 t -178.78 112.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.618 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.4 p -166.66 -42.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 110.641 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 178.83 30.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.894 -1.129 . . . . 0.0 110.668 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' N ' HD12 ' A' ' 19' ' ' ILE . . . 179.26 -32.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 110.65 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 50.8 m -70.05 -43.39 19.24 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.974 -1.079 . . . . 0.0 112.003 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.7 Cg_endo -72.72 -47.41 0.36 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 N-CA-C 107.126 -1.913 . . . . 0.0 107.126 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 16' ' ' ALA 0.259 3.5 mt -54.95 -33.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 177.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 24.6 m -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 109.158 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG21 HG21 ' A' ' 9' ' ' VAL . 22.2 t -67.7 -31.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -67.9 -41.82 82.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.0 tmtt? -62.17 -37.95 87.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.567 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -59.54 -58.05 10.29 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.896 -0.503 . . . . 0.0 111.461 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.979 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -62.31 -33.98 75.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.041 -1.037 . . . . 0.0 109.831 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.492 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -63.35 -24.75 67.99 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -125.29 15.25 8.35 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.404 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.979 HG12 ' O ' ' A' ' 25' ' ' LEU . 2.2 p -58.75 -63.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.168 -0.958 . . . . 0.0 111.276 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.766 ' H ' HG13 ' A' ' 28' ' ' VAL . 3.1 mt-10 -165.47 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.713 -1.242 . . . . 0.0 110.721 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -98.67 6.15 60.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 7.7 p -39.73 132.17 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.421 -1.046 . . . . 0.0 110.479 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -109.47 -13.03 14.64 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.564 0.697 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' C ' HG23 ' A' ' 34' ' ' VAL . 2.9 tttt -165.83 160.58 17.13 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.799 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.664 HG13 HG22 ' A' ' 45' ' ' VAL . 61.2 t -152.28 151.19 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.452 ' OD2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p-10 -168.34 95.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 37' ' ' GLY . 2.1 m -107.85 -158.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.113 0.958 . . . . 0.0 111.824 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -142.95 115.72 0.95 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 19' ' ' ILE . 3.2 m-30 -52.69 -114.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.045 -0.68 . . . . 0.0 110.257 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.7 mt-10 -36.65 -30.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.044 -1.035 . . . . 0.0 110.548 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.4 mtpt -88.91 50.28 1.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.561 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.918 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 3.1 ppt_? -16.37 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 121.544 0.687 . . . . 0.0 112.569 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 40' ' ' LYS . 15.4 tt0 -154.38 111.27 3.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.436 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -110.18 115.24 29.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.769 -1.207 . . . . 0.0 111.907 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 24.2 t -107.23 120.45 58.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.645 -1.285 . . . . 0.0 107.552 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.87 HG21 ' CB ' ' A' ' 25' ' ' LEU . 19.0 t -131.73 150.84 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.837 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -110.0 156.09 20.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.758 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.6 p90 -170.88 -177.27 2.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.14 -1.424 . . . . 0.0 111.797 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.0 m-20 -106.21 112.61 25.71 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -66.37 -6.04 12.91 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.656 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.693 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -63.32 -18.46 63.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -138.25 -38.2 0.55 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.939 . . . . 0.0 110.479 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -108.15 -168.94 1.43 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.981 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER 179.26 160.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 110.412 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.065 HG23 HG21 ' A' ' 70' ' ' VAL . 3.8 p -41.78 -43.73 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.135 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -61.38 -44.24 97.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -0.956 . . . . 0.0 109.316 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 1.7 mtpp -64.15 -25.79 68.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.432 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 54' ' ' VAL . 28.4 mt -72.79 -50.51 23.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.858 -1.151 . . . . 0.0 108.101 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 59.4 m -64.34 -18.14 64.36 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 3.2 ttpp -80.01 -28.88 39.35 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -69.47 -43.85 72.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.325 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.73 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.1 t -74.42 -36.99 63.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.06 -28.52 67.86 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.99 -19.43 25.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.138 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.5 -14.06 60.4 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.612 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 102.6 35.08 3.91 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.2 m-85 -138.15 96.19 10.24 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.946 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.9 Cg_exo -55.34 97.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.636 1.335 . . . . 0.0 108.912 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -108.02 -177.91 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 111.794 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.16 133.31 17.29 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.065 HG21 HG23 ' A' ' 54' ' ' VAL . 7.3 p -99.79 158.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.611 -1.306 . . . . 0.0 111.207 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -154.47 50.73 0.63 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.645 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 4.1 pp0? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.784 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.133 0.492 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.77 91.09 1.35 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 4.3 mm100 -114.12 153.93 28.66 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.649 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.4 m -131.67 129.65 41.04 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 72' ' ' GLN . 31.5 m -133.93 170.85 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.968 -1.082 . . . . 0.0 110.273 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.871 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.2 159.33 16.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.034 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.31 154.1 50.97 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.337 -177.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -130.11 108.97 10.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.075 HG11 HG21 ' A' ' 21' ' ' VAL . 12.2 p -113.18 83.32 6.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.991 . . . . 0.0 111.203 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 6.9 Cg_endo -70.87 -6.61 19.54 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.624 1.329 . . . . 0.0 110.662 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 12' ' ' MET . . . -46.45 -40.03 10.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.567 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.6 mmm -156.56 132.19 9.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.539 -0.977 . . . . 0.0 109.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.529 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -133.75 93.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 110.234 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -149.55 -71.45 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.825 -1.172 . . . . 0.0 110.258 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . 179.92 49.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 109.467 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.39 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.413 -0.805 . . . . 0.0 110.43 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.6 m -71.16 -50.63 11.23 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -57.68 -43.12 53.02 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 N-CA-C 107.927 -1.605 . . . . 0.0 107.927 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.22 -28.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.723 0.773 . . . . 0.0 109.816 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 42.6 m -66.47 -23.72 66.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.924 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.075 HG21 HG11 ' A' ' 9' ' ' VAL . 25.2 t -68.88 -28.63 40.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.2 tttt -64.15 -45.6 87.75 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 17.9 mmtt -69.58 -20.92 63.64 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.38 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -40.23 65.84 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.683 -0.635 . . . . 0.0 110.227 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.87 ' HB3' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -77.97 -34.47 51.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 0.0 109.357 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.579 ' C ' HG11 ' A' ' 31' ' ' VAL . 23.8 t -71.23 -21.82 62.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -110.38 -0.51 17.54 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.297 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.6 p -49.04 -45.16 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.91 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 28' ' ' VAL . 2.2 mt-10 161.09 -83.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.735 -0.603 . . . . 0.0 111.275 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.29 7.39 72.2 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.579 HG11 ' C ' ' A' ' 26' ' ' SER . 4.0 p -41.04 134.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.198 -1.178 . . . . 0.0 110.293 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -14.82 14.26 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.813 0.816 . . . . 0.0 108.9 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -161.25 158.69 27.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -150.11 162.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 111.192 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t0 -156.61 151.47 26.0 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 22' ' ' LYS . 1.6 p -154.37 161.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.201 -1.399 . . . . 0.0 111.982 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -137.91 111.48 0.82 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' LYS . 26.1 p90 -54.29 -155.78 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' PHE . 35.2 tt0 5.88 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -38.97 -24.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.496 -1.377 . . . . 0.0 111.737 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 10' ' ' PRO . 8.7 tmm_? 62.94 76.97 0.35 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.121 -0.987 . . . . 0.0 111.358 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -165.38 126.41 1.94 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.051 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -125.77 128.36 47.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.8 -1.187 . . . . 0.0 110.245 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.871 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -109.11 140.34 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.823 -1.173 . . . . 0.0 108.312 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.884 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -149.32 156.01 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.418 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.9 m -125.56 156.74 38.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.1 p90 -172.62 -179.61 2.2 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.823 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -107.33 123.48 48.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -65.21 -5.52 7.15 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.85 -177.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.784 HG23 ' HB1' ' A' ' 1' ' ' ALA . 6.9 p -62.73 -37.59 87.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.168 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.84 23.27 5.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.507 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . . . -169.53 -171.61 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.42 155.59 0.52 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.011 HG23 HG21 ' A' ' 70' ' ' VAL . 5.6 p -43.43 -34.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.533 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.7 tt0 -65.3 -46.91 78.49 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.353 -0.842 . . . . 0.0 108.983 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -64.64 -24.64 67.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.62 -0.675 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.884 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.5 mt -72.06 -56.12 6.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.688 -1.258 . . . . 0.0 108.299 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' HA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -63.68 -19.74 65.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 ttpt -81.71 -26.21 34.8 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -72.35 -41.72 66.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.096 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.762 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.3 t -75.86 -36.85 59.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.43 -30.94 69.95 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -90.27 -15.58 31.0 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.47 -21.03 61.28 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 118.27 23.63 3.45 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.3 m-85 -139.39 105.28 7.11 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 0.0 110.561 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 6.3 Cg_exo -57.62 94.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.517 1.272 . . . . 0.0 109.34 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 9' ' ' VAL . 3.8 t -110.49 -176.26 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.784 . . . . 0.0 111.158 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.571 ' HA ' HG21 ' A' ' 58' ' ' THR . 3.4 t -147.24 -176.43 5.22 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 7' ' ' LEU . 9.5 p -134.81 159.68 41.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.681 -1.262 . . . . 0.0 111.657 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.91 47.04 1.01 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.061 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 23.7 mp0 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.239 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.07 88.93 1.48 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 mm-40 -114.0 154.76 27.08 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.582 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.495 HG23 ' OG1' ' A' ' 46' ' ' THR . 16.0 m -127.61 160.32 31.97 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 109.539 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.95 HG11 HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -166.94 170.69 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.979 0.895 . . . . 0.0 109.798 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -109.27 163.72 13.12 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.964 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -135.66 144.2 45.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.93 -1.106 . . . . 0.0 111.303 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -113.82 99.52 7.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 109.487 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 5.4 p -111.19 85.47 5.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.038 -1.039 . . . . 0.0 111.962 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 1.7 Cg_endo -64.77 -6.3 12.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.629 1.331 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.85 2.06 56.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.596 ' HB2' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -99.33 173.76 6.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 110.613 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 14' ' ' CYS . 3.1 t -179.22 15.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.996 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 179.61 -162.16 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.281 -1.512 . . . . 0.0 110.197 179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.83 52.72 2.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 110.28 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 17' ' ' CYS . . . -172.75 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 111.177 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.709 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 51.8 m -152.62 -50.83 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.325 -0.859 . . . . 0.0 111.48 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 9.8 Cg_endo -73.98 -50.31 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 N-CA-C 108.267 -1.474 . . . . 0.0 108.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.2 mt -65.7 -25.38 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.928 0.87 . . . . 0.0 108.692 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.471 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 2.7 m -62.81 -23.93 67.5 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.5 t -72.77 -32.98 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' VAL . 15.1 tttt -59.77 -35.45 74.67 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.4 -37.61 77.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.816 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -61.17 -56.1 24.59 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.612 -0.68 . . . . 0.0 111.042 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -63.49 -32.93 74.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.055 . . . . 0.0 110.176 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' HG11 ' A' ' 31' ' ' VAL . 8.2 p -68.52 -20.19 64.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -120.07 6.85 10.79 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.6 p -55.6 -49.31 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.123 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.6 OUTLIER 171.64 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 111.152 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -94.54 10.44 70.96 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.561 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.61 HG21 ' CG2' ' A' ' 34' ' ' VAL . 10.6 p -41.89 133.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.126 . . . . 0.0 110.089 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.26 -18.05 13.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' C ' HG23 ' A' ' 34' ' ' VAL . 10.6 tttm -163.61 158.39 20.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 45' ' ' VAL . 71.4 t -156.15 142.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 111.918 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -141.93 158.68 43.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 9.8 p -154.09 168.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 117.623 -1.631 . . . . 0.0 112.794 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -130.07 110.65 1.06 Allowed Glycine 0 N--CA 1.48 1.588 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.65 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.429 -0.453 . . . . 0.0 111.742 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 1.1 tt0 -28.68 -31.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.432 -0.793 . . . . 0.0 112.293 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 38' ' ' PHE . 55.2 mttt -80.38 27.81 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.734 -1.228 . . . . 0.0 110.996 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER 13.49 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.5 tt0 -165.67 109.65 0.83 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.419 -1.426 . . . . 0.0 111.107 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.08 125.25 53.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.068 -1.02 . . . . 0.0 111.424 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.7 p -109.59 114.26 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.806 HG21 ' CB ' ' A' ' 25' ' ' LEU . 22.3 t -128.42 150.03 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.468 -1.293 . . . . 0.0 113.113 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -112.42 160.38 17.8 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 57' ' ' LEU . 50.3 p90 -171.68 -171.46 0.91 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.186 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.4 m-20 -106.57 123.56 48.28 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -71.85 3.54 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.442 -177.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.507 HG23 ' CB ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -85.23 -33.24 22.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.912 -1.118 . . . . 0.0 109.64 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 -4.42 10.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.098 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . . . -145.77 -172.7 3.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 179.68 153.54 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.822 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.95 HG12 HG11 ' A' ' 5' ' ' VAL . 26.7 m -43.35 -32.72 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.025 -1.047 . . . . 0.0 109.858 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.9 tt0 -68.18 -46.94 69.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 108.874 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 5.0 mttm -63.34 -25.5 68.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.544 -0.722 . . . . 0.0 110.297 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 54' ' ' VAL . 46.2 mt -71.05 -53.11 15.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.846 -1.159 . . . . 0.0 108.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.441 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 5.1 m -62.27 -24.23 67.16 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.23 -28.73 42.49 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.39 -45.42 76.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.882 ' HB ' HG13 ' A' ' 21' ' ' VAL . 12.9 t -72.29 -38.18 68.83 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.64 -27.89 65.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 2.5 t70 -90.29 -20.69 22.64 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.554 -0.716 . . . . 0.0 109.413 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.09 -17.38 62.0 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.605 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 111.53 27.19 4.22 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 18.8 m-85 -138.6 92.38 11.6 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.555 -0.968 . . . . 0.0 110.166 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.4 Cg_exo -54.22 96.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.583 1.307 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.531 ' HB3' HG21 ' A' ' 61' ' ' THR . 8.6 t -108.85 -167.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.392 -0.818 . . . . 0.0 111.34 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -142.87 -167.68 2.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.964 HG23 ' CD1' ' A' ' 7' ' ' LEU . 1.6 p -142.9 155.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.944 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.68 53.77 0.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.4 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.489 ' N ' HG23 ' A' ' 5' ' ' VAL . 1.4 tm0? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.446 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.254 0.55 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 90.3 1.59 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mm-40 -109.97 169.33 8.8 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.016 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.7 m -144.02 125.58 14.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.506 -0.746 . . . . 0.0 109.553 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.845 HG21 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -130.28 169.65 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.803 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.1 t -108.73 159.25 16.91 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.965 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -133.58 152.03 51.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.208 -1.397 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.528 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.0 102.1 7.36 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 12' ' ' MET . 2.6 p -110.37 91.32 11.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.851 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.1 Cg_endo -66.29 -11.02 29.63 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.679 1.357 . . . . 0.0 110.305 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.84 48.8 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -136.42 158.16 45.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -1.154 . . . . 0.0 110.568 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 12' ' ' MET . 10.7 t 179.47 33.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.578 0.704 . . . . 0.0 109.161 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -160.93 127.05 3.92 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -35.68 83.49 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.64 -0.663 . . . . 0.0 111.615 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 177.83 -67.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.194 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 m -82.17 -44.16 1.01 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.945 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 38' ' ' PHE . 23.7 Cg_exo -54.1 -55.94 3.0 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' HB3' ' A' ' 38' ' ' PHE . 37.9 mt -53.9 -27.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.828 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 22.6 m -69.08 -30.96 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.003 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.809 HG22 ' OG1' ' A' ' 61' ' ' THR . 55.5 t -65.95 -33.24 62.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HA ' HD12 ' A' ' 25' ' ' LEU . 8.0 tttt -70.05 -33.19 71.63 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mmtp -74.37 -29.01 61.37 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.264 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.8 -46.47 87.82 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.324 0.583 . . . . 0.0 109.804 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.697 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -72.7 -33.69 66.64 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.754 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.481 ' HA ' HG11 ' A' ' 31' ' ' VAL . 23.3 t -64.6 -18.62 65.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -127.62 8.58 6.41 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.774 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.624 HG22 ' OE2' ' A' ' 29' ' ' GLU . 14.6 p -49.52 -52.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 110.509 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 3.9 pt-20 165.17 -48.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.195 -0.941 . . . . 0.0 110.724 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -125.1 2.12 8.38 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.739 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.71 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 t -42.82 130.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.29 . . . . 0.0 109.562 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.51 -13.48 14.56 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -163.6 164.15 24.22 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.47 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 45' ' ' VAL . 7.2 p -152.82 162.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 111.179 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' N ' HG22 ' A' ' 34' ' ' VAL . 2.1 m-20 -168.63 80.14 0.14 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG13 ' CA ' ' A' ' 43' ' ' ALA . 33.0 t -108.32 164.99 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.904 0.859 . . . . 0.0 111.556 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -126.42 107.34 0.91 Allowed Glycine 0 N--CA 1.48 1.611 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.46 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.605 -0.938 . . . . 0.0 111.764 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' C ' ' O ' ' A' ' 38' ' ' PHE . 63.3 mt-10 -22.54 -67.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.8 -0.563 . . . . 0.0 112.273 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.638 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 19.5 tptp -42.1 -55.36 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.041 -1.037 . . . . 0.0 110.235 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.638 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.1 tmm_? 99.39 76.5 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 C-N-CA 123.493 0.717 . . . . 0.0 110.815 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -169.0 115.13 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 0.0 110.439 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.721 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -108.12 119.95 40.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.636 -1.29 . . . . 0.0 111.502 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.5 t -108.76 118.58 56.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.71 ' CG1' HG22 ' A' ' 31' ' ' VAL . 9.3 t -133.82 157.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.697 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.6 m -116.82 160.94 20.07 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.9 p90 -171.99 -175.23 1.44 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.906 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 14.1 p-10 -106.88 112.31 25.22 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -63.61 -9.65 14.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.833 . . . . 0.0 110.718 -177.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.499 ' CG2' ' OD2' ' A' ' 48' ' ' ASP . 5.9 t -62.1 -23.72 66.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.01 -1.056 . . . . 0.0 109.776 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -38.5 1.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 110.317 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . . . -108.0 -168.94 1.44 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.643 -0.66 . . . . 0.0 109.961 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.616 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 31.4 t -179.5 155.68 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.045 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.052 ' CG2' HG21 ' A' ' 70' ' ' VAL . 6.7 p -42.94 -40.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.624 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.508 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.4 tt0 -61.88 -44.72 96.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.361 -0.837 . . . . 0.0 109.451 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' CD ' ' HA ' ' A' ' 52' ' ' ALA . 38.0 mttp -67.34 -23.27 65.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 54' ' ' VAL . 40.0 mt -71.14 -51.57 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.619 -1.301 . . . . 0.0 108.492 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 69' ' ' SER . 1.3 m -64.99 -19.77 66.16 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 7.2 mttt -82.49 -25.47 33.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -70.65 -44.06 67.9 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.438 -0.789 . . . . 0.0 109.134 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.809 ' OG1' HG22 ' A' ' 21' ' ' VAL . 10.2 t -75.84 -38.73 57.73 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 61' ' ' THR . . . -61.49 -24.21 66.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.22 -21.92 24.26 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -17.02 60.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.608 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.47 27.94 3.17 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -136.59 91.18 16.17 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.621 -0.929 . . . . 0.0 110.633 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.93 93.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.71 1.374 . . . . 0.0 110.055 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.548 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -108.99 -163.85 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 110.942 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.609 ' HA ' HG21 ' A' ' 58' ' ' THR . 2.5 t -150.09 -170.86 3.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.052 HG21 ' CG2' ' A' ' 54' ' ' VAL . 7.5 p -139.9 160.06 26.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.993 -1.067 . . . . 0.0 111.452 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.601 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -172.07 48.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.408 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.547 ' C ' ' O ' ' A' ' 71' ' ' LYS . 38.3 tt0 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.957 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.35 94.11 1.46 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 9.2 mm-40 -110.91 150.22 29.52 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.165 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.451 HG23 ' OG1' ' A' ' 46' ' ' THR . 38.4 m -129.51 120.68 25.8 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 54' ' ' VAL . 33.4 m -127.7 170.42 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.881 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -108.14 157.6 18.15 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.857 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -132.48 152.37 51.56 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.104 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.543 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -120.88 109.19 14.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.725 HG22 ' CB ' ' A' ' 68' ' ' SER . 12.4 t -111.47 73.91 1.11 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.725 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 6.6 Cg_endo -67.35 -7.52 19.32 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.317 1.167 . . . . 0.0 111.389 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' O ' ' SD ' ' A' ' 12' ' ' MET . . . -50.08 -42.34 39.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 65.4 mmm -152.2 163.38 39.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.446 -1.032 . . . . 0.0 109.134 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.519 ' O ' HG23 ' A' ' 13' ' ' THR . 2.3 t -174.14 108.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 111.181 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 1.3 p -167.26 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 110.347 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 177.2 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.748 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -123.76 22.79 8.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 81.8 m -121.23 -66.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.002 -1.061 . . . . 0.0 110.25 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 5.2 Cg_exo -52.87 -39.04 79.34 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -61.36 -38.3 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.641 0.734 . . . . 0.0 109.182 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 23.7 m -61.56 -22.08 64.86 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.032 HG13 ' HB ' ' A' ' 61' ' ' THR . 11.9 t -77.11 -31.61 18.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.716 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.17 -36.83 85.44 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -74.01 -33.94 63.97 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.539 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -62.31 -49.86 73.96 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 110.794 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -65.45 -47.01 77.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 109.863 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.604 ' HB2' HG21 ' A' ' 34' ' ' VAL . 8.8 t -61.1 -17.54 53.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 108.676 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -103.51 -13.22 16.67 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.46 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.784 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.8 t -47.54 -57.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.448 -0.782 . . . . 0.0 109.602 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 154.67 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.616 0.722 . . . . 0.0 110.248 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.47 -22.75 73.34 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 25' ' ' LEU . 22.9 t -42.63 121.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.41 -1.053 . . . . 0.0 109.703 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -109.53 -14.8 14.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.571 0.701 . . . . 0.0 109.782 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.695 ' O ' HG13 ' A' ' 45' ' ' VAL . 21.5 tttt -154.3 155.69 35.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.451 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.964 HG13 HG22 ' A' ' 45' ' ' VAL . 3.7 t -149.33 153.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -170.45 94.81 0.23 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -107.63 -152.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.967 0.889 . . . . 0.0 111.742 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -146.59 108.73 0.46 Allowed Glycine 0 N--CA 1.48 1.582 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -81.92 62.25 5.62 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.535 0.683 . . . . 0.0 110.749 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.8 tp10 179.31 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.22 40.51 2.05 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 25.08 79.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.922 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 37' ' ' GLY . 4.3 tp10 -146.09 113.01 6.08 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.395 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -112.32 115.06 28.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.716 -1.24 . . . . 0.0 110.969 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.2 t -108.65 121.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 107.756 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.964 HG22 HG13 ' A' ' 34' ' ' VAL . 75.2 t -136.97 155.03 32.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.226 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.92 157.21 24.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' THR . 49.0 p90 -172.8 178.84 2.5 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 117.891 -1.524 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 70.2 m-20 -106.69 120.52 42.21 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD2' ' CB ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -62.75 -8.37 6.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.689 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 1' ' ' ALA . 2.4 p -66.93 -27.27 67.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.01 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -128.07 -8.39 5.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.001 -1.062 . . . . 0.0 111.129 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -146.02 -167.67 2.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 110.021 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.629 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -178.24 155.53 0.92 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 110.033 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.047 ' CG1' HG21 ' A' ' 70' ' ' VAL . 24.9 t -43.05 -39.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 2.7 tt0 -60.9 -46.07 92.1 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.506 -0.746 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.07 -22.04 65.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.412 -0.805 . . . . 0.0 111.028 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 54' ' ' VAL . 33.8 mt -73.99 -56.75 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.653 -1.279 . . . . 0.0 108.319 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.619 ' N ' HD21 ' A' ' 7' ' ' LEU . 2.5 m -65.1 -20.45 66.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.69 -28.34 33.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.784 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.5 -41.87 79.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.905 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.032 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.0 t -74.77 -36.67 62.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.44 -27.19 67.32 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.1 -19.44 24.31 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.99 -18.74 61.32 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.17 27.31 3.46 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 21.0 m-85 -138.2 98.41 9.29 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 110.856 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -58.08 93.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.611 1.322 . . . . 0.0 109.658 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.725 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -108.45 -161.44 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 111.317 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.525 ' HA ' HG21 ' A' ' 58' ' ' THR . 45.5 p -156.95 -169.48 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 ' CG1' ' A' ' 54' ' ' VAL . 5.7 p -135.61 158.87 40.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.886 -1.134 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.881 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.7 OUTLIER -171.54 47.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.756 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' N ' HG22 ' A' ' 6' ' ' THR . 1.4 pp0? . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.112 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.902 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.09 0.471 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.7 89.94 1.44 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.673 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 18.6 pt20 -122.21 165.16 16.59 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.792 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 45' ' ' VAL . 11.9 m -128.81 136.1 50.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.681 -0.637 . . . . 0.0 109.694 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 57' ' ' LEU . 21.0 m -130.32 167.46 25.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.531 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -106.51 157.15 17.87 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.92 149.27 51.28 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.355 -1.338 . . . . 0.0 111.219 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -119.94 113.98 21.37 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.756 -0.59 . . . . 0.0 109.45 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.991 HG22 ' HB2' ' A' ' 68' ' ' SER . 2.3 t -117.06 78.11 9.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.026 -1.046 . . . . 0.0 111.062 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 13.6 Cg_endo -80.7 40.52 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.234 1.289 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.36 2.46 10.45 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -159.49 21.2 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.076 -1.249 . . . . 0.0 110.579 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 39' ' ' GLU . 15.5 m -47.19 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -179.8 112.15 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 108.55 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -26.17 77.01 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 174.74 -49.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.221 -0.925 . . . . 0.0 110.593 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 32.7 m -97.62 -39.41 0.25 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.644 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 6.2 Cg_exo -59.89 -38.57 78.41 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 N-CA-C 107.95 -1.596 . . . . 0.0 107.95 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 10.2 mt -63.89 -29.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 6.8 m -65.4 -23.77 67.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.925 HG11 HG21 ' A' ' 9' ' ' VAL . 59.8 t -70.21 -29.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.37 -39.26 85.66 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 23.0 mmtt -71.04 -29.85 65.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -43.65 95.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.76 -0.588 . . . . 0.0 110.367 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -74.84 -36.23 62.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.064 -1.022 . . . . 0.0 109.451 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.798 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.31 -19.85 65.7 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.4 mptp? -115.21 1.76 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.171 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.0 p -52.64 -40.66 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.8 OUTLIER 165.0 -83.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.425 -0.797 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -99.49 5.96 58.96 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.06 -1.067 . . . . 0.0 110.752 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.798 HG11 ' C ' ' A' ' 26' ' ' SER . 8.1 p -39.49 129.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -1.077 . . . . 0.0 110.189 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.5 t -108.53 -10.99 15.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.469 0.652 . . . . 0.0 109.665 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.63 168.22 18.35 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.014 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 10.2 p -165.5 152.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.962 . . . . 0.0 110.953 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 44' ' ' VAL . 28.1 t0 -163.32 93.69 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.665 HG13 ' CA ' ' A' ' 43' ' ' ALA . 20.8 t -108.11 174.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 111.746 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.554 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -130.16 121.44 3.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 16.3 p90 -55.89 -145.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 1.033 ' O ' HG23 ' A' ' 13' ' ' THR . 14.1 tp10 1.13 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -36.01 -63.1 0.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.318 -0.864 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.689 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 8.2 tmm_? 103.98 77.47 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 C-N-CA 123.306 0.642 . . . . 0.0 111.17 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.0 tm-20 -168.51 117.56 0.72 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.508 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.665 ' CA ' HG13 ' A' ' 36' ' ' VAL . . . -112.15 118.93 36.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.927 -1.108 . . . . 0.0 111.329 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 35' ' ' ASP . 4.2 p -107.35 121.93 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.78 -1.2 . . . . 0.0 108.017 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 4' ' ' THR . 3.5 p -129.41 159.02 41.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.79 -1.164 . . . . 0.0 113.184 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -118.01 154.69 31.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -171.83 179.61 2.71 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.232 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.605 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 3.4 m-20 -106.79 117.16 33.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 1.5 t70 -64.15 -7.14 8.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 110.883 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.22 -26.2 61.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.935 -1.103 . . . . 0.0 110.196 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -0.54 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.197 -0.94 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -159.41 -166.39 1.78 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.44 159.16 0.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.094 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.0 p -41.08 -42.44 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.599 -0.688 . . . . 0.0 110.0 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -60.79 -46.78 89.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.256 -0.902 . . . . 0.0 109.682 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.87 -23.54 67.26 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.974 HD12 ' HA ' ' A' ' 54' ' ' VAL . 35.3 mt -72.49 -52.89 13.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.667 -1.271 . . . . 0.0 108.265 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 69' ' ' SER . 2.1 m -63.94 -21.1 66.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 ttpt -81.47 -26.58 35.13 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -71.07 -43.46 67.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.209 -0.932 . . . . 0.0 108.94 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.686 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.23 -38.7 63.46 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.15 -27.14 66.85 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -90.21 -19.68 23.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.172 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.79 -16.16 60.72 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.604 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 112.03 27.26 4.05 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 21.0 m-85 -138.84 97.89 8.81 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.617 -0.931 . . . . 0.0 110.515 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 5.3 Cg_exo -55.52 96.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.59 1.311 . . . . 0.0 109.4 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.991 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.91 -167.19 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 111.536 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.6 OUTLIER -156.56 -172.22 3.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.094 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.8 p -133.63 161.8 40.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.595 -1.315 . . . . 0.0 111.444 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -148.07 54.76 1.04 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.721 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 110.238 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.44 87.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -127.08 153.02 46.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.05 -1.032 . . . . 0.0 111.624 -177.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -118.29 154.27 32.57 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.407 0.622 . . . . 0.0 109.634 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 72' ' ' GLN . 17.5 m -145.76 170.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.342 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.913 ' OG1' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -108.55 156.48 19.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.051 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.61 147.92 51.52 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.938 -1.505 . . . . 0.0 111.308 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -116.99 112.16 20.58 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.733 HG21 HG11 ' A' ' 21' ' ' VAL . 71.6 t -109.6 73.4 0.63 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.97 -1.081 . . . . 0.0 111.782 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.9 Cg_endo -58.6 -13.46 17.55 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.477 1.251 . . . . 0.0 110.073 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.64 15.24 31.7 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.604 ' HG2' ' CG ' ' A' ' 41' ' ' ARG . 2.2 ppp? -96.71 -164.71 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -1.221 . . . . 0.0 109.435 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.554 ' N ' ' SD ' ' A' ' 12' ' ' MET . 1.6 t 178.5 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.838 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 2.1 p -158.59 -154.16 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.536 -1.352 . . . . 0.0 110.673 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 14' ' ' CYS . . . -84.93 42.5 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.951 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.81 -36.83 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.906 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 13.8 m -89.95 -44.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 0.0 111.757 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.63 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 14.0 Cg_endo -75.96 -43.94 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 N-CA-C 107.902 -1.615 . . . . 0.0 107.902 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.61 HG13 ' CE1' ' A' ' 38' ' ' PHE . 2.9 tt -55.66 -38.3 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.904 0.859 . . . . 0.0 109.635 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 5.2 m -62.8 -23.83 67.44 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.943 0.878 . . . . 0.0 108.636 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG13 ' HB ' ' A' ' 61' ' ' THR . 32.6 t -69.32 -31.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB2' HG21 ' A' ' 36' ' ' VAL . 3.8 tttt -67.65 -41.78 83.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.55 -24.86 65.58 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.378 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -70.63 -54.7 10.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.803 -0.561 . . . . 0.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -59.66 -35.94 75.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.069 -1.02 . . . . 0.0 109.812 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -22.71 60.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.504 -0.748 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -100.81 -5.7 25.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.895 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -46.61 -81.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.749 ' N ' HG12 ' A' ' 28' ' ' VAL . 4.0 tt0 169.93 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.348 -0.845 . . . . 0.0 109.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.582 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -104.95 -21.33 9.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 25' ' ' LEU . 74.1 t -42.2 126.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -1.068 . . . . 0.0 109.79 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -113.13 -9.82 13.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -147.85 156.33 42.6 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.008 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.938 ' HA ' HG12 ' A' ' 45' ' ' VAL . 6.1 p -154.86 129.69 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.683 0.754 . . . . 0.0 111.01 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.68 89.66 1.57 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 22' ' ' LYS . 2.2 m -108.32 -160.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.962 0.887 . . . . 0.0 111.47 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.57 110.06 0.55 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 4.9 m-30 -52.7 -98.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.019 -0.695 . . . . 0.0 109.927 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 1.2 mm-40 -54.42 -12.7 0.74 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.606 -1.309 . . . . 0.0 111.643 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.3 mptt -81.85 -24.83 35.57 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.79 -1.194 . . . . 0.0 111.002 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.604 ' CG ' ' HG2' ' A' ' 12' ' ' MET . 7.4 tmm_? 68.41 63.52 0.35 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.581 -0.699 . . . . 0.0 110.655 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.7 tt0 -162.06 113.95 1.69 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.229 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.73 113.6 26.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.96 -1.087 . . . . 0.0 110.834 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.913 HG22 ' OG1' ' A' ' 6' ' ' THR . 89.2 t -114.31 121.76 67.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.631 -1.293 . . . . 0.0 108.967 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.938 HG12 ' HA ' ' A' ' 34' ' ' VAL . 25.8 m -137.66 -179.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 118.234 -1.386 . . . . 0.0 113.789 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.61 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.8 m -127.74 158.41 37.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.8 p90 -171.49 178.94 3.04 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.143 -1.423 . . . . 0.0 111.097 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.5 m-20 -107.41 117.7 34.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -63.25 -8.64 8.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 110.958 -177.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -74.06 -26.73 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.629 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -121.33 -13.22 8.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.498 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.582 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.14 -165.68 2.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.473 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.48 159.07 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 57' ' ' LEU . 10.9 p -43.64 -37.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.773 . . . . 0.0 109.763 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -64.85 -44.22 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -0.856 . . . . 0.0 109.357 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 10.2 mtpt -67.68 -22.4 65.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.413 -0.805 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.8 mt -74.36 -58.51 3.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.664 -1.273 . . . . 0.0 108.413 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.612 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.3 m -63.07 -21.53 66.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 8.4 ttmt -80.27 -27.97 38.49 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -68.04 -43.13 79.41 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.306 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.761 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.4 t -74.19 -38.01 63.76 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.72 -27.71 65.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -86.34 -23.4 26.24 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -73.3 -14.5 61.32 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.74 30.22 4.1 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 23.4 m-85 -135.82 94.96 14.27 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.703 -0.88 . . . . 0.0 110.514 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.09 93.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.7 1.369 . . . . 0.0 109.758 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.537 ' CB ' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -108.75 -169.06 1.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 111.139 -179.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.438 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -146.48 -174.99 4.61 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.051 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.8 p -139.86 150.44 22.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.705 -1.247 . . . . 0.0 112.654 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB3' HG22 ' A' ' 6' ' ' THR . 0.6 OUTLIER -134.14 77.62 1.71 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.435 0.636 . . . . 0.0 109.513 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.8 pt20 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.328 0.585 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -150.4 88.4 1.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 21.6 mm-40 -120.98 155.83 33.45 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.623 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.638 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 5.2 t -136.39 144.23 44.42 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.46 174.31 12.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.664 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 72' ' ' GLN . 12.1 t -107.98 153.49 23.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -130.41 150.26 51.71 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.444 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -118.25 115.94 25.76 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.62 HG13 ' CB ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -110.99 76.18 1.2 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.019 -1.051 . . . . 0.0 111.49 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 1.2 Cg_endo -62.8 -15.23 45.61 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.466 1.245 . . . . 0.0 111.355 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -55.65 -21.78 30.04 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -144.79 -174.5 4.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.955 . . . . 0.0 109.691 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 178.58 75.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 110.724 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -178.89 -178.61 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.888 -1.133 . . . . 0.0 110.047 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.37 75.48 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 0.0 109.822 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.53 -45.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.118 -0.989 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 5.3 m -96.84 -45.03 0.25 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.959 -1.088 . . . . 0.0 113.145 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -59.23 -38.23 86.91 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 N-CA-C 108.231 -1.488 . . . . 0.0 108.231 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.447 HG13 ' HB3' ' A' ' 38' ' ' PHE . 2.2 tt -63.62 -35.23 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.18 0.99 . . . . 0.0 108.575 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 6.8 m -62.65 -20.75 65.12 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.804 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.9 t -73.81 -32.65 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.624 ' HG3' HG12 ' A' ' 34' ' ' VAL . 18.6 tttm -64.61 -36.13 83.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 26' ' ' SER . 0.1 OUTLIER -66.4 -37.54 85.47 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.25 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.505 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . . . -57.56 -59.6 4.92 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.821 -0.55 . . . . 0.0 110.357 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.31 -26.78 68.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 109.572 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 12.9 t -63.7 -25.73 68.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.93 7.3 7.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.666 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.2 p -49.86 -49.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.826 -1.171 . . . . 0.0 110.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.9 -86.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.263 -0.898 . . . . 0.0 111.318 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -84.1 1.95 88.22 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.046 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 25' ' ' LEU . 6.5 p -43.99 131.18 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.835 -1.391 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.57 -15.43 13.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -164.35 160.1 20.47 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.916 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.624 HG12 ' HG3' ' A' ' 22' ' ' LYS . 14.1 t -150.96 151.99 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 110.318 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -169.95 96.24 0.28 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 22' ' ' LYS . 3.2 m -107.88 -154.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.025 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' VAL . . . -144.87 109.5 0.52 Allowed Glycine 0 N--CA 1.483 1.767 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.621 ' O ' ' CD2' ' A' ' 38' ' ' PHE . 49.0 p90 -83.46 57.81 4.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.829 . . . . 0.0 110.437 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -179.01 -60.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.27 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -78.99 2.65 19.67 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 9' ' ' VAL . 8.7 tmm_? 60.46 84.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.771 -0.581 . . . . 0.0 111.252 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' GLY . 22.5 tt0 -167.17 120.38 0.97 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.977 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -113.65 118.21 33.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.022 -1.049 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 2.3 t -107.94 124.45 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.748 -1.22 . . . . 0.0 107.825 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 57' ' ' LEU . 8.7 p -134.49 150.07 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.478 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.638 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.7 m -112.95 157.68 21.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.3 p90 -171.44 -176.16 1.78 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.346 -1.342 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -106.79 113.52 27.07 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -59.72 -10.09 3.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.192 -177.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 48' ' ' ASP . 10.0 t -70.6 -28.01 64.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 110.643 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 11.1 mtpt -124.13 -14.08 7.12 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.88 -1.137 . . . . 0.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -141.24 -170.64 3.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -0.898 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.5 p 179.42 160.14 0.73 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.162 -0.961 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.047 HG23 HG21 ' A' ' 70' ' ' VAL . 3.9 p -41.01 -44.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.563 -0.711 . . . . 0.0 109.914 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.547 ' N ' HG13 ' A' ' 54' ' ' VAL . 32.5 tt0 -57.37 -47.77 80.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -64.11 -27.09 68.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.571 -0.705 . . . . 0.0 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.5 mt -70.43 -55.55 8.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.798 -1.189 . . . . 0.0 108.718 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' SER . 6.5 m -64.34 -20.72 66.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -83.37 -24.85 31.85 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.42 -41.3 69.69 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.62 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.544 ' HB ' HG13 ' A' ' 21' ' ' VAL . 10.7 t -75.16 -39.4 60.37 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.539 ' N ' HG23 ' A' ' 61' ' ' THR . . . -56.09 -32.27 64.0 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -86.27 -21.78 27.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.528 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.98 60.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.212 -0.93 . . . . 0.0 108.734 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 104.24 31.77 4.55 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.434 -1.867 . . . . 0.0 108.434 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.666 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 24.5 m-85 -138.77 89.75 12.96 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 122.015 -0.697 . . . . 0.0 110.488 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -54.85 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.634 1.333 . . . . 0.0 109.642 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.04 -168.66 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 111.254 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.541 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -152.99 -179.19 7.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 54' ' ' VAL . 7.4 p -134.32 156.25 40.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 120.371 -1.456 . . . . 0.0 111.863 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.681 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -162.65 43.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.129 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.701 ' C ' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.906 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.199 0.523 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.5 87.5 1.58 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 25.6 mm-40 -109.83 157.04 19.6 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.001 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.511 HG23 ' OG1' ' A' ' 46' ' ' THR . 13.8 m -135.77 115.28 12.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.648 HG11 ' HB ' ' A' ' 54' ' ' VAL . 11.4 m -121.84 168.05 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.85 HG23 ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -107.98 159.01 16.88 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.016 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.2 mp -131.89 152.08 51.28 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.324 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -122.74 106.1 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.901 HG11 HG21 ' A' ' 21' ' ' VAL . 10.6 p -112.24 88.56 10.76 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.026 -1.046 . . . . 0.0 111.937 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 3.9 Cg_endo -68.64 -1.19 7.1 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.592 1.312 . . . . 0.0 111.338 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.92 12.67 47.83 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.604 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -106.99 -164.45 0.99 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.336 -1.097 . . . . 0.0 110.338 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.794 HG22 ' SG ' ' A' ' 17' ' ' CYS . 1.7 t 179.77 -4.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 18' ' ' PRO . 13.8 p -172.2 -158.77 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 119.72 -1.863 . . . . 0.0 110.273 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 62.57 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.203 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -162.27 -42.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 111.333 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 13' ' ' THR . 10.3 p -108.09 -25.05 0.17 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.657 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 12.5 Cg_endo -78.28 -37.76 0.7 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 N-CA-C 106.75 -2.058 . . . . 0.0 106.75 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.576 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 72.0 mt -63.88 -29.93 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.151 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 66' ' ' TYR . 9.4 m -65.91 -20.65 66.29 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.982 HG13 ' OG1' ' A' ' 61' ' ' THR . 58.1 t -69.53 -33.23 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -67.92 -37.46 81.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -62.61 -32.17 73.14 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.103 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -62.68 -56.3 18.98 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.76 -0.588 . . . . 0.0 110.543 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -64.74 -24.1 67.45 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -76.68 -21.41 55.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -111.48 1.06 16.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.483 -0.761 . . . . 0.0 109.91 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.6 t -46.61 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.084 -1.01 . . . . 0.0 109.418 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.796 ' N ' HG12 ' A' ' 28' ' ' VAL . 10.4 pt-20 179.44 -41.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 110.802 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 29' ' ' GLU . . . -112.54 -10.26 17.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -50.45 125.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 110.028 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.61 14.86 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.628 0.727 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.93 160.51 41.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 22' ' ' LYS . 7.3 p -155.8 163.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.84 -1.163 . . . . 0.0 111.938 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.69 143.59 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.89 HG13 ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -108.95 127.88 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.042 . . . . 0.0 112.08 -177.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -114.75 49.73 0.83 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -25.76 -118.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.2 tp10 -41.32 -35.82 0.71 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.55 -1.344 . . . . 0.0 110.718 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -86.43 38.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.0 110.529 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.562 ' HB3' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 8.31 86.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 5.8 tt0 -162.07 110.87 1.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.014 -1.054 . . . . 0.0 110.715 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -111.58 120.23 41.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 110.248 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.6 t -107.94 122.03 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.861 -1.15 . . . . 0.0 108.037 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 25' ' ' LEU . 24.6 t -132.94 152.66 36.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 118.141 -1.424 . . . . 0.0 113.332 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -114.59 155.31 26.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 57' ' ' LEU . 48.7 p90 -172.51 -178.86 2.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.595 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -106.75 117.13 33.23 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 178.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 24.7 t0 -70.78 0.54 6.91 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.255 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' HG3' ' A' ' 51' ' ' LYS . 14.0 t -64.62 -16.68 63.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.93 -1.107 . . . . 0.0 109.599 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG3' HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -138.32 -43.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.05 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -104.5 -169.34 1.61 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.766 -0.584 . . . . 0.0 109.721 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.639 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.5 t -178.35 158.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.926 ' HA ' HD12 ' A' ' 57' ' ' LEU . 2.7 p -41.94 -42.72 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.506 ' N ' HG13 ' A' ' 54' ' ' VAL . 38.0 tt0 -60.61 -45.83 92.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 108.957 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.415 -0.803 . . . . 0.0 111.075 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 54' ' ' VAL . 34.8 mt -73.04 -55.82 5.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.586 -1.321 . . . . 0.0 108.302 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.553 ' N ' HD21 ' A' ' 7' ' ' LEU . 54.4 m -62.76 -20.56 65.09 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -81.49 -28.86 33.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.899 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -69.05 -39.96 78.85 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.283 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.982 ' OG1' HG13 ' A' ' 21' ' ' VAL . 13.1 t -75.46 -41.0 56.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HG23 ' A' ' 61' ' ' THR . . . -58.07 -26.49 62.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.53 -21.84 21.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.857 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.21 -17.49 61.35 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.159 -0.963 . . . . 0.0 108.649 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.51 24.85 4.24 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.618 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 20.3 m-85 -138.66 88.66 13.94 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.631 -0.923 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.3 Cg_exo -54.84 95.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.853 1.449 . . . . 0.0 110.194 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.581 ' OG ' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -108.5 -163.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 110.861 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -149.04 -171.44 3.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.016 HG23 ' CD1' ' A' ' 7' ' ' LEU . 4.0 p -139.1 153.44 24.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 111.826 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HG3' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -155.83 39.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.585 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 71' ' ' LYS . 79.1 mt-30 . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.392 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.17 88.22 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -110.01 156.66 20.21 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.683 -177.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.552 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 23.4 m -135.1 137.24 42.64 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.597 -0.689 . . . . 0.0 109.258 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' CG1' ' A' ' 54' ' ' VAL . 27.9 m -146.77 175.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.84 ' O ' HD12 ' A' ' 7' ' ' LEU . 12.2 t -109.59 162.85 14.01 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.864 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.3 mp -130.68 138.99 50.3 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.074 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -112.91 93.8 4.59 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.789 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 ' SD ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -115.73 101.47 54.13 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.178 -0.952 . . . . 0.0 111.262 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 9.7 Cg_endo -76.36 5.37 4.7 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.628 1.331 . . . . 0.0 111.066 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 67' ' ' PRO . . . -82.08 8.29 60.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.932 ' SD ' HG21 ' A' ' 21' ' ' VAL . 3.8 ptm -139.87 156.97 46.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.4 -1.059 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 12' ' ' MET . 2.8 t 179.14 39.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -170.46 -178.27 2.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -79.5 76.26 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.722 -1.236 . . . . 0.0 109.807 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.88 -51.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.055 -1.028 . . . . 0.0 111.357 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.66 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.0 m -90.35 -45.8 0.39 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.894 -1.129 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.676 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 17.6 Cg_exo -59.43 -64.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 122.838 0.915 . . . . 0.0 110.759 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 38' ' ' PHE . 26.6 mt -45.48 -27.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.925 -1.109 . . . . 0.0 110.296 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 90.4 m -70.44 -38.17 74.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.801 -1.187 . . . . 0.0 108.771 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.978 HG22 ' OG1' ' A' ' 61' ' ' THR . 19.7 t -60.01 -26.5 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 36' ' ' VAL . 9.9 tptm -71.83 -43.76 65.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -66.21 -26.91 67.6 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.703 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . . . -66.63 -48.68 68.69 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.657 -0.652 . . . . 0.0 110.811 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.677 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -72.91 -41.49 64.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.107 -0.996 . . . . 0.0 110.345 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -62.21 -24.07 67.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.538 -0.726 . . . . 0.0 109.276 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -122.24 7.62 9.68 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.434 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.1 p -50.89 -48.13 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.478 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.26 -84.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.398 -0.814 . . . . 0.0 110.778 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.572 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -85.23 0.07 88.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.843 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.571 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.6 p -44.14 127.93 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.888 -1.36 . . . . 0.0 110.0 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -110.29 -14.39 14.16 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.669 0.747 . . . . 0.0 109.116 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 2.9 tttm -162.57 161.63 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.713 HG23 HG22 ' A' ' 45' ' ' VAL . 9.2 p -150.65 154.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 110.725 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 15.0 t70 -168.99 82.91 0.14 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 22' ' ' LYS . 4.7 m -109.23 -163.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.001 0.905 . . . . 0.0 111.475 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.15 93.19 0.15 Allowed Glycine 0 C--N 1.298 -1.552 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.676 ' CA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 p90 -54.93 -54.66 39.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.877 . . . . 0.0 109.675 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.14 -24.75 65.04 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.025 -1.047 . . . . 0.0 110.183 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 0.27 57.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HA ' ' CE ' ' A' ' 12' ' ' MET . 0.2 OUTLIER 46.69 70.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.371 -0.831 . . . . 0.0 111.079 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.49 119.79 0.79 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.41 -0.806 . . . . 0.0 109.981 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -108.19 119.1 38.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.798 -1.188 . . . . 0.0 112.356 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -110.13 110.22 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.713 HG22 HG23 ' A' ' 34' ' ' VAL . 60.2 t -130.45 150.79 34.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.309 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.4 m -109.68 159.43 17.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.752 ' CE2' HD11 ' A' ' 57' ' ' LEU . 54.0 p90 -171.81 -174.86 1.41 Allowed 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.055 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 4.2 m-20 -106.61 126.82 52.75 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 1' ' ' ALA . 5.9 p-10 -75.01 10.75 1.33 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.61 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.776 HG23 ' HB1' ' A' ' 1' ' ' ALA . 61.5 p -87.28 -36.34 17.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -118.68 -11.27 9.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.088 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -135.7 -174.36 3.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 3.7 t -178.44 154.48 0.8 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.895 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.901 ' HA ' HD12 ' A' ' 57' ' ' LEU . 34.3 m -42.59 -38.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.253 -0.904 . . . . 0.0 109.488 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' N ' HG23 ' A' ' 54' ' ' VAL . 2.6 tt0 -64.01 -47.25 81.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -62.0 -26.91 68.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 54' ' ' VAL . 45.7 mt -69.65 -54.68 12.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.856 -1.152 . . . . 0.0 108.306 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.75 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.0 OUTLIER -65.55 -17.34 64.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.6 ttpt -86.15 -21.64 27.46 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.474 -0.766 . . . . 0.0 109.183 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -76.63 -40.15 50.2 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.576 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.978 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.9 t -79.94 -36.26 36.49 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.46 -27.72 69.18 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 m-20 -84.76 -20.29 31.3 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -19.56 60.66 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 114.36 28.76 2.93 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 21.6 m-85 -134.83 105.0 10.64 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.717 -0.872 . . . . 0.0 110.642 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 11' ' ' GLY . 7.6 Cg_exo -49.39 101.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.75 ' OG ' HG22 ' A' ' 58' ' ' THR . 53.0 p -107.82 158.22 17.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 112.05 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 1.3 t -126.84 -178.15 4.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.864 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.9 p -142.91 150.25 18.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 120.761 -1.212 . . . . 0.0 111.069 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.759 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -168.26 51.09 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.801 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.5 tt0 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 117.955 -1.022 . . . . 0.0 111.368 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.58 86.07 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.92 153.6 23.32 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.231 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.521 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 19.0 m -135.15 132.26 37.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.539 -0.725 . . . . 0.0 109.918 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.838 HG11 HG12 ' A' ' 54' ' ' VAL . 21.5 m -135.51 171.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.13 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.44 154.98 20.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 ' HB ' ' A' ' 70' ' ' VAL . 1.2 mp -130.01 157.12 43.22 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.155 -1.418 . . . . 0.0 111.214 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -127.31 112.15 14.72 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.358 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.854 HG21 HG11 ' A' ' 21' ' ' VAL . 62.0 t -116.85 74.56 6.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.923 -1.11 . . . . 0.0 111.408 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 Cg_endo -67.27 -5.52 14.02 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.591 1.311 . . . . 0.0 111.226 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -54.39 -23.16 25.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.862 ' HE1' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -144.5 -178.8 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 109.279 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 12' ' ' MET . 0.9 OUTLIER 177.91 75.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.021 -1.05 . . . . 0.0 110.721 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -149.33 -55.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 117.893 -1.523 . . . . 0.0 111.603 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 176.67 -27.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.413 -1.429 . . . . 0.0 111.363 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . . . -115.24 -40.42 3.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.611 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' C ' ' HE2' ' A' ' 12' ' ' MET . 7.6 m -66.3 -47.45 59.99 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.124 -0.985 . . . . 0.0 111.202 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 2.1 Cg_endo -62.54 -37.86 55.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.72 HD12 ' HB3' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -68.57 -24.6 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 21.6 m -62.97 -20.12 64.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.854 HG11 HG21 ' A' ' 9' ' ' VAL . 41.6 t -74.18 -33.45 35.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -62.48 -35.5 79.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' CE ' ' HE3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -67.14 -44.51 79.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.987 0.899 . . . . 0.0 109.837 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -57.35 -52.35 65.7 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -63.74 -41.22 98.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.017 -1.052 . . . . 0.0 109.854 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.527 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -63.11 -21.41 66.17 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HE3' ' CE ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -108.44 -2.11 19.3 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.414 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.04 HG23 ' HB2' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -46.01 -53.16 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -0.915 . . . . 0.0 109.541 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 153.62 -72.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.79 0.805 . . . . 0.0 109.562 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -83.55 -16.72 67.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.4 p -38.75 122.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 110.348 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 m -112.68 -12.7 13.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.627 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 1.2 tttt -143.62 155.64 44.33 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.206 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.686 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.3 t -151.23 129.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.662 0.744 . . . . 0.0 110.707 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 65.3 m-20 -155.02 89.2 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 43' ' ' ALA . 2.4 m -109.42 -159.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 122.15 0.976 . . . . 0.0 111.816 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 40' ' ' LYS . . . -149.93 113.93 0.63 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HB3' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -49.99 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.731 -0.864 . . . . 0.0 111.825 -178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -33.59 -33.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.337 -0.852 . . . . 0.0 111.372 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 41' ' ' ARG . 16.2 ptmt -89.6 51.41 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.501 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.761 ' NH1' ' HB1' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -13.42 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.411 0.624 . . . . 0.0 112.557 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' LYS . 18.3 mt-10 -152.22 112.79 4.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 110.156 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.21 115.67 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.903 -1.123 . . . . 0.0 111.095 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.13 ' CG2' HG22 ' A' ' 6' ' ' THR . 8.2 t -107.53 116.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.642 -1.286 . . . . 0.0 108.298 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CB ' ' A' ' 25' ' ' LEU . 11.8 m -132.43 162.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.245 -1.382 . . . . 0.0 113.354 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.627 ' HB ' ' CB ' ' A' ' 33' ' ' LYS . 1.6 m -119.07 162.35 18.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -172.17 -175.22 1.39 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.959 -1.496 . . . . 0.0 111.815 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.29 116.95 32.82 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 7.8 p-10 -67.91 -2.07 6.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.373 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -24.74 44.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.008 -1.058 . . . . 0.0 110.614 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -125.72 -3.33 7.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.048 -1.033 . . . . 0.0 110.463 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -156.43 -168.42 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.634 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.6 p 179.7 164.71 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 m -43.2 -33.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.361 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' N ' HG23 ' A' ' 54' ' ' VAL . 3.0 tt0 -65.77 -47.87 73.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.472 -0.768 . . . . 0.0 109.148 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.67 -24.08 66.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.645 -0.66 . . . . 0.0 110.763 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 54' ' ' VAL . 41.7 mt -71.98 -55.82 6.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.814 -1.179 . . . . 0.0 108.379 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 1.2 m -63.96 -19.89 65.47 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 1.6 ttmt -80.81 -27.37 36.6 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.04 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -69.73 -43.15 72.93 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.656 -0.817 . . . . 0.0 109.274 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.585 ' HB ' HG13 ' A' ' 21' ' ' VAL . 14.8 t -75.66 -37.38 59.68 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 61' ' ' THR . . . -60.25 -26.52 66.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.39 -21.63 22.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.81 -15.86 61.62 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.613 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 108.28 30.94 3.68 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CE1' ' HG2' ' A' ' 12' ' ' MET . 23.3 m-85 -138.29 102.74 8.06 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.639 -0.918 . . . . 0.0 110.603 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.09 98.92 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.564 1.297 . . . . 0.0 109.396 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.791 ' CB ' HG22 ' A' ' 9' ' ' VAL . 12.4 p -107.95 -166.39 1.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.235 -0.916 . . . . 0.0 111.604 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.6 t -163.84 126.74 2.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 7' ' ' LEU . 6.6 p -91.69 161.84 2.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.868 -1.145 . . . . 0.0 110.958 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLN . 3.9 ptmt -145.86 42.22 1.22 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.563 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.2 mp0 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.839 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -147.45 89.72 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 3.9 mm100 -109.61 158.28 18.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.76 0.79 . . . . 0.0 111.627 -177.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 45' ' ' VAL . 96.9 m -137.08 141.74 42.36 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.659 -0.651 . . . . 0.0 109.398 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.807 HG11 ' CG1' ' A' ' 54' ' ' VAL . 4.7 m -146.1 165.54 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.001 . . . . 0.0 109.766 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.958 HG22 ' O ' ' A' ' 72' ' ' GLN . 13.6 t -107.42 151.84 25.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.733 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -125.95 156.81 39.2 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 120.957 -1.09 . . . . 0.0 110.668 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -137.24 107.47 6.41 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.994 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 68' ' ' SER . 1.9 t -108.22 102.41 46.31 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.176 -0.952 . . . . 0.0 110.776 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.0 Cg_endo -71.11 9.95 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.366 1.377 . . . . 0.0 112.4 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.51 -5.71 42.15 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.508 -1.37 . . . . 0.0 110.167 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.712 ' HE1' ' HB3' ' A' ' 17' ' ' CYS . 4.2 mmm -93.39 151.25 19.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.207 -1.172 . . . . 0.0 110.179 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 12' ' ' MET . 9.3 t -179.04 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.134 -0.979 . . . . 0.0 111.543 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 179.03 162.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.678 -1.264 . . . . 0.0 109.536 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -71.16 79.86 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.708 -1.245 . . . . 0.0 110.483 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 178.13 -56.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.007 -1.058 . . . . 0.0 111.007 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 5.0 m -86.92 -45.15 0.54 Allowed Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.236 -0.915 . . . . 0.0 111.873 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.634 ' HB2' ' CA ' ' A' ' 38' ' ' PHE . 21.1 Cg_exo -54.8 -52.19 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 N-CA-C 108.911 -1.226 . . . . 0.0 108.911 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 38' ' ' PHE . 27.6 mt -59.17 -23.82 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.632 -0.667 . . . . 0.0 110.105 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 37.2 m -65.75 -26.74 67.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 108.544 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 61' ' ' THR . 33.1 t -69.89 -26.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.738 ' HD2' HG22 ' A' ' 36' ' ' VAL . 14.2 tttt -68.58 -44.42 74.44 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 3.1 mptp? -67.45 -29.61 69.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.363 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -59.29 -45.08 92.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.278 0.561 . . . . 0.0 109.891 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.79 HD22 ' HB ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -66.9 -47.87 70.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.861 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.44 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 8.3 t -66.12 -11.46 49.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.479 -0.763 . . . . 0.0 109.006 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -110.58 -9.3 14.56 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.069 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.0 t -48.79 -58.34 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.106 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 154.79 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.606 0.717 . . . . 0.0 110.072 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -80.01 -8.07 87.97 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 25' ' ' LEU . 2.5 t -43.72 122.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 109.38 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.37 -11.17 15.23 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.668 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -156.23 161.17 40.3 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.564 HG13 HD13 ' A' ' 25' ' ' LEU . 12.9 t -150.0 152.27 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.028 -1.045 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 6.4 t0 -167.69 82.8 0.2 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 22' ' ' LYS . 3.2 m -109.24 -165.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 111.773 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -152.07 95.35 0.16 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -46.06 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.707 -0.878 . . . . 0.0 111.666 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.2 mm-40 1.53 -75.31 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.201 0.524 . . . . 0.0 112.035 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -62.49 -82.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 108.734 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 143.49 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 122.864 0.466 . . . . 0.0 109.91 178.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 19.5 mt-10 -134.29 116.78 15.67 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -110.18 115.38 29.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 0.0 111.606 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 3.0 t -106.83 124.16 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.713 -1.242 . . . . 0.0 107.71 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.79 ' HB ' HD22 ' A' ' 25' ' ' LEU . 3.9 p -139.34 161.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.457 -1.297 . . . . 0.0 113.536 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.8 m -121.39 157.66 29.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.835 ' CE2' HD11 ' A' ' 57' ' ' LEU . 47.9 p90 -171.63 -174.39 1.37 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.922 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 82.3 m-20 -106.76 123.46 48.17 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -71.88 1.9 6.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.032 -177.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.839 HG23 ' CB ' ' A' ' 1' ' ' ALA . 24.7 p -78.87 -27.33 44.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.961 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -122.58 -18.04 6.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -138.38 -169.9 2.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.372 -0.83 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.637 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -177.99 159.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.868 ' HA ' HD12 ' A' ' 57' ' ' LEU . 11.7 m -42.8 -42.58 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.598 ' N ' HG23 ' A' ' 54' ' ' VAL . 6.3 tt0 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.065 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -65.49 -24.17 67.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.57 -0.706 . . . . 0.0 111.011 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 54' ' ' VAL . 23.0 mt -75.5 -52.83 9.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 0.0 108.289 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.534 HG22 ' OG ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -66.66 -18.76 65.54 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -84.15 -25.72 29.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -70.98 -42.34 69.8 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.944 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.53 ' HB ' HG13 ' A' ' 21' ' ' VAL . 11.7 t -77.17 -38.78 51.0 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -60.34 -25.27 65.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.52 -25.93 28.44 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.91 -13.29 60.88 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.66 32.69 3.3 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.835 ' HB3' HG11 ' A' ' 9' ' ' VAL . 24.0 m-85 -135.16 84.17 37.09 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.691 -0.888 . . . . 0.0 110.21 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -54.19 97.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.781 1.411 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.868 ' HB3' HG13 ' A' ' 9' ' ' VAL . 49.5 p -107.8 -165.59 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.889 0.852 . . . . 0.0 111.886 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -153.44 126.19 8.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.733 HG23 ' CD1' ' A' ' 7' ' ' LEU . 6.7 p -95.05 159.72 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.93 -1.106 . . . . 0.0 110.431 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HG2' HG23 ' A' ' 6' ' ' THR . 0.4 OUTLIER -151.3 51.49 0.84 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.224 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.958 ' O ' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.24 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.734 HG23 ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -148.29 89.21 1.7 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 152.35 44.75 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.926 0.87 . . . . 0.0 111.943 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -121.0 152.66 38.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.446 0.641 . . . . 0.0 109.873 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 54' ' ' VAL . 16.0 m -142.51 174.34 5.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.821 ' O ' HD12 ' A' ' 7' ' ' LEU . 11.1 t -108.17 160.97 15.41 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.007 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.4 mp -130.68 141.77 50.42 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.878 -1.529 . . . . 0.0 111.707 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -110.39 101.21 9.95 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.3 p -112.55 79.64 3.22 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 111.051 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 5.7 Cg_endo -68.11 -3.38 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.766 1.403 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' C ' ' HG3' ' A' ' 12' ' ' MET . . . -56.24 -17.28 17.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.715 ' SD ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -154.18 -171.25 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 110.027 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 12' ' ' MET . 7.0 t 179.93 58.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -160.31 173.64 15.37 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.305 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -73.89 78.72 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 110.59 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 179.16 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.926 -1.109 . . . . 0.0 111.189 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB2' ' CB ' ' A' ' 12' ' ' MET . 2.6 m -91.77 -44.7 0.36 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.639 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 4.9 Cg_exo -61.03 -44.59 23.64 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.651 ' HA ' HG23 ' A' ' 36' ' ' VAL . 85.4 mt -57.67 -29.66 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.967 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 14.6 m -65.46 -28.43 69.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 108.695 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.901 HG13 ' HB ' ' A' ' 61' ' ' THR . 98.0 t -68.31 -27.42 36.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.826 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.9 tttt -69.84 -43.2 72.43 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.4 mptt -64.99 -25.01 67.68 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.351 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.48 -43.27 77.28 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.777 -0.577 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -69.19 -41.89 76.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.055 -1.028 . . . . 0.0 109.64 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.828 ' HA ' HG11 ' A' ' 31' ' ' VAL . 2.9 p -67.4 -18.17 65.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -99.75 -9.65 22.77 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.903 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.5 t -45.32 -63.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.039 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 1.4 tt0 160.28 -64.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.355 0.597 . . . . 0.0 109.782 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -93.4 -6.91 62.37 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.565 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 26' ' ' SER . 13.7 p -41.77 129.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 109.732 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 m -108.24 -10.85 15.32 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.369 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -164.93 159.54 18.28 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.296 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 25' ' ' LEU . 60.4 t -147.49 160.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.838 -1.164 . . . . 0.0 111.581 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 44' ' ' VAL . 8.3 t70 -136.84 135.65 38.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG23 ' HA ' ' A' ' 19' ' ' ILE . 1.6 p -109.39 127.31 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.888 -1.133 . . . . 0.0 112.07 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -109.45 59.34 0.36 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -28.77 -110.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.373 0.606 . . . . 0.0 112.498 -177.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -50.9 -50.18 57.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.572 -1.33 . . . . 0.0 112.134 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.2 tmmm? -55.21 -14.04 1.54 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.0 111.506 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' VAL . 7.7 tmm_? 61.45 84.01 0.14 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.432 -0.792 . . . . 0.0 111.216 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -171.8 120.51 0.46 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.398 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -114.04 119.55 37.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 110.487 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -107.36 123.62 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.8 p -133.96 152.07 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.664 -1.214 . . . . 0.0 113.752 -176.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 1.6 m -113.16 152.33 29.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.807 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.0 p90 -170.45 -179.91 3.15 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.734 ' OD2' HG23 ' A' ' 2' ' ' THR . 5.8 m-20 -107.11 123.69 48.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.686 ' OD1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -67.34 -2.45 6.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.285 -177.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 48' ' ' ASP . 6.0 t -81.57 -23.43 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 110.154 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -125.52 -5.84 7.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.155 -0.965 . . . . 0.0 110.479 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.15 -170.07 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 179.71 158.93 0.71 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.817 ' HA ' HD12 ' A' ' 57' ' ' LEU . 17.4 m -41.84 -41.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.579 ' N ' HG23 ' A' ' 54' ' ' VAL . 22.2 tp60 -60.59 -45.61 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 109.392 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -65.61 -25.97 67.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.639 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 45' ' ' VAL . 39.5 mt -72.62 -56.32 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.893 -1.129 . . . . 0.0 108.346 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 ' OG ' ' A' ' 68' ' ' SER . 3.2 m -64.45 -17.74 64.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 4.2 ttmm -81.73 -27.95 33.63 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.41 -43.61 66.45 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.071 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.901 ' HB ' HG13 ' A' ' 21' ' ' VAL . 9.9 t -74.29 -36.25 63.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -60.9 -29.77 69.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -90.28 -15.51 31.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.28 178.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.9 -18.82 58.06 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 117.48 23.91 3.62 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -142.13 90.56 8.25 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.571 -0.958 . . . . 0.0 109.993 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.5 Cg_exo -55.71 97.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.63 1.332 . . . . 0.0 110.103 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.679 ' OG ' HG23 ' A' ' 58' ' ' THR . 3.5 p -108.5 -163.21 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.874 . . . . 0.0 111.036 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.656 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -147.3 -175.37 4.81 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.007 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.56 142.08 33.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.817 -1.177 . . . . 0.0 112.184 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -131.77 79.95 1.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.457 0.646 . . . . 0.0 109.595 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 5' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -157.44 90.79 1.12 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.3 mt-30 -114.54 158.0 22.24 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.6 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.535 ' CG2' ' OG1' ' A' ' 46' ' ' THR . 50.0 m -136.64 121.57 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.665 -0.647 . . . . 0.0 109.321 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' A' ' 72' ' ' GLN . 5.1 m -131.97 172.8 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 110.477 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.707 ' O ' HD12 ' A' ' 7' ' ' LEU . 10.6 t -108.48 157.33 18.54 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -126.17 156.56 39.97 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.002 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -132.33 103.33 6.15 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.0 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.6 t -108.71 102.76 49.23 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.526 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 4.6 Cg_endo -71.37 2.19 4.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.198 1.265 . . . . 0.0 111.8 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.41 -1.0 60.87 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -107.16 161.2 14.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -1.22 . . . . 0.0 110.055 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.2 t 179.01 32.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.102 -0.999 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -173.19 170.37 4.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.739 -1.226 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -77.05 78.31 3.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.8 -48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 6.1 m -93.66 -44.72 0.31 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.978 -1.076 . . . . 0.0 112.048 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.68 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 1.5 Cg_endo -65.45 -38.11 27.27 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 107.661 -1.707 . . . . 0.0 107.661 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.66 HG13 ' CE1' ' A' ' 38' ' ' PHE 0.267 6.7 tt -59.21 -36.16 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.402 1.096 . . . . 0.0 108.711 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 49.9 m -63.44 -21.31 66.23 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.72 ' O ' HD12 ' A' ' 25' ' ' LEU . 21.5 t -69.77 -33.09 54.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.774 ' HB2' HG21 ' A' ' 36' ' ' VAL . 27.5 tttm -66.16 -41.23 90.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -25.65 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.182 179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' VAL . . . -69.51 -55.6 9.75 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.687 -0.633 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.875 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.95 -37.23 81.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.606 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -70.37 -20.49 62.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 108.978 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -112.88 10.72 19.07 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.18 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 25' ' ' LEU . 11.6 p -66.35 -44.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.457 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.44 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.476 -0.765 . . . . 0.0 111.269 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.703 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -90.27 0.98 79.07 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.271 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG11 ' C ' ' A' ' 26' ' ' SER . 7.3 p -42.86 128.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.922 -1.34 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -113.87 -14.87 12.45 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.596 0.713 . . . . 0.0 109.58 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.816 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -156.7 159.77 38.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.435 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 45' ' ' VAL . 13.4 p -152.65 157.4 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 111.08 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t0 -170.54 87.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 22' ' ' LYS . 6.1 m -108.02 -159.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.885 . . . . 0.0 111.783 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.12 115.19 0.82 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.68 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 2.6 m-30 -56.6 -105.66 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 O-C-N 122.216 -0.579 . . . . 0.0 109.713 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -47.87 -34.21 8.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.358 -1.464 . . . . 0.0 110.476 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 33.4 tttt -52.78 -41.97 64.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.077 -1.014 . . . . 0.0 110.7 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER 81.37 70.03 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.425 0.631 . . . . 0.0 110.989 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -170.83 120.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.755 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -111.99 115.62 29.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.949 -1.094 . . . . 0.0 111.993 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 2.3 t -107.97 117.16 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.875 HG21 HD22 ' A' ' 25' ' ' LEU . 21.8 t -137.3 155.5 32.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.228 -1.389 . . . . 0.0 113.09 -177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 4' ' ' THR . 1.8 m -114.9 160.55 19.39 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.753 ' CE1' HD11 ' A' ' 57' ' ' LEU . 53.4 p90 -171.82 -176.52 1.75 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.796 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.63 114.78 29.09 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -62.67 -9.01 7.65 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.59 -177.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' A' ' 1' ' ' ALA . 7.4 t -67.59 -26.92 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.013 -1.054 . . . . 0.0 109.574 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -0.9 5.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.456 -0.778 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -148.35 -168.81 3.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 179.73 156.15 0.59 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.846 . . . . 0.0 109.62 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.794 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.2 m -44.74 -39.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.347 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.02 -43.74 97.87 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.327 -0.858 . . . . 0.0 109.105 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -65.24 -25.17 67.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.443 -0.786 . . . . 0.0 110.736 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 54' ' ' VAL . 54.4 mt -69.57 -56.1 8.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.861 -1.149 . . . . 0.0 108.704 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 3.0 m -64.65 -21.43 66.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mttp -81.43 -23.85 37.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' VAL . . . -73.47 -44.18 58.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.325 -0.86 . . . . 0.0 108.933 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.632 ' OG1' HG13 ' A' ' 21' ' ' VAL . 11.5 t -75.59 -35.34 60.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.12 -29.78 70.57 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 40.3 t0 -79.21 -23.73 43.61 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.28 59.97 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.618 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 107.71 32.94 3.21 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG11 ' A' ' 9' ' ' VAL . 25.2 m-85 -137.35 84.62 23.33 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.681 -0.894 . . . . 0.0 110.262 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.19 97.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.67 1.353 . . . . 0.0 109.235 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.0 ' OG ' HG22 ' A' ' 9' ' ' VAL . 12.6 t -108.03 -172.03 1.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.887 0.851 . . . . 0.0 112.12 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.58 121.55 8.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 7' ' ' LEU . 7.3 p -92.86 156.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.808 -1.182 . . . . 0.0 110.572 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' O ' ' C ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -154.78 45.43 0.52 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.339 -1.344 . . . . 0.0 110.841 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.635 ' HB3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.838 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.938 ' HB1' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.3 t -178.05 107.65 0.05 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.289 1.042 . . . . 0.0 108.725 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.656 ' CG ' ' CZ ' ' A' ' 47' ' ' PHE . 3.7 pt20 -130.24 173.62 10.61 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.158 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 45' ' ' VAL . 7.0 m -126.37 137.82 53.49 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.578 -0.701 . . . . 0.0 109.737 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.763 HG21 HG23 ' A' ' 54' ' ' VAL . 33.7 m -133.13 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.834 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -106.91 157.01 18.1 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.79 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -136.47 152.4 50.51 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.814 -178.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' C ' ' HD3' ' A' ' 10' ' ' PRO . . . -125.39 117.26 23.32 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.632 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.9 HG21 HG11 ' A' ' 21' ' ' VAL . 98.9 t -112.56 75.94 1.93 Allowed Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 120.845 -1.159 . . . . 0.0 112.184 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 8' ' ' ALA . 5.9 Cg_endo -69.27 -13.95 36.79 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.222 1.117 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 10' ' ' PRO . . . -43.89 -42.19 6.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 83.5 mmm -153.39 140.14 19.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -1.067 . . . . 0.0 110.044 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.558 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 2.4 t -134.6 78.36 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 110.878 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -147.68 -142.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.035 -1.04 . . . . 0.0 108.881 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -110.11 64.81 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.805 -1.184 . . . . 0.0 109.335 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . -179.04 -54.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.048 -1.032 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.1 m -77.29 -48.38 2.45 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 120.835 -1.165 . . . . 0.0 111.601 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 17' ' ' CYS . 27.3 Cg_exo -51.02 -56.19 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.082 1.043 . . . . 0.0 109.776 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -57.66 -27.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.767 -0.583 . . . . 0.0 110.42 179.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 67.8 m -66.43 -24.54 66.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.741 -1.225 . . . . 0.0 108.717 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.9 HG11 HG21 ' A' ' 9' ' ' VAL . 57.3 t -69.17 -31.72 51.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.671 ' CA ' HG21 ' A' ' 36' ' ' VAL . 17.4 tttm -70.51 -40.16 73.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -68.51 -21.05 64.61 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.451 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -72.51 -53.47 11.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.706 -0.621 . . . . 0.0 110.321 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -61.55 -30.13 70.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.0 109.373 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.8 -27.43 61.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.502 -0.749 . . . . 0.0 109.16 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.44 6.89 37.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.264 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.838 HG22 ' HB2' ' A' ' 60' ' ' ALA . 2.5 t -56.13 -77.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.731 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.0 OUTLIER 177.89 -81.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.3 -1.06 87.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 25' ' ' LEU . 5.4 p -42.11 133.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.206 -1.173 . . . . 0.0 110.582 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -110.15 -17.94 13.43 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.5 tttt -167.63 158.63 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.165 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 45' ' ' VAL . 24.4 t -154.64 145.12 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.773 -1.204 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -141.66 154.67 45.51 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.671 HG21 ' CA ' ' A' ' 22' ' ' LYS . 46.6 t -155.29 158.48 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.352 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . -124.3 81.94 0.35 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -35.93 -101.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 122.276 -0.544 . . . . 0.0 111.812 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -28.8 -44.03 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.474 -0.766 . . . . 0.0 111.025 -179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -89.8 50.8 1.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -10.38 76.84 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' LYS . 5.6 tm-20 -149.82 109.6 4.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.627 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -110.17 126.79 54.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.815 -1.178 . . . . 0.0 111.431 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.834 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -108.08 120.84 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.902 ' CG1' HD13 ' A' ' 57' ' ' LEU . 9.9 p -126.02 156.06 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.589 1.185 . . . . 0.0 113.955 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -121.43 153.31 38.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 2' ' ' THR . 43.9 p90 -172.31 179.86 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 117.879 -1.528 . . . . 0.0 111.294 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.0 m-20 -106.54 112.33 25.28 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.938 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -62.45 -8.22 5.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.985 -177.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 t -71.6 -10.26 59.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.996 -1.065 . . . . 0.0 110.155 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -132.39 -39.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.273 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -123.79 -169.96 2.04 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.724 -0.61 . . . . 0.0 109.696 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' ' C ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.28 154.28 5.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.939 ' HA ' HD12 ' A' ' 57' ' ' LEU . 8.3 p -41.07 -30.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.844 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 22.3 tt0 -70.08 -50.03 45.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -22.38 65.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' A' ' 54' ' ' VAL . 42.3 mt -72.27 -51.56 20.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.641 -1.287 . . . . 0.0 108.155 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -65.91 -19.31 65.83 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -82.57 -24.05 34.15 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.838 ' HB2' HG22 ' A' ' 28' ' ' VAL . . . -72.7 -43.05 63.53 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.94 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.612 ' HB ' HG13 ' A' ' 21' ' ' VAL . 8.3 t -76.46 -38.29 55.63 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -61.93 -26.08 67.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.55 -24.24 29.36 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.97 -19.08 62.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 113.03 28.56 3.32 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 17.3 m-85 -134.82 87.55 30.14 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 121.499 -1.0 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.25 100.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.795 1.418 . . . . 0.0 109.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 9' ' ' VAL . 11.4 p -107.66 -167.91 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.59 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -150.47 129.64 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.915 HG21 HG22 ' A' ' 54' ' ' VAL . 6.9 p -99.14 158.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.889 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HG3' ' OG1' ' A' ' 6' ' ' THR . 0.7 OUTLIER -137.7 45.58 2.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.657 -1.217 . . . . 0.0 110.915 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.582 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_